<SEC-DOCUMENT>0001213900-25-114872.txt : 20251125
<SEC-HEADER>0001213900-25-114872.hdr.sgml : 20251125
<ACCEPTANCE-DATETIME>20251125173004
ACCESSION NUMBER:		0001213900-25-114872
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		29
FILED AS OF DATE:		20251125
DATE AS OF CHANGE:		20251125

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Global Interactive Technologies, Inc.
		CENTRAL INDEX KEY:			0001911545
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
		ORGANIZATION NAME:           	06 Technology
		EIN:				000000000
		STATE OF INCORPORATION:			X1
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-288665
		FILM NUMBER:		251522766

	BUSINESS ADDRESS:	
		STREET 1:		160, YEOUISEO-RO
		STREET 2:		YEONGDEUNGPO-GU
		CITY:			SEOUL
		STATE:			M5
		ZIP:			07231
		BUSINESS PHONE:		82-2-564-8588

	MAIL ADDRESS:	
		STREET 1:		160, YEOUISEO-RO
		STREET 2:		YEONGDEUNGPO-GU
		CITY:			SEOUL
		STATE:			M5
		ZIP:			07231

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Hanryu Holdings, Inc.
		DATE OF NAME CHANGE:	20220216
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>ea0266107-s1a3_global.htm
<DESCRIPTION>AMENDMENT NO. 3 TO FORM S-1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center"> <B>As filed with the Securities and Exchange
Commission on November 25, 2025.</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><B>Registration No.&nbsp;333-288665</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <B>Amendment No. 3</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>to</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM S-1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>REGISTRATION STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>UNDER</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>THE SECURITIES ACT OF 1933</I></B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Global Interactive Technologies, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Exact name of registrant as specified
in its charter)</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; width: 32%; font-size: 10pt; text-underline-color: black; text-align: center"><FONT STYLE="font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%; font-size: 10pt; text-underline-color: black">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; width: 32%; font-size: 10pt; text-underline-color: black; text-align: center"><FONT STYLE="font-size: 10pt"><B>7370</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%; font-size: 10pt; text-underline-color: black">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; width: 32%; font-size: 10pt; text-underline-color: black; text-align: center"><FONT STYLE="font-size: 10pt"><B>88-1368281</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><B>(State or other jurisdiction of</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><B>incorporation or organization)</B></P></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-underline-color: black">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><B>(Primary Standard Industrial</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><B>Classification Code Number)</B></P></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-underline-color: black">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><B>(I.R.S.&nbsp;Employer</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><B>Identification Number)</B></P></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>160, Yeouiseo-ro, Yeongdeungpo-gu</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Seoul, Republic of Korea,&nbsp;07231</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>+82-2-564-8588</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center"><B>(Address, including zip code, and telephone
number, including</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center"><B>area code, of registrant<FONT STYLE="font-family: Times New Roman, Times, Serif">&rsquo;</FONT>s
principal executive offices)</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center"><B>Taehoon Kim</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center"> <B>Interim Chief Executive Officer</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center"><B>Global Interactive Technologies, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>160, Yeouiseo-ro, Yeongdeungpo-gu</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Seoul, Republic of Korea,&nbsp;07231</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>+82-2-564-8588</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center"><B>(Name, address, including zip code, and
telephone number, including area code, of agent for service)</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center"><B><I>Copies to:</I></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>Spencer G. Feldman, Esq.</B> </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>Olshan Frome Wolosky LLP</B> </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>1325 Avenue of the Americas, 15<SUP>th</SUP>
    Floor</B> </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>New York, New York 10019</B> </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>(212) 451-2300</B> </P></TD>
    <TD STYLE="width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt 0pt 0; text-align: center"> <B>Matthew Bernstein, Esq.</B> </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt 0pt 0; text-align: center"> <B>Ellenoff Grossman &amp; Schole
    LLP</B> </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt 0pt 0; text-align: center"> <B>1345 Avenue of the Americas,
    11<SUP>th</SUP> Floor</B> </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt 0pt 0; text-align: center"> <B>New York, New York 10105</B> </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt 0pt 0; text-align: center"> <B>(212) 370-1300</B> </P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center"><B>Approximate date of commencement of proposed
sale to public:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center"><B>As soon as practicable after this Registration
Statement is declared effective.</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">If any of the securities being registered on this Form are to
be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box.&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number
of the earlier effective registration statement for the same offering.&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective
registration statement for the same offering.&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">If this Form is a post-effective amendment filed pursuant to Rule 462(d)
under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective
registration statement for the same offering.&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of
<FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;</FONT>large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo;
&ldquo;smaller reporting company&rdquo; and <FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;</FONT>emerging growth company&rdquo;
in Rule 12b-2 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 35%; text-underline-color: black"><FONT STYLE="font-size: 10pt">Large&nbsp;accelerated&nbsp;filer</FONT></TD>
    <TD STYLE="width: 7%; text-underline-color: black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="width: 35%; text-underline-color: black"><FONT STYLE="font-size: 10pt">Accelerated filer</FONT></TD>
    <TD STYLE="width: 23%; text-underline-color: black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-underline-color: black"><FONT STYLE="font-size: 10pt">Non-accelerated&nbsp;filer</FONT></TD>
    <TD STYLE="text-underline-color: black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="text-underline-color: black"><FONT STYLE="font-size: 10pt">Smaller&nbsp;reporting&nbsp;company</FONT></TD>
    <TD STYLE="text-underline-color: black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><FONT STYLE="font-size: 10pt">Emerging growth&nbsp;company</FONT></TD>
    <TD STYLE="text-underline-color: black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.5pt; text-indent: -12.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt 0pt 0pt">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to
Section&nbsp;7(a)(2)(B) of the Securities Act.&ensp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The Registrant hereby amends this Registration Statement on such
date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states
that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until
the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section
8(a), may determine.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: Red"><B>The information contained in this preliminary
prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities
and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities, and it is not soliciting
an offer to buy these securities in any state where the offer or sale is not permitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: Red">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <FONT STYLE="color: Red">SUBJECT TO COMPLETION<BR>
PRELIMINARY PROSPECTUS DATED NOVEMBER 25, 2025</FONT> </P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"> Up to 4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,032,258</FONT>
Shares of Common Stock<BR>
Up to 4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,032,258</FONT> Pre-Funded Warrants to Purchase up to
4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,032,258</FONT> Shares of Common Stock<BR>
Up to 4,032,258 Common Warrants to Purchase up to 4,032,258 Shares of Common Stock </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"> Up to 8,064,516 Shares
of Common Stock Underlying the Common Warrants and Pre-Funded Warrants </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We are offering on a &ldquo;reasonable best
efforts&rdquo; basis up to 4,032,258 shares of common stock, par value $0.001 per share (the &ldquo;common stock&rdquo;), together with
common warrants (the &ldquo;Common Warrants&rdquo;) to purchase up to 4,032,258 shares of common stock. Each share of our common stock,
or pre-funded warrant (the &ldquo;Pre-Funded Warrant&rdquo;) in lieu thereof, is being sold together with a Common Warrant to purchase
one share of our common stock. The shares of common stock and Common Warrants are immediately separable and will be issued separately
in this offering but must be purchased together in this offering. The assumed public offering price for each share of common stock and
accompanying Common Warrant is $1.24, which was the closing price of our common stock on The Nasdaq Capital Market (&ldquo;Nasdaq&rdquo;)
on November 21, 2025. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We are offering Pre-Funded Warrants to purchase
up to 4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,032,258</FONT> shares of common stock to those purchasers whose purchase of shares of common stock in this offering would result in
the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% of our outstanding common
stock immediately following the consummation of this offering, in lieu of shares of common stock that would result in beneficial ownership
in excess of 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding common stock. Each Pre-Funded Warrant is exercisable
for one share of our common stock at an exercise price equal to $0.001, the exercise price of each Pre-Funded Warrant. Each Pre-Funded
Warrant is being offered together with the Common Warrants at price equal to the purchase price of one share of common stock and accompanying
Common Warrant in this offering minus the exercise price of each Pre-Funded Warrant. The Pre-Funded Warrants and Common Warrants are
immediately separable and will be issued separately in this offering but must be purchased together in this offering. For each Pre-Funded
Warrant that we sell, the number of shares of common stock we are offering will be reduced on a one-for-one basis. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Pursuant to this prospectus, we are also offering
the shares of common stock issuable upon the exercise of the Pre-Funded Warrants, the Common Warrants and the Placement Agent Warrants
(as defined below) offered hereby. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The shares of our common stock, Pre-Funded
Warrants and Common Warrants being offered will be sold in a single closing. The shares issuable upon exercise of the Pre-Funded Warrants
or Common Warrants will be issued upon the exercise thereof. Because there is no minimum number of securities or minimum aggregate amount
of proceeds for this offering to close, we may sell fewer than all of the securities offered hereby, and investors in this offering will
not receive a refund in the event that we do not sell an amount of securities sufficient to pursue the business goals outlined in this
prospectus. Because there is no escrow account and there is no minimum offering amount, investors could be in a position where they have
invested in our company, but we are unable to fulfill our objectives due to a lack of interest in this offering. Also, any proceeds from
the sale of securities offered by us will be available for our immediate use, despite uncertainty about whether we would be able to use
such funds effectively. The offering of the shares of our common stock, Pre-Funded Warrants and Common Warrants will terminate no later
than December 31, 2025; however, the shares of our common stock underlying the Pre-Funded Warrants and the Common Warrants will be offered
on a continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;). </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Our common stock trades on The Nasdaq Capital
Market under the symbol &ldquo;GITS.&rdquo; The closing price of our common stock on Nasdaq on November 21, 2025 was $1.24 per share.
There is no established public trading market for the Pre-Funded Warrants and the Common Warrants, and we do not expect a market to develop. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Without an active trading market, the liquidity
of the Pre-Funded Warrants and the Common Warrants will be limited. In addition, we do not intend to apply for a listing of the Pre-Funded
Warrants or the Common Warrants on any national securities exchange or other nationally recognized trading system.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Certain information in this prospectus is based
on an assumed combined public offering price of $1.24 per share and accompanying Common Warrant (the last reported sale price of our
common stock on Nasdaq on November&nbsp;21, 2025). The actual combined public offering price per share and accompanying Common Warrant
will be determined between us and prospective investors in consultation with Maxim Group LLC (the &ldquo;Placement Agent&rdquo;), as
the placement agent, based on market conditions at the time of pricing, and may be at a discount to the current market price of our common
stock. The Placement Agent is not required to buy or sell any specific number or dollar amount of the securities offered hereby, but
they will use their reasonable best efforts to solicit offers to purchase the securities offered by this prospectus. See the section
entitled &ldquo;Plan of Distribution&rdquo; of this prospectus. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You should read this prospectus carefully, together
with additional information described under the heading &ldquo;Where You Can Find More Information,&rdquo; before you invest in any of
our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">There is substantial doubt
about our ability to continue as a going concern. As a reasonable best efforts offering in which no minimum number or dollar amount of
securities is required to be sold, we may be unable to raise sufficient capital to extend our cash runway through the end of this year.
For additional information, see &ldquo;Risk Factors &mdash; Our auditor has included an explanatory paragraph in their opinion expressing
substantial doubt about our ability to continue as a going concern. If we are unable to continue as a going concern, our securities will
have little or no value.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"> <B>Investing in our
securities is highly speculative and involves a high degree of risk. See <FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;</FONT>Risk
Factors&rdquo; beginning on page 14 of this prospectus </B>and <B>in the documents incorporated by reference into this prospectus for
a discussion of information that should be considered in connection with an investment in our securities.</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per
    Share and<BR> Related Common Warrant</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per
    Pre-Funded<BR> Warrant and<BR> Related Common &nbsp;Warrant</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 66%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
    offering price</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement
    agent fees (1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    to us, before expenses (2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in"> (1) </TD><TD> We have agreed to provide the Placement Agent a cash placement commission
up to 7.0% of the public offering price. In addition, we have agreed to issue to the Placement Agent, or its designees, warrants (the &ldquo;Placement
Agent Warrants&rdquo;) to purchase up to a number of shares of common stock equal to 5.0% of the aggregate number of our securities being
offered in this offering, at an exercise price equal to 100% of the combined public offering price per share of common stock and accompanying
Common Warrant. We have also agreed to reimburse the Placement Agent for certain expenses. See &ldquo;Plan of Distribution&rdquo; for
additional information. </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in"> (2) </TD><TD> The amount of the offering proceeds to us presented in this table does not give effect to any cash exercise of the Pre-Funded
                                                                    Warrants or the Common Warrants being issued in this offering. </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus.
Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Delivery of the securities being offered pursuant
to this prospectus is expected to be made on or about&emsp;&nbsp;&nbsp;, 2025, subject to the satisfaction of certain closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Sole Placement Agent</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <FONT STYLE="font-size: 16pt"><B>Maxim Group
LLC</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>Table of Contents</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Page</B></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="width: 95%; text-align: left"><A HREF="#a_001"> ABOUT THIS PROSPECTUS </A></TD>
    <TD STYLE="width: 5%; text-align: center"> ii </TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left"><A HREF="#a_002"> PROSPECTUS SUMMARY </A></TD>
    <TD STYLE="text-align: center"> 1 </TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><A HREF="#a_003"> THE OFFERING </A></TD>
    <TD STYLE="text-align: center"> 12 </TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left"><A HREF="#a_004"> RISK FACTORS </A></TD>
    <TD STYLE="text-align: center"> 14 </TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><A HREF="#a_005"> CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </A></TD>
    <TD STYLE="text-align: center"> 42 </TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left"><A HREF="#a_006"> USE OF PROCEEDS </A></TD>
    <TD STYLE="text-align: center"> 44 </TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><A HREF="#a_007"> MARKET PRICE OF OUR COMMON STOCK </A></TD>
    <TD STYLE="text-align: center"> 44 </TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left"><A HREF="#a_009"> DILUTION </A></TD>
    <TD STYLE="text-align: center"> 45 </TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><A HREF="#a_010"> CAPITALIZATION </A></TD>
    <TD STYLE="text-align: center"> 46 </TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left"><A HREF="#a_011"> DESCRIPTION OF CAPITAL STOCK </A></TD>
    <TD STYLE="text-align: center"> 47 </TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><A HREF="#a_012"> DESCRIPTION OF SECURITIES WE ARE OFFERING </A></TD>
    <TD STYLE="text-align: center"> 49 </TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left"><A HREF="#a_013"> PLAN OF DISTRIBUTION </A></TD>
    <TD STYLE="text-align: center"> 52 </TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><A HREF="#a_014"> LEGAL MATTERS </A></TD>
    <TD STYLE="text-align: center"> 55 </TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left"><A HREF="#a_015"> EXPERTS </A></TD>
    <TD STYLE="text-align: center"> 55 </TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><A HREF="#a_016"> WHERE YOU CAN FIND MORE INFORMATION </A></TD>
    <TD STYLE="text-align: center"> 56 </TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left"><A HREF="#a_017"> INCORPORATION OF CERTAIN INFORMATION BY REFERENCE </A></TD>
    <TD STYLE="text-align: center"> 57 </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="a_001"></A>ABOUT THIS PROSPECTUS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We incorporate important information into this
prospectus by reference. You may obtain the information incorporated by reference without charge by following the instructions under &ldquo;Where
You Can Find More Information.&rdquo; You should carefully read this prospectus as well as additional information described under &ldquo;Incorporation
of Certain Information by Reference,&rdquo; before deciding to invest in our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Neither we nor the Placement Agent have authorized
anyone to provide you with information different from or inconsistent with the information contained in or incorporated by reference in
this prospectus. We and the Placement Agent take no responsibility for and can provide no assurance as to the reliability of, any other
information that others may give you. You should assume that the information appearing in this prospectus and the documents incorporated
by reference in this prospectus is accurate only as of the date of those respective documents, regardless of the time of delivery of those
respective documents. Our business, financial condition, results of operations and prospects may have changed since those dates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The information incorporated by reference or provided
in this prospectus contains statistical data and estimates, including those relating to market size and competitive position of the markets
in which we participate, that we obtained from our own internal estimates and research, as well as from industry and general publications
and research, surveys and studies conducted by third parties. Industry publications, studies and surveys generally state that they have
been obtained from sources believed to be reliable. While we believe our internal company research is reliable and the definitions of
our market and industry are appropriate, neither this research nor these definitions have been verified by any independent source.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We further note that the representations, warranties
and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference into this prospectus
were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among
the parties to such agreement, and should not be deemed to be a representation, warranty or covenant to you. Moreover, such representations,
warranties or covenants were accurate only as of the date when made. Accordingly, such representations, warranties and covenants should
not be relied on as accurately representing the current state of our affairs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are offering to sell, and seeking offers to
buy, shares of our common stock, Pre-Funded Warrants and Common Warrants only in jurisdictions where offers and sales are permitted. The
distribution of this prospectus and the offering of our common stock, Pre-Funded Warrants and Common Warrants in certain jurisdictions
may be restricted by law. Persons outside the United States who come into possession of this prospectus must inform themselves about,
and observe any restrictions relating to, the offering of our securities and the distribution of this prospectus outside the United States.
This prospectus does not constitute, and may not be used in connection with, an offer to sell, or a solicitation of an offer to buy, any
securities offered by this prospectus by any person in any jurisdiction in which it is unlawful for such person to make such an offer
or solicitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">When we refer to &ldquo;we,&rdquo; &ldquo;our,&rdquo;
&ldquo;us&rdquo; and the &ldquo;Company&rdquo; in this prospectus, we mean Global Interactive Technologies, Inc. and its consolidated
subsidiaries, unless otherwise specified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This prospectus contains, or incorporates by reference,
trademarks, tradenames, service marks and service names of the Company and its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="a_002"></A>PROSPECTUS SUMMARY</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>This summary highlights information contained
elsewhere in this prospectus. This summary does not contain all of the information that you should consider before deciding to invest
in our securities. You should read this entire prospectus carefully, including the &ldquo;Risk Factors&rdquo; section in this prospectus
and under similar captions in the documents incorporated by reference into this prospectus. If any of the risks materialize, our business,
financial condition, operating results and prospects could be materially and adversely affected. In that event, the price of our securities
could decline, and you could lose part or all of your investment.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">The Company</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Global Interactive Technologies, Inc. is a technology-driven
platform company connecting global fans of modern Korean culture through innovative digital experiences. We operate Faning, a comprehensive
interactive social media platform designed to facilitate content discovery, monetization, user-generated content and deep community engagement
among global &ldquo;fandom&rdquo; communities. We focus on leveraging technology to expand Korean culture (referred to as Hallyu) beyond
traditional K-pop to span digital media, entertainment and interactive platform services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Faning allows fans to interact within their
fandoms and discuss, create and share content and interact through a number of channels including (i) secure direct messaging, (ii) open
social pages and (iii) virtual spaces known as &ldquo;Faning Clubs.&rdquo; Faning Clubs concentrate on a specific topic, allowing moderators
to control the Club functions and Club members to aggregate their rewards of Faning Points (&ldquo;FP&rdquo;). Integrated within each
Faning Club is a &ldquo;Club Vault,&rdquo; which is a service provided by Faning that allows individual members of a Club to donate their
personal FP to an account held by the Club. The Club Vault allows the Club&rsquo;s members to aggregate their FP and increase their purchasing
power. This increase in purchasing power allows the Club&rsquo;s individual users to more rapidly accumulate FP and pool their rewards
with other users in order to purchase services such as fan events or the ability to live stream a concert from their favorite music group.
Decisions regarding the use of the accumulated FP within the Club Vault are determined by a vote of the Club members. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_002.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our users are the core of our business. We provide
our users with customized experiences including unique interactions within the Faning community. Faning algorithms curate individual
user experiences, recommending content, clubs to join and users to connect with, and enabling users to subscribe to keywords and access
automatic content geared towards their interests. Through these services, Faning provides the fandom community a way to stay connected
and up to date with their fandom communities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Faning offers each user the ability to freely
create, upload and monetize their own content by earning in-platform rewards of FP. Faning removes language barriers, providing live
chat ability between users worldwide and global access to platform content, as the Faning platform supports automatic, real-time translation
services for 17 languages. Faning also offers a fast, secure and easy-to-use commerce and user-to-user transaction system. These unique
features are designed to allow Faning to generate user loyalty, maintain user interest in the platform and attract new users. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For future growth, we intend to develop short content,
typically of approximately two minutes in duration, that will focus on interesting pop music and cultural topics. These videos will be
distributed through Faning while concurrently being shown on third-party social media platforms and video-sharing websites. This is a
key aspect of our growth strategy. We believe these videos will enhance the strength of our Faning community by fostering a greater degree
of engagement and will allow for greater visibility for K-pop on a global basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The Faning Ecosystem</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We designed Faning as an ecosystem that is easy
for users to adapt and use all features throughout the platform, and for us to develop and roll-out new technologies and functionality.
Faning&rsquo;s launch included a rollout of our messenger, community and club technologies, along with our reward system for users. Since
Faning&rsquo;s launch in May 2021, the platform has attracted more than 26.6 million registered users as of December 31, 2024 from the
regions in the following chart:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="image_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The main age groups that compose our use base are
the 20-29 year old age group and 30-39 year old age group as set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_004.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The combined age groups of 20-39 years old have
the highest purchasing power among commercial and entertainment industries and account for more than 80% of all Faning users with a median
age of 27 years old. Faning is available to individuals 12 years and older and has an age restriction set that will not allow users under
the age of 12 years to sign up.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>
</DIV>
<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">User Reward System</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_005.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The reward system is the basis of the Faning ecosystem.
Users earn FP based on the level of each user&rsquo;s activity within the Faning platform and the revenue we derive from Faning&rsquo;s
advertising sales. At midnight of each day, all advertising revenue for that day is accumulated, and 50% of that day&rsquo;s total net
advertising profits are distributed as FP to users, based upon their level of contribution within the Faning platform. From the 50% of
any future profits that are distributed to users as FP, approximately 30% of the distribution of rewards will go to users who are content
creators and the remaining 20% will be issued to general users who participate on the platform. For calculating advertising profits allocated
for user rewards, the amount of FP issued will be exchanged at a ratio of one FP for every 100 South Korean won (or approximately $0.07).
The issuance of FP from advertising revenue is limited to advertising revenue generated within the Faning platform, and we may earn revenue
from advertising outside of the Faning platform that would not result in the issuance of FP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Faning Points</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> FP is a measurement of reward points within
the Faning platform. We have designed FP to allow users to redeem FP for a wide variety of products and services within Faning, including
content from other users and artists available on Faning, and K-Culture merchandise. This redemption feature is scheduled to launch in
early 2026. FP is anticipated to be stored and quantified as reward points within the platform under the in-platform reward system structure
that consists of (i) our FP reserve account, (ii) our active account for collected advertising revenue which would be converted into
FP and ready to distribute to users based on user contributions to the Faning platform, (iii) our recycled FP account, which would store
FP after being spent by users to make purchases within the application, and (iv) each user&rsquo;s individual account stores. The value
of FP would be set at a fixed ratio of 1:100 FP to Korean Won. We do not intend to repurchase FP from users now or in the future. FP
would not expire, and FP that is not redeemed by a user would accumulate in such user&rsquo;s account unless and until such user deactivates
their account, at which time such FP would be forfeited and moved to our reserve account for redistribution. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">FP Storage and Security</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> FP is stored and managed through a database
that is separate and apart from other databases used to store and manage other Faning app data. The separate FP database is operated
to ensure maximum data confidentiality by minimizing access to the database and limiting the number of individuals who are able to access
such database. Access to the database is limited to permitted IP bands, and the backup function of the cloud service used to store data
can be restored within a few hours in the event of a disaster recovery event such as a server failure. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">User-to-User Interactions</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We developed Faning to include numerous opportunities
for our users to engage with the platform, including clubs, community forums, chat functions, and functionality to create user-generated
content, each of which are intended to build the Faning brand and deepen the loyalty of our users.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>
</DIV>
<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_006.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Faning Clubs</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Faning Clubs are user-created based upon areas
of interest in order to link users across the globe and create friendships. Users have the ability to create clubs based upon topics of
their own choosing, such as favorite artists, television series, movies, video games and sports. A club can be customized by its moderator
according to various policies and preferences to cultivate a close group of users based upon a shared culture. Integrated within each
Faning Club is a &ldquo;Club Vault,&rdquo; a service provided by Faning that allows the individual members of a Club to donate their personal
FP to an account held by the Club. The Club Vault allows the Club&rsquo;s members to aggregate their FP and increase their purchasing
power. This increase in purchasing power allows the Club&rsquo;s users to more rapidly accumulate FP and pool their rewards, in order
to purchase services such as fan events or the ability to live stream a concert from their favorite band. Decisions regarding the use
of accumulated FP within the Club Vault are determined by a vote of the Club members.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Faning Communities</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Faning communities are open forums where user-generated
content is socially promoted and curated by Faning users. Once user requests for a community based around a certain topic exceed a pre-determined
threshold, the Faning platform will create such a community based upon the users submitting the requests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Faning Chats</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Real-time multilingual translation capability,
currently offered in 17 languages, allows both private messages and open chats via the Faning chats function without language barriers.
Messages and chats are protected utilizing end-to-end encryption to prevent leakage of personal information. End-to-end encryption is
a system of secured communication to prevent third parties from accessing chat messages, increasing the level of security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Faning Content</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>User-Created Content</B>. Core to our business
is moving into a user-based content creation model that allows users varying ways to create and sell fandom content to other Faning users,
including the content types described below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> Fanart
                                            is artwork created by fans relating to artists, movies and dramas they like. </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> Web
                                            novels are user written novels, uploaded by users to the Faning platform. Readers can make
                                            comments at very specific areas within the novel. Novels can be viewed in the language of
                                            each user&rsquo;s choice. If the desired language is not available, users can request or
                                            suggest the corresponding language translation. Through the process of &ldquo;translation
                                            matching,&rdquo; writers can search for translators while translators can ask writers for
                                            permissions to obtain the right to translate their stories. Once the writer and translator
                                            approve and consent, these translated stories can be sold to users. Any profit will be distributed
                                            automatically by Faning based on their prior agreement. </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>
</DIV>
<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> Webtoons
                                            are user-created digital comics, uploaded by users to the Faning platform. Users can also
                                            buy and sell user-translated copies of these webtoons through the &ldquo;translation matching&rdquo;
                                            services referenced above, allowing users across the globe to enjoy their favorite webtoons
                                            in their own language. </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> User-generated
                                            content also includes any other content created and sold by Faning users, such as the Faning
                                            Fanshop offerings described below. </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B>Faning-<I>Hosted</I> Content</B>. While
we do not currently create and distribute content, we plan to host content in the future. As the business grows, we intend to hire more
employees and produce high-quality content that engages the users into the Faning platform. In addition to the content types similar
to the categories listed above for user-generated content, Faning hosts concerts for its users across numerous musical genres, from Korean
pop to independent music, in venues of all sizes, from stadiums to small stages. Users that cannot attend these concerts in person can
access these concerts on Faning via our online streaming service, and tickets can be purchased, using FP or cash, in the Faning Fanshop,
also known as the &ldquo;Fanshop.&rdquo; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B>Third-Party Content</B>. While there is
currently no third-party content on the platform, we plan to incorporate third-party content into Faning. Third-party content is anticipated
to include content that may be uploaded from trusted third-party media companies. Third-party content can be uploaded to Faning pursuant
to certain agreements between our company and third-party providers. Any third-party content that is uploaded will be provided in real
time, with automatic translation support in 17 languages. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Faning Fanshop</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The Faning Fanshop is an e-commerce service
that we plan to provide through the Faning platform to our users. The Fanshop is currently in development. Once operational, the Fanshop
is anticipated to allow users to purchase various items directly from Faning, such as gifts for artists, pre-paid cards, concert tickets,
and other fandom goods using FP or cash. To the extent that items are purchased by us to sell within the Fanshop, we plan to use cash
to purchase the products and then list the items in the Fanshop. The Fanshop is also planned to offer a video commerce service that is
intended to be an online version of traditional home shopping networks on cable television. For example, users would be able to purchase
items relating to their favorite K-pop artist, such as the artist&rsquo;s latest album, at the same time such user is streaming the artist&rsquo;s
live event. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="image_007.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Within the Fanshop, Faning users would be able
to participate in user-to-user transactions, such as selling or purchasing the following: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> Emojis
                                            used within chats on the Faning platform. Users would have the ability to create emojis and
                                            register them in the Fanshop to generate sales by selling them to other users, generating
                                            FP in such transactions. </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>
</DIV>
<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> Augmented
                                            reality (&ldquo;AR&rdquo;) filters used in videos within the Faning platform. Users would
                                            have the ability to create and sell registered AR filters within the Fanshop to other users. </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> Digital
                                            stickers used within the Faning platform. Users would have the ability to create and sell
                                            registered digital stickers within the Fanshop to other users. </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> For both user-to-user transactions and transactions
with our company, payment is expected to be made either by credit card through a secure, third-party payment system built into the Faning
platform, or by settling the total with the use of FP. Sales settled in FP are expected to include a transaction fee based upon the specific
item sold, ranging between 7% to 15% of the sale price. For user-to-user transactions, the selling user would receive the proceeds upon
the purchaser&rsquo;s confirmation of receipt of the good sold. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> If the item sold in the user-to-user transaction
requires shipping, we intend on partnering with providers such as Qxpress to provide shipping services for which the fee would be bundled
into the total transaction cost. Alternatively, we plan to allow users the option of shipping the item directly using another third-party
shipping service, rather than through our partnered providers. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Our Market Opportunity</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The global expansion of the &ldquo;Korean Wave&rdquo;
(Hallyu) has transformed Korean culture into a powerful force shaping entertainment, fashion and consumer behavior worldwide. According
to the Korea Foundation&rsquo;s 2023 Global Hallyu Trends Report, the global K-Culture fan base reached approximately 229 million across
119 countries, up nearly 50% from 156.6 million in 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of 2022, the Korean Foundation for International
Cultural Exchange (KOFICE) reported 178 million K-Culture fans globally, with China (86.32 million fans), the United States (27.17 million
fans), and Thailand (17.37 million fans) among the top markets. While updated country-level data is unavailable, the 2025 Overseas Hallyu
Survey (reflecting 2024 trends) indicates continued growth, with global audiences spending an average of 14 hours per month consuming
Korean content, an increase of 2.3 hours over the prior year. Favorability rates remain especially high in Indonesia (86.3%), India (84.5%)
and Thailand (83%), according to that survey. Due to regulatory restrictions, we do not operate in China, Hong Kong or Macau.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">K-Culture&rsquo;s economic impact continues to
expand. The Korea Creative Content Agency (KOCCA) estimated global purchasing power tied to K-Culture at $147.3 billion as of 2023. In
2024, KOCCA reported a 48.6% increase in export contract volume across its 25 global business centers, with K-dramas and webtoons driving
international demand through platforms such as Netflix and Webtoon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This momentum is fueled by mobile-first consumption.
As of January 2023, over 5.6 billion people worldwide used mobile phones, and more than 60% of the global population was active on social
media, according to DataReportal. K-Culture content is primarily accessed through mobile platforms such as YouTube, TikTok, Spotify and
Webtoon, with streaming, digital fandoms and virtual events forming the backbone of global engagement, particularly in emerging markets
where mobile access outpaces traditional infrastructure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The market for virtual experiences also continues
to scale. BTS&rsquo;s Bang Bang Con: The Live, held in June 2020, drew 756,000 concurrent viewers from 107 countries and set a Guinness
World Record for the most viewers for a paid online concert. According to Grand View Research, the global virtual events market was valued
at $98.07 billion in 2024 and is projected to grow to $297.16 billion by 2030, at a compound annual growth rate (CAGR) of 20.0%. The Asia
Pacific region, including South Korea, accounted for over a quarter of the global market share in 2023, reflecting the region&rsquo;s
leadership in immersive, mobile-first digital experiences.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We believe Faning is positioned to serve this demand.
With real-time engagement tools, multilingual support (17 languages), monetization features and cross-platform accessibility, the platform
aligns with how global audiences consume and participate in K-Culture. Supported by an integrated reward system, partnerships across the
Korean entertainment industry and a growing user base, Faning is built to become a player in the global digital K-Culture experience economy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>
</DIV>
<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Our Value Proposition</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Faning is designed as an all-in-one, user-centric
platform that enhances the global fan experience by consolidating fandom-related content, community engagement and monetization tools
in one place. The platform offers access to entertainment news, pop culture updates, discussion forums, live shows and fan-created content,
curated to serve the diverse interests of fandom communities worldwide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Faning supports 17 languages and features real-time
translation services, currently provided through Google&rsquo;s Google Translate service, to facilitate communication among users across
different geographies without language barriers. We are in the process of developing, but have not yet deployed, a proprietary translation
model to translate words and phrases, including youthful slang, in real-time. For languages not yet covered by real-time translation,
Faning offers a peer-based translation matching service, allowing users to collaborate in translating content accurately and expanding
accessibility for a broader global audience. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition to content consumption and community
interaction, Faning empowers users to create and monetize their own content through a secure, user-to-user marketplace. Our integrated
reward system, Faning Points, incentivizes platform engagement by rewarding users for active participation, creative contributions and
user referrals. FP can be redeemed for goods and services within the platform, increasing users&rsquo; purchasing power and deepening
their connection to the Faning ecosystem.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Our Competitive Strengths</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We differentiate ourselves from competing social
networks through the power of a fully integrated platform and established partnerships with leaders in the entertainment industry within
South Korea. Our platform and partnerships enable our users to create clubs, communities, and gather over similar fandoms, all while monetizing
their content and contributing to the Faning platform experience. Our core strengths include the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> <B><I>Value
                                            Creation through Revenue Derived from User Activity</I></B>. We intend to generate revenue
                                            from the sale of goods and/or services within the Faning platform from one user to another.
                                            Revenue is derived from user-to-user sales as follows: (i) from the sale of emojis and online
                                            stickers, from which we will collect 30% of the price paid by the purchaser, with the remaining
                                            70% being remitted to the seller; (ii) from web novels and webtoons. If posted for free,
                                            the creator will only receive rewards in FP in relation to the number of views and likes;
                                            however, if the creator charges for the content, we intend to collect 30% of the price paid
                                            by the user, with the remaining 70% being remitted to the seller; (iii) users can offer the
                                            service of translation matching, where a user offers to translate another user&rsquo;s content
                                            for a commission (in either cash or FP), and the parties agree to split the sales revenue
                                            from the translated content at a pre-determined ratio, for which we will collect 30% of each
                                            sale, and remit the remainder to the creator and translator based on a split determined by
                                            the parties; and (iv) for transactions between users involving tangible goods or other non-platform
                                            based fandom items (such as concert tickets), we intend to charge a fee of 3.5% of the total
                                            value of the transaction at the time of sale. </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> <B><I>Faning&rsquo;s
                                            Direct Advertising Platform</I></B>. We intend to directly engage with our advertisers. Without
                                            the need for third-party engagement, we can leverage the Faning platform to better understand
                                            advertisers and their expectations, ensuring we can create highly curated advertising products
                                            that will promote high levels of engagement and sales conversions for advertisers. We believe
                                            this will increase advertising revenue and build sustainable relationships with advertisers,
                                            while concurrently increasing the attractiveness of the Faning platform to new advertisers
                                            and users interested in the products advertised within the Faning platform. </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> <B><I>High
                                            User Engagement</I></B>. We intend to drive user engagement by offering a one-stop fandom
                                            platform and by offering an in-platform reward system. These features are intended to allow
                                            the Faning platform to keep and maintain a highly engaged user base, loyal to the Faning
                                            platform and its brand. This brand loyalty will assist by reducing our advertising costs
                                            by replacing it with non-paid platform promotion through the word-of-mouth of our current
                                            user base. </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>
</DIV>
<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Our Growth Strategy</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our core strategy is to pursue initiatives that
promote the growth of our user base and, in doing so, drive advertising revenue, user-generated revenue and create other revenue streams.
Our focus on user acquisition and retention provides the primary lens to view our plans for community growth, engagement and long-term
brand equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> <B><I>Attract
                                            Global Users</I></B>. Our core business strategy is to promote the Faning platform and grow
                                            our global user base, which will drive revenue growth by increasing advertising revenue and
                                            user activity-based revenue. </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> <B><I>Broaden
                                            Product and Service Offerings</I></B>. Within the Faning platform, our objective is for users
                                            to benefit from a wide range of products and services offered, and we intend to continuously
                                            expand our product and service offerings as the user-base and revenue grow. Broadening our
                                            product offerings will ensure Faning grows along with the fandom community in which it operates,
                                            eventually creating a one-stop platform for our users across all fandoms. </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> <B><I>Continue
                                            Research and Tech Development</I></B>. We intend to continue to invest in developing and
                                            implementing the newest technologies to ensure a better and more secure user experience compared
                                            to other social media platforms. </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our revenue growth strategy spans multiple time
horizons. In the short term, we aim to generate revenue through virtual events hosted on the Faning platform, monetizing both commissions
and operational profits. Additionally, we plan to establish a base of steady monthly income by offering premium subscription services
tailored to both individual users and institutional partners. In the mid-term, we intend to drive revenue growth by leveraging Faning&rsquo;s
advertising infrastructure, which will include affiliate marketing partnerships and platform-driven advertising sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Recent Developments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Financial Mismanagement and Operational Challenges
Following Our IPO. </B>In August 2023, we completed our initial public offering and listed our shares of common stock on Nasdaq, raising
approximately $8.77 million through the issuance of 877,328 shares at $10.00 per share. As disclosed in our initial public offering prospectus,
the intended use of proceeds was for general corporate purposes, including technology development, sales and marketing, staffing and capital
expenditures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">While a portion of the net proceeds was used appropriately,
such as covering public listing expenses and supporting operational and administrative costs, an internal investigation initiated by our
Board of Directors (the &ldquo;Board&rdquo;) in February 2024 determined that a substantial amount of the funds was not allocated in line
with the stated objectives. By May 2024, our primary U.S. bank account had been fully depleted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The investigation identified significant deficiencies
in our internal financial controls, including inadequate expense tracking and lack of proper oversight. These failures severely limited
our ability to support key operational initiatives, including product development, talent acquisition and long-term growth strategies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In response, the Board took immediate corrective
action. Between February and March 2024, we replaced the former Chief Executive Officer, terminated key members of senior management and
appointed new leadership. We also restructured our Board to strengthen governance, re-establish financial discipline and set a more focused
strategic direction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Regulatory and Financial Status. </B>Since early
2025, we have responded to information requests from the U.S. Securities and Exchange Commission regarding the use of our initial public
offering proceeds and certain trading activities. As of the date of this filing, no enforcement actions or formal proceedings have been
initiated. We remain committed to full cooperation with any ongoing or future regulatory reviews.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
</DIV>
<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Due to the financial challenges described above,
we have not had sufficient resources to operate the business as originally planned. Currently, we maintain limited cash reserves and do
not have adequate liquidity to fund operations over the next 12 months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Throughout 2024, we raised internal capital
to sustain limited operations and preserve platform continuity. Based on our current projections, we estimate that between $2.0 million
and $3.0 million in additional funding will be required to support operations over the next 12 months. We are actively evaluating strategic
alternatives, including equity financing, partnerships and potential business combinations, to secure the necessary capital for long-term
growth. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Korean Securities and Futures Commission Administrative
Fine</B>. On November 6, 2024, the Securities Futures and Exchange Commission (the &ldquo;SFC&rdquo;) under the Financial Services Commission
of the Republic of Korea imposed an administrative fine of KRW 142.1 million (or approximately $104,750) against us for alleged violations
of Korean securities regulations. The fine was issued pursuant to Article 119(1) and Article 429(1)(2) of the Capital Market and Financial
Investment Business Act and Article 25 of the Regulations on Capital Market Investigations in connection with a failure to submit a securities
registration statement for a private placement that took place between April 20, 2023 and July 31, 2023 in which we raised approximately
KRW 5.92 billion (or approximately $4,628,500) through the issuance of 462,847 shares of common stock to 124 Korean investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> On January 2, 2025, we filed with the SFC a
formal objection to the regulatory sanction. On March 27, 2025, the SFC dismissed our objection. In accordance with Korean administrative
law, we retain the right to seek further redress by filing an appeal. On June 24, 2025, we filed an administrative appeal challenging
the sanction as we believe that the sanction is without merit and we have adequate defenses. A hearing was scheduled for October 14,
2025. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> As a result of the hearing, the SFC dismissed
our appeal to cancel the fine of KRW&nbsp;142.1 million. We received the written decision of the administrative appeal by mail on November
6, 2025, and plan to file an administrative lawsuit with the Seoul Central District Court within 90 days after the date of receipt of
the decision. The SFC has not imposed any sanctions or restrictions on any member of current management or on any currently serving directors.
See also &ldquo;Risk Factors - We may be the subject of an administrative fine by the Korean Securities and Futures Commission and any adverse outcome in the related proceedings could negatively impact our business, financial condition and results of operations.&rdquo; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>PixelArc Debt-to-Equity Conversion.</B> On February
18, 2025, we entered into a Promissory Note (the <FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;</FONT>February 2025
Note&rdquo;) payable to PixelArc, LLC (&ldquo;PixelArc&rdquo;), a California limited liability company in which Amy Xianglin Shi, a director
of our company, holds a direct ownership interest and serves in a managerial capacity. The February 2025 Note evidences a loan of $86,660
extended by PixelArc to support essential operating obligations during a period of limited liquidity. The note accrued interest at 8%
per annum, had a maturity date of March 14, 2026, and included a 5% late fee and 12% default interest rate, along with customary default
provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On April 18, 2025, we executed a second Promissory
Note (the &ldquo;April 2025 Note&rdquo;) payable to PixelArc, evidencing a short-term, interest-free loan of $86,000 used to satisfy outstanding
Nasdaq listing fees and maintain our continued listing. The note matured on May 15, 2025, and contained the same late fee and default
interest terms as the February 2025 Note. In connection with the April 2025 Note, we also entered into a Security Agreement, dated April
18, 2025 (the &ldquo;Security Agreement&rdquo;), with PixelArc to secure repayment obligations under both notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Following nonpayment of the April 2025 Note, PixelArc
became entitled to exercise its rights under the Security Agreement. On May 19, 2025, PixelArc submitted a proposal to convert its outstanding
loan balances into equity. On May 20, 2025, PixelArc delivered a formal Notice of Conversion to us, pursuant to which the combined $172,666
in principal amount under the February 2025 and April 2025 Notes were converted into 246,666 shares of our common stock at a price of
$0.70 per share (the &ldquo;PixelArc Conversion&rdquo;). While the conversion price was below the then fair market value of our common
stock, the transaction was structured to enhance our financial flexibility and did not constitute equity compensation for Ms. Shi in her
capacity as a director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>
</DIV>
<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The February 2025 Note, April 2025 Note and Security
Agreement were submitted to and approved by the Board, including disinterested members. The PixelArc Conversion proposal was subsequently
circulated to the Board for review and received unanimous support without objection. The Board acknowledged that, under our circumstances,
the transactions served the best interests of our company and our stockholders by addressing immediate financial obligations in a responsible
manner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the PixelArc Conversion, PixelArc
expressly reserved the right to receive equivalent or superior terms, including, but not limited to, warrants or other equity-linked securities,
on terms no less favorable than those offered to similarly situated investors in capital transactions occurring between February 2025
and December 2025. PixelArc also reserved the right to board-level participation, including the designation of a non-voting observer or
equivalent strategic consultation rights, for so long as it directly or indirectly holds 5% or more of our outstanding equity securities.
These rights were expressly reserved in the Notice of Conversion and implemented by our company in accordance with our applicable governance
procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Implications of Being an Emerging Growth Company
and a Smaller Reporting Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We qualify as an &ldquo;emerging growth company&rdquo;
as defined in the Jumpstart Our Business Startups Act&nbsp;of&nbsp;2012 (the &ldquo;JOBS Act&rdquo;). For as long as we remain an emerging
growth company, we may take advantage of specified reduced reporting requirements and other burdens that are otherwise applicable generally
to other public companies. These provisions include, but are not limited to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"> &#9679; </TD><TD STYLE="text-align: left"> reduced obligations
                                            with respect to financial data, including presenting only two&nbsp;years of audited financial
                                            statements and selected financial data, and only two&nbsp;years of related Management&rsquo;s
                                            Discussion and Analysis of Financial Condition and Results of Operations disclosure in our
                                            initial registration statement; </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"> &#9679; </TD><TD STYLE="text-align: left"> an exemption from
                                            the auditor attestation requirement in the assessment of our internal control over financial
                                            reporting pursuant to the Sarbanes-Oxley&nbsp;Act&nbsp;of&nbsp;2002, as amended; </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"> &#9679; </TD><TD STYLE="text-align: left"> reduced disclosure
                                            about executive compensation arrangements in our periodic reports, registration statements
                                            and proxy statements; and </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"> &#9679; </TD><TD STYLE="text-align: left"> exemptions from
                                            the requirements to seek non-binding&nbsp;advisory votes on executive compensation or stockholder
                                            approval of any golden parachute arrangements. </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We may take advantage of some or all of these provisions
until we are no longer an emerging growth company. We will remain an emerging growth company until the earliest of (i)&nbsp;the last&nbsp;day
the fiscal year following the fifth anniversary of the completion of our initial public offering, (ii)&nbsp;the last&nbsp;day of the first
fiscal year in which our annual gross revenues exceed $1.235&nbsp;billion, (iii)&nbsp;the date on which we have, during the immediately
preceding three-year&nbsp;period, issued more than $1.0&nbsp;billion in non-convertible&nbsp;debt securities and (iv)&nbsp;the date on
which we are deemed to be a large accelerated filer under the rules of the SEC.&nbsp;We may choose to take advantage of some but not all
of these reduced burdens. For example, we have taken advantage of the reduced reporting requirements with respect to disclosure regarding
our executive compensation arrangements, have presented only two&nbsp;years of audited financial statements and only two&nbsp;years of
related &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&rdquo; disclosure in this prospectus,
and have taken advantage of the exemption from auditor attestation on the effectiveness of our internal control over financial reporting.
To the extent that we take advantage of these reduced burdens, the information that we provide stockholders may be different than what
you might obtain from other public companies in which you hold shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, the JOBS Act permits emerging growth
companies to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies.
We have elected to use this extended transition period. As a result of this election, our timeline to comply with new or revised accounting
standards will in many cases be delayed as compared to other public companies that are not eligible to take advantage of this election
or have not made this election. Therefore, our financial statements may not be comparable to those of companies that comply with the public
company effective dates for these accounting standards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>
</DIV>
<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are also a &ldquo;smaller reporting company&rdquo;
as defined in the Securities Exchange&nbsp;Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), and have elected to take advantage
of certain of the scaled disclosures available to smaller reporting companies. To the extent that we continue to qualify as a &ldquo;smaller
reporting company&rdquo; as such term is defined in Rule&nbsp;12b-2&nbsp;under the Exchange&nbsp;Act, after we cease to qualify as an
emerging growth company, certain of the exemptions available to us as an &ldquo;emerging growth company&rdquo; may continue to be available
to us, including exemption from compliance with the auditor attestation requirements pursuant to the Sarbanes-Oxley&nbsp;Act and reduced
disclosure about our executive compensation arrangements. We will continue to be a &ldquo;smaller reporting company&rdquo; until we have
$250&nbsp;million or more in public float (based on our common stock) measured as of the last business&nbsp;day of our most recently completed
second fiscal quarter or, in the event we have no public float (based on our common stock) or a public float (based on our common stock)
that is less than $700&nbsp;million, annual revenues of $100&nbsp;million or more during the most recently completed fiscal year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Corporate Background and Information</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We were incorporated in the State of Delaware
on October 20, 2021 as Hanryu Holdings, Inc. On December 5, 2024, we formally changed our corporate name to Global Interactive Technologies,
Inc. pursuant to an amendment to our Certificate of Incorporation filed with the Secretary of State of Delaware. In connection with our
name change, we changed our Nasdaq ticker symbol to &ldquo;GITS&rdquo;. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Our primary operating subsidiary is Faning
Korea, LLC, a wholly owned subsidiary based in Seoul, Republic of Korea (&ldquo;Faning Korea&rdquo;). Faning Korea oversees the development,
maintenance and operation of the Faning application and related web services. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In July 2023, we completed our initial public offering
and the listing of our shares on Nasdaq, raising approximately $8.77 million through the issuance of 877,328 shares of common stock at
$10.00 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our address is 160, Yeouiseo-ro, Yeongdeungpo-gu,
Seoul, Republic of Korea, 07231 and our telephone number is +82-2-564-8588. Our corporate website is www.gitechnologies.com. Our website
and the information contained on, or that can be accessed through, our website shall not be deemed to be incorporated by reference in,
and are not considered part of, this prospectus. You should not rely on any such information in making your decision whether to purchase
our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

</DIV>
<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="a_003"></A>THE OFFERING</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 36%; text-underline-color: black"> Common Stock Offered: </TD>
    <TD STYLE="width: 64%; text-underline-color: black"> Up to 4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,032,258</FONT> shares. </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black"> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black"> Pre-Funded Warrants Offered: </TD>
    <TD STYLE="text-underline-color: black"> We are offering to certain purchasers whose purchase of shares of common stock in this
    offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more
    than 4.99% (or, at the election of such purchaser, 9.99%) of our outstanding shares of common stock immediately following the
    closing of this offering, the opportunity to purchase, if such purchasers so choose, Pre-Funded Warrants, in lieu of shares of
    common stock that would otherwise result in any such purchaser&rsquo;s beneficial ownership, together with its affiliates and
    certain related parties, exceeding 4.99% (or, at the election of such purchaser, 9.99%) of our outstanding shares of common stock
    immediately following the consummation of this offering. The purchase price of each Pre-Funded Warrant is equal to the purchase
    price of the shares of common stock in this offering minus $0.001, the exercise price of each Pre-Funded Warrant. Each Pre-Funded
    Warrant is immediately exercisable and may be exercised at any time until it has been exercised in full. For each Pre-Funded Warrant
    we sell, the number of shares of common stock we are offering will be decreased on a one-for-one basis. This offering also relates
    to the shares of common stock issuable upon exercise of any Pre-Funded Warrants sold in this offering. </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black"> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black"> Common Stock Outstanding after this Offering: </TD>
    <TD STYLE="text-underline-color: black"> Up to 7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,706,466</FONT> shares of common stock, assuming (i) no sales of Pre-Funded
Warrants which, if sold, would reduce the number of shares of common stock that we are offering on a one-for-one basis and (ii) no exercise
of the Common Warrants or Placement Agent Warrants. </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black"> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black"> Common Warrants: </TD>
    <TD STYLE="text-underline-color: black"> Each share of common stock, or Pre-Funded Warrant in lieu thereof, will be sold together
    with a Common Warrant to purchase one share of common stock. Each Common Warrant has an assumed exercise price per share equal to
    $1.24, subject to potential further adjustments as a result of a stock issuance or sale at a price less than the exercise price in
    effect. Additionally, if at any time on or after the date of issuance there occurs any stock split, stock dividend, stock
    combination, recapitalization or other similar transaction involving our common stock and the average daily volume weighted-average
    price ( VWAP) during the period commencing five consecutive trading days commencing on such event is less than the exercise price of
    the Common Warrants then in effect, the exercise price of the Common Warrants will be reduced to the average daily VWAP during such
    period and the number of shares issuable upon exercise will be proportionately adjusted such that the aggregate exercise price will
    remain unchanged; provided the adjusted exercise price shall not be less than 20% of the exercise price on the issuance date of the
    Common Warrants (the &ldquo;Floor Price&rdquo;). The Common Warrant expires on the fifth
    anniversary of the original issuance date. Because we will issue a Common Warrant for each share of common stock and for each
    Pre-Funded Warrant sold in this offering, the number of Common Warrants sold in this offering will not change as a result of a
    change in the mix of shares of common stock and Pre-Funded Warrants sold. This offering also relates to the shares of common stock
    issuable upon exercise of any Common Warrants sold in this offering. </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black"> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black"> Best Efforts: </TD>
    <TD STYLE="text-underline-color: black"> We have agreed to issue and sell the securities offered hereby to the purchasers through
    the Placement Agent. The Placement Agent is not required to buy or sell any specific number or dollar amount of the securities offered
    hereby, but they will use their reasonable best efforts to solicit offers to purchase the securities offered by this prospectus.
    See the section entitled &ldquo;Plan of Distribution&rdquo; of this prospectus. </TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>
</DIV>
<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black; width: 36%"> Use of Proceeds: </TD>
    <TD STYLE="text-underline-color: black; width: 64%"> We estimate that the net proceeds of this offering, after deducting the placement
    agent fees and estimated offering expenses, will be approximately $4.4&nbsp;million if all of the securities offered hereby are sold
    in this offering. However, this is a reasonable best efforts offering with no minimum number of securities or amount of proceeds
    as a condition to closing, and we may not sell all or any of the securities offered pursuant to this prospectus; and, as a result,
    we may receive significantly less in net proceeds in this offering. For example, if we sell only 10%, 25%, 50% or 75% of the maximum
    amount offered, our net proceeds will be approximately $0.3&nbsp;million, $1.0&nbsp;million, $2.2&nbsp;million or $3.3&nbsp;million,
    respectively. We intend to use all of the net proceeds we receive from this offering for working capital and general corporate purposes,
    including investing in our sales and marketing efforts. See &ldquo;Use of Proceeds.&rdquo; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black"> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black"> Lock-up: </TD>
    <TD STYLE="text-underline-color: black"> All of our directors, executive officers and holders of 10.0% or more of the outstanding
    shares of our common stock as of the effective date of this offering &nbsp;have agreed with the Placement Agent, subject to certain
    exceptions, not to sell, transfer or dispose of, directly or indirectly, any of our common stock or securities convertible into or
    exercisable or exchangeable for our common stock for a period of three months after the closing of this offering. In addition, we
    have agreed that, subject to certain exceptions, we will not conduct any issuances of our common stock for a period of three months
    after the closing of this offering. See &ldquo;Plan of Distribution&rdquo; for more information. </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black"> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black"> Risk Factors: </TD>
    <TD><P STYLE="margin: 0pt 0; font-size: 10pt"> Investment in our securities involves a high degree of risk and could result in a loss
    of your entire investment. See &ldquo;Risk Factors&rdquo; beginning on page 14, and the other information included and incorporated
    by reference in this prospectus for a discussion of the factors you should consider carefully before deciding to invest in our securities. </P>
    <P STYLE="margin: 0pt 0; font-size: 10pt"> &nbsp; </P>
    <P STYLE="margin: 0pt 0; font-size: 10pt">There is substantial doubt about our ability to continue as a going concern. As a reasonable
    best efforts offering in which no minimum number or dollar amount of securities is required to be sold, we may be unable to raise
    sufficient capital to extend our cash runway through the end of this year. For additional information, see &ldquo;Risk Factors &mdash;
    Our auditor has included an explanatory paragraph in their opinion expressing substantial doubt about our ability to continue as
    a going concern. If we are unable to continue as a going concern, our securities will have little or no value.&rdquo;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black"> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black">Nasdaq Capital Market Symbol:</TD>
    <TD STYLE="text-underline-color: black">GITS</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The above discussion is based on 3,674,208
shares of our common stock outstanding as of November&nbsp;25, 2025, does not give effect to the shares of common stock issuable upon
exercise of the Pre-Funded Warrants, Common Warrants and Placement Agent Warrants issued in this offering, and excludes (unless otherwise
indicated), as of such date: </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> 207,122
                                            shares of common stock issuable upon the exercise of outstanding warrants; and </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> an
                                            aggregate of 75,000 shares of common stock reserved for future issuance under our 2020 Omnibus
                                            Equity Incentive Plan as of November&nbsp;25, 2025. </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Unless expressly indicated or the context requires
otherwise, all information in this prospectus assumes (i) no investor elects to purchase Pre-Funded Warrants, (ii) no exercise of the
Common Warrants or Placement Agent Warrants offered hereby and (iii) no conversion of outstanding warrants after November&nbsp;25, 2025. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All shares and per share information in this prospectus
reflect, and where appropriate, is restated for, a 1-for-20 reverse stock split of our outstanding shares of common stock, effective January&nbsp;27,
2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

</DIV>
<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><A NAME="a_004"></A>RISK FACTORS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>An investment in our common stock involves a
high degree of risk. Before deciding whether to invest in our securities, you should carefully consider the risks and uncertainties described
below, together with the information under the heading &ldquo;Risk Factors&rdquo; in our most recent Annual Report on Form 10-K for the
year ended December 31, 2024 filed with the Securities and Exchange Commission, all of which are incorporated herein by reference, as
updated or superseded by the risks and uncertainties described under similar headings in the other documents that are filed after the
date hereof and incorporated by reference into this prospectus, together with all of the other information contained or incorporated by
reference in this prospectus, and any free writing prospectus that we have authorized for use in connection with this offering before
you make a decision to invest in our securities. The risks and uncertainties we have described are not the only ones we face. Additional
risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our operations. Past financial
performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends
in future periods. If any of these risks actually occurs, our business, business prospects, financial condition or results of operations
could be seriously harmed. This could cause the trading price of our common stock to decline, resulting in a loss of all or part of your
investment. Please also read carefully the section below entitled &ldquo;Cautionary Note Regarding Forward-Looking Statements.&rdquo;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Risks Related to Our Business</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>We have incurred significant losses since
our inception, and we intend to continue to invest in our business. We have no sales. As a result, we may continue to experience losses
in the future.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We incurred a net loss of approximately $1.8
million, $6.2 million and $9.4 million for the nine months ended September 30, 2025 and the years ended December 31, 2024 and 2023, respectively.
For these three fiscal periods, we had no or nominal sales and limited cash. As of September 30, 2025, we had an accumulated deficit
of approximately $39.7 million and a working capital deficiency of approximately $0.5 million. The audited report of our independent
registered public accounting firm to the financial statements for the years ended December 31, 2024 and 2023 contains an explanatory
paragraph stating that our recurring losses from operations, accumulated deficit and negative working capital raise substantial doubt
about our ability to continue as a going concern. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We expect to continue to invest heavily in
our product development and operations, to focus on our Faning platform to increase our user base to support future growth, and to meet
our expanded reporting and compliance obligations as a public company. We may not generate sufficient revenue to offset such costs to
achieve or sustain profitability in the future. Based on our current projections, we estimate that between $2.0 million and $3.0 million
in additional funding will be required to support operations over the next 12 months. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We believe our current cash, net proceeds from
debt issuances and the amount raised from future issuances of common stock will be sufficient to fund our working capital requirements
for the next 12&nbsp;months. This belief assumes, among other things, that we will be able to raise additional equity financing, will
continue to be successful in implementing our business strategy and that there will be no material adverse developments in our business,
liquidity or capital requirements. If one or more of these factors do not occur as expected, it could have a material adverse impact on
our activities, including (i)&nbsp;reduction or delay of our business activities, (ii)&nbsp;forced sales of material assets, (iii)&nbsp;defaults
on our obligations, or (iv)&nbsp;insolvency. Our planned investments may not result in increased revenue or growth of our business. We
cannot assure you that we will be able to generate revenue sufficient to offset our expected cost increases and planned investments in
our business and platform. As a result, we may incur significant losses for the foreseeable future and may not be able to achieve and/or
sustain profitability. If we fail to achieve and sustain profitability, then we may not be able to achieve our business plan, fund our
business or continue as a going concern. The financial statements included in our public filings do not contain any adjustments which
might be necessary if we were unable to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><B><I>Our auditor has
included an explanatory paragraph in their opinion expressing substantial doubt about our ability to continue as a going concern. If we
are unable to continue as a going concern, our securities will have little or no value.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">OneStop Assurance PAC,
our independent registered public accounting firm for the years ended December 31, 2024 and December 31, 2023, has included an explanatory
paragraph in their opinion that accompanies our audited consolidated financial statements as of and for the years ended December 31, 2024
and December 31, 2023, indicating that our recurring losses from operations and a working capital deficiency raise substantial doubt about
our ability to continue as a going concern. If we are unable to obtain profitability or improve our liquidity position, we may not be
able to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We anticipate that we
will continue to generate operating losses and use cash in operations through the foreseeable future. As further set forth below, we anticipate
that we will need significant additional capital, or we may be required to curtail or cease operations. No assurance can be provided that
this offering or any other capital raise conducted by us will be in a sufficient amount to address these liquidity concerns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><B><I>To continue as a
going concern, we will require significant additional capital, which we may be unable to obtain.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"> We have had no sales
in the last two full fiscal years and nominal sales in 2025. Therefore, we will need to raise additional capital in the future to continue
our operations. We anticipate that our principal sources of liquidity will not be sufficient to fund our activities to obtain long-term,
sustainable profitability. To have sufficient cash to fund our operations to obtain long-term, sustainable profitability, we will need
to raise additional equity or debt capital. There can be no assurance that additional funds will be available when needed from any source
or, if available, will be available on terms that are acceptable to us. We will be required to pursue sources of additional capital through
various means, including debt or equity financing. Future financing through equity investments will be dilutive to existing stockholders.
The terms of securities we may issue in future capital transactions may be more favorable for new investors. Newly issued securities
may include preferences, superior voting rights, the issuance of warrants or other derivative securities, and the issuances of incentive
awards under our Omnibus Equity Incentive Plan, all of which will have additional dilutive effects. Further, we may incur substantial
costs in pursuing future capital and/or financing, including investment banking fees, legal fees, accounting fees, printing and distribution
expenses and other costs. We may also be required to recognize non-cash expenses in connection with certain securities we may issue,
such as convertible notes and warrants, which may adversely impact our financial condition. Our ability to obtain needed financing may
be impaired by such factors as the capital markets and our history of losses, which could impact the availability and cost of future
financing. If the amount of capital we can raise from financing activities, together with our revenues and profits from operations, is
not sufficient to satisfy our capital needs, even to the extent that we reduce our operations accordingly, we may be required to curtail
or cease operations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Additionally, even if
this offering is successful, we will only be able to extend our cash runway for approximately 12 to 15 months. Further, as a reasonable
best efforts offering in which no minimum number or dollar amount of securities is required to be sold, we may be unable to raise sufficient
capital to extend our cash runway through the end of this year. See &ldquo;Risk Factors &mdash; This is a reasonable best efforts offering,
in which no minimum number or dollar amount of securities is required to be sold, and we may not raise the amount of capital we believe
is required for our business plans.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>We are a development stage company, and we
may not be able to sustain our growth, effectively manage our anticipated future growth or implement our business strategies.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have a limited operating history. Although we
have experienced growth since Faning was launched, our historical growth rate may not be indicative of our future performance due to our
limited operating history and the evolution of our business model, including a focus on the Faning application. We may not be able to
achieve similar results or accelerate growth at the same rate as we have historically. As our application offerings continue to develop,
we may adjust our strategy and business model to adapt. These adjustments may not achieve expected results and may have a material and
adverse impact on our financial condition and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, our growth and expansion have placed,
and continue to place, significant strain on our management and resources. This level of significant growth may not be sustainable or
achievable at all in the future. We believe that our continued growth will depend on many factors, including our ability to develop new
sources of revenues, diversify monetization methods including advertising revenue, attract and retain users, increase engagement on our
Faning platform, continue developing innovative technologies and application uses in response to shifting demand in the market, increase
brand awareness, and expand into new markets. We cannot assure you that we will achieve any of the above, and our failure to do so may
materially and adversely affect our business and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Global Interactive Technologies is a holding
company with no business operations of its own and manages a network of South Korean subsidiaries, subject to South Korean regulation.
Further, as we have no business operations of our own, we will depend on the cash flow and business of our subsidiaries to make payments
to us and meet our obligations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Global Interactive Technologies is a&nbsp;holding&nbsp;company&nbsp;with
no independent operations of our own. Our South Korean subsidiaries, including Faning Korea, conduct substantially all of our business
operations. Managing the regulatory compliance activities for each of these subsidiaries is a complicated task, and we may expend significant
resources doing so. However, we cannot guarantee that we will be able to keep abreast of the changing legal and regulatory landscapes
for each of the jurisdictions in which our subsidiaries exist. If any of the regulatory environments applicable to our subsidiaries change
materially, and we fail to adapt to such changes, our business and financial results may be harmed. Applicable tax laws may also subject
such payments to us by our subsidiaries to further taxation. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Additionally, as a holding company, we may rely
on our operating subsidiaries for distributions or payments for cash flow. Therefore, our ability to fund and conduct our business, service
any debt, and pay dividends, if any, in the future may depend on the ability of our South Korean subsidiaries to make upstream cash distributions
or payments to us, which may be impacted, for example, by their ability to generate sufficient cash flow or limitations on the ability
to repatriate funds, whether as a result of currency liquidity restrictions, monetary or exchange controls, regulatory restrictions, or
otherwise. Further, our subsidiaries&rsquo; ability to make payments to us will depend on:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-underline-color: black">&#9679;</TD>
    <TD STYLE="text-underline-color: black">their earnings;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&#9679;</TD>
    <TD STYLE="text-underline-color: black">covenants contained in any debt agreements to which we may then be subject, including any debt agreements of our subsidiaries;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&#9679;</TD>
    <TD STYLE="text-underline-color: black">covenants contained in other agreements to which we or our subsidiaries are or may become subject;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&#9679;</TD>
    <TD STYLE="text-underline-color: black">business and tax considerations; and</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&#9679;</TD>
    <TD STYLE="text-align: left; text-underline-color: black">applicable law, including any restrictions under South Korean law that may be imposed on our subsidiaries and affiliates, that would restrict our ability to make payments to us.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We cannot assure you that the operating results
of our subsidiaries at any given time will be sufficient to make distributions or other payments to us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>We are subject to risks associated with operating
in a rapidly developing industry and a relatively new market.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Many elements of our business are unique, evolving
and relatively unproven. Our business and prospects depend on the continuing development of the social media market, which is relatively
new, rapidly developing and subject to significant challenges. Our business relies upon our ability to cultivate and grow an active online
community, and our ability to successfully monetize such community through methods that include, without limitation, advertising revenue.
In addition, our continued growth depends, in part, on our ability to respond to constant changes in the industry, including rapid technological
evolution, continued shifts in user trends. Developing and integrating new content, products, services or infrastructure could be expensive
and time-consuming, and these efforts may not yield the benefits we expect to achieve at all. We cannot assure you that we will succeed
in any of these aspects or that the industry will continue to grow as rapidly as it has in the past.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>We will face numerous business and legal
challenges in foreign jurisdictions as we plan to expand our operations beyond South Korea and the United States. </I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> As we grow, we must comply with diverse and
evolving non-Korean and U.S. laws and regulations, including those relating to privacy and data protection, content and platform rules,
consumer protection, payments and currency controls, anti-corruption/sanctions, employment, import/export, taxation, and data-localization
or transfer restrictions. These regimes may conflict, change with limited notice, and be enforced unpredictably, which can increase costs,
delay launches, require product changes or feature limits, or, in some cases, require us to restrict, relocate, or cease operations in
certain countries. We also depend on third-party platforms, app stores and hosting/providers that may impose jurisdiction-specific requirements
or restrictions. If we develop or acquire intellectual property in the future, protecting and enforcing those rights in some jurisdictions
may be costly or impractical. We may need to establish and maintain additional policies and procedures, including terms of service, privacy
notices, and content-moderation procedures, implement new compliance controls, and engage local advisors to address jurisdiction-specific
requirements. Any of the foregoing could adversely affect our business, financial condition, and results of operations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Our success depends on our ability to develop
products and services to address the rapidly evolving market for the content creation and social media platform industry and, if we are
not able to implement successful enhancements and new features for our products and services, our business could be materially and adversely
affected.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We expect that new services and technologies applicable
to the content creation and social media platform industry in which we operate will continue to emerge and evolve. Rapid and significant
technological changes continue to confront the industries in which we operate, including developments in the social media platform and
content creation industry. Incorporating new technologies into our products and services may require substantial expenditures and take
considerable time, and we may not be successful in realizing a return on these development efforts in a timely manner or at all. There
can be no assurance that any new products or services we develop and offer to our customers will achieve significant commercial acceptance.
Our ability to develop new products and services may be inhibited by industry-wide standards, laws and regulations, resistance to change
from buyers or sellers, or third parties&rsquo; intellectual property rights. Our success will depend on our ability to develop new technologies
and to adapt to technological changes and evolving industry standards. If we are unable to provide enhancements and new features for our
products and services or to develop new products and services that achieve market acceptance or that keep pace with rapid technological
developments and evolving industry standards, our business would be materially and adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The success of enhancements, new features, products
and services depends on several factors, including the timely completion, introduction and market acceptance of the enhancements or new
features or services. We often rely not only on our own initiatives and innovations, but also on third parties, including some of our
competitors, for the development of and access to new technologies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, because our products and services
are designed to operate with a variety of systems, infrastructures and devices, we need to continuously modify and enhance our products
and services to keep pace with changes in mobile, software, communication and database technologies. We may not be successful in either
developing these modifications and enhancements or in bringing them to the market in a timely and cost-effective manner. Any failure
of our products and services to continue to operate effectively with third-party infrastructures and technologies could reduce the demand
for our products and services, result in dissatisfaction of our sellers or their customers, and materially and adversely affect our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>As a creator and a distributor of digital
media content, we face liability and expenses for legal claims based on the nature and content of the materials that we create or distribute,
including materials provided by third parties. If we are required to pay damages or expenses in connection with these legal claims, our
business and results of operations may be harmed.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We display original content and&nbsp;third-party&nbsp;content&nbsp;on
our websites and in our marketing messages. As a result, we have faced and will continue to&nbsp;face potential liability based on a variety
of theories, including deceptive advertising and copyright or trademark infringement. We generally rely on&nbsp;the <FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;</FONT>fair
use&rdquo; exception for our use of third-party brand names and marks, but these third parties may disagree, and the laws governing the
fair use of these third-party materials are imprecise and adjudicated on a case-by-case basis. We also create content we believe to be
original for our websites.&nbsp;While we do not believe that this content&nbsp;infringes on any third-party copyrights or other intellectual
property rights, owners of competitive websites that present similar content have taken and may take the position that our content infringes
on their intellectual property rights.&nbsp;We are also exposed to the risk that content provided by third parties is inaccurate or misleading,
and for material posted to our websites by users and other third parties. These claims could divert management time and attention away
from our business and result in significant costs to investigate and defend, regardless of the merit of these claims. The general liability
insurance we maintain&nbsp;may not cover potential claims of this type or may not be adequate to indemnify us for all liability that may
be imposed. Any imposition of liability that is not covered by insurance, or is in excess of insurance coverage, could materially adversely
affect our business, financial condition and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> In addition to copyright and trademark claims,
we may be subject to claims of patent infringement, including claims that our technology, platform features, or user-generated content
infringe on patents held by third parties. Patent litigation can be costly, time-consuming, and disruptive to our business, regardless
of the outcome. Although our current practices and procedures with regard to the display of user content are intended to limit potential
liability for these patent infringement claims, they may be inadequate or ineffective in avoiding claims of infringement. As a result,
we could be required to pay substantial damages, enter into costly license agreements, or modify our platform or business practices,
any of which could materially and adversely affect our business, financial condition, and results of operations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Our intellectual property rights may
not adequately protect our technology or prevent third parties from competing with the us. </I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B>&nbsp;</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Our only registered trademark is for Fantoo
and we have not filed a trademark application for Faning. We have also not applied for patents on our Faning technology. We regard our
software as proprietary and rely primarily on a combination of copyright, trademark and trade secret laws of general applicability, employee
confidentiality and invention assignment agreements, distribution and software protection agreements and other intellectual property
protection methods to safeguard our technology and software products. However, our standard employment agreements do not contain express
intellectual property assignment provisions. We also rely upon our efforts to design and produce new products, and upon improvements
to existing products, to maintain a competitive position in the marketplace. We have no assurance that our technology will remain proprietary.
However, our standard employment agreements do not contain express intellectual property assignment provisions. Other than our registered
trademark for Fantoo, we do not currently maintain any U.S. trademark registrations. We have not implemented formal written notice-and-takedown
procedures to address third-party infringement of our intellectual property. We are still developing tools intended to detect infringing
or inappropriate content and other misuse of our technology. We do not have formal policies and procedures governing the storage of users&rsquo;
personally identifiable information. We also lack material agreements, procedures or protocols governing the creation, use, licensing
and enforcement of our intellectual property. &nbsp;If we are unable to develop and implement more robust intellectual property and data
protection measures, our business, financial condition, and results of operations could be materially and adversely affected<FONT STYLE="text-decoration-style: double">.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Our dependence on third-party relationships
with content producers and distribution channels to develop and distribute entertainment content is critical to the success of the Faning
platform.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We rely on third-party relationships with content
producers and distribution channels to develop and distribute entertainment content. Our financial performance may be adversely affected
by our relationships with content producers and distribution channels. Some of our content producers may have their own or other distribution
capabilities in the markets in which we operate. These&nbsp;third-party&nbsp;content&nbsp;producers and distribution channels may decide,
or be required by their respective parent companies, to use their intracompany distribution or content production capabilities rather
than posting such content with us. Our business may be harmed if the content producers and distribution channels with which we work stop
or reduce the amount of content they produce for us, or otherwise demand less favorable terms to us. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Our decision not to provide products and
services and to restrict user access in China (including Hong Kong and Macau) will limit our total addressable market and may limit our
ability to grow our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">China and Hong Kong could represent a large market
opportunity for our business. However, although we believe that such a decision may benefit our company in the long run, by choosing not
to provide products and services, and restricting user access in China (including Hong Kong and Macau), we are sacrificing potential business
opportunities that may negatively impact us. As a result, our total addressable market and potential growth may be limited and, as a result,
the market price of our common stock may significantly decrease or become worthless.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>If our content streaming initiatives are
unsuccessful, our business, financial condition or results of operations could be adversely affected.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Content streaming is intensely competitive and
cash intensive and there can be no assurance that our content creation initiatives will be profitable or otherwise successful. Our ability
to attract, engage and retain users within the Faning platform, as well as the corresponding advertising revenues they generate, will
depend on our ability to consistently provide appealing and differentiated content globally, effectively market our content and services
and provide a quality experience for selecting and viewing that content. Our success will require significant investments to produce original
content and acquire the rights to&nbsp;third-party&nbsp;content, as well as the establishment and maintenance of key content and distribution
partnerships.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We must continually add new users and meaningfully
engage with existing users to manage turnover, or <FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;</FONT>churn,&rdquo;
to grow our business. If we are unable to successfully compete with competitors in attracting, engaging with and retaining users as well
as creative talent, our business, financial condition or results of operations could be adversely affected. The relative service levels,
content offerings, promotions and pricing and related features of our competitors<FONT STYLE="font-family: Times New Roman, Times, Serif">&rsquo;
</FONT>services may adversely impact our ability to attract, engage and retain users. If consumers do not consider our platform to be
of value compared to our competitors<FONT STYLE="font-family: Times New Roman, Times, Serif">&rsquo; </FONT>platforms, including because
we fail to introduce attractive new content and features, do not maintain competitive pricing, terminate or modify promotional or trial
period offerings, experience technical issues, or change the mix of content in a manner that is unfavorably received, we may not be able
to attract, engage and retain users. If we are not able to attract new users, or our existing users decide to not continue using our services
for any reason, including a perception that they do not use our platform sufficiently, the need to cut household expenses, unsatisfactory
content, promotions or offers expire or are modified, competitive platforms provide a better value or experience or customer service or
technical issues are not satisfactorily resolved, our business, financial condition or results of operations could be adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>We are dependent on the continued services
and on the performance of key third-party content contributors, the loss of which could adversely affect our business.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We rely on content contributed by third-party
providers, which has in turn attracted users that drive advertising revenue. The loss of the services of any of such key contributors
could have a material adverse effect on our business, operating results and financial condition. We also depend on our ability to identify,
attract and retain other highly skilled third-party content contributors. Competition for such contributors is intense, and there can
be no assurance that we will be able to successfully attract, assimilate or retain them. The loss or limitation of the services of any
of our key third-party contributors, or the inability to attract and retain additional qualified key contributors, could have a material
adverse effect on our business, financial condition or results of operations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I></I></B></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Substantial and increasingly intense competition
in the social media platform and content creation industry may harm our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We compete in markets characterized by vigorous
competition, changing technology, evolving industry standards and frequent introductions of new products and services. We expect competition
to intensify in the future as existing and new competitors introduce new services or enhance existing services. We compete against many
companies to attract customers, and some of these companies have greater financial resources and substantially larger bases of customers
than we do, which may provide them with significant competitive advantages. These companies may devote greater resources to the development,
promotion and sale of products and services, and they may introduce their own innovative products and services that adversely impact our
growth. Mergers and acquisitions by these companies may lead to even larger competitors with more resources. We also expect new entrants
to offer competitive products and services. If we are unable to differentiate ourselves from and successfully compete with our competitors,
our business will be materially and adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We may also face pressures from competitors for
user engagement and, in the future, advertising revenues. Some potential competitors are able to offer greater returns on content sales
to content creators for similar services by cross subsidizing their payments services through other services they offer. Such competition
may result in the need for us to alter the amount we charge creators in content-sales transactions and could reduce our gross profit.
In addition, as we grow, influential creators may demand more customized and favorable pricing from us, and competitive pressures may
require us to agree to such pricing, further reducing our gross profit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Systems failures, interruptions, delays in
service, catastrophic events and resulting interruptions in the availability of our products or services could harm our business and our
brand, and subject us to substantial liability.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our systems and those of our third-party data center
facilities may experience service interruptions, denial-of-service and other cyber-attacks, human error, earthquakes, hurricanes, floods,
fires, natural disasters, power losses, disruptions in telecommunications services, fraud, military or political conflicts, terrorist
attacks and other geopolitical unrest, computer viruses, or other events. Our systems are also subject to break-ins, sabotage, and acts
of vandalism. Some of our systems are not fully redundant, and our disaster-recovery planning is not sufficient for all eventualities.
In addition, as a provider of payments solutions, we are subject to increased scrutiny by regulators that may require specific business
continuity and disaster recovery plans and more rigorous testing of such plans. This increased scrutiny may be costly and time-consuming
and may divert our resources from other business priorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We may, and are likely to, experience denial-of-service
attacks, system failures, and other events or conditions that interrupt the availability or reduce the speed or functionality of our products
and services. These events, should they occur, would likely result in loss of revenue. In addition, they could result in significant expense
to repair or replace damaged equipment and remedy resultant data loss or corruption. A prolonged interruption in the availability or reduction
in the speed or other functionality of our products or services could materially harm our reputation and business. Frequent or persistent
interruptions in our products and services could cause users to believe that our products and services are unreliable, leading them to
switch to our competitors or to avoid our products and services, and could permanently harm our reputation and business. Moreover, to
the extent that any system failure or similar event results in damages to customers or their businesses, these customers could seek compensation
from us for their losses, and those claims, even if unsuccessful, would likely be time-consuming and costly for us to address.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Our success depends largely on the continued
service and availability of key personnel.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Much of our future success depends on the continued
availability and service of key personnel, including Taehoon Kim, our Interim Chief Executive Officer, and our executive team and other
highly skilled employees. Since the technology industry is characterized by high demand and intense competition for talent, we cannot
assure you that we will be able to attract or retain qualified staff or other highly skilled employees. In addition, as we are relatively
young, our ability to train and integrate new employees into our operations may not meet the growing demands of our business which may
materially and adversely affect our ability to grow our business and hence our results of operations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>From time to time, we may become involved
in legal proceedings, claims, litigation and government investigations or inquiries.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">From time to time, we may become subject to legal
proceedings, claims, litigation and government investigations or inquiries, as noted in the next paragraph, which could be expensive,
lengthy, disruptive to normal business operations and occupy a significant amount of our employees<FONT STYLE="font-family: Times New Roman, Times, Serif">&rsquo;
</FONT>time and attention. In addition, the outcome of any legal proceedings, claims, litigation, investigations or inquiries may be difficult
to predict and could have a material adverse effect on our business, operating results or financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>We may be the subject of an administrative
fine by the Korean Securities and Futures Commission (the &ldquo;SFC&rdquo;) and any adverse outcome in the related proceedings could
negatively impact our business, financial condition and results of operations. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> As disclosed on June 25, 2025 in our Current
Report on Form 8-K filed with the SEC on November 6, 2024, the Securities and Futures Commission (&ldquo;SFC&rdquo;) under the Financial
Services Commission of the Republic of Korea imposed an administrative fine of KRW 142.1 million (or approximately $104,750) against
us for violations of Korean securities regulations in connection with an alleged failure to submit a securities registration statement.
Under Korean law, a public offering is deemed to occur when securities are solicited from 50 or more investors. We have formally objected
to and appealed that sanction and currently plan to file an administrative lawsuit with the Seoul Central District Court in early 2026
to challenge the fine.&nbsp; No sanctions or restrictions have been imposed on any member of current management or the current Board
of Directors. We will continue to cooperate fully with the SFC and any other regulator&nbsp;that may inquire regarding these same legacy
matters. We have fully complied with all requests to date. To date, there have been no requests for interviews of current management.&nbsp;
While we believe these matters relate solely to conduct of prior management, there can be no assurance as to the outcome of the pending
appeal or any future proceedings. Responding to regulatory inquiries may involve additional costs, could divert management&rsquo;s attention,
and may result in negative publicity, any of which could adversely affect our business, financial condition, or results of operations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>The preparation of our financial statements
involves the use of good faith estimates, judgments and assumptions, and our financial statements may be materially affected if such good
faith estimates, judgments or good faith assumptions prove to be inaccurate</I></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Financial statements prepared in accordance with
accounting principles generally accepted in the United&nbsp;States of America (&ldquo;GAAP&rdquo;) typically require the use of good faith
estimates, judgments and assumptions that affect the reported amounts. Often, different estimates, judgments and assumptions could reasonably
be used that would have a material effect on such financial statements, and changes in these estimates, judgments and assumptions may
occur from period to period over time. Significant areas of accounting requiring the application of management<FONT STYLE="font-family: Times New Roman, Times, Serif">&rsquo;</FONT>s
judgment include, but are not limited to, determining the fair value of assets, share-based compensation and the timing and amount of
cash flows from assets. These estimates, judgments and assumptions are inherently uncertain and, if our estimates were to prove to be
wrong, we would face the risk that charges to income or other financial statement changes or adjustments would be required. Any such charges
or changes would require a restatement of our financial statements and could harm our business, including our financial condition and
results of operations and the price of our securities. See &ldquo;Management<FONT STYLE="font-family: Times New Roman, Times, Serif">&rsquo;</FONT>s
Discussion and Analysis of Financial Condition and Results of Operations&rdquo; in our Annual Report on Form 10-K for the year ended December
31, 2024 for a discussion of the accounting estimates, judgments and assumptions that we believe are the most critical to an understanding
of our financial statements and our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>We currently have ineffective internal
control over financial and our remediation efforts may be insufficient.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>&nbsp;</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Management has identified control deficiencies
regarding inadequate accounting resources, the lack of segregation of duties and the need for a stronger internal control environment,
as further evidenced by the restatement of our 2022 financial statements. Our management believes that these material weaknesses are
due to the small size of our accounting staff. The small size of our outsourced accounting staff may prevent adequate controls in the
future due to the cost/benefit of such remediation. To mitigate the current limited resources and limited employees, we rely heavily
on direct management oversight of transactions, along with the use of external legal and accounting professionals. As we grow, we expect
to increase our number of employees, which will enable us to implement adequate segregation of duties within the internal control framework.
If our remediation measures are insufficient to address the deficiencies in our internal control over financial reporting, we may not
detect errors in a timely manner, our financial statements could be misstated, we could face a loss of confidence by stakeholders, or
we could be subject to regulatory scrutiny, sanctions or litigation, any of which could harm our business, financial condition, results
of operations, or the market price of our shares. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>Risks Related to Government Regulation</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Our business is subject to regulation,
and changes in applicable regulations may negatively impact our business.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>&nbsp;</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We are subject to a number of foreign and domestic
laws and regulations relating to user privacy, data collection, retention, electronic commerce, virtual items and currency, consumer
protection, content, advertising, localization, and information security which have been adopted or are being considered for adoption
by many jurisdictions and countries throughout the world. These laws could harm our business by limiting the products and services we
can offer consumers or the manner in which we offer them. The costs of compliance with these laws may increase in the future as a result
of changes in interpretation. Further, any failure on our part to comply with these laws or the application of these laws in an unanticipated
manner may harm our business and result in penalties or significant legal liability. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Actions by governments that restrict
access to Faning in their countries, or that otherwise impair our ability to sell advertising in their countries, could substantially
harm our business and financial results.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>&nbsp;</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Governments, from time to time, seek to censor
content available on social media platforms or restrict access to social media platforms from their country entirely, or impose other
restrictions that may affect the accessibility of our products in their country for an extended period of time or indefinitely. For example,
user access to certain other company social media platforms has been or is currently restricted in whole or in part in China, Iran and
North Korea. In addition, government authorities in other countries may seek to restrict user access to our products if they consider
us to be in violation of their laws or a threat to public safety or for other reasons, and certain of our products have been restricted
by governments in other countries from time to time. It is also possible that government authorities could take action that impairs our
ability to sell advertising, including in countries where access to our consumer-facing products may be blocked or restricted. In the
event that content shown on Faning is subject to censorship, access to our products is restricted, in whole or in part, in one or more
countries, we are required to or elect to make changes to our operations, or other restrictions are imposed on our products, or our competitors
are able to successfully penetrate new geographic markets or capture a greater share of existing geographic markets that we cannot access
or where we face other restrictions, our ability to retain or increase our user base, user engagement, or the level of advertising by
marketers may be adversely affected, we may not be able to maintain or grow our revenue as anticipated, and our financial results could
be adversely affected. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>&nbsp;</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Our business is subject to complex and
evolving U.S.&nbsp;and foreign laws and regulations regarding privacy, data use and data protection, content, competition, consumer protection,
and other matters. Many of these laws and regulations are subject to change and uncertain interpretation, and could result in claims,
changes to our business practices, monetary penalties, increased cost of operations, or declines in user growth or engagement, or otherwise
harm our business.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>&nbsp;</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We are subject to a variety of laws and regulations
that involve matters central to our business, including privacy, data use, data protection and personal information, rights of publicity,
content, intellectual property, advertising, marketing, distribution, data security, data retention and deletion, data localization and
storage, data disclosure, artificial intelligence, electronic contracts and other communications, competition, protection of minors,
consumer protection, telecommunications, product liability, e-commerce, taxation, economic or other trade prohibitions or sanctions,
anti-corruption and political law compliance, securities law compliance, and online payment services. The introduction of new products,
expansion of our activities in certain jurisdictions, or other actions that we may take may subject us to additional laws, regulations,
or other government scrutiny. In addition, foreign data protection, privacy, content, competition, and other laws and regulations can
impose different obligations or be more restrictive than those in the United&nbsp;States. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Since our operations are based in Korea, where
most of our users are domiciled, we are subject to, among others, the Personal Information Protection Act and related legislation, regulations
and orders (the &ldquo;PIPA&rdquo;), the Act on the Promotion of Information and Communications Network Utilization and Protection of
Information Act (Korea), and the Credit Information Act in Korea that specifically regulates certain sensitive personal information.
PIPA requires consent by the consumer with respect to the use of his or her data and requires the persons responsible for management
of personal data to take the necessary technological and managerial measures to prevent data breaches and, among other duties, to notify
the Personal Information Protection Commission of any data breach incidents within 24&nbsp;hours. Failure to comply with PIPA in any
manner may subject these persons responsible to personal liability for not obtaining such consent in an appropriate manner or for such
breaches, including even negligent breaches, and violators face varying penalties ranging from monetary penalties to imprisonment. We
strive to take the necessary technological and managerial measures to comply with PIPA, including the implementation of privacy policies
concerning the collection, use, and disclosure of subscriber data on our apps and websites, and we regularly review and update our policies
and practices. Despite these efforts to comply with PIPA, these rules are complex and evolving, subject to interpretation by government
regulators which may change over time and therefore we are subject to the risk of claims by regulators of failure to comply with PIPA.&nbsp;Any
failure, or perceived failure, by us to comply with such policies, laws, regulations, and other legal obligations and regulatory guidance
could adversely affect our reputation, brand, and business, and may result in claims, proceedings, or actions, including criminal proceedings,
against us and certain of our executive officers by governmental entities or others or other liabilities. Any such claim, proceeding,
or action, could hurt our reputation, brand, and business, force us to incur significant expenses in defense of such proceedings, distract
our management, increase our costs of doing business, result in a loss of customers and merchants, and could have an adverse effect on
our business, financial condition, and results of operations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> These U.S.&nbsp;federal and state and foreign
laws and regulations, which in some cases can be enforced by private parties in addition to government entities, are constantly evolving
and can be subject to significant change. As a result, the application, interpretation, and enforcement of these laws and regulations
are often uncertain, particularly in the new and rapidly evolving industry in which we operate, and may be interpreted and applied inconsistently
from country to country and inconsistently with our current policies and practices. For example, regulatory or legislative actions affecting
the manner in which we display content to our users or obtain consent to various practices could adversely affect user growth and engagement.
Such actions could affect the manner in which we provide our services or adversely affect our financial results. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We are also subject to evolving laws and regulations
that dictate whether, how, and under what circumstances we can transfer, process and/or receive certain data that is critical to our
operations, including data shared between countries or regions in which we operate and data shared among our products and services. If
we are unable to transfer data between and among countries and regions in which we operate, or if we are restricted from sharing data
among our products and services, it could affect our ability to provide our services, the manner in which we provide our services or
our ability to target ads, which could adversely affect our financial results. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Proposed or new legislation and regulations
could also significantly affect our business. Laws and regulations are evolving and subject to interpretation, and resulting limitations
on our advertising services, or reductions of advertising by marketers, have to some extent adversely affected, and will continue to
adversely affect, our advertising business. Changes to our products or business practices as a result of these developments may adversely
affect our advertising business. Similarly, there are a number of legislative proposals in the European Union, the United&nbsp;States,
at both the federal and state level, as well as other jurisdictions that could impose new obligations or limitations in areas affecting
our business. In addition, some countries are considering or have passed legislation implementing data protection requirements or requiring
local storage and processing of data or similar requirements that could increase the cost and complexity of delivering our services. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> For example, the European Union traditionally
has imposed stricter obligations under its laws and regulations relating to privacy, data protection and consumer protection than the
United&nbsp;States. In May&nbsp;2018, the European Union&rsquo;s new regulation governing data practices and privacy called the General
Data Protection Regulation, or GDPR, became effective and substantially replaced the data protection laws of the individual European
Union member states. The law requires companies to meet more stringent requirements regarding the handling of personal data of individuals
in the EU than were required under predecessor EU requirements. In the United Kingdom, a Data Protection Bill that substantially implements
the GDPR also became law in May&nbsp;2018. The law also increases the penalties for non-compliance, which may result in monetary penalties
of up to &euro;20.0&nbsp;million or 4% of a company&rsquo;s worldwide turnover, whichever is higher. The GDPR and other similar regulations
require companies to give specific types of notice and in some cases seek consent from consumers and other data subjects before collecting
or using their data for certain purposes, including some marketing activities. Outside of the European Union, many countries have laws,
regulations, or other requirements relating to privacy, data protection, information security, and consumer protection, and new countries
are adopting such legislation or other obligations with increasing frequency. Many of these laws may require consent from consumers for
the use of data for various purposes, including marketing, which may reduce our ability to market our products. There is no harmonized
approach to these laws and regulations globally. Consequently, we increase our risk of non-compliance with applicable foreign data protection
laws by operating internationally. We may need to change and limit the way we use personal information in operating our business and
may have difficulty maintaining a single operating model that is compliant. In addition, various federal, state and foreign legislative
and regulatory bodies, or self-regulatory organizations, may expand current laws or regulations, enact new laws or regulations or issue
revised rules or guidance regarding privacy, data protection, information security and consumer protection. For example, California recently
adopted the California Consumer Privacy Act&nbsp;of&nbsp;2018 (&ldquo;CCPA&rdquo;), which provides new data privacy rights for consumers
and new operational requirements for businesses. The CCPA includes a statutory damages framework and private rights of action against
businesses that fail to comply with certain CCPA terms or implement reasonable security procedures and practices to prevent data breaches.
The CCPA went into effect in January&nbsp;2020. The effects of the CCPA potentially are significant, however, and may require us to modify
our data processing practices and policies and to incur substantial costs and expenses in an effort to comply. As a general matter, compliance
with laws, regulations, and any applicable rules or guidance from self-regulatory organizations relating to privacy, data protection,
information security and consumer protection, may result in substantial costs and may necessitate changes to our business practices,
which may compromise our growth strategy, adversely affect our ability to acquire customers, and otherwise adversely affect our business,
financial condition and operating results. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> These laws and regulations, as well as any
associated claims, inquiries, or investigations or any other government actions, have in the past led to, and may in the future lead
to, unfavorable outcomes including increased compliance costs, delays or impediments in the development of new products, negative publicity
and reputational harm, increased operating costs, diversion of management time and attention, and remedies that harm our business, including
fines or demands or orders that we modify or cease existing business practices. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Payment transactions may subject us to
additional regulatory requirements and other risks that could be costly and difficult to comply with or that could harm our business.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>&nbsp;</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Our users can purchase virtual and digital
goods from creators and developers within our platform and infrastructure on Faning.&nbsp;In addition, certain of our users can use our
Faning infrastructure, including within Clubs and communities, for other activities, such as sending money to other users or purchasing
goods and/or services from other users. We are subject to a variety of laws and regulations in the United&nbsp;States, Europe, and elsewhere,
including those governing anti-money laundering and counter-terrorist financing, money transmission, gift cards and other prepaid access
instruments, electronic funds transfer, charitable fundraising, and import and export restrictions.&nbsp;Depending on how our payments
product evolves, we may also be subject to other laws and regulations including those governing gambling, banking and lending. In some
jurisdictions, the application or interpretation of these laws and regulations is not clear. Our efforts to comply with these laws and
regulations could be costly and result in diversion of management time and effort and may still not guarantee compliance. In the event
that we are found to be in violation of any such legal or regulatory requirements, we may be subject to monetary fines or other penalties
such as a cease and desist order, or we may be required to make product changes, any of which could have an adverse effect on our business
and financial results. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> In addition, we are subject to a variety of
additional risks as a result of payments transactions, including: increased costs and diversion of management time and effort and other
resources to deal with bad transactions or customer disputes; potential fraudulent or otherwise illegal activity by users, developers,
employees or third parties; restrictions on the investment of consumer funds used to transact payments; and additional disclosure and
reporting requirements. We have also announced plans to develop digital payments products and services, which may subject us to many
of the foregoing risks and additional licensing requirements. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Changes in tax laws or regulations that
are applied adversely to us or our customers may have a material adverse effect on our business, cash flow, financial condition or results
of operations.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B><I>&nbsp;</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> New income, sales, use or other tax laws, statutes,
rules, regulations or ordinances could be enacted at any time, which could affect the tax treatment of our earnings and adversely affect
our operations, and our business and financial performance. Further, existing tax laws, statutes, rules, regulations or ordinances could
be interpreted,&nbsp;changed, modified or applied adversely to us. There may be material adverse effects resulting from the legislation
that we have not yet identified. No estimated tax provision has been recorded in the financial statements included herein for tax attributes
that are incomplete or subject to change. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The foregoing items could have a material adverse
effect on our business, cash flow, financial condition or results of operations. In addition, it is unclear how these U.S.&nbsp;federal
income tax changes will affect state and local taxation, which often uses federal taxable income as a starting point for computing state
and local tax liabilities. The impact of this tax legislation on holders of our common stock is also uncertain and could be adverse.
We urge our stockholders and investors to consult with their legal and tax advisors with respect to this legislation and the potential
tax consequences of investing in or holding our common stock. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Failure to comply with the U.S.&nbsp;Foreign
Corrupt Practices Act could result in fines, criminal penalties and an adverse effect on our business.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We may operate in a number of countries throughout
the world, including countries known to have a reputation for corruption. We are committed to doing business in accordance with applicable
anti-corruption laws and have adopted a code of business conduct and ethics which is consistent and in full compliance with the U.S.&nbsp;Foreign
Corrupt Practices Act&nbsp;of&nbsp;1977, or the FCPA.&nbsp;We are subject, however, to the risk that we, our affiliated entities or our
or their respective officers, directors, employees and agents may take actions determined to be in violation of such anti- corruption
laws, including the FCPA.&nbsp;Any such violation could result in substantial fines, sanctions, civil and/or criminal penalties, curtailment
of operations in certain jurisdictions, and might adversely affect our business, results of operations or financial condition. In addition,
actual or alleged violations could damage our reputation and ability to do business. Further, detecting, investigating, and resolving
actual or alleged violations is expensive and can consume significant time and attention of our senior management. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>If we fail to remediate our internal
control weaknesses and maintain an effective system of internal controls over financial reporting, we may be unable to accurately report
our results of operations, meet our reporting obligations or prevent fraud, and investor confidence and the market price of our common
stock may be materially and adversely affected.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We have historically operated as a private
company with limited accounting personnel and other resources with which to address our internal controls and procedures. Our management
has reviewed the current internal controls over financial reporting and concluded that our internal controls are ineffective. Our independent
registered public accounting firm has not conducted an audit of our internal control over financial reporting. Our reporting obligations
place a significant strain on our management, operational and financial resources and systems and we may be unable to timely complete
our evaluation testing and any required remediation. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> During the course of documenting and testing
our internal control procedures, we identified weaknesses and deficiencies in our internal control over financial reporting. If we fail
to remediate these weaknesses and maintain the adequacy of our internal control over financial reporting, as these standards are modified,
supplemented, or amended from time to time, we will not be able to conclude on an ongoing basis that we have effective internal control
over financial reporting. Generally, if we continue to fail to achieve and maintain an effective internal control environment, we could
suffer material misstatements in our financial statements and fail to meet our reporting obligations, which would likely cause investors
to lose confidence in our reported financial information. This could in turn limit our access to capital markets, harm our results of
operations, and lead to a decline in the trading price of our common stock. Additionally, ineffective internal control over financial
reporting could expose us to increased risk of fraud or misuse of corporate assets and subject us to potential delisting from the stock
exchange on which we list, regulatory investigations and civil or criminal sanctions. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>Risks Related to Doing Business in Korea</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Fluctuations in exchange rates could
result in foreign currency exchange losses to us.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The value of the Korean Won and other currencies
against the U.S.&nbsp;dollar has fluctuated, and may continue to fluctuate and is affected by, among other things, changes in political
and economic conditions. It is difficult to predict how market forces or Korean or U.S.&nbsp;government policy, including any interest
rate increases by the Federal Reserve, may impact the exchange rate between the Korean Won and the U.S.&nbsp;dollar in the future. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> A substantial percentage of our revenue and
costs are denominated in Korean Won, and a significant portion of our financial assets are also denominated in Korean Won, while we anticipate
that a substantial portion of any debt incurred will be denominated in U.S.&nbsp;dollars. We are a holding company and we may receive
dividends, loans and other distributions on equity paid by our operating subsidiaries in Korea. Any significant fluctuations in the value
of the Korean Won may materially and adversely affect our liquidity and cash flows. For example, the depreciation of the Korean Won and
other foreign currencies against the U.S.&nbsp;dollar typically results in a material increase in the cost of hosting services and equipment
purchased from outside of Korea and the cost of servicing debt denominated in currencies other than the Korean Won. As a result, any
significant depreciation of the Korean Won or other major foreign currencies against the U.S.&nbsp;dollar may have a material adverse
effect on our results of operations. If we decide to convert our Korean Won into U.S.&nbsp;dollars for the purpose of repaying principal
or interest expense on any future U.S.&nbsp;dollar-denominated debt, making payments for dividends on our common stock, or other business
purposes, depreciation of the Korean Won or other foreign currencies against the U.S.&nbsp;dollar would have a negative effect on the
U.S.&nbsp;dollar amount we would receive. Conversely, to the extent that we need to convert U.S.&nbsp;dollars into Korean Won for our
operations, appreciation of the Korean Won against the U.S.&nbsp;dollar would have an adverse effect on the Korean Won amount we would
receive. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Tensions with North Korea could have
an adverse effect on our business, financial condition, and results of operations, and the price per share of our common stock.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Relations between Korea and North Korea have
fluctuated over the&nbsp;years. Tension between Korea and North Korea may increase or change abruptly as a result of current and future
events. In particular, there have been heightened security concerns in recent&nbsp;years stemming from North Korea&rsquo;s nuclear weapon
and ballistic missile programs as well as its hostile military actions against Korea. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> North Korea&rsquo;s economy also faces severe
challenges, which may further aggravate social and political pressures within North Korea. Since April&nbsp;2018, North Korea has held
a series of bilateral summit meetings with Korea and the United&nbsp;States to discuss peace and denuclearization of the Korean peninsula.
However, North Korea has since resumed its missile testing, heightening tensions, and the outlook of such discussions remains uncertain. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Further tensions in North Korean relations
could develop due to a leadership crisis, breakdown in high-level inter-Korea contacts or military hostilities. Alternatively, tensions
may be resolved through reconciliatory efforts, which may include peace talks, alleviation of sanctions or reunification. We cannot assure
you that future negotiations will result in a final agreement on North Korea&rsquo;s nuclear program, including critical details such
as implementation and timing, or that the level of tensions between Korea and North Korea will not escalate. Any increase in the level
of tension between Korea and North Korea, an outbreak in military hostilities or other actions or occurrences, could adversely affect
our business, prospects, financial condition, and results of operations and could lead to a decline in the price per share of our common
stock. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>There are special risks involved with
investing in Korean companies, including the possibility of restrictions being imposed by the Korean government in emergency circumstances,
accounting and corporate disclosure standards that differ from those in other jurisdictions, and the risk of direct or vicarious criminal
liability for executive officers of our Korean affiliates.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Our wholly owned subsidiary, Faning Korea,
is our Korean subsidiary and operates in a business and cultural environment that is different from that of other countries. For example,
under the Foreign Exchange Transaction Act&nbsp;of&nbsp;Korea, if the Korean government determines that in certain emergency circumstances,
including sudden fluctuations in interest rates or exchange rates, extreme difficulty in stabilizing the balance of payments or substantial
disturbance in the Korean financial and capital markets are likely to occur, it may impose any necessary restriction such as requiring
Korean or foreign investors to obtain prior approval from the Minister of Economy and Finance of Korea prior to entering into a capital
markets transaction, repatriating interest, dividends or sales proceeds arising from Korean securities or from the disposition of such
securities or other transactions involving foreign exchange. Although investors will hold shares of our common stock, Faning Korea may
experience adverse risks and in turn could adversely impact our business, prospects, financial condition, and results of operations and
could lead to a decline in the price per share of our common stock. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> In addition, under Korean law, there are circumstances
in which certain executive officers of a company may be investigated or held criminally liable either directly or vicariously for the
actions of the company and its executives and employees. For example, complaints alleging infringement of intellectual property rights,
breaches of certain Korean laws (e.g., labor standards laws and fair trade laws), and product-related claims may be investigated and
prosecuted as criminal offenses with both the company and the company&rsquo;s executive officers being named as defendants in such proceedings.
These risks change over time. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> As a result of these current and changing risks,
Faning Korea&rsquo;s executive officers may be named in the future in criminal investigations or proceedings stemming from our operations.
In Korea, company executive officers being named in such investigations or proceedings is a common occurrence, even though in practice
many such cases result in no liability to the individual. If Faning Korea&rsquo;s executive officers were to be named in such criminal
proceedings or held either directly or vicariously criminally liable for the actions of the company and its executives and employees,
our business, financial condition, and results of operations may be harmed. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Faning Korea&rsquo;s transactions with
its subsidiaries and affiliates may be restricted under Korean fair trade regulations.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>&nbsp;</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Faning Korea enters into business relationships
and transactions with its subsidiaries and affiliates, which are subject to scrutiny by the Korean Fair Trade Commission (&ldquo;<I>KFTC</I>&rdquo;)
as to, among other things, whether such relationships and transactions constitute undue financial support among companies in the same
business group. If, in the future, the KFTC determines that Faning Korea has engaged in transactions that violate the fair trade laws
and regulations, it may be subject to an administrative and/or criminal fine, surcharge or other actions, which may have an adverse effect
on our business, financial condition, and results of operations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>&nbsp;</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Our Korean subsidiary, Faning Korea,
together with its affiliated companies, may be designated as an affiliated group under Korean law, in which case the group of companies
would be required to make certain disclosures and implement additional corporate governance requirements.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Our Korean subsidiary,&nbsp;Faning Korea, together
with its subsidiaries and other affiliated companies,&nbsp;are likely to be designated as a business group subject to disclosure under
the Korean Monopoly Regulation and Fair Trade Act. Such a designation would impose additional corporate governance and public disclosure
requirements on this group of affiliated companies. These requirements would create additional costs of compliance and could subject
this group of affiliated companies to greater regulatory scrutiny and risk of penalties for any failure to comply with the additional
obligations imposed. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Faning Korea is subject to certain requirements
and restrictions under Korean law that may, in certain circumstances, require it to act in a manner that may not be in our or our stockholders</I></B>&rsquo;&nbsp;<B><I>best
interest.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Under applicable Korean law, directors of a
Korean company, such as Faning Korea, owe a fiduciary duty to the company itself rather than to its stockholders. This fiduciary duty
obligates directors of a Korean company to perform their duties faithfully for the good of the company as a whole. As a result, if circumstances
arise in which the good of Faning Korea conflicts with the good of Global Interactive Technologies, Inc. or our stockholders, Faning
Korea may not be permitted under applicable Korean law to act in a manner that is in the best interest of Global Interactive Technologies,
Inc, as its parent, or our stockholders. For example, providing guarantees or collateral by Faning Korea in favor of Global Interactive
Technologies, Inc., as its parent, without a justifiable cause and on other than arm&rsquo;s length terms may cause breach of a fiduciary
duty of directors to Faning Korea. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Approval by the board of directors of a Korean
company is required for, among other things, all transactions between a director or major stockholder (including a 10% or more stockholder)
and the company for the director&rsquo;s or the major stockholder&rsquo;s account. As a result, intercompany transactions between us
and Faning Korea (or any other Korean subsidiary we may own, from time to time), could arise in the future in which the directors of
the Korean subsidiary are not able to act in ours or our stockholders&rsquo; best interest as a result of competing interests of the
subsidiary. Since substantially all of our operations are conducted by Faning Korea, any such occurrence with respect to Faning Korea
could adversely affect our business, financial condition, and results of operations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Faning Korea&rsquo;s transactions with
related parties are subject to close scrutiny by the Korean tax authorities, which may result in adverse tax consequences.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Under Korean tax law, there is an inherent
risk that&nbsp;Faning Korea&rsquo;s transactions with its subsidiaries, affiliates or any other person or company that is related to
us may be challenged by the Korean tax authorities if such transactions are viewed as having been made on terms that were not on an arm&rsquo;s-length
basis. If the Korean tax authorities determine that any of its transactions with related parties were on other than arm&rsquo;s-length
terms, it may not be permitted to deduct as expenses, or may be required to include as taxable income, any amount which is found to be
undue financial support between related parties in such transaction, which may have adverse tax consequences for us and, in turn, may
adversely affect our business, financial condition, and results of operations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>If&nbsp;we are deemed to have a&nbsp;</I></B>&ldquo;<B><I>place
of effective management</I></B>&rdquo;&nbsp;<B><I>in Korea, we will be treated as a Korean company for the purpose of Korean corporate
income tax with regards to our worldwide income.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Under the Corporate Tax Act (&ldquo;CTA&rdquo;),
as amended on August&nbsp;17, 2021, a corporation having a &ldquo;place of effective management&rdquo; in Korea will be treated as a
Korean company for the purposes of Korean corporate income tax. However, the CTA does not clearly define what constitutes &ldquo;place
of effective management&rdquo; and, to date, there has not been any court precedent. If we are deemed to have a &ldquo;place of effective
management&rdquo; in Korea, we will be required to file annual corporate income tax returns with the Korean tax authorities and be subject
to Korean corporate income tax. Currently, the applicable rates are 9.9% (inclusive of local corporate taxes) for taxable income up to
200&nbsp;million Korean Won, 23.1% (inclusive of local corporate taxes) for taxable income exceeding 200&nbsp;million Korean Won and
less than 20&nbsp;billion Korean Won, 24.2% (inclusive of local corporate taxes) for taxable income greater than 20&nbsp;billion won
and less than 300&nbsp;billion Korean Won, and 26.4% (inclusive of local corporate tax) for taxable income greater than 300&nbsp;billion
Korean Won. Taxable income would include any worldwide income, such as dividends we receive from our Korean operating company and any
interest income earned outside of Korea. If we are required to pay Korean corporate income tax, it may reduce our cash flow and negatively
impact the returns to investors. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>If we are deemed to have a&nbsp;</I></B>&ldquo;<B><I>permanent
establishment</I></B>&rdquo;&nbsp;<B><I>in Korea, we will be subject to Korean corporate income tax with regards to any Korean source
income attributable to or effectively connected with such permanent establishment.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> If we are deemed to have a &ldquo;permanent
establishment&rdquo; as defined under Korean tax law, we would be required to file annual corporate income tax returns with the Korean
tax office and be subject to Korean corporate income tax. The applicable rates are 9.9% (inclusive of local corporate taxes) for taxable
income up to 200&nbsp;million Korean Won, 20.9% (inclusive of local corporate taxes) for taxable income exceeding 200&nbsp;million Korean
Won and less than 20&nbsp;billion Korean Won, 23.1% (inclusive of local corporate taxes) for taxable income greater than 20&nbsp;billion
won and less than 300&nbsp;billion Korean Won, and 26.4% (inclusive of local corporate tax) for taxable income greater than 300&nbsp;billion
Korean Won. Taxable income includes any Korean source income attributable to or effectively connected with such permanent establishment,
such as dividends we receive from our Korean operating company. If we are required to pay Korean corporate income tax, it may reduce
our cash flow and negatively impact the returns to investors. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>A focus on regulating copyright and patent
infringement by the Korean government subjects us to extra scrutiny in our operations and could subject us to sanctions, fines, or other
penalties, which could adversely affect our business and operations in Korea.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The Korean government has recently focused
on addressing copyright and patent infringement in Korea, particularly with respect to luxury and brand name merchandise. Despite measures
we have taken to address copyright and patent infringement, the Korean government may subject us to sanctions, fines, or other penalties,
which could adversely affect our business and operations in Korea. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Our business may be adversely affected
by developments that negatively impact the Korean economy and uncertainties in economic conditions that impact spending patterns of our
customers in Korea.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We have historically generated a substantial
majority of our revenue from sales in Korea. Our future performance will depend in large part on Korea&rsquo;s future economic growth.
Adverse developments in Korea&rsquo;s economy as a result of various factors, including economic, political, legal, regulatory, and social
conditions in Korea may have an adverse effect on customer spending, which may not allow us to achieve our desired revenue growth. The
economic indicators in Korea in recent&nbsp;years have shown mixed signs of growth and uncertainty, and in 2020, the Korean and global
economies were affected as a result of the COVID-19 pandemic. As a result, future growth of the Korean economy is subject to many factors
beyond our control, including developments in the global economy. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The Korean economy is closely tied to, and
is affected by developments in, the global economy. In recent&nbsp;years, adverse conditions and volatility in the worldwide financial
markets, fluctuations in oil and commodity prices, and the COVID-19 pandemic, have contributed to the uncertainty of global economic
prospects in general and have adversely affected, and may continue to adversely affect, the Korean economy. Due to liquidity and credit
concerns and volatility in the global financial markets, the value of the Korean Won relative to the U.S.&nbsp;dollar and other foreign
currencies and the stock prices of Korean companies have fluctuated significantly in recent&nbsp;years. Further declines in the Korea
Composite Stock Price Index, and large amounts of sales of Korean securities by foreign investors and subsequent repatriation of the
proceeds of such sales may adversely affect the value of the Won, the foreign currency reserves held by financial institutions in Korea,
and the ability of Korean companies to raise capital. Any future deterioration of the Korean economy or the global economy could adversely
affect our business, financial condition, and results of operations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>New legislative proposals may expose
our business to additional risks from litigation, regulation, and government investigations.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We are subject to changing laws and regulations
everywhere we do business, including in Korea. For example, on September&nbsp;28, 2020, the Korean Ministry of Justice announced (i)&nbsp;a
proposed amendment to the Korean Commercial Code to adopt a punitive damages system that would apply generally to all areas of business,
and (ii)&nbsp;a proposed bill to introduce a class action litigation system in Korea. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Previously, punitive or exemplary damages have
been available in Korea only in specific business fields. The proposed legislation would broaden the potential availability of such damages.
Similarly, the proposal relating to class actions would make such litigation applicable to a broader scope of cases, would allow for
a Korean style discovery process, jury trials in many cases, and would apply to claims whose cause arose before the bill&rsquo;s enactment. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Additionally, on September&nbsp;28, 2020, the
KFTC introduced a proposed bill entitled the &ldquo;Fair Online Platform Intermediary Transactions Act.&rdquo; This proposed act is intended
to augment the existing legal framework under the Monopoly Regulation and Fair Trade Act&nbsp;of&nbsp;Korea to regulate competition and
fairness issues arising in the business of online platforms. This proposed act would enhance liability of online platform operators to
merchants, suppliers, and customers. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Also, on January&nbsp;8, 2021, the main session
of the Korean National Assembly passed a draft Bill on Punishment for Serious Accidents, etc. (the &ldquo;<FONT STYLE="font-style: normal; font-weight: normal">Serious
Accidents Act</FONT>&rdquo;), which came into effect January&nbsp;27, 2022. The Serious Accidents Act imposes enhanced liability (including
criminal liability) on businesses, managers, and individuals who are responsible for causing loss of life by failing to fulfill duties
relating to workplace safety and health or risk prevention. The Serious Accidents Act provides the potential for criminal punishment,
public disclosure of punishment, and monetary damages, including punitive damages up to five times the actual damages suffered. The Serious
Accidents Act extends potential liability to a wider group of persons than under existing law, including those who oversee safety and
health matters for the business concerned and also general managers of the business. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> These are just some examples of how our business
could be affected by changing regulations. If these proposals are enacted and implemented, our Korean subsidiary, Faning Korea, could
face substantial costs and management could be required to spend significant time and attention on these matters, which would divert
our focus from our core business. This could adversely affect our business, financial condition, and results of operations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>As Faning Korea is incorporated in Korea,
it may be more difficult to enforce judgments obtained in courts outside Korea.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Our operations are primarily conducted outside
of the United&nbsp;States. In addition, all of our directors and officers are non-residents of the United&nbsp;States, and all or a substantial
portion of the assets of these non-residents are located outside the United&nbsp;States. As a result, it may be difficult or impossible
for U.S.&nbsp;investors to serve process within the United&nbsp;States upon us, our subsidiaries or our directors and officers or to
enforce a judgment against us for civil liabilities in U.S.&nbsp;courts. In addition, you should not assume that courts in the countries
in which we or our subsidiaries are incorporated or where our or the assets of our subsidiaries are located (1)&nbsp;would enforce judgments
of U.S.&nbsp;courts obtained in actions against us or our subsidiaries based upon the civil liability provisions of applicable U.S.&nbsp;federal
and state securities laws or (2)&nbsp;would enforce, in original actions, liabilities against us or our subsidiaries based on those laws. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"> <B>Risks Related to Our
Technology</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Technology changes rapidly in our business
and if we fail to anticipate or successfully implement new technologies or adopt new business strategies, technologies or methods, the
quality and competitiveness of our service offerings may suffer.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Technology changes rapidly in the social media
market which requires us to anticipate which technologies we must develop, implement and take advantage of in order to remain competitive.
We have invested, and in the future may invest, in new business strategies including technologies, products, and to continue to persistently
deliver the best product. Such endeavors may involve significant risks and uncertainties, and no assurance can be given that the technology
we choose to adopt and the features that we pursue will be successful. If we do not successfully implement these new technologies, our
reputation may be materially adversely affected and our financial condition and operating results may be impacted. We also may miss opportunities
to adopt technology, or develop new technologies, which could adversely affect our financial results. It may take significant time and
resources to shift our focus to new technologies, putting us at a competitive disadvantage.&nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>There may be losses or unauthorized access
to or releases of confidential information, including personally identifiable information (&ldquo;PII&rdquo;), that could subject us
to significant reputational, financial, legal and operational consequences.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Our business requires us to use and store confidential
information including, among other things, PII, with respect to our customers and employees. We devote significant resources to network
and data security, including through the use of encryption and other security measures intended to protect our systems and data. However,
these measures cannot provide absolute security, and losses or unauthorized access to or releases of confidential information occur and
could materially adversely affect our reputation, financial condition and operating results. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Our business also requires us to share confidential
information with suppliers and other third parties. Although we take steps to secure confidential information that is provided to third
parties, such measures are not always effective and losses or unauthorized access to or releases of confidential information occur and
could materially adversely affect our reputation, financial condition and operating results. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> For example, we may experience a security breach
impacting our information technology systems, which, for the avoidance of doubt, includes our separate FP database, that compromises
the confidentiality, integrity or availability of confidential information. Such an incident could, among other things, impair our ability
to attract and retain customers for its products and services, impact our stock price, materially damage supplier relationships, and
expose us to litigation or government investigations, which could result in penalties, fines or judgments against us. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We have implemented systems and processes intended
to secure our information technology systems and prevent unauthorized access to or loss of sensitive data, including through the use
of encryption and authentication technologies. As with all companies, these security measures may not be sufficient for all eventualities
and may be vulnerable to hacking, employee error, malfeasance, system error, faulty password management or other irregularities. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> In addition to the risks relating to general
confidential information described above, we are also subject to specific obligations relating to payment card data. Under payment card
rules and obligations, if cardholder information is potentially compromised, we could be liable for associated investigatory expenses
and could also incur significant fees or fines if we fail to follow payment card industry data security standards. We could also experience
a significant increase in payment card transaction costs or lose the ability to process payment cards if we fail to follow payment card
industry data security standards, which would materially adversely affect our reputation, financial condition and operating results. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> While we maintain insurance coverage that is
intended to address certain aspects of data security risks, such insurance coverage may be insufficient to cover all losses or all types
of claims that may arise. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>We use third-party services and technologies
in connection with our business, and any disruption to the provision of these services and technologies to us could result in negative
publicity and a slowdown in the growth of our users, which could materially and adversely affect our business, financial condition and
results of operations.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Our business partially depends on services
provided by, and relationships with, various third parties, including cloud hosting and broadband providers, among others. To this end,
when our cloud hosting and broadband vendors experience outages, our services offered through Faning and related applications will be
negatively impacted and alternative resources will not be immediately available. We exercise no control over the third-party vendors
that we rely upon for cloud hosting, broadband and software service. If such third parties increase their prices, fail to provide their
services effectively, terminate their service or agreements or discontinue their relationships with us, we could suffer service interruptions,
reduced revenues or increased costs, any of which may have a material adverse effect on our business, financial condition and results
of operations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Growth of our client base depends upon
effective interoperability with mobile operating systems, networks, mobile devices and standards that we do not control.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We are dependent on the interoperability of
our services with popular mobile devices and mobile operating systems that we do not control, such as Android and iOS.&nbsp;Any changes
in such mobile operating systems or devices that degrade the functionality of our services or give preferential treatment to competitive
services could adversely affect usage of our services. In order to deliver high quality services, it is important that our services work
well across a range of mobile operating systems, networks, mobile devices and standards that we do not control. We may not be successful
in developing relationships with key participants in the mobile industry or in developing services that operate effectively with these
operating systems, networks, devices and standards. In the event that it is difficult for our users to access and use our services, particularly
on their mobile devices, our user growth and user engagement could be harmed, and our business and operating results could be adversely
affected. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Security breaches, improper access to
or disclosure of our data or user data, other hacking and phishing attacks on our systems, or other cyber incidents could harm our reputation
and adversely affect our business.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Our industry is prone to cyber-attacks by third
parties seeking unauthorized access to our data or users&rsquo; data or to disrupt our ability to provide service. Our products and services
involve the collection, storage, processing, and transmission of a large amount of data, including FP stored in our separate FP database.
Any failure to prevent or mitigate security breaches and improper access to or disclosure of our data or user data, including personal
information, content, or payment information from users, or information from marketers, could result in the loss, modification, disclosure,
destruction, or other misuse of such data, including FP stored in our separate FP database, which could harm our business and reputation
and diminish our competitive position. In addition, computer malware, viruses, social engineering (predominantly spear phishing attacks),
scraping, and general hacking have become more prevalent in our industry, have occurred on our systems in the past, and will occur on
our systems in the future. Our efforts to protect our company data or the information we receive, and to disable undesirable activities
on our platform, may also be unsuccessful due to software bugs or other technical malfunctions; employee, contractor, or vendor error
or malfeasance, including defects or vulnerabilities in our vendors&rsquo; information technology systems or offerings; government surveillance;
breaches of physical security of our facilities or technical infrastructure; or other threats that evolve. In addition, third parties
may attempt to fraudulently induce employees or users to disclose information in order to gain access to our data or our users&rsquo;
data. Cyber-attacks continue to evolve in sophistication and volume, and inherently may be difficult to detect for long periods of time.
Although we have developed systems and processes that are designed to protect our data and user data, to prevent data loss, to disable
undesirable accounts and activities on our platform, and to prevent or detect security breaches, we cannot assure you that such measures
will provide absolute security, that we will be able to react in a timely manner, or that our remediation efforts will be successful. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We may experience such cyber-attacks and other
security incidents of varying degrees from time to time, and we may incur significant costs in protecting against or remediating such
incidents. In addition, we are subject to a variety of laws and regulations in the United&nbsp;States and abroad relating to cybersecurity
and data protection. As a result, affected users or government authorities could initiate legal or regulatory actions against us in connection
with any actual or perceived security breaches or improper access to or disclosure of data, which could cause us to incur significant
expense and liability or result in orders or consent decrees forcing us to modify our business practices. Such incidents or our efforts
to remediate such incidents may also result in a decline in our active users base or engagement levels. Any of these events could have
a material and adverse effect on our business, reputation, or financial results. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>&nbsp;</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>We anticipate that our ongoing efforts
related to privacy, safety, security, and content review will identify instances of misuse of user data or other undesirable activity
by third parties on our platform.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> In addition to our efforts to mitigate cybersecurity
risks, we are making significant investments in privacy, safety, security, and content review efforts to combat misuse of our services
and user data by third parties, including investigations and audits of platform applications. As a result of these efforts, we anticipate
that we may discover incidents of misuse of user data or other undesirable activity by third parties. We may not discover all such incidents
or activity, whether as a result of our data or technical limitations, including our lack of visibility over our encrypted services,
the scale of activity on our platform, challenges related to our personnel working remotely during the COVID-19 pandemic, the allocation
of resources to other projects, or other factors, and we may be notified of such incidents or activity by the media or other third parties.
Such incidents and activities may, in the future, include the use of user data or our systems in a manner inconsistent with our terms,
contracts or policies, the existence of false or undesirable user accounts, improper advertising practices, activities that threaten
people&rsquo;s safety on- or offline, or instances of spamming, scraping, data harvesting, unsecured datasets, or spreading misinformation.
We may also be unsuccessful in our efforts to enforce our policies or otherwise remediate any such incidents. Any of the foregoing developments
may negatively affect user trust and engagement, harm our reputation and brands, require us to change our business practices in a manner
adverse to our business, and adversely affect our business and financial results. Any such developments may also subject us to litigation
and regulatory inquiries, which could subject us to monetary penalties and damages, divert management&rsquo;s time and attention, and
lead to enhanced regulatory oversight. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Our products and internal systems rely
on software and hardware that is highly technical, and any errors, bugs, or vulnerabilities in these systems, or failures to address
or mitigate technical limitations in our systems, could adversely affect our business.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Our products and internal systems rely on software
and hardware, including software and hardware developed or maintained internally and/or by third parties, that is highly technical and
complex. In addition, our products and internal systems depend on the ability of such software and hardware to store, retrieve, process,
and manage immense amounts of data. The software and hardware on which we rely may contain, and will in the future may further contain
errors, bugs, or vulnerabilities, and our systems are subject to certain technical limitations that may compromise our ability to meet
our objectives. Some errors, bugs, or vulnerabilities inherently may be difficult to detect and may only be discovered after the code
has been released for external or internal use. Errors, bugs, vulnerabilities, design defects, or technical limitations within the software
and hardware on which we rely have in the past led to, and may in the future lead to, outcomes including a negative experience for users
and marketers who use our products, compromised ability of our products to perform in a manner consistent with our terms, contracts,
or policies, delayed product introductions or enhancements, targeting, measurement, or billing errors, compromised ability to protect
the data of our users and/or our intellectual property or other data, or reductions in our ability to provide some or all of our services.
For example, we make commitments to our users as to how their data will be used within and across our products, and our systems are subject
to errors, bugs and technical limitations that may prevent us from fulfilling these commitments reliably. In addition, any errors, bugs,
vulnerabilities, or defects in our systems or the software and hardware on which we rely, failures to properly address or mitigate the
technical limitations in our systems, or associated degradations or interruptions of service or failures to fulfil our commitments to
our users may in the future lead to outcomes including damage to our reputation, loss of users, loss of marketers, loss of revenue, regulatory
inquiries, litigation, or liability for fines, damages, or other remedies, any of which could adversely affect our business and financial
results. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"> <B>Risks Related to Digital
Assets</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Regulatory changes or actions may restrict
the use of digital assets in a manner that adversely affects our business, prospects or operations.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> FP may be considered a digital asset.&nbsp;Although
FP is not offered on a public blockchain and its value is derived primarily from its utility exclusively within its closed network community,
it may also be subject to increasingly restrictive, complex and evolving U.S.&nbsp;and foreign laws and regulations regarding digital
assets, including commodities and securities, anti-money laundering and counter-terrorist financing, money transmission, consumer protection,
taxation, intellectual property, property rights and other matters (for the purposes of this section, the &ldquo;Digital Asset Laws&rdquo;).
Many of these laws and regulations are subject to change and uncertain interpretation, and could result in outright bans in certain jurisdictions,
sanctions, monetary penalties, claims, increased compliance costs, or declines in adoption that could impede user growth or engagement,
or otherwise harm our business. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> For example, in the United&nbsp;States, the
SEC has been particularly active in pursuing digital asset issuers for unregistered security offerings to U.S.&nbsp;residents. In Korea,
the Financial Services Commission has banned initial coin offerings within Korea. We have not offered KDC in jurisdictions where it would
be prohibited or in a manner that is prohibited. The initial public offering of KDC was conducted on centralized digital asset exchanges
that excluded subscribers from prohibited jurisdictions. Further, we conducted no public solicitation for the offering of KDC in the
United&nbsp;States or South Korea. Nonetheless, because KDC is available on the public blockchain it may be possible for residents in
such jurisdictions to acquire KDC in peer to peer transactions, as most jurisdictions, including the United&nbsp;States and South Korea,
do not prohibit private parties from engaging in peer to peer digital asset transactions. With respect to resales or secondary digital
asset transactions, jurisdictions generally regulate intermediaries for such transactions dependent on the extent and nature of an intermediary&rsquo;s
role in a transaction. Decentralized finance (&ldquo;defi&rdquo;) applications that are connected to the public blockchain have substantially
minimized the role of the intermediary. Given the emerging nature of such defi applications, the regulatory landscape pertaining to such
applications is still evolving and consequently, numerous defi applications are available to transaction parties, often irrespective
of the physical location of a party and irrespective of the actions or inactions of the issuers of such digital assets. To date, we do
not monitor for such defi transactions, nor do we have any prospective plans to do so. Furthermore, given that we would never have access
to the personal information of the parties to such transactions, even if we had the ability to restrict private defi transactions we
would not have the ability to identify whether any particular transaction should be restricted under the Digital Asset Laws of any given
jurisdiction or whether we would be under any obligation to endeavor to enforce such restrictions, to the extent possible. To the extent
government enforcement authorities or regulators seek to enforce current or future Digital Asset Laws against us for these transactions,
we may be subject to investigation, administrative or court proceedings, and civil or criminal monetary fines and penalties, all of which
could harm our reputation and negatively impact our business operations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Regulation of digital assets and digital asset
exchanges is currently undeveloped and likely to evolve rapidly, vary significantly among international regulatory agencies, and is subject
to significant uncertainty. A failure by us to comply with any laws, rules and regulations, some of which may not exist yet or are subject
to interpretation and may be subject to change, could result in a variety of adverse consequences, including civil penalties and fines
imposed by governmental authorities. Under certain circumstances, such failure to comply by us could also result in criminal sanctions </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> As blockchain networks and digital assets have
grown in popularity and in market size, governments and regulatory agencies have begun to take interest in, and in some cases regulate,
their use and operation. To the extent that a government or quasi-governmental agency exerts regulatory authority over a blockchain network
or asset upon which our business relies, our business could be adversely affected. Blockchain networks currently face an uncertain regulatory
landscape in many jurisdictions. The effect of any future legal or regulatory change is impossible to predict, but such laws, regulations
or directives may directly and negatively impact our business. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Governments may in the future curtail or outlaw
the acquisition, use or redemption of digital assets. Ownership of, holding or trading in digital assets may then be considered illegal
and subject to sanction. Governments may also take regulatory action that may increase the cost and/or subject digital asset companies
to additional regulation. Judicial determinations may also have an adverse impact on the trading of digital assets. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Users of Faning are issued FP for engaging
and transacting within our ecosystem. FP may be subject to various regulations in South Korea that restrict or limit the use of FP on
Faning.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> In addition to the application of the Digital
Asset Laws arising as a result of the use of FP in various jurisdictions, our operation of the Faning platform within South Korea and
the issuance of FP to users engaging with the&nbsp;Faning platform may subject us to various regulations in South Korea, including the
Financial Investment Services and Capital Markets Act&nbsp;(&ldquo;FISCM&rdquo;) and the Act on Reporting and Using Specified Financial
Transaction Information (&ldquo;RSFTI&rdquo;). The FISCM was enacted&nbsp;to advance the Korean financial market&nbsp;by improving the
competitive edge of the nation&rsquo;s capital market and financial investment industry, and the RSFTI provides for the regulation of
matters concerning reporting on and use of specified financial transaction information necessary to regulate money laundering and financing
of terrorism through financial transactions, such as foreign exchange transactions, thereby contributing to preventing crimes and further
establishing a sound and transparent financial system. Although FP is not currently classified as a financial investment instrument as
such term is defined in the FISCM, or a virtual asset, as such term is defined by the RSFTI, any amendments to or interpretations of
the FISCM, RSFTI or FP in the future may subject us to regulation, including among other requirements, providing financial transaction
information in order to, among others, prevent money laundering and financing of terrorism. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>We may have security laws exposure relating
to the previous issuances of Kingdom Coin.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> While we no longer hold or otherwise possess
KC, we are subject to compliance with securities laws, which could expose us to potential&nbsp;liabilities, including potential rescission
rights. In August of 2021, we issued to certain creditors of HBC an aggregate total of 348,679,380 KDC in exchange for the cancellation
of an aggregate value of $9,428,664 in HBC debt (the &ldquo;KDC Exchange&rdquo;). Kingdom Coin (&ldquo;KDC&rdquo;) was further listed
on LBank.com in August, 2021, and XT.com in September&nbsp;2021 (LBank.com and XT.com are collectively, the &ldquo;Listing Platforms&rdquo;).
The current market price of KDC ($0.00011) is significantly lower than the valuation of KDC used to extinguish the HBC debt. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> At the time of the KDC Exchange, and subsequently
at the time of listing of KDC on the Listing Platforms, HBC was operated solely under the jurisdiction of the ROK. During the KDC Exchange,
and subsequently upon the listing of KDC on the Listing Platforms, we did not direct any sales efforts in the United&nbsp;States or to
U.S.&nbsp;Persons. Further, pursuant to the terms and conditions of each Listing Platform, neither Listing Platform permits U.S.&nbsp;Persons
as customers. While we therefore believes there were no sales of KDC to or by a U.S.&nbsp;person, or efforts to sell KDC to U.S.&nbsp;persons
that would be subject to U.S.&nbsp;federal securities laws, we relied on each of the Listing Platforms to prevent offers and sales in
the United&nbsp;States and to U.S.&nbsp;persons. As such, we may be subject to the risks below in the event that the policies and procedures
of the Listing Platforms are not effective and/or sufficient to prevent such offers and sales or that persons may have been able to circumvent
such policies and procedures. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> While we do not believe that we were subject
to U.S.&nbsp;federal securities laws at the time of the KDC Exchange and the listing of KDC on the Listing Platforms, and therefore did
not need to conduct the offerings pursuant to an available exemption under the U.S.&nbsp;federal securities laws, the analysis of such
jurisdictional question is factual. The applicability of jurisdiction under the Securities Act, and the availability of any exemptions
thereunder, depends upon our conduct and that of those persons contacting potential investors and making the offering. We further relied
on the terms and conditions of the Listing Platforms to ensure that no offers or sales were made in the United&nbsp;States or to U.S.&nbsp;persons.
As such, if the KDC Exchange, the listing of KDC on the Listing Platforms, or any other such&nbsp;offering of securities by us&nbsp;is
determined by either judicial decision or by the SEC to fall under the jurisdiction of U.S.&nbsp;federal securities laws, and does not
qualify for an exemption from registration under the Securities Act, an investor would have the right to rescind its purchase of the
securities if it so desired. It is possible that if an investor should seek rescission, such investor would succeed. If investors were
successful in seeking rescission, we would face severe financial demands that could adversely affect our business and operations. Additionally,
if we did in fact fall under the jurisdiction of U.S.&nbsp;federal securities laws, or alternatively, if such offerings do not qualify
for an exemption thereunder, we may become subject to significant fines and penalties imposed by the SEC and state securities agencies. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Our certificate of incorporation designates
a state or federal court located within the State of Delaware as the exclusive forum for certain litigation that may be initiated by
our stockholders, which could limit our stockholders</I></B>&rsquo;&nbsp;<B><I>ability to obtain a favorable judicial forum for disputes
with us.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Pursuant to our certificate of incorporation
and our bylaws, unless we consent in writing to the selection of an alternative forum, the sole and exclusive forum for (i)&nbsp;any
derivative action or proceeding brought on our behalf, (ii)&nbsp;any action asserting a claim of breach of a fiduciary duty owed by any
of our directors, officers or other employees to us or our stockholders, (iii)&nbsp;any action asserting a claim against us arising pursuant
to any provision of the Delaware General Corporation Law, (iv)&nbsp;any action asserting a claim against the Corporation governed by
the internal affairs doctrine, in each case subject to the Court of Chancery of the State of Delaware having jurisdiction over the subject
matter and personal jurisdiction over the indispensable parties name as defendants therein, or (v)&nbsp;any action asserting an &ldquo;internal
corporate claim&rdquo; as that term is defined in Section&nbsp;115 of the DGCL.&nbsp;Any person or entity purchasing or otherwise acquiring
any interest in shares of our capital stock shall be deemed to have notice of and consented to this provision. The&nbsp;forum selection&nbsp;clause
in our bylaws may have the effect of discouraging lawsuits against us or our directors and officers and may limit our stockholders&rsquo;
ability to obtain a favorable judicial forum for disputes with us. These choice of forum provisions will not apply to suits brought to
enforce a duty or liability created by the Securities Act, the Exchange&nbsp;Act, or any other claim for which federal courts have exclusive
jurisdiction. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> These exclusive forum provisions may limit
the ability of our stockholders to bring a claim in a judicial forum that such stockholders find favorable for disputes with us or our
directors, officers, or employees, if any, which may discourage such lawsuits against us and our directors, officers, and employees,
if any. Alternatively, if a court were to find the choice of forum provisions contained in our certificate of incorporation to be inapplicable
or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could
materially adversely affect our business, financial condition, and operating results. For example, under the Securities Act, federal
courts have concurrent jurisdiction over all suits brought to enforce any duty or liability created by the Securities Act, and investors
cannot waive compliance with the federal securities laws and the rules and regulations thereunder. In addition, the exclusive forum provisions
described above do not apply to any actions brought under the Exchange&nbsp;Act. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Risks Related to This Offering</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are currently in compliance with
the continued listing requirements of The Nasdaq Capital Market but have a history of non-compliance and should we fail to maintain compliance
with the continued listing requirements of Nasdaq, Nasdaq may delist our common stock.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are required to comply with Nasdaq continued
listing requirements, including a minimum bid price for our common stock and timely filing requirements of all required periodic reports
with the SEC. If we fail in the future to maintain compliance with any of those requirements, our common stock could be delisted from
Nasdaq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On February 5, 2024, we received a delinquency
compliance alert notice from Nasdaq stating that we were not in compliance with the minimum bid price requirement for continued listing
on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2), because the closing bid price of our common stock had been
below $1.00 for the previous 30 consecutive business days. To regain compliance with the minimum bid price requirement, our common stock
was required to maintain a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days during the 180
calendar-day period from February 5, 2024 to August 4, 2024, which was subsequently extended to February 3, 2025. Subsequently, on February
5, 2025, we received a determination letter from the Nasdaq staff stating that we were subject to delisting for failing to meet the minimum
bid price requirement under Nasdaq Listing Rule 5550(a)(2). In order to resolve the deficiency, we implemented a reverse stock split on
January 27, 2025. Following the reverse split, the closing bid price of our common stock met or exceeded $1.00 for ten consecutive business
days and, on February 10, 2025, we received a notice from Nasdaq confirming that we had regained compliance with the minimum bid price
requirement and that the matter was closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On April 18, 2024, we received a delinquency compliance
alert notice from Listing Qualifications Department of The Nasdaq Stock Market LLC advising us that due to our failure to timely file
our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, with the SEC, we are not in compliance with Nasdaq&rsquo;s
continued listing requirements under Nasdaq Listing Rule 5250(c)(1), which requires the timely filing of all required periodic reports
with the SEC. Nasdaq requested that we submit a plan to address the noncompliance issue by June&nbsp; 17, 2024. We submitted the plan
on June 14, 2024. Subsequently, on July 16, 2024, we filed our Annual Report on Form 10-K for the year ended December 31, 2023, thereby
resolving the basis for delisting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On May 21, 2024, we received a delinquency compliance
alert notice from Nasdaq. The notice stated that we were not in compliance with Nasdaq&rsquo;s continued listing requirements under Nasdaq
Listing Rule 5250(c)(1), as we had failed to timely file our Quarterly Report on Form 10-Q for the period ended March 31, 2024, and remained
delinquent in filing our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, with the SEC. Subsequently, we filed
our Quarterly Report on Form 10-Q for the first quarter on September 30, 2024, thereby resolving the basis for delisting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On August 20, 2024, we received a delinquency compliance
alert notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC. The notice stated that we were not in compliance
with Nasdaq&rsquo;s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) because we failed to timely file our Quarterly
Report on Form 10-Q for the period ended June 30, 2024, with the SEC. Subsequently, we filed the Form 10-Q for the second quarter on October
15, 2024, thereby resolving the basis for delisting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On April 24, 2025, we received written notice from
the Listing Qualifications Department of Nasdaq notifying us that we did not timely file our Annual Report on Form 10-K for the year ended
December 31, 2024, as required for continued listing on The Nasdaq Stock Market pursuant to Nasdaq Listing Rule 5250(c)(1).&nbsp;On April
30, 2025, we received written notice from Nasdaq notifying us that, based on the April 30, 2025 filing of the 2024 Form 10-K, we are in
compliance with Nasdaq rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> If, for any reason, Nasdaq delists our common
stock from trading on its exchange and we are unable to obtain listing on another national securities exchange or take action to restore
our compliance with the Nasdaq continued listing requirements, a reduction in some or all of the following may occur, each of which could
have a material adverse effect on our stockholders: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> the
                                            liquidity of our common stock; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> the
                                            market price of our common stock; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> we
                                            will become a &ldquo;penny stock,&rdquo; which will make trading of our common stock much
                                            more difficult; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> our
                                            ability to obtain financing for the continuation of our operations; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> the
                                            number of institutional and general investors that will consider investing in our common
                                            stock; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> the
                                            number of investors in general that will consider investing in our common stock; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> the
                                            number of market makers in our common stock; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> the
                                            availability of information concerning the trading prices and volume of our common stock;
                                            and </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> the
                                            number of broker-dealers willing to execute trades in shares of our common stock. </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The delisting of our common stock from Nasdaq may
make it more difficult for us to raise capital on favorable terms in the future. Such a delisting would likely have a negative effect
on the price of our common stock and would impair your ability to sell or purchase our common stock when you wish to do so. Further, if
our common stock were to be delisted from Nasdaq, it would cease to be recognized as covered securities and we would be subject to regulation
in each state in which we offer our securities. Moreover, there is no assurance that any action that we take to restore our compliance
with the minimum bid price requirement would stabilize the market price or improve the liquidity of our common stock, prevent our common
stock from falling below the minimum bid price required for continued listing again, or prevent future non-compliance with Nasdaq&rsquo;s
listing requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Management will have broad discretion
as to the use of the proceeds from this offering, and we may not use the proceeds effectively.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our management will have broad discretion in the
application of the net proceeds from this offering, including for any of the purposes described in the section entitled &ldquo;Use of
Proceeds,&rdquo; and could spend the proceeds in ways that do not improve our results of operations or enhance the value of our common
stock. Our failure to apply these funds effectively could have a material adverse effect on our business and cause the price of our common
stock to decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You will experience immediate and substantial
dilution in the net tangible book value per share of the common stock you purchase.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Based on an assumed combined public offering
price of $1.24 per share and accompanying Common Warrant (the last reported sales price of our common stock on Nasdaq on November 21,
2025), if you purchase shares of our common stock and related warrants in this offering, you will suffer immediate and substantial dilution
of $0.56 per share with respect to the net tangible book value of the common stock. See the section entitled &ldquo;Dilution&rdquo; below
for a more detailed discussion of the dilution you will incur if you purchase common stock in this offering. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You may experience future dilution
as a result of future equity offerings and other issuances of our common stock or other securities. In addition, this offering and future
equity offerings and other issuances of our common stock or other securities may adversely affect our common stock price.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In order to raise additional capital, we may in
the future offer additional shares of our common stock or other securities convertible into or exchangeable for our common stock at prices
that may not be the same as the price per share in this offering. We may not be able to sell shares or other securities in any other offering
at a price per share that is equal to or greater than the price per share paid by investors in this offering, and investors purchasing
shares or other securities in the future could have rights superior to existing stockholders. The price per share at which we sell additional
shares of our common stock or securities convertible into common stock in future transactions may be higher or lower than the price per
share in this offering. The Common Warrants being issued in this offering contain a full ratchet anti-dilution adjustment which, subject
to limited circumstances, would reduce the exercise price of the Common Warrants in the event that we in the future issue common stock,
or securities convertible into or exercisable to purchase common stock, at a price per share lower than the exercise price then in effect.
You will incur dilution upon exercise of any outstanding stock options, warrants or upon the issuance of shares of common stock under
our Omnibus Equity Incentive Plan. In addition, the sale of shares in this offering and any future sales of a substantial number of shares
of our common stock in the public market, or the perception that such sales may occur, could adversely affect the price of our common
stock. We cannot predict the effect, if any, that market sales of those shares of common stock or the availability of those shares of
common stock for sale will have on the market price of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There is no public market for the Pre-Funded
Warrants and Common Warrants being offered in this offering.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There is no established public trading market for
the Pre-Funded Warrants and Common Warrants being offered in this offering, and we do not expect a market to develop. In addition, we
do not intend to apply to list the Pre-Funded Warrants and Common Warrants on any securities exchange or nationally recognized trading
system. Without an active market, the liquidity of the Pre-Funded Warrants and Common Warrants will be limited.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Holders of our Pre-Funded Warrants
and Common Warrants will have no rights as common stockholders until they acquire our common stock.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Until you acquire shares of common stock upon exercise
of your Pre-Funded Warrants or Common Warrants, you will have no rights with respect to the shares of common stock issuable upon exercise
of your Pre-Funded Warrants or Common Warrants. Upon exercise of your Pre-Funded Warrants or the Common Warrants, you will be entitled
to exercise the rights of a holder of shares only as to matters for which the record date occurs after the exercise date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Pre-Funded Warrants and the Common
Warrants are speculative in nature.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The Pre-Funded Warrants and Common Warrants
offered hereby do not confer any rights of common stock ownership on their holders, such as voting rights or the right to receive dividends,
but rather merely represent the right to acquire shares of common stock at a fixed price. Specifically, commencing on the date of issuance,
holders of the Pre-Funded Warrants may acquire the common stock issuable upon exercise of such warrants at an exercise price of $0.001
per share and holders of the Common Warrants may acquire the common stock issuable upon exercise of such warrants at an exercise price
per share equal to the combined public offering price per share and accompanying Common Warrant in this offering (subject to potential
full ratchet anti-dilution adjustment as a result of a stock issuance or sale at a price less than the exercise price in effect, as provided
in the Common Warrant). Moreover, following this offering, the market value of the Pre-Funded Warrants and the Common Warrants is uncertain,
and there can be no assurance that the market value of the Pre-Funded Warrants or the Common Warrants will equal or exceed their public
offering price. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Common Warrants may not have any
value.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Common Warrant has an exercise price per share
equal to the combined public offering price per share of common stock and accompanying Common Warrant in this offering (subject to potential
full ratchet anti-dilution adjustment as a result of a stock issuance or sale at a price less than the exercise price in effect, as provided
in the Common Warrant) and expires on the fifth anniversary of its original issuance date. In the event the market price per share of
common stock does not exceed the exercise price of the Common Warrants during the period when the Common Warrants are exercisable, the
Common Warrants may not have any value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This is a reasonable best efforts offering,
in which no minimum number or dollar amount of securities is required to be sold, and we may not raise the amount of capital we believe
is required for our business plans.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Placement Agent has agreed to use its reasonable
best efforts to solicit offers to purchase the securities in this offering. The Placement Agent has no obligation to buy any of the securities
from us or to arrange for the purchase or sale of any specific number or dollar amount of the securities. There is no required minimum
number of securities that must be sold as a condition to completion of this offering. Because there is no minimum offering amount required
as a condition to the closing of this offering, the actual offering amount, placement agent fees and proceeds to us are not presently
determinable and may be substantially less than the maximum amounts set forth herein. We may sell fewer than all of the securities offered
hereby, which may significantly reduce the amount of proceeds received by us, and investors in this offering will not receive a refund
in the event that we do not sell an amount of securities sufficient to support our operations. Thus, we may not raise the amount of capital
we believe is required for our operations in the short term and may need to raise additional funds to complete such short-term operations.
Such additional fundraises may not be available or available on terms acceptable to us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Certain provisions of the Pre-Funded
Warrants and Common Warrants could discourage an acquisition of us by a third party.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Certain provisions of the Pre-Funded Warrants and
Common Warrants could make it more difficult or expensive for a third party to acquire us. The Pre-Funded Warrants and Common Warrants
prohibit us from engaging in certain transactions constituting &ldquo;fundamental transactions&rdquo; unless, among other things, the
surviving entity assumes our obligations under the Pre-Funded Warrants and Common Warrants. Further, the Common Warrants provide that,
in the event of certain transactions constituting &ldquo;fundamental transactions,&rdquo; with some exception, holders of such warrants
will have the right, at their option, to require us to repurchase such Common Stock Warrants at a price described in such warrants. These
and other provisions of the Pre-Funded Warrants and Common Warrants could prevent or deter a third party from acquiring us even where
the acquisition could be beneficial to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Purchasers who purchase our securities in
this offering pursuant to a securities purchase agreement may have rights not available to purchasers that purchase without the benefit
of a securities purchase agreement.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> In addition to rights and remedies available
to all purchasers in this offering under U.S. federal securities and state law, the purchasers that enter into a securities purchase
agreement will also be able to bring claims of breach of contract against us. The ability to pursue a claim for breach of contract provides
those investors with the means to enforce the covenants uniquely available to them under the securities purchase agreement including:
(i) timely delivery of shares; (ii) agreement to not enter into variable rate financings for 90 days from closing, subject to certain
exceptions; (iii) agreement to not enter into any equity sales for 90 days from closing, unless the Placement Agent provides its prior
written consent; and (iv) indemnification for breach of contract. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Significant holders or beneficial holders
of our common stock may not be permitted to exercise Pre-Funded Warrants that they hold.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A holder of a Pre-Funded Warrant will not be entitled
to exercise any portion of any Pre-Funded Warrants which, upon giving effect to such exercise, would cause the aggregate number of shares
of our common stock beneficially owned by the holder (together with its affiliates) to exceed 4.99% (or, at the election of the purchaser,
9.99%) of the number of shares of our common stock outstanding immediately after giving effect to the exercise. Such percentage may be
increased or decreased by written notice by the holder of the Pre-Funded Warrants to any other percentage not in excess of 9.99%. Such
increase or decrease will not be effective until the 61st day after such notice is delivered to us. As a result, you may not be able to
exercise your Pre-Funded Warrants for shares of our common stock at a time when it would be financially beneficial for you to do so. In
such circumstances, you could seek to sell your Pre-Funded Warrants to realize value, but you may be unable to do so in the absence of
an established trading market for the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Our stock price may be volatile, and
you could lose all or part of your investment.</I></B>&nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The trading price of our common stock following
our offering may fluctuate substantially and may be higher or lower than the assumed public offering price of $1.24 per share of common
stock and accompanying Common Warrant. This may be especially true for companies with a small public float. The trading price of our
common stock following our offering will depend on several factors, including those described in this &ldquo;Risk Factors&rdquo; section,
many of which are beyond our control and may not be related to our operating performance. These fluctuations could cause you to lose
all or part of your investment in our common stock since you might be unable to sell your shares at or above the price you paid in the
offering.&nbsp; </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> In addition, the stock market in general, and
the market for technology companies in particular, have experienced extreme price and volume fluctuations that have often been unrelated
or disproportionate to the operating performance of those companies. Broad market and industry factors, as well as general economic,
political and market conditions such as recessions or interest rate changes, may seriously affect the market price of our common stock,
regardless of our actual operating performance. These fluctuations may be even more pronounced in the trading market for our stock shortly
following our offering. If the market price of our common stock after our offering does not exceed the initial public offering price,
you may not realize any return on your investment in us and may lose some or all of your investment. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> In addition, in the past, following periods
of volatility in the overall market and the market prices of particular companies&rsquo; securities, securities class action litigations
have often been instituted against these companies. Litigation of this type, if instituted against us, could result in substantial costs
and a diversion of our management&rsquo;s attention and resources. Any adverse determination in any such litigation or any amounts paid
to settle any such actual or threatened litigation could require that we make significant payments. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>If securities industry analysts do not
publish research reports on us, or publish unfavorable reports on us, then the market price and market trading volume of our common stock
could be negatively affected.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Any trading market for our common stock will
be influenced in part by any research reports that securities industry analysts publish about us. We may not obtain any future research
coverage by securities industry analysts. In the event we are covered by research analysts, and one or more of such analysts downgrade
our securities, or otherwise reports on us unfavorably, or discontinues coverage of us, the market price and market trading volume of
our common stock could be negatively affected. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>We have not paid cash dividends in the
past and do not expect to pay dividends in the future. Any return on investment will likely be limited to the value of our common stock.</I></B>&nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We have never paid cash dividends on our common
stock and do not anticipate doing so in the foreseeable future. The payment of dividends on our common stock will depend on earnings,
financial condition and other business and economic factors affecting us at such time as our board of directors may consider relevant.
If we do not pay dividends, our common stock may be less valuable because a return on your investment will only occur if our stock price
appreciates.&nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Since we do not anticipate paying any
cash dividends on our capital stock in the foreseeable future, stock price appreciation, if any, will be your sole source of gain.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We currently intend to retain all of our future
earnings, if any, to finance the growth and development of our business. In addition, the terms of any future debt agreements may preclude
us from paying dividends. As a result, appreciation, if any, in the market price of our common stock will be your sole source of gain
for the foreseeable future. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Future issuances of debt securities,
which would rank senior to our common stock upon our bankruptcy or liquidation, and future issuances of preferred stock, which would
rank senior to our common stock for the purposes of dividends and liquidating distributions, may adversely affect the level of return
you may be able to achieve from an investment in our common stock</I></B>. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> In the future, we may attempt to increase our
capital resources by offering debt securities. In the event of a bankruptcy or liquidation, holders of our debt securities, and lenders
with respect to other borrowings we may make, would receive distributions of our available assets prior to any distributions being made
to holders of our common stock. Moreover, if we issue preferred stock in the future, the holders of such preferred stock could be entitled
to preferences over holders of common stock in respect of the payment of dividends and the payment of liquidating distributions. Because
our decision to issue debt or preferred securities in any future offering, or borrow money from lenders, will depend in part on market
conditions and other factors beyond our control, we cannot predict or estimate the amount, timing or nature of any such future offerings
or borrowings. Holders of our common stock must bear the risk that any such future offerings we conduct or borrowings we make may adversely
affect the level of return they may be able to achieve from an investment in our common stock. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Substantial future sales or perceived
potential sales of our common stock in the public market could cause the price of our common stock to decline.</I></B>&nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> On January 27, 2025, we implemented a 1-for-20
reverse stock split of our issued and outstanding shares of common stock. As a result of the reverse stock split, every 20 shares of
existing common stock were consolidated into one share, reducing the total number of issued shares from 52,808,589 to 2,640,402. All
registered shares of common stock are freely transferable without restriction or additional registration under the Securities Act. Sales
of common stock in the market by registered stockholders, or even the perception that such sales may occur, could cause a decline in
the market price of our common stock and could have a material adverse effect on our business, financial condition, and results of operations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="a_005"></A>CAUTIONARY NOTE
REGARDING FORWARD-LOOKING STATEMENTS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The information in this prospectus and the documents
incorporated by reference herein and any free writing prospectus that we have authorized for use in connection with this offering contain
forward-looking statements and information within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act,
which are subject to the &ldquo;safe harbor&rdquo; created by those sections. These forward-looking statements include, but are not limited
to, statements regarding our future results of operations and financial position, business strategy, prospective platform enhancements,
features, products and services, their expected performance and likelihood of success, plans and objectives of management for future operations
and future results of anticipated platform developments. These statements involve known and unknown risks, uncertainties and other important
factors that may cause our actual results, performance or achievements to be materially different from any future results, performance
or achievements expressed or implied by the forward-looking statements. In some cases, you can identify forward-looking statements by
terms such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;expect,&rdquo; &ldquo;plan,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;could,&rdquo; &ldquo;intend,&rdquo; &ldquo;target,&rdquo; &ldquo;project,&rdquo; &ldquo;contemplate,&rdquo; &ldquo;believe,&rdquo;
&ldquo;estimate,&rdquo; &ldquo;forecast,&rdquo; &ldquo;predict,&rdquo; &ldquo;potential&rdquo; or &ldquo;continue&rdquo; or the negative
of these terms or other similar expressions. These risks and uncertainties include, among other things, the risk that we may not be able
to successfully implement our growth strategy due to the following reasons:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> overall
                                            strength and stability of general economic conditions and of the social media platform and
                                            content creation industry in the United States and globally; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> our
                                            ability to continue as a going concern; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> the
                                            accuracy of our estimates regarding expenses, future revenue, capital requirements and needs
                                            for additional financing; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> changes
                                            in consumer demand for, and acceptance of, our services, including our platform, as well
                                            as social media platforms in general; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> changes
                                            in the competitive environment, including adoption of technologies, services and products
                                            that compete with our own; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> our
                                            expectations regarding our future operating and financial performance; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> the
                                            accuracy of our estimates regarding expenses, future revenue, capital requirements, and needs
                                            for additional financing; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> our
                                            ability to continue as a going concern; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> our
                                            ability to effectively execute our business plan and continue to expand internationally; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> our
                                            ability to recruit, retain and motivate skilled personnel, including key members of senior
                                            management; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> changes
                                            in the price of equipment, network infrastructure, hosting and maintenance; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> uncertainties
                                            around the successful improvement and modification of our existing applications and development
                                            of new products and services, which may require significant expenditures and time; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> changes
                                            in laws or regulations governing our business and operations; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> our
                                            ability to maintain adequate liquidity and financing sources and an appropriate level of
                                            debt on terms favorable to us; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> our
                                            ability to effectively market our services; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> costs
                                            and risks associated with legal proceedings, claims, litigation and government investigations
                                            or inquiries brought against us; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> our
                                            ability to obtain and protect our existing intellectual property protections, including trademarks
                                            and copyrights; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> changes
                                            in accounting principles, or their application or interpretation, and our ability to make
                                            estimates and the assumptions underlying the estimates, which could have an effect on earnings; </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> our
                                            ability to maintain the listing of our shares on The Nasdaq Capital Market or any other exchange;
                                            and </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD><TD> other
                                            risks described from time to time in periodic and current reports that we file with the SEC. </TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As more fully described under the heading &ldquo;Risk
Factors&rdquo; and elsewhere in this prospectus and under &ldquo;Risk Factors&rdquo; in our Annual Report on Form 10-K for the year ended
December 31, 2024 and any additional documents incorporated by reference herein and any free writing prospectus, many important factors
affect our ability to achieve our stated objectives and to develop our Faning platform. We may not actually achieve the plans, intentions
or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements.
These forward-looking statements involve risks and uncertainties that could cause our actual results to differ materially from those in
the forward-looking statements, including, without limitation, the risks and uncertainties set forth in our filings with the SEC and incorporated
by reference herein. You should read this prospectus and the documents incorporated by reference herein and any free writing prospectuses
that we have authorized for use in this offering with the understanding that our actual results or events could differ materially from
the plans, intentions and expectations disclosed in the forward-looking statements that we make. The forward-looking statements are applicable
only as of the date on which they are made, and we do not assume any obligation to update any forward-looking statements, whether as a
result of new information, future events or otherwise, except as required by U.S. federal securities law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You should read this prospectus and the documents
that we incorporate by reference in this prospectus and have filed as exhibits to the registration statement of which this prospectus
is a part completely and with the understanding that our actual future results may be materially different from what we expect. We qualify
all of our forward-looking statements by these cautionary statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><A NAME="a_006"></A>USE OF PROCEEDS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We estimate that the net proceeds from this
offering will be approximately $4.4 million, assuming the number of shares of common stock and Pre-Funded Warrants offered by us, as
set forth on the cover page of this prospectus, remains the same, assuming no exercise of the Common Warrants issued in connection with
this offering, and after deducting placement agent fees and estimated offering expenses payable to us. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">However, this is a reasonable best efforts offering
with no minimum number of securities or amount of proceeds as a condition to closing, and we may not sell all or any of the securities
offered pursuant to this prospectus; and, as a result, we may receive significantly less in net proceeds in this offering. For example,
if we sell only 10%, 25%, 50% or 75% of the maximum amount offered, our net proceeds will be approximately $0.3 million, $1.0 million,
$2.2 million or $3.3 million, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We intend to use the net proceeds from the offering
for working capital and general corporate purposes, including investing in our sales and marketing efforts. As of the date of this prospectus,
we cannot specify with certainty all of the particular uses for the net proceeds from this offering. The amounts and timing of our actual
expenditures will depend on numerous factors, including factors described under &ldquo;Risk Factors&rdquo; in this prospectus and the
documents incorporated by reference herein. Pending our use of the net proceeds from this offering, we intend to invest the net proceeds
in a variety of capital preservation investments, including short-term, investment-grade, interest-bearing instruments and U.S. government
securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><A NAME="a_007"></A>MARKET PRICE OF
OUR COMMON STOCK</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Our common stock trades on The Nasdaq Capital
Market under the symbol &ldquo;GITS.&rdquo; On November 21, 2025, the last reported sale price of our common stock on Nasdaq was $1.24
per share. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> As of November 25, 2025, there were approximately
41 holders of record of our common stock. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>DIVIDEND INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have never paid cash dividends on our common
stock and do not anticipate doing so in the foreseeable future. The payment of dividends on our common stock will depend on earnings,
financial condition and other business and economic factors affecting us at such time as our Board may consider relevant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><A NAME="a_009"></A>DILUTION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If you invest in our securities in this offering,
assuming no sale of any Pre-Funded Warrants and no exercise of the Common Warrants issued in connection with this offering, your ownership
interest will be immediately diluted to the extent of the difference between the assumed combined public offering price per share of our
common stock and accompanying Common Warrant and the as adjusted net tangible book value per share of our common stock immediately after
this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The net tangible book value of our common stock
as of September 30, 2025, was approximately $843,553, or approximately $0.23 per share of common stock based on 3,674,208 shares of common
stock outstanding at that time. &ldquo;Net tangible book value&rdquo; is the amount of our total tangible assets minus our total liabilities.
&ldquo;Net tangible book value per share&rdquo; is net tangible book value divided by the total number of shares outstanding as of September
30, 2025. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> After giving effect to the sale of shares of
common stock in this offering at an assumed combined public offering price of $1.24 per share and accompanying Common Warrant (the last
reported sale price of our common stock on Nasdaq on November 21, 2025), assuming no sale of any Pre-Funded Warrants and no exercise
of the Common Warrants issued in connection with this offering, and after deducting placement agent fees and estimated offering expenses
payable by us, our as adjusted net tangible book value as of September 30, 2025 would have been approximately $5,243,553, or approximately
$0.68 per share of common stock. This amount represents an immediate increase in as adjusted net tangible book value of $0.68 per share
to our existing stockholders and an immediate dilution of $0.56 per share to investors participating in this offering, as illustrated
by the following table: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; text-indent: -9pt; padding-left: 9pt"> Assumed combined public offering price per share and accompanying Common Warrant </TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 9%; text-align: right"> 1.24 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -9pt; padding-left: 9pt"> Net tangible book value per share of common stock as of September&nbsp;30, 2025 </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 0.23 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt"> As adjusted net tangible book value per share after this offering </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 0.68 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt"> Dilution per share to new investors purchasing shares in this offering </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 0.56 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Each $1.00 increase or decrease in the assumed
combined public offering price of $1.24 per share and accompanying Common Warrant, which was the last reported sale price of our common
stock on Nasdaq on November 21, 2025, would increase or decrease the as adjusted net tangible book value per share by $0.43 per share
and the dilution per share to investors participating in this offering by $0.57 per share, assuming that the number of shares offered
by us, as set forth on the cover page of this prospectus, remains the same, assuming no sale of any Pre-Funded Warrants and no exercise
of the Common Warrants issued in connection with this offering, and after deducting placement agent fees and estimated offering expenses
payable by us. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We may also increase or decrease the number
of shares we are offering. A 100,000 share increase in the number of shares offered by us, as set forth on the cover page of this prospectus,
would increase the as adjusted net tangible book value per share by approximately $0.02 and decrease the dilution per share to new investors
participating in this offering by approximately $0.02, based on an assumed combined public offering price of $1.24 per share and accompanying
Common Warrant, which was the last reported sale price of our common stock on Nasdaq on November 21, 2025, remaining the same, assuming
no sale of any Pre-Funded Warrants and no exercise of the Common Warrants issued in connection with this offering, and after deducting
placement agent fees and estimated offering expenses payable by us. Similarly, a 100,000 share decrease in the number of shares offered
by us, as set forth on the cover page of this prospectus, would decrease the as adjusted net tangible book value per share by approximately
$0.02 and increase the dilution per share to new investors participating in this offering by approximately $0.02, based on an assumed
combined public offering price of $1.24 per share and accompanying Common Warrant, which was the last reported sale price of our common
stock on Nasdaq on November 21, 2025, remaining the same, assuming no sale of any Pre-Funded Warrants and no exercise of the Common Warrants
issued in connection with this offering, and after deducting placement agent fees and estimated offering expenses payable by us. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The information above is based on 3,674,208
shares of our common stock outstanding as of September 30, 2025, and excludes as of such date (unless otherwise indicated), the following: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT> </TD><TD> 207,122
                                            shares of common stock issuable upon the exercise of outstanding warrants; and </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT> </TD><TD> an
                                            aggregate of 75,000 shares of common stock reserved for future issuance under our 2022 Omnibus
                                            Equity Incentive Plan as of September 30, 2025. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">To the extent that outstanding exercisable options
or warrants are exercised, you may experience further dilution. In addition, we may need to raise additional capital and to the extent
that we raise additional capital by issuing equity or convertible debt securities your ownership will be further diluted. The information
discussed above is illustrative only and will adjust based on the actual public offering price and other terms of this offering determined
at pricing.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><A NAME="a_010"></A>CAPITALIZATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The following table sets forth our cash and
cash equivalents and our capitalization as of September 30, 2025, as follows: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</FONT> </TD><TD> on
                                            an actual basis; and </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</FONT> </TD><TD> on
                                            an as adjusted basis to give effect to the sale by us of 4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,032,258</FONT> shares of our common stock
                                            in this offering at the assumed public offering price of $1.24 per share of common stock
                                            and accompanying Common Warrant (assuming no sale of any Pre-Funded Warrants and no exercise
                                            of the Common Warrants being sold in this offering), and after deducting placement agent
                                            fees and estimated offering expenses payable by us. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You should consider this table in conjunction with
&ldquo;Use of Proceeds&rdquo; above, as well as our &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results
of Operations&rdquo; and our consolidated audited and unaudited financial statements and the notes to those financial statements incorporated
by reference into this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> As of September&nbsp;30, 2025 </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD><TD STYLE="font-weight: bold; text-decoration: none; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-decoration: none; text-align: center; border-bottom: Black 1.5pt solid"> Actual </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-decoration: none"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <B>As Adjusted <BR> for this <FONT STYLE="text-decoration: none"><BR>
    Offering<BR></FONT></B> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> (unaudited) </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> (unaudited) </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; padding-bottom: 4pt"> Cash and cash equivalents </TD><TD STYLE="width: 1%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left"> $ </TD><TD STYLE="width: 9%; border-bottom: Black 4pt double; text-align: right"> 36,915 </TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left"> &nbsp;$ </TD><TD STYLE="width: 9%; border-bottom: Black 4pt double; text-align: right"> 4,436,915 </TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> Stockholders&rsquo; equity: </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.25in"> Common Stock, 100,000,000 shares authorized; 3,674,208 shares issued and outstanding as of September&nbsp;30, 2025, actual; 7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,706,466</FONT> shares issued and outstanding as of September&nbsp;30, 2025, as adjusted </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"> $ </TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"> 73,485 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp;$ </TD><TD STYLE="text-align: right"> 1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,130</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in"> Additional paid-in capital </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 45,246,934 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 49,5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">66,289</FONT> </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in"> Accumulated deficit </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> (39,689,008 </TD><TD STYLE="text-align: left"> ) </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> (39,689,008 </TD><TD STYLE="text-align: left"> ) </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in"> Accumulated other comprehensive loss </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> (385,825 </TD><TD STYLE="text-align: left"> ) </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> (385,825 </TD><TD STYLE="text-align: left"> ) </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"> Total stockholders&rsquo; equity </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 5,245,586 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 9,645,586 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt"> Total capitalization </TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"> 5,245,586 </TD><TD STYLE="padding-bottom: 4pt; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"> 9,645,586 </TD><TD STYLE="padding-bottom: 4pt; text-align: left"> &nbsp; </TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The information above is based on 3,674,208
shares of our common stock outstanding as of September 30, 2025, and excludes as of such date (unless otherwise indicated), the following: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</FONT> </TD><TD> 207,122
                                            shares of common stock issuable upon the exercise of outstanding warrants; and </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</FONT> </TD><TD> an
                                            aggregate of 75,000 shares of common stock reserved for future issuance under our 2022 Omnibus
                                            Equity Incentive Plan as of September 30, 2025. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We may also increase or decrease the number
of shares we are offering. A 100,000 share increase in the number of shares offered by us, as set forth on the cover page of this prospectus,
would increase the as adjusted total capitalization by approximately $124,000, based on an assumed combined public offering price of
$1.24 per share and accompanying Common Warrant, which was the last reported sale price of our common stock on Nasdaq on November 21,
2025, remaining the same, assuming no sale of any Pre-Funded Warrants and no exercise of the Common Warrants issued in connection with
this offering, no change in the estimated valuation of the Common Warrants liabilities, and after deducting placement agent fees and
estimated offering expenses payable by us. Similarly, a 100,000 share decrease in the number of shares offered by us, as set forth on
the cover page of this prospectus, would decrease the as adjusted total capitalization by approximately $124,000, based on an assumed
combined public offering price of $1.24 per share and accompanying Common Warrant, which was the last reported sale price of our common
stock on Nasdaq on November 21, 2025, remaining the same, assuming no sale of any Pre-Funded Warrants and no exercise of the Common Warrants
issued in connection with this offering, no change in the estimated valuation of the Common Warrants liabilities, and after deducting
placement agent fees and estimated offering expenses payable by us. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The information discussed above is illustrative
only and will adjust based on the actual public offering price and other terms of this offering determined at pricing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="a_011"></A>DESCRIPTION OF
CAPITAL STOCK</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following description of our capital stock
is not complete and may not contain all the information you should consider before investing in our capital stock. This description is
summarized from, and qualified in its entirety by reference to, our certificate of incorporation, which has been publicly filed with the
SEC. See &ldquo;Where You Can Find More Information&rdquo; and &ldquo;Incorporation of Certain Information by Reference.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our authorized capital stock consists of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</FONT> </TD><TD> 100,000,000
                                            shares of common stock, $0.001 par value; and </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</FONT> </TD><TD> 10,000,000
                                            shares of preferred stock, $0.001 par value. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Stock</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Our certificate of incorporation currently
authorizes 100,000,000&nbsp;shares of common stock, par value $0.001 per share, for issuance. As of November&nbsp;25, 2025, there were
3,674,208 shares of our common stock issued and outstanding, which were held by approximately 41 stockholders of record, and 75,000&nbsp;shares
of common stock authorized and available for issuance pursuant to our 2022 Omnibus Equity Incentive Plan. Each holder of common stock
is entitled to one vote for each share of common stock held on all matters submitted to a vote of the stockholders, including the election
of directors. Our certificate of incorporation and bylaws do not and will not provide for cumulative voting rights. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Holders of our common stock have no preemptive,
conversion or subscription rights, and there are no redemption or sinking fund provisions applicable to the common stock. The rights,
preferences and privileges of the holders of common stock are subject to, and may be adversely affected by, the rights of the holders
of shares of any series of our preferred stock that we may designate and issue in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Preferred Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under our certificate of incorporation, our Board
of Directors has the authority, without further action by our stockholders, to issue up to 10,000,000&nbsp;shares of preferred stock,
par value $0.001 per share, in one or more series and to fix the voting powers, designations, preferences and the relative participating,
optional or other special rights and qualifications, limitations and restrictions of each series, including, without limitation, dividend
rights, dividend rates, conversion rights, voting rights, terms of redemption, liquidation preferences and the number of shares constituting
any series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> As of November 25, 2025, no shares of our authorized
preferred stock are outstanding. Because our Board of Directors has the power to establish the preferences and rights of the shares of
any additional series of preferred stock, it may afford holders of any preferred stock preferences, powers and rights, including voting
and dividend rights, senior to the rights of holders of our common stock, which could adversely affect the holders of the common stock
and could delay, discourage or prevent a takeover of us even if a change of control of our company would be beneficial to the interests
of our stockholders. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> As of November 25, 2025, warrants to purchase
a total of 207,122&nbsp;shares of common stock were outstanding, consisting of 125,383 shares at an exercise price of $1.42 per share
and 81,739 shares at an exercise price of $1.29 per share, all exercisable through May 6, 2030. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Anti-Takeover Matters</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B><I>Charter and Bylaw Provisions</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The provisions of Delaware law, our certificate
of incorporation and our bylaws include a number of provisions that may have the effect of delaying, deferring or discouraging another
person from acquiring control of our company and discouraging takeover bids. These provisions may also have the effect of encouraging
persons considering unsolicited tender offers or other unilateral takeover proposals to negotiate with our Board rather than pursue non-
negotiated takeover attempts. These provisions include the items described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B><I>Board Composition and Filling Vacancies</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our bylaws provide that any vacancy on our Board
may only be filled by the affirmative vote of a majority of our directors then in office, even if less than a quorum. Further, any directorship
vacancy resulting from an increase in the size of our Board of Directors, may be filled by election of the Board of Directors, but only
for a term continuing until the next election of directors by our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B><I>No Cumulative Voting</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The Delaware General Corporation Law (DGCL)
provides that stockholders are not entitled to the right to cumulate votes in the election of directors unless the certificate of incorporation
of the company in which they own stock provides otherwise. Neither our certificate of incorporation nor our bylaws provide that our stockholders
shall be entitled to cumulative voting. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B><I>Delaware&nbsp;Anti-Takeover&nbsp;Statute</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are subject to the provisions of Section&nbsp;203
of the DGCL.&nbsp;In general, Section&nbsp;203 prohibits persons deemed to be &ldquo;interested stockholders&rdquo; from engaging in a
&ldquo;business combination&rdquo; with a publicly held Delaware corporation for three&nbsp;years following the date these persons become
interested stockholders unless the business combination is, or the transaction in which the person became an interested stockholder was,
approved in a prescribed manner or another prescribed exception applies. Generally, an &ldquo;interested stockholder&rdquo; is a person
who, together with affiliates and associates, owns, or within three&nbsp;years prior to the determination of interested stockholder status
did own, 15% or more of a corporation&rsquo;s voting stock. Generally, a &ldquo;business combination&rdquo; includes a merger, asset or
stock sale, or other transaction resulting in a financial benefit to the interested stockholder. The existence of this provision may have
an anti-takeover&nbsp;effect with respect to transactions not approved in advance by the Board. A Delaware corporation may &ldquo;opt
out&rdquo; of these provisions with an express provision in its original certificate of incorporation or an express provision in its certificate
of incorporation or bylaws resulting from an amendment approved by at least a majority of the outstanding voting shares. We have not opted
out of these provisions. As a result, mergers or other takeover or change in control attempts of us may be discouraged or prevented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B><I>Choice of Forum</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our bylaws provide that Delaware will be the exclusive
forum for any derivative action or proceeding brought on our behalf; any action asserting a breach of fiduciary duty; any action asserting
a claim against us arising pursuant to the DGCL, our certificate of incorporation or our bylaws; or any action asserting a claim against
us that is governed by the internal affairs doctrine. Such exclusive forum provision does not apply to suits brought to enforce any liability
or duty created by the Securities Act&nbsp;of&nbsp;1933, as amended, or the Securities Exchange&nbsp;Act&nbsp;of&nbsp;1934, as amended.
The enforceability of similar choice of forum provisions in other companies&rsquo; certificates of incorporation has been challenged in
legal proceedings, and it is possible that a court could find these types of provisions to be inapplicable or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Listing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our common stock trades on The Nasdaq Capital Market
under the symbol &ldquo;GITS.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Transfer Agent and Registrar</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our transfer agent is Colonial Stock Transfer whose
address is 66 Exchange Place, Suite 100, Salt Lake City, Utah 84111 and its telephone number is (801)&nbsp;355-5740.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="a_012"></A>DESCRIPTION OF
SECURITIES WE ARE OFFERING</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Stock</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The material terms and provisions of our common
stock are described in the section titled, &ldquo;Description of Capital Stock&rdquo; in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pre-Funded Warrants</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>The following summary of certain terms and provisions
of Pre-Funded Warrants that are being offered hereby is not complete and is subject to, and qualified in its entirety by, the provisions
of the Pre-Funded Warrant, the form of which is filed as an exhibit to the registration statement of which this prospectus forms a part.
Prospective investors should carefully review the terms and provisions of the form of Pre-Funded Warrant for a complete description of
the terms and conditions of the Pre-Funded Warrants.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Duration and Exercise Price</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Each Pre-Funded Warrant offered hereby will
have an initial exercise price of $0.001 per share. The Pre-Funded Warrants will be immediately exercisable and may be exercised at any
time until the Pre-Funded Warrants are exercised in full. The exercise price and number of shares of common stock issuable upon exercise
is subject to appropriate adjustment in the event of stock dividends, stock splits, reorganizations or similar events affecting our common
stock and the exercise price, as described in the Pre-Funded Warrant. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Exercisability</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The Pre-Funded Warrants will be exercisable,
at the option of each holder, in whole or in part, by delivering a duly executed exercise notice accompanied by payment in full for the
number of shares purchased upon such exercise (except in the case of a cashless exercise as discussed below). A holder (together with
its affiliates) may not exercise any portion of the Pre-Funded Warrant to the extent that the holder would own more than 4.99% (or 9.99%
at the election of the holder) of the outstanding common stock immediately after exercise, except that upon at least 61 days&rsquo; prior
notice from the holder to us, the holder may increase the amount of ownership of outstanding stock after exercising the holder&rsquo;s
Pre-Funded Warrants up to 9.99% of the number of shares of common stock outstanding immediately after giving effect to the exercise,
as such percentage ownership is determined in accordance with the terms of the Pre-Funded Warrants. No fractional shares of common stock
will be issued in connection with the exercise of a Pre-Funded Warrant. In lieu of fractional shares, we will pay the holder an amount
in cash equal to the fractional amount multiplied by the exercise price. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Cashless Exercise</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In lieu of making the cash payment otherwise contemplated
to be made to us upon such exercise in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise
(either in whole or in part) the net number of shares of common stock determined according to a formula set forth in the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Fundamental Transactions</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the event of a fundamental transaction, as described
in the Pre-Funded Warrants and generally including any reorganization, recapitalization or reclassification of our common stock pursuant
to which the shares of common stock are converted or exchanged for other securities, cash, or property, the sale, transfer or other disposition
of all or substantially all of our properties or assets, our consolidation or merger with or into another person pursuant to which we
are not the surviving entity, the acquisition of more than 50% of our outstanding voting securities, the holders of the Pre-Funded Warrants
will be entitled to receive upon exercise of the Pre-Funded Warrants the kind and amount of securities, cash or other property that the
holders would have received had they exercised the Pre-Funded Warrants immediately prior to such fundamental transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Transferability</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Subject to applicable laws, a Pre-Funded Warrant
may be transferred at the option of the holder upon surrender of the Pre-Funded Warrant together with the appropriate instruments of transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Exchange Listing</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We do not intend to list the Pre-Funded Warrants
on any securities exchange or nationally recognized trading system.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Rights as a Stockholder</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Except as otherwise provided in the Pre-Funded
Warrants or by virtue of such holder&rsquo;s ownership of, the holders of the Pre-Funded Warrants do not have the rights or privileges
of holders of our common stock, including any voting rights, until they exercise their Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Warrants</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>The following summary of certain terms and provisions
of the Common Warrants that are being offered hereby is not complete and is subject to, and qualified in its entirety by, the provisions
of the Common Warrants, the form of which is filed as an exhibit to the registration statement of which this prospectus forms a part.
Prospective investors should carefully review the terms and provisions of the form of Common Warrant for a complete description of the
terms and conditions of the Common Warrants.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Duration and Exercise Price</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Each Common Warrant offered has an assumed
initial exercise price of $1.24 per share (the last reported sales price of our common stock on Nasdaq on November 21, 2025). The Common
Warrants will be exercisable immediately and will expire on the fifth anniversary of the issuance date. The shares of common stock (or
Pre-Funded Warrants, as applicable) and the Common Warrants will be issued separately and will be immediately separable upon issuance
but will be purchased together in this offering. For each share of common stock (or Pre-Funded Warrant, as applicable) purchased in this
offering, one Common Warrant will be issued. Each whole Common Warrant is exercisable for one share of common stock. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>Anti-Dilution Adjustments to Exercise
Price; Share Combination Event Adjustment</I></B> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B><I>&nbsp;</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The exercise price and number of shares of
common stock issuable upon exercise is subject to appropriate adjustment in the event of stock dividends, stock splits, reorganizations
or similar events affecting our common stock and the exercise price, as described in the Common Warrant. In addition, if we issue or
sell (or are deemed to have issued or sold) any common stock or securities convertible or exercisable into common stock, but excluding
shares of common stock or securities deemed to have been issued or sold by us in an Exempt Issuance (as defined in the Common Warrant)
or to extend the term of such securities, for a consideration per share (the &ldquo;New Issuance Price&rdquo;) less than a price equal
to the exercise price in effect immediately prior to such issuance or sale or deemed issuance or sale (each of the foregoing, a &ldquo;Dilutive
Issuance&rdquo;), then immediately after such Dilutive Issuance, the exercise price then in effect shall be reduced to an amount equal
to the lower of the New Issuance Price and the lowest VWAP of the common stock on Nasdaq on any trading day during the five consecutive
trading day period immediately following the announcement of the Dilutive Issuance, provided the adjusted exercise price shall not be
less than the Floor Price, representing 20% of the exercise price on the issuance date of the Common Warrants. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <FONT STYLE="text-decoration: underline double"></FONT> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <FONT STYLE="text-decoration: none double">If
at any time on or after the date of issuance there occurs any stock split, stock dividend, stock combination, recapitalization or other
similar transaction involving our common stock and the lowest daily VWAP during the period commencing five consecutive trading days immediately
preceding such event is less than the exercise price of the Common Warrants then in effect, then the exercise price of the Common Warrants
will be reduced to the lowest daily VWAP during such period and the number of shares issuable upon exercise will be proportionately adjusted
such that the aggregate exercise price will remain unchanged; provided the adjusted exercise price shall not be less than the Floor Price.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Exercisability</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The Common Warrants will be exercisable, at
the option of each holder, in whole or in part, by delivering a duly executed exercise notice accompanied by payment in full for the
number of purchased upon such exercise (except in the case of a cashless exercise as discussed below). A holder (together with its affiliates)
may not exercise any portion of the Common Warrant to the extent that the holder would own more than 4.99% (or 9.99% at the election
of the holder) of the outstanding common stock immediately after exercise, except that upon at least 61 days&rsquo; prior notice from
the holder to us, the holder may increase the amount of ownership of outstanding stock after exercising the holder&rsquo;s Common Warrants
up to 9.99% of the number of shares of common stock outstanding immediately after giving effect to the exercise, as such percentage ownership
is determined in accordance with the terms of the Common Warrants. No fractional shares of common stock will be issued in connection
with the exercise of a Common Warrant. In lieu of fractional shares, we will pay the holder an amount in cash equal to the fractional
amount multiplied by the exercise price. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Cashless Exercise</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If, at the time a holder exercises its Common Warrants,
a registration statement registering the issuance of the shares of common stock underlying the Common Warrants under the Securities Act
is not then effective or available, then in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise
in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the
net number of shares of common stock determined according to a formula set forth in the Common Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Fundamental Transaction</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the event of a fundamental transaction, as described
in the Common Warrants and generally including any reorganization, recapitalization or reclassification of our common stock pursuant to
which the shares of common stock are converted or exchanged for other securities, cash, or property, the sale, transfer or other disposition
of all or substantially all of our properties or assets, our consolidation or merger with or into another person pursuant to which we
are not the surviving entity, the acquisition of more than 50% of our outstanding voting securities, the holders of the Common Warrants
will be entitled to receive upon exercise of the Common Warrants the kind and amount of securities, cash or other property that the holders
would have received had they exercised the Common Warrants immediately prior to such fundamental transaction. In addition, the holders
of the Common Warrants have the right to require us or a successor entity to redeem the Common Warrant for the cash paid in the fundamental
transaction in the amount of the Black Scholes value of the unexercised portion of the Common Warrant on the date of the consummation
of the fundamental transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Transferability</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Subject to applicable laws, a Common Warrant may
be transferred at the option of the holder upon surrender of the Common Warrant together with the appropriate instruments of transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Exchange Listing</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We do not intend to list the Common Warrants on
any securities exchange or nationally recognized trading system.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Rights as a Stockholder </P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Except as otherwise provided in the Common Warrants
or by virtue of such holder&rsquo;s ownership of, the holders of the Common Warrants do not have the rights or privileges of holders of
our common stock, including any voting rights, until they exercise their Common Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-indent: 0.5in"> <B>Placement Agent Warrants</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <B>&nbsp;</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We have also agreed to issue to the Placement Agent, or its designees, Placement Agent Warrants to purchase
up to a number of shares of common stock equal to 5.0% of the aggregate number of our securities sold in this offering. The Placement
Agent Warrants will have an exercise price equal to 100% of the combined public offering price per share of common stock and accompanying
Common Warrant, will be non-exercisable for six months after the commencement of sales in this offering and will expire five years after
the commencement of sales. See &ldquo;Plan of Distribution&rdquo; below. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="a_013"></A>PLAN OF DISTRIBUTION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to a placement agency agreement, <FONT STYLE="text-decoration-style: double">dated as of [</FONT></FONT><FONT STYLE="text-decoration: none double; font-family: Symbol">&middot;</FONT><FONT STYLE="text-decoration: none double; font-family: Times New Roman, Times, Serif">],
2025,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">between Maxim Group LLC (&ldquo;Maxim&rdquo; or the &ldquo;Placement
Agent&rdquo;) and us, we will engage Maxim to act as our exclusive placement agent in connection with this offering. The Placement Agent
is not purchasing or selling any of the securities offered by this prospectus, nor is it required to arrange the purchase or sale of
any specific number or dollar amount of securities but has agreed to use its reasonable best efforts to arrange for the sale of all of
the securities offered hereby. Therefore, we may not sell the entire amount of securities offered pursuant to this prospectus. Because
there is no minimum offering amount required as a condition to closing this offering, we may sell fewer than all of the securities offered
hereby, which may significantly reduce the amount of proceeds received by us. The Placement Agent does not guarantee that it will be
able to raise new capital in any prospective offering. We will enter into a securities purchase agreement directly with the investors,
at the investor&rsquo;s option, who purchase our securities in this offering. Investors who do not enter into a securities purchase agreement
shall rely solely on this prospectus in connection with the purchase of our securities in this offering. The Placement Agent may engage
one or more subagents or selected dealers in connection with this offering.</FONT> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif">We
will deliver the securities being issued to the investors delivery versus payment. We expect to deliver the securities being offered
pursuant to this prospectus on o<FONT STYLE="text-decoration: none">r about&nbsp;<FONT STYLE="text-decoration-style: double">[</FONT></FONT></FONT><FONT STYLE="font-family: Symbol; text-decoration: none double">&middot;</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; text-decoration: none double">]</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; text-decoration: none">,
2025, subject to the satisfactio</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">n of customary closing conditions.</FONT> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fees and Expenses</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We have engaged Maxim as our exclusive placement
agent in connection with this offering. This offering is being conducted on a &ldquo;reasonable best efforts&rdquo; basis, and the Placement
Agent has no obligation to buy any of the securities from us or to arrange for the purchase or sale of any specific number or dollar
amount of securities. The following table shows the public offering price, placement agent fees, and proceeds (before expenses) to us,
assuming the sale of all securities in this offering and no exercise of any warrants. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Per Share and<BR> Related Common
    Warrant </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Per Pre-Funded<BR> Warrant and<BR>
    Related Common &nbsp;Warrant </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Total </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> Public offering price </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&emsp;&emsp;&nbsp;</FONT> </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&emsp;&emsp;&emsp;&nbsp;</FONT> </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 64%; text-align: left"> Placement agent fees (1) </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 9%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 9%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 9%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> Proceeds to us, before expenses (2) </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"> (1) </TD><TD> We have agreed to provide the Placement Agent a cash placement commission
                                            equal to 7.0% of the public offering price. We have also agreed to reimburse the Placement
                                            Agent for certain expenses incurred in connection with this offering. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"> &nbsp; </TD>
    <TD STYLE="width: 48px; font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT> </TD>
    <TD STYLE="font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount of the offering
    proceeds to us presented in this table does not give effect to any cash exercise of the Pre-Funded Warrants or Common Warrants being
    issued in this offering.</FONT> </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We have also agreed to pay or reimburse the
Placement Agent at closing all reasonable out-of-pocket costs and expenses incident to the performance of the obligations of the Placement
Agent, including without limitation, the reasonable and documented fees and expenses of the Placement Agent&rsquo;s legal counsel, in
an aggregate amount not to exceed $100,000 without our prior approval. In the event the offering does not close, we will reimburse the
Placement Agent for legal fees not to exceed $50,000. We estimate the total expenses payable by us for this offering, excluding placement
agent fees and expenses, will be approximately $100,000. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Placement Agent may be deemed to be an underwriter
within the meaning of Section 2(a)(11) of the Securities Act, and any commissions received by it and any profit realized on the resale
of the shares sold by it while acting as principal might be deemed to be underwriting discounts or commissions under the Securities Act.
As an underwriter, the Placement Agent would be required to comply with the requirements of the Securities Act and the Exchange Act, including,
without limitation, Rule 415(a)(4) under the Securities Act and Rule 10b-5 and Regulation M under the Exchange Act. These rules and regulations
may limit the timing of purchases and sales of shares by the Placement Agent acting as principal. Under these rules and regulations, the
Placement Agent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</FONT> </TD><TD> may
                                            not engage in any stabilization activity in connection with our securities; and </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</FONT> </TD><TD> may
                                            not bid for or purchase any of our securities or attempt to induce any person to purchase
                                            any of our securities, other than as permitted under the Exchange Act, until it has completed
                                            its participation in the distribution. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indemnification</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have agreed to indemnify the Placement Agent
against specified liabilities, including liabilities under the Securities Act, and to contribute to payments the Placement Agent may be
required to make in respect thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Tail Financing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"> Upon a closing, or if
the engagement period ends prior to a closing (other than a termination for &ldquo;cause&rdquo;), then if within 12 months following
such time, we complete any financing of equity, equity-linked, convertible or debt or other capital raising activity with, or receives
any proceeds from, any of the investors contacted or introduced by the Placement Agent during the engagement period, then we will pay
the Placement Agent upon the closing of such financing or receipt of such proceeds the compensation equivalent to (i) a discount or spread
of 7.0% of the public offering price and (ii) common stock purchase warrants covering a number of shares of common stock equal to 5.0%
of the total number of securities being sold in the offering. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <B>Placement Agent Warrants</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We have agreed to grant the Placement Agent,
or its designees, common stock purchase warrants (the &ldquo;Placement Agent Warrants&rdquo;) covering a number of shares of common stock
equal to 5.0% of the total number of securities sold in this offering. The Placement Agent Warrants will be non-exercisable for six months
after the commencement of sales in this offering and will expire five years after the commencement of sales. The Placement Agent Warrants
will be exercisable at a price equal to 100% of the public offering price in connection with this offering. The Placement Agent Warrants
will not be redeemable. The Placement Agent Warrants and the underlying shares of common stock are being registered pursuant to this
registration statement of which this prospectus forms a part. The Placement Agent Warrants may not be transferred, assigned or hypothecated
for a period of six months following the commencement of sales of the offering, except as provided by FINRA Rule 5510(e). The Placement
Agent Warrants will contain provisions for certain demand and piggyback registration rights. The Placement Agent Warrants are otherwise
in substantially similar form to the Common Warrants hereunder. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <B>Right of First Refusal</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <B>&nbsp;</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"> Upon the closing of this
offering, we have agreed, for a period of 12 months following the closing, to grant the Placement Agent the right of first refusal to
act as sole managing underwriter and sole book runner, sole placement agent, or sole sales agent, for any and all future public or private
equity, equity-linked, convertible or debt (excluding commercial bank debt) offerings for which we retain the service of an underwriter,
agent, advisor, finder or other person or entity in connection with such offering by us, or any successor or any subsidiary of ours,
during such 12 month period. We will not offer to retain any entity or person in connection with any such offering on terms more favorable
than terms on which it offers to retain the Placement Agent. Such offer will be made in writing in order to be effective. The Placement
Agent will notify us within ten business days of its receipt of the written offer contemplated above as to whether or not it agrees to
accept such retention. If the Placement Agent declines such retention, we will have no further obligations to the Placement Agent with
respect to the offering for which it has offered to retain the Placement Agent, except as otherwise provided for in the placement agency
agreement. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lock-up Agreements</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Our directors, executive officers and holders
of 10.0% or more of our outstanding shares of common stock as of the effective date of this offering have agreed to enter into lock-up
agreements. Under these agreements, these individuals have agreed, subject to specified exceptions, not to sell or transfer any shares
of common stock or securities convertible into, or exchangeable or exercisable for, our shares of common stock for a period of ninety
days after the closing of this offering, without first obtaining the written consent of the Placement Agent. Specifically, these individuals
have agreed, in part, not to: </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</FONT> </TD><TD> sell,
                                            offer, issue, contract or grant any option to sell (including any short sale), pledge, transfer,
                                            establish an open &ldquo;put equivalent position&rdquo; within the meaning of Rule 16a-l(h)
                                            under the Securities Exchange Act of 1934, as amended; </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</FONT> </TD><TD> enter
                                            into any swap or other arrangement that transfers to another, in whole or in part, any of
                                            the economic consequences of ownership of our securities, whether any such transaction is
                                            to be settled by delivery of our shares of common stock, in cash or otherwise; </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</FONT> </TD><TD> make
                                            any demand for or exercise any right with respect to the registration of any of our securities; </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</FONT> </TD><TD> publicly
                                            disclose the intention to make any offer, sale, pledge or disposition, or to enter into any
                                            transaction, swap, hedge; </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</FONT> </TD><TD> or
                                            other arrangement relating to any of our securities. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Notwithstanding these limitations, these shares
of common stock may be transferred under limited circumstances, including, without limitation, by gift, will or intestate succession.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> In addition, we have agreed that, subject to
certain exceptions, we will not conduct any issuances of, or enter into any agreement to issue or announce the issuance of proposed issuances
of, our common stock or securities convertible into, or exchangeable or exercisable for, our shares of common stock for a period of ninety
days after the closing of this offering. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Discretionary Accounts</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Placement Agent does not intend to confirm
sales of the securities offered hereby to any accounts over which it has discretionary authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Electronic Offer, Sale and Distribution of Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A prospectus in electronic format may be made available
on the websites maintained by the Placement Agent, if any, and the Placement Agent may distribute prospectuses electronically. Other than
the prospectus in electronic format, the information on these websites is not part of this prospectus or the registration statement of
which this prospectus forms a part, has not been approved or endorsed by us or the Placement Agent, and should not be relied upon by investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Other Activities and Relationships</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The Placement Agent and certain of its affiliates
are full service financial institutions engaged in various activities, which may include securities trading, commercial and investment
banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities.
The Placement Agent and certain of its affiliates may in the future perform, various commercial and investment banking and financial
advisory services for us and our affiliates, for which they may receive customary fees and expenses. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the ordinary course of their various business
activities, the Placement Agent and certain of its affiliates may make or hold a broad array of investments and actively trade debt and
equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the
accounts of their customers, and such investment and securities activities may involve securities and/or instruments issued by us and
our affiliates. If the Placement Agent or its affiliates have a lending relationship with us, they routinely hedge their credit exposure
to us consistent with their customary risk management policies. The Placement Agent and its affiliates may hedge such exposure by entering
into transactions that consist of either the purchase of credit default swaps or the creation of short positions in our securities or
the securities of our affiliates, including potentially the common stock offered hereby. Any such short positions could adversely affect
future trading prices of the common stock offered hereby. The Placement Agent and certain of its affiliates may also communicate independent
investment recommendations, market color or trading ideas and/or publish or express independent research views in respect of such securities
or instruments and may at any time hold, or recommend to clients that they acquire, long and/or short positions in such securities and
instruments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Listing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our common stock is traded on The Nasdaq Capital
Market under the symbol &ldquo;GITS.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Transfer Agent and Registrar</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The transfer agent and registrar for our common
stock is Colonial Stock Transfer Company, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Offer Restrictions Outside the United States</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Other than in the United States, no action has
been taken by us or the Placement Agent that would permit a public offering of the securities offered by this prospectus in any jurisdiction
where action for that purpose is required. The securities offered by this prospectus may not be offered or sold, directly or indirectly,
nor may this prospectus or any other offering material or advertisements in connection with the offer and sale of any such securities
be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable rules and
regulations of that jurisdiction. Persons into whose possession this prospectus comes are advised to inform themselves about and to observe
any restrictions relating to the offering and the distribution of this prospectus. This prospectus does not constitute an offer to sell
or a solicitation of an offer to buy any securities offered by this prospectus in any jurisdiction in which such an offer or a solicitation
is unlawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="a_014"></A>LEGAL MATTERS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Olshan Frome Wolosky LLP will pass upon certain
legal matters relating to the issuance and sale of the securities offered hereby on behalf of Global Interactive Technologies, Inc. The
Placement Agent is being represented in connection with this offering by Ellenoff Grossman &amp; Schole LLP. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="a_015"></A>EXPERTS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The consolidated financial statements of Global
Interactive Technologies, Inc. (the Company) as of December 31, 2024 and 2023 and for each of the two years in the period ended December
31, 2024 incorporated by reference in this Prospectus and in the Registration Statement have been so incorporated in reliance on the report
of OneStop Assurance PAC, an independent registered public accounting firm, given on the authority of said firm as experts in auditing
and accounting. The report on the consolidated financial statements contains an explanatory paragraph regarding the Company&rsquo;s ability
to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="a_016"></A>WHERE YOU CAN FIND
MORE INFORMATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This prospectus is part of a registration statement
we filed with the SEC. This prospectus does not contain all of the information set forth in the registration statement and the exhibits
to the registration statement. The registration statement, its exhibits and the documents incorporated by reference in this prospectus
and their exhibits, all contain information that is material to the offering of the securities hereby. Whenever a reference is made in
this prospectus to any of our contracts or other documents, the reference may not be complete. You should refer to the exhibits that are
a part of the registration statement in order to review a copy of the contract or documents. You may obtain copies of the registration
statement and its exhibits via the SEC&rsquo;s EDGAR database.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We file annual, quarterly and current reports,
proxy statements and other information with the SEC. The SEC maintains an Internet site at http://www.sec.gov that contains reports, proxy
and information statements, and other information regarding issuers, such as us, that file electronically with the SEC. Additionally,
you may access our filings with the SEC through our website at www.gitechnologies.com. We have included our website address as an inactive
textual reference only and our website and the information contained on, or that can be accessed through, our website will not be deemed
to be incorporated by reference in, and are not considered part of, this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We will provide you without charge, upon your oral
or written request, with an electronic or paper copy of any or all reports, proxy statements and other documents we file with the SEC,
as well as any or all of the documents incorporated by reference in this prospectus (other than exhibits to such documents unless such
exhibits are specifically incorporated by reference into such documents). Requests for such copies should be directed to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Global Interactive Technologies, Inc.<BR>
160, Yeouiseo-ro, Yeongdeungpo-gu<BR>
Seoul, Republic of Korea, 07231</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Attn.: Chief Financial Officer<BR>
+82-2-564-8588</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You should rely only on the information in this
prospectus and the additional information described above and under the heading &ldquo;Incorporation of Certain Information by Reference&rdquo;
below. We have not authorized any other person to provide you with different information. If anyone provides you with different or inconsistent
information, you should not rely upon it. We are not making an offer to sell these securities in any jurisdiction where such offer or
sale is not permitted. You should assume that the information in this prospectus was accurate on the date of the front cover of this prospectus
only. Our business, financial condition, results of operations and prospects may have changed since that date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="a_017"></A>INCORPORATION OF
CERTAIN INFORMATION BY REFERENCE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The SEC allows us to &ldquo;incorporate by reference&rdquo;
information that we file with it into this prospectus, which means that we can disclose important information to you by referring you
to those documents. The information incorporated by reference is an important part of this prospectus. The information incorporated by
reference is considered to be a part of this prospectus, and information that we file later with the SEC will automatically update and
supersede information contained in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We incorporate by reference the following information
or documents that we have filed with the SEC:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</FONT> </TD><TD> our
                                            Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1911545/000121390025036973/ea0239736-10k_global.htm">Form 10-K</A> for the year ended December 31, 2024, filed on April 30, 2025; </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</FONT> </TD><TD> our
                                            Quarterly Reports on Form 10-Q for the quarter ended March 31, 2025, filed on <A HREF="http://www.sec.gov/Archives/edgar/data/1911545/000121390025045898/ea0242753-10q_globalint.htm">May 20, 2025</A>,
                                            the quarter ended June 30, 2025, filed on <A HREF="http://www.sec.gov/Archives/edgar/data/1911545/000121390025077460/ea0253370-10q_global.htm">August 15, 2025</A>, and the quarter ended September
                                            30, 2025, filed on <A HREF="http://www.sec.gov/Archives/edgar/data/1911545/000121390025108989/ea0264998-10q_global.htm">November 12, 2025</A>; </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</FONT> </TD><TD> our
                                            Current Reports on Form 8-K filed on <A HREF="http://www.sec.gov/Archives/edgar/data/1911545/000121390025001235/ea0226847-8k_global.htm">January 6, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1911545/000121390025005691/ea0228448-8k_global.htm">January 23, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1911545/000121390025011753/ea0230503-8k_global.htm">February 10, 2025</A>,
                                            <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000101376225000590/ea0234733-8k_global.htm" STYLE="-sec-extract: exhibit">March 18, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1911545/000121390025036233/ea0239688-8k_global.htm">April 29, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1911545/000121390025039447/ea0240860-8k_global.htm">May 5, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1911545/000121390025046902/ea0243224-8k_globalint.htm">May 22, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1911545/000121390025057462/ea0246891-8k_globalint.htm">June 25, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1911545/000121390025060743/ea0247980-8k_global.htm">July 2, 2025</A>, and
                                            <A HREF="http://www.sec.gov/Archives/edgar/data/1911545/000121390025085876/ea0256466-8k_global.htm">September 9, 2025</A>, and Form 8-K/A on <A HREF="http://www.sec.gov/Archives/edgar/data/1911545/000121390025063765/ea0248624-8ka1_global.htm">July 14, 2025</A>; and </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</FONT> </TD><TD> the
                                            description of our common stock contained in our Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1911545/000121390023061163/ea182453-8a12b_hanryuhold.htm">Form 8-A </A>filed
                                            with the SEC on July 31, 2023, including any amendments and reports filed for the purpose
                                            of updating such description. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> All reports and other documents (other than
current reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed in such forms that are related to such items unless
such Form 8-K expressly provides to the contrary) we subsequently file pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange
Act, subsequent to the date of this prospectus until the termination of this offering, including all such documents we may file with
the SEC after the date of the initial registration statement and prior to the effectiveness of the registration statement, will also
be incorporated by reference in this prospectus and deemed to be part of this prospectus from the date of the filing of such reports
and documents. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any statement contained in a document incorporated
or deemed to be incorporated by reference in this prospectus shall be deemed modified, superseded or replaced for purposes of this prospectus
to the extent that a statement contained in this prospectus, or in any subsequently filed document that also is deemed to be incorporated
by reference in this prospectus, modifies, supersedes or replaces such statement. Any statement so modified, superseded or replaced shall
not be deemed, except as so modified, superseded or replaced, to constitute a part of this prospectus. None of the information that we
disclose under Items 2.02 or 7.01 of any Current Report on Form 8-K or any corresponding information, either furnished under Item 9.01
or included as an exhibit therein, that we may from time to time furnish to the SEC will be incorporated by reference into, or otherwise
included in, this prospectus, except as otherwise expressly set forth in the relevant document. Subject to the foregoing, all information
appearing in this prospectus is qualified in its entirety by the information appearing in the documents incorporated by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> Up to 4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,032,258</FONT>
Shares of Common Stock<BR>
Up to 4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,032,258</FONT> Pre-Funded Warrants to Purchase up to
4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,032,258</FONT> Shares of Common Stock<BR>
Up to 4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,032,258</FONT> Common Warrants to Purchase up to 4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,032,258</FONT>
Shares of Common Stock </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>Up to 8,064,516 Shares of Common Stock Underlying
the Common Warrants and Pre-Funded Warrants</B> </P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>&nbsp;</B> </P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_001.jpg" ALT=""><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 50%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>PRELIMINARY PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 50%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Sole Placement Agent</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <B>Maxim Group LLC</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-style: normal"><B>,
2025</B></FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 63 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PART II<BR></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">INFORMATION NOT REQUIRED IN PROSPECTUS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item&thinsp;13. Other Expenses of Issuance and
Distribution.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table indicates the expenses to be
incurred in connection with the offering described in this registration statement, other than underwriting discounts and commissions,
all of which will be paid by us. All amounts are estimated except the Securities and Exchange Commission registration fee and the Financial
Industry Regulatory Authority, Inc., or FINRA, filing fee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"> Amount </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left"> Securities and Exchange Commission registration fee </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 9%; text-align: right"> 1,531.00 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> FINRA filing fee </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 1,250.00 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> Accountants&rsquo; fees and expenses </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 16,800.00 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> Legal fees and expenses </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 80,000.00 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt"> Miscellaneous </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 419.00 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> &nbsp; </TD><TD STYLE="font-size: 1pt"> &nbsp; </TD>
    <TD STYLE="font-size: 1pt; text-align: left"> &nbsp; </TD><TD STYLE="font-size: 1pt; text-align: right"> &nbsp; </TD><TD STYLE="font-size: 1pt; text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"> Total expenses </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> 100,000.00 </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> &nbsp; </TD></TR>
  </TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item&thinsp;14. Indemnification of Directors and Officers.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section 145(a) of the Delaware General Corporation
Law (&ldquo;DGCL&rdquo;) provides, in general, that a Delaware corporation may indemnify any person who was or is a party, or is threatened
to be made a party, to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative
(other than an action by or in the right of the corporation) because that person is or was a director, officer, employee or agent of the
corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation or
other enterprise. The indemnity may include expenses (including attorneys&rsquo; fees), judgments, fines and amounts paid in settlement
actually and reasonably incurred by the person in connection with such action, so long as the person acted in good faith and in a manner
he or she reasonably believed was in or not opposed to the corporation&rsquo;s best interests, and, with respect to any criminal action
or proceeding, had no reasonable cause to believe his or her conduct was unlawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section 145(b) of the DGCL provides, in general,
that a Delaware corporation may indemnify any person who was or is a party, or is threatened to be made a party, to any threatened, pending
or completed action or suit by or in the right of the corporation to obtain a judgment in its favor because the person is or was a director,
officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee
or agent of another corporation or other enterprise. The indemnity may include expenses (including attorneys&rsquo; fees) actually and
reasonably incurred by the person in connection with the defense or settlement of such action, so long as the person acted in good faith
and in a manner the person reasonably believed was in or not opposed to the corporation&rsquo;s best interests, except that no indemnification
shall be permitted without judicial approval if a court has determined that the person is to be liable to the corporation with respect
to such claim. Section 145(c) of the DGCL provides that, if a present or former director or officer has been successful in defense of
any action referred to in Sections 145(a) and (b) of the DGCL, the corporation must indemnify such officer or director against the expenses
(including attorneys&rsquo; fees) he or she actually and reasonably incurred in connection with such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section 145(g) of the DGCL provides, in general,
that a corporation may purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of
the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation
or other enterprise against any liability asserted against and incurred by such person, in any such capacity, or arising out of his or
her status as such, whether or not the corporation could indemnify the person against such liability under Section 145 of the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 64; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our certificate of incorporation, as amended, and
our bylaws, as amended, provide for the indemnification of our directors and officers to the fullest extent permitted under the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We also expect to enter into separate indemnification
agreements with our directors and officers in addition to the indemnification provided for in our certificate of incorporation and bylaws.
These indemnification agreements will provide, among other things, that we will indemnify our directors and officers for certain expenses,
including damages, judgments, fines, penalties, settlements and costs and attorneys&rsquo; fees and disbursements, incurred by a director
or officer in any claim, action or proceeding arising in his or her capacity as a director or officer of our company or in connection
with service at our request for another corporation or entity. The indemnification agreements also provide for procedures that will apply
in the event that a director or officer makes a claim for indemnification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We also maintain a directors&rsquo; and officers&rsquo;
insurance policy pursuant to which our directors and officers are insured against liability for actions taken in their capacities as directors
and officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions
or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed
in the Securities Act and is, therefore, unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">See also the undertakings set out in response to
Item 17 of this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item&thinsp;15. Recent Sales of Unregistered Securities.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On January&nbsp;4, 2023 through March&nbsp;8, 2023,
warrants of $1,813,120 were exercised with an exercise price of $1.27 to purchase 1,427,653 shares of common stock by cash of $1,420,144
and debt conversion of $392,776.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In February and March 2023, the Company closed
two private placements solely to accredited investors (as defined by Rule&nbsp;501(a)&nbsp;of Regulation&nbsp;D of the Securities Act)
pursuant to which the Company sold an aggregate amount of 240,000 shares of common stock for $10.00 per share, resulting in gross proceeds
of $2,400,000. The purchase price of the common stock purchased in the private placements is subject to adjustment to the price of the
common stock sold in the Company&rsquo;s initial public offering (IPO), such that additional common stock shall be issued to the purchasers
if the price of common stock sold in the IPO is less than $10.00 per share, or the purchasers shall return common stock to the Company
if the price of the common stock sold in the IPO is greater than $10.00 per share, in each case resulting in the purchasers purchasing
an aggregate amount of $2,400,000 of Company common stock at the IPO price. The offerings were exempt from registration under Section&nbsp;4(a)(2)&nbsp;of
the Securities Act. The subscription agreements pursuant to which the common stock was sold to accredited investors contain customary
representations and warranties of the Company and the investors and customary indemnification rights and obligations of the parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On March&nbsp;24, 2023, warrants of $8,400 were
exercised with an exercise price of $0.42 to purchase 20,000 shares of common stock by cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On April&nbsp;13, 2023, warrants of $420,000 were
exercised with an exercise price of $0.42 to purchase 1,000,000 shares of common stock by cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Between April 20, 2023 and July 31, 2023, Hanryu
Holdings, Inc., now known as Global Interactive Technologies, Inc., raised approximately KRW 5.92 billion (or approximately $4,628,500)
through the issuance of 462,847 shares of common stock at a price of KRW 1,279 (or $10.00) per share in a private placement to 124 Korean
investors. The issuance and sale of these shares of common stock were exempt from registration under the Securities Act pursuant to Section
4(a)(2) of the Securities Act and Regulation S promulgated thereunder. The issuance and sale of the shares of common stock were made pursuant
to an offshore transaction with non-U.S. persons and no directed selling efforts were made in the United States by the Company, a distributor,
any of their respective affiliates, or any person acting on behalf of any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 65 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> On May&nbsp;4, 2023 through May 8, 2023, warrants
of $3,894,666 were exercised with an exercise price of $1.27 to purchase 3,066,666 shares of common stock by cash. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On May&nbsp;31, 2023, the Company completed a private
placement to solely to an accredited investor (as defined by Rule&nbsp;501(a)&nbsp;of Regulation&nbsp;D of the Securities Act) pursuant
to which the Company sold an aggregate amount of 760,000 shares of common stock for $10.00 per share, resulting in gross proceeds of $7,600,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On February 18, 2025, the Company entered into
that certain Debt Conversion Agreement (the <FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;</FONT>Debt Conversion Agreement&rdquo;)
with Evan Trust, a trust for which Amy Shi, a director of the Company, serves as the trustee (the <FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;</FONT>Trust&rdquo;).
Pursuant to the Debt Conversion Agreement, the Company and the Trust agreed to convert certain debt in the amount of $210,000 owed by
the Company to Evan Trust, into 300,000 shares of the Company<FONT STYLE="font-family: Times New Roman, Times, Serif">&rsquo;</FONT>s
common stock. The transaction was conducted pursuant to Regulation S. As a result, the total number of issued shares increased to 2,940,402.
Each holder of common stock is entitled to one vote per share at all meetings of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On February 18, 2025, the Company entered into
a Promissory Note (the &ldquo;February 2025 Note&rdquo;) payable to PixelArc, LLC (&ldquo;PixelArc&rdquo;), a California limited liability
company in which Amy Xianglin Shi, a director of the Company, holds a direct ownership interest and serves in a managerial capacity. The
February 2025 Note evidenced a loan of $86,660 extended by PixelArc to support essential operating obligations during a period of limited
liquidity. The note accrued interest at 8% per annum, had a maturity date of March 14, 2026, and included a 5% late fee and 12% default
interest rate, along with customary default provisions. On April 18, 2025, the Company executed a second Promissory Note (the &ldquo;April
2025 Note&rdquo;) payable to PixelArc, evidencing a short-term, interest-free loan of $86,000 used to satisfy outstanding Nasdaq listing
fees and maintain the Company&rsquo;s continued listing. The note matured on May 15, 2025, and contained the same late fee and default
interest terms as the February 2025 Note. In connection with the April 2025 Note, the Company also entered into a Security Agreement,
dated April 18, 2025 (the &ldquo;Security Agreement&rdquo;), with PixelArc to secure repayment obligations under both notes. Following
nonpayment of the April 2025 Note, PixelArc became entitled to exercise its rights under the Security Agreement. On May 19, 2025, PixelArc
submitted a proposal to convert its outstanding loan balances into equity. On May 20, 2025, PixelArc delivered a formal Notice of Conversion
to the Company, pursuant to which the combined $172,666 in principal amount under the February 2025 and April 2025 Notes were converted
into 246,666 shares of the Company&rsquo;s common stock at a price of $0.70 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> On May 7, 2025, three creditors who lent money
to the Company requested to convert the outstanding loan balance of $455,854 payable by the Company into shares, resulting in the conversion
of 90,123 shares at a price of $1.17 per share and 271,634 shares at a price of $1.29 per share, for a total of 361,757 shares of common
stock. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> On August 19, 2025, warrants to purchase 125,383
shares of common stock were exercised at an aggregate exercise price of $178,044. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The foregoing issuances of common stock were made
to accredited investors in transactions that were exempt from registration under Section 4(a)(2) of the Securities Act and/or Regulation
D or Regulation S thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 66 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item&thinsp;16. Exhibits and Financial Statement
Schedules.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 9%"> <B>Exhibit<BR> Number</B> </TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 90%"> <B>Description</B> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black"> 1.1* </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="ea026610701ex1-1_global.htm">Form of Placement Agency Agreement.</A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black"> 3.1 </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025036973/ea023973601ex3-1_global.htm">Amended
    and Restated Certificate of Incorporation of the Company.<SUP>(1)</SUP></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black"> 3.2 </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390024108011/ea022439201ex3-1_global.htm">Certificate
    of Amendment to the Amended and Restated Certificate of Incorporation of the Company.<SUP>(2)</SUP></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black"> 3.3 </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025005691/ea022844801ex3-1_global.htm">Certificate
    of Amendment to the Amended and Restated Certificate of Incorporation of the Company.<SUP>(3)</SUP></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black"> 3.4 </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025036973/ea023973601ex3-2_global.htm">Bylaws
    of the Company.<SUP>(1)</SUP></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black"> 3.5 </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390024108011/ea022439201ex3-2_global.htm">Amendment
    to the Bylaws of the Company.<SUP>(2)</SUP></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black"> 3.6 </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"><A HREF="http://www.sec.gov/Archives/edgar/data/1911545/000121390025085876/ea025646601ex3-1_global.htm"> Amendment to the Bylaws of the Company.<SUP>(6)</SUP> </A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black"> 4.1 </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025036973/ea023973601ex4-1_global.htm">Form
    of Common Stock Certificate of the Company.<SUP>(1)</SUP></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black"> 4.3* </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="ea026610701ex4-3_global.htm">Form of Common Warrant of the Company to be issued in this offering.</A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black"> 4.4* </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"><A HREF="ea026610701ex4-4_global.htm"> Form of Pre-Funded Warrant of the Company to be issued in this offering. </A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black"> 4.5* </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="ea026610701ex4-5_global.htm">Form of Placement Agent Warrant.</A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black"> 5.1* </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="ea026610701ex5-1_global.htm">Opinion of Olshan Frome Wolosky LLP.</A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black"> 10.2 </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025036973/ea023973601ex10-2_global.htm">2022
    Omnibus Equity Incentive Plan of the Company.<SUP>(1)</SUP></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black"> 10.3 </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025036973/ea023973601ex10-3_global.htm">Employment
    Agreement by and between Taehoon Kim and the Company (formerly Hanryu Holdings, Inc.), dated April 1, 2024.<SUP>(1)</SUP></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black"> 10.4 </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025036973/ea023973601ex10-4_global.htm">Employment
    Agreement by and between Juhyon Shin and the Company (formerly Hanryu Holdings, Inc.), dated April 1, 2024.<SUP>(1)</SUP></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black"> 10.8 </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000101376225000590/ea023473301ex10-1_global.htm">Debt
    Conversion Agreement between the Company and Evan Trust.<SUP>(4)</SUP></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black"> 10.9 </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025046902/ea024322401ex10-1_globalint.htm">Promissory
    Note, dated February 18, 2025, by the Company in favor of PixelArc.<SUP>(5)</SUP></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black"> 10.10 </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025046902/ea024322401ex10-2_globalint.htm">Promissory
    Note, dated April 18, 2025, by the Company in favor of PixelArc.<SUP>(5)</SUP></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black"> 10.11 </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025046902/ea024322401ex10-3_globalint.htm">Security
    Agreement, dated April 18, 2025, between the Company and PixelArc.<SUP>(5)</SUP></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black"> 10.12 </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025046902/ea024322401ex10-4_globalint.htm">Notice
    of Conversion, dated May 20, 2025, between the Company and PixelArc.<SUP>(5)</SUP></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black"> 10.13* </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="ea026610701ex10-13_global.htm">Form of Securities Purchase Agreement.</A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black"> 21.1 </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025036973/ea023973601ex21-1_global.htm">List
    of Subsidiaries.<SUP>(1)</SUP></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black"> 23.1* </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="ea026610701ex23-1_global.htm">Consent of OneStop Assurance PAC, Independent Registered
    Public Accounting Firm.</A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black"> 23.2* </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="ea026610701ex5-1_global.htm">Consent of Olshan Frome Wolosky LLP (included in
    the opinion filed as Exhibit 5.1).</A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black"> 24.1 </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"><A HREF="#d_002"> Power of Attorney (set forth on signature page of the Registration Statement). </A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black"> 107* </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="ea026610701ex-fee_global.htm">Filing Fee Table.</A> </TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">Unless otherwise indicated, the exhibit
has been previously filed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in"> * </TD><TD> Filed herewith. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"> (1) </TD><TD> Incorporated by reference to the Company&rsquo;s Annual Report on Form
                                            10-K filed with the SEC on April 30, 2025. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"> (2) </TD><TD> Incorporated by reference to the Company&rsquo;s Current Report on
                                            Form 8-K filed with the SEC on December 12, 2024. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"> (3) </TD><TD> Incorporated by reference to the Company&rsquo;s Current Report on
                                            Form 8-K filed with the SEC on January 23, 2025. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"> (4) </TD><TD> Incorporated by reference to the Company&rsquo;s Current Report on
                                            Form 8-K filed with the SEC on March 18, 2025. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"> (5) </TD><TD> Incorporated by reference to the Company&rsquo;s Current Report on
                                            Form 8-K filed with the SEC on May 22, 2025. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"> (6) </TD><TD> Incorporated by reference to the Company&rsquo;s Current Report on
                                            Form 8-K filed with the SEC on September 9, 2025. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 67 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item&thinsp;17. Undertakings.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> The undersigned registrant hereby undertakes: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"> (a) </TD><TD STYLE="text-align: justify"> To file, during any
                                            period in which offers or sales are being made, a post-effective amendment to this registration
                                            statement: </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"> (i) </TD><TD> To include any prospectus required by Section 10(a)(3) of the Securities
                                            Act; </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"> (ii) </TD><TD STYLE="text-align: left"> To reflect in the prospectus any facts
                                            or events arising after the effective date of the registration statement (or the most recent
                                            post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental
                                            change in the information set forth in the registration statement. Notwithstanding the foregoing,
                                            any increase or decrease in volume of securities offered (if the total dollar value of securities
                                            offered would not exceed that which was registered) and any deviation from the low or high
                                            end of the estimated maximum offering range may be reflected in the form of prospectus filed
                                            with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price
                                            represent no more than 20 percent change in the maximum aggregate offering price set forth
                                            in the &ldquo;Calculation of Registration Fee&rdquo; or &ldquo;Calculation of Registration
                                            Fee&rdquo; table in the effective registration statement; and </TD></TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 1in"></TD><TD STYLE="text-align: left; width: 0.5in"> (iii) </TD><TD STYLE="text-align: left"> To
                                            include any material information with respect to the plan of distribution not previously
                                            disclosed in the registration statement or any material change to such information in the
                                            registration statement; </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>provided, however</I>, that paragraphs (1)(i), (1)(ii) and (1)(iii)
above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports
filed with or furnished to the Securities and Exchange Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities
Exchange Act of 1934 that are incorporated by reference in the registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"> (b) </TD><TD STYLE="text-align: left"> That, for the purpose
                                            of determining any liability under the Securities Act, each such post-effective amendment
                                            shall be deemed to be a new registration statement relating to the securities offered therein,
                                            and the offering of such securities at that time shall be deemed to be the initial bona fide
                                            offering thereof. </TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"> (c) </TD><TD STYLE="text-align: left"> To
                                            remove from registration by means of a post-effective amendment any of the securities being
                                            registered which remain unsold at the termination of the offering. </TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"> (d) </TD><TD STYLE="text-align: left"> that,
                                            for the purpose of determining liability under the Securities Act of 1933 to any purchaser,
                                            each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating
                                            to an offering, other than registration statements relying on Rule 430B or other than prospectuses
                                            filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration
                                            statement as of the date it is first used after effectiveness. Provided, however, that no
                                            statement made in a registration statement or prospectus that is part of the registration
                                            statement or made in a document incorporated or deemed incorporated by reference into the
                                            registration statement or prospectus that is part of the registration statement will, as
                                            to a purchaser with a time of contract of sale prior to such first use, supersede or modify
                                            any statement that was made in the registration statement or prospectus that was part of
                                            the registration statement or made in any such document immediately prior to such date of
                                            first use. </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 68 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"> (e) </TD><TD STYLE="text-align: left"> That, for the purpose
                                            of determining liability of the registrant under the Securities Act to any purchaser in the
                                            initial distribution of the securities, the undersigned registrant hereby undertakes that
                                            in a primary offering of securities of the undersigned registrant pursuant to this registration
                                            statement, regardless of the underwriting method used to sell the securities to the purchaser,
                                            if the securities are offered or sold to such purchaser by means of any of the following
                                            communications, the undersigned registrant will be a seller to the purchaser and will be
                                            considered to offer or sell such securities to such purchaser: </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"> (i) </TD><TD> Any preliminary prospectus or prospectus of the undersigned registrant
                                            relating to the offering required to be filed pursuant to Rule 424 (&sect; 230.424 of this
                                            chapter); </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"> (ii) </TD><TD> Any free writing prospectus relating to the offering prepared by
                                            or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"> (iii) </TD><TD> The portion of any other free writing prospectus relating to the
                                            offering containing material information about the undersigned registrant or its securities
                                            provided by or on behalf of the undersigned registrant; and </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"> (iv) </TD><TD> Any other communication that is an offer in the offering made by
                                            the undersigned registrant to the purchaser. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"> (f) </TD><TD STYLE="text-align: left"> Insofar as indemnification
                                            for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers
                                            and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise,
                                            the Registrant has been advised that in the opinion of the SEC such indemnification is against
                                            public policy as expressed in the Act and is, therefore, unenforceable. In the event that
                                            a claim for indemnification against such liabilities (other than the payment by the Registrant
                                            of expenses incurred or paid by a director, officer or controlling person of the Registrant
                                            in the successful defense of any action, suit or proceeding) is asserted by such director,
                                            officer or controlling person in connection with the securities being registered, the Registrant
                                            will, unless in the opinion of its counsel the matter has been settled by controlling precedent,
                                            submit to a court of appropriate jurisdiction the question whether such indemnification by
                                            it is against public policy as expressed in the Act and will be governed by the final adjudication
                                            of such issue. </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"> (g) </TD><TD STYLE="text-align: justify"> That: </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"> (i) </TD><TD> For purposes of determining any liability under the Securities Act
                                            of 1933, the information omitted from the form of prospectus filed as part of this registration
                                            statement in reliance upon Rule 430A and contained in a form of prospectus filed by the Registrant
                                            pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be
                                            part of this registration statement as of the time it was declared effective. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"> (ii) </TD><TD> For the purpose of determining any liability under the Securities
                                            Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed
                                            to be a new registration statement relating to the securities offered therein, and the offering
                                            of such securities at that time shall be deemed to be the initial bona fide offering thereof. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"> (h) </TD><TD STYLE="text-align: left"> That, for purposes of
                                            determining any liability under the Securities Act of 1933, each filing of the Registrant<FONT STYLE="font-family: Times New Roman, Times, Serif">&rsquo;</FONT>s
                                            annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of
                                            1934 (and, where applicable, each filing of an employee benefit plan<FONT STYLE="font-family: Times New Roman, Times, Serif">&rsquo;</FONT>s
                                            annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated
                                            by reference in the registration statement shall be deemed to be a new registration statement
                                            relating to the securities offered therein, and the offering of such securities at that time
                                            shall be deemed to be the initial bona fide offering thereof. </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 69 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="d_002"></A>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Pursuant to the requirements of the Securities
Act of 1933, the registrant has duly caused this Amendment No. 3 to the registration statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in Seoul, Republic of South Korea on the 25<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">th
</FONT> day of November 2025. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD COLSPAN="3"> GLOBAL INTERACTIVE TECHNOLOGIES, INC. </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD COLSPAN="3"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> By: </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"> <I>/s/ Taehoon Kim</I> </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"> &nbsp; </TD>
    <TD STYLE="width: 3%"> &nbsp; </TD>
    <TD STYLE="width: 5%"> Name: </TD>
    <TD STYLE="width: 32%"> Taehoon Kim </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> Title: </TD>
    <TD> Interim Chief Executive Officer </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Pursuant to the requirements of the Securities
Act of 1933, this Amendment No. 3 to the registration statement has been signed by the following persons in the capacities and on the
dates indicated. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: left; width: 33%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="text-align: center; border-bottom: black 1.5pt solid; width: 45%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="text-align: center; border-bottom: black 1.5pt solid; width: 20%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Taehoon Kim</I></FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="text-align: center; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim
    Chief Executive Officer</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
25</FONT>, 2025 </TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taehoon
    Kim</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="text-align: center; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(principal
    executive officer)</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="text-align: center; vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Juhyon Shin</I></FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="text-align: center; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    25</FONT>, 2025 </TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Juhyon
    Shin</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="text-align: center; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(principal
    financial and accounting officer)</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="text-align: center; vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    John S. Morris *</I></FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD ROWSPAN="2" STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    25</FONT>, 2025 </TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
    S. Morris</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Jay Hyong Woo *</I></FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    25, 2025</FONT> </TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jay
    Hyong Woo</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Amy Shi *</I></FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    25, 2025</FONT> </TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amy
    Shi</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Larry Namer *</I></FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    25, 2025</FONT> </TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Larry
    Namer</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt">*By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 36%"><FONT STYLE="font-size: 10pt"><I>/s/ Taehoon Kim</I></FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Taehoon Kim</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Attorney-in-Fact</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 70; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ea026610701ex1-1_global.htm
<DESCRIPTION>FORM OF PLACEMENT AGENCY AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 1.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLACEMENT AGENCY AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 4.5in">[____], 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Maxim Group LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">300 Park Avenue, 16<SUP>th</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">New York, NY 10022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><B>Introduction</B>. Subject
to the terms and conditions herein (this &ldquo;<U>Agreement</U>&rdquo;), Global Interactive Technologies, Inc., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), hereby agrees to sell up to an aggregate of $[____] of registered securities of the Company, including,
but not limited to, an aggregate of [___] shares (the &ldquo;<U>Shares</U>&rdquo;) of the Company&rsquo;s common stock, $0.001 par value
per share (the &ldquo;<U>Common Stock</U>&rdquo;), pre-funded Common Stock purchase warrants to purchase up to an aggregate of [____]
shares of Common Stock (the &ldquo;<U>Prefunded Warrants</U>&rdquo;) and Common Stock purchase warrants to purchase up to an aggregate
of [___] shares of Common Stock (the &ldquo;<U>Common Warrants</U>&rdquo;, together with the Pre-Funded Warrants, the &ldquo;<U>Warrants</U>&rdquo;
and the Common Stock underlying the Warrants, the &ldquo;<U>Warrant Shares</U>&rdquo;, and the Shares, the Warrants, and the Warrant Shares,
the &ldquo;<U>Securities</U>&rdquo;) directly to various investors (each, an &ldquo;<U>Investor</U>&rdquo; and, collectively, the &ldquo;<U>Investors</U>&rdquo;)
through Maxim Group LLC (the &ldquo;<U>Placement Agent</U>&rdquo;) as placement agent. The documents executed and delivered by the Company
and the Investors in connection with the Offering (as defined below), including, without limitation, a securities purchase agreement (the
&ldquo;<U>Purchase Agreement</U>&rdquo;), shall be collectively referred to herein as the &ldquo;<U>Transaction Documents</U>.&rdquo;
Capitalized terms not otherwise defined herein shall have the meaning set forth in the Purchase Agreement. The Placement Agent may retain
other brokers or dealers to act as sub-agents or selected dealers on its behalf in connection with the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The Company hereby confirms
its agreement with the Placement Agent as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 1. Agreement to
Act as Placement Agent</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(a) On
the basis of the representations, warranties and agreements of the Company herein contained, and subject to all the terms and conditions
of this Agreement, the Placement Agent shall be the exclusive placement agent in connection with the offering and sale by the Company
of the Securities pursuant to the Company&rsquo;s registration statement on Form S-1 (File No. 333-288665), as amended (the &ldquo;<U>Registration
Statement</U>&rdquo;), with the terms of such offering (the &ldquo;<U>Offering</U>&rdquo;) to be subject to market conditions and negotiations
between the Company, the Placement Agent and the prospective Investors. The Placement Agent will act on a reasonable best efforts basis
and the Company agrees and acknowledges that there is no guarantee of the successful placement of the Securities, or any portion thereof,
in the prospective Offering. Under no circumstances will the Placement Agent or any of its &ldquo;Affiliates&rdquo; (as defined below)
be obligated to underwrite or purchase any of the Securities for its own account or otherwise provide any financing. The Placement Agent
shall act solely as the Company&rsquo;s agent and not as principal. The Placement Agent shall have no authority to bind the Company with
respect to any prospective offer to purchase Securities and the Company shall have the sole right to accept offers to purchase Securities
and may reject any such offer, in whole or in part. Subject to the terms and conditions hereof, payment of the purchase price for, and
delivery of, the Securities shall be made at one or more closings (each a &ldquo;<U>Closing</U>&rdquo; and the date on which each Closing
occurs, a &ldquo;<U>Closing Date</U>&rdquo;). The Closing of the issuance of the Securities shall occur via &ldquo;Delivery Versus Payment&rdquo;,
i.e., on the Closing Date: (i) the Company shall issue the Shares directly to the account designated by the Placement Agent and, upon
receipt of such Shares, the Placement Agent shall electronically deliver such Shares to the applicable Investor and payment shall be made
by the Placement Agent (or its clearing firm) by wire transfer to the Company and (ii) the Warrants shall be delivered to the Investors
in certificated form. As compensation for services rendered, on each Closing Date, the Company shall pay to the Placement Agent the fees
and expenses set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(i) A
cash fee equal to 7.0% of the gross proceeds received by the Company from the sale of the Securities at the Closing of the Offering;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(ii) Such
number of Common Stock purchase warrants (the &ldquo;<U>Placement Agent Warrants</U>&rdquo;) to the Placement Agent or its designees at
the Closing to purchase shares of Common Stock equal to 5.0% of the aggregate number of Securities sold in the Offering. The Placement
Agent Warrants exercise price shall be 100% of the public offering price per share, shall have an expiration date of 5 years from the
commencement of sales of the Offering and be in a form as agreed upon between the Company and the Placement Agent. The Placement Agent
Warrants shall be subject to a lock-up period for 180 days from the commencement of sales of the Offering except as permitted by Financial
Industry Regulatory Authority (&ldquo;<U>FINRA</U>&rdquo;) Rule 5110(E)(1); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(iii) The
Company also agrees to reimburse Placement Agent&rsquo;s expenses up to a maximum of $100,000 (inclusive of any advance paid by the Company
to the Placement Agent), unless otherwise agreed by the Company and the Placement Agent, payable immediately upon and only in the event
of the Closing of the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(b) The
term of the Placement Agent&rsquo;s exclusive engagement shall be as set forth in the Engagement Letter (as defined herein). Notwithstanding
anything to the contrary contained herein, the provisions concerning confidentiality, indemnification and contribution contained herein
and the Company&rsquo;s obligations contained in the indemnification provisions will survive any expiration or termination of this Agreement,
and the Company&rsquo;s obligation to pay fees actually earned and payable and to reimburse expenses actually incurred and reimbursable
pursuant to Section 1 hereof and which are permitted to be reimbursed under FINRA Rule 5110(g)(4)(A), will survive any expiration or termination
of this Agreement; provided, however, that if for any reason an Offering is not consummated, then the obligation of the Company to reimburse
the Placement Agent for expenses shall not exceed $50,000 in the aggregate. Nothing in this Agreement shall be construed to limit the
ability of the Placement Agent or its Affiliates to pursue, investigate, analyze, invest in, or engage in investment banking, financial
advisory or any other business relationship with Persons (as defined below) other than the Company. As used herein (i) &ldquo;Persons&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind and (ii) &ldquo;Affiliate&rdquo; means
any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with
a Person as such terms are used in and construed under Rule 405 under the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(c) Upon
a Closing or if the Closing of the Offering does not occur prior to the end of the Placement Agent&rsquo;s Engagement Period (as defined
in the Engagement Letter) (other than a termination for Cause (as defined in the Engagement Letter)), then if within twelve (12) months
following such time, the Company completes any financing of equity, equity-linked, convertible or debt or other capital-raising activity
with, or receives any proceeds from, any investors contacted or introduced by the Placement Agent to the Company, then the Company shall
pay to the Placement Agent upon closing of such financing or receipt of such proceeds the cash and warrant compensation as described herein,
in each case only with respect to the portion of such proceeds received from such investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: left; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: left; text-indent: 40.5pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: left; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: left; text-indent: 40.5pt">(d) Upon
the Closing of the Offering or Alternative Transaction (as defined in the Engagement Letter), for a period of twelve (12) months from
such closing, the Company grants the Placement Agent the right of first refusal to act as sole managing underwriter and sole book runner,
sole placement agent, or sole sales agent, for any and all future public and private equity, equity-linked, or debt offerings (excluding
commercial bank debt) for which the Company retains the service of an underwriter, agent, advisor, finder or other person or entity in
connection with such offering, during such twelve (12) month period of the Company, or any successor to or any subsidiary of the Company
(a &ldquo;<U>Subsequent Offering</U>&rdquo;). The Company shall provide the Placement Agent with written notice of its election to engage
in a Subsequent Offering, which notice shall describe the proposed terms and conditions of such Subsequent Offering. The Placement Agent
shall notify the Company within ten (10) Business Days of its receipt of the written offer contemplated above as to whether it agrees
to accept such retention. If the Placement Agent declines to exercise its right of first refusal, the Company shall have the right to
retain any other entity or person in connection with the Subsequent Offering on terms which are not materially more favorable to such
other entity or person than the terms declined by the Placement Agent. If the Placement Agent should decline to exercise its right of
first refusal, the Company shall have no further obligation to the Placement Agent with respect to such other Subsequent Offering, except
as otherwise provided for herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 2. A. Representations,
Warranties and Covenants of the Company</B>. The Company hereby represents, warrants and covenants to the Placement Agent as of the date
hereof, and as of each Closing Date, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(a) <U>Securities
Law Filings</U>. The Company has filed with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) the Registration
Statement under the Securities Act, which was initially confidentially submitted on June 5, 2025, publicly filed on July 14, 2025, as
further amended and declared effective on [____], 2025 for the registration of the Securities under the Securities Act. Following the
determination of pricing among the Company and the prospective Investors introduced to the Company by Placement Agent, the Company will
file with the Commission pursuant to Rules 430A and 424(b) under the Securities Act, and the rules and regulations (the &ldquo;<U>Rules
and Regulations</U>&rdquo;) of the Commission promulgated thereunder, a final prospectus relating to the placement of the Securities,
their respective pricings and the plan of distribution thereof and will advise the Placement Agent of all further information (financial
and other) with respect to the Company required to be set forth therein. Such registration statement, at any given time, including the
exhibits thereto filed at such time, as amended at such time, is hereinafter called the &ldquo;<U>Registration Statement</U>&rdquo;; such
prospectus in the form in which it appears in the Registration Statement at the time of effectiveness is hereinafter called the &ldquo;<U>Preliminary
Prospectus</U>&rdquo;; and the final prospectus, in the form in which it will be filed with the Commission pursuant to Rules 430A and/or
424(b) (including the Preliminary Prospectus as it may be amended or supplemented) is hereinafter called the &ldquo;<U>Final Prospectus</U>.&rdquo;
The Registration Statement at the time it originally became effective is hereinafter called the &ldquo;<U>Original Registration Statement</U>.&rdquo;
Any reference in this Agreement to the Registration Statement, the Original Registration Statement, the Preliminary Prospectus or the
Final Prospectus shall be deemed to refer to and include the documents incorporated by reference therein (the &ldquo;<U>Incorporated Documents</U>&rdquo;),
if any, which were or are filed under the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;), at any
given time, as the case may be; and any reference in this Agreement to the terms &ldquo;amend,&rdquo; &ldquo;amendment&rdquo; or &ldquo;supplement&rdquo;
with respect to the Registration Statement, the Original Registration Statement, the Preliminary Prospectus or the Final Prospectus shall
be deemed to refer to and include the filing of any document under the Exchange Act after the date of this Agreement, or the issue date
of the Preliminary Prospectus or the Final Prospectus, as the case may be, deemed to be incorporated therein by reference. All references
in this Agreement to financial statements and schedules and other information which is &ldquo;contained,&rdquo; &ldquo;included,&rdquo;
&ldquo;described,&rdquo; &ldquo;referenced,&rdquo; &ldquo;set forth&rdquo; or &ldquo;stated&rdquo; in the Registration Statement, the
Preliminary Prospectus or the Final Prospectus (and all other references of like import) shall be deemed to mean and include all such
financial statements and schedules and other information which is or is deemed to be incorporated by reference in the Registration Statement,
the Preliminary Prospectus or the Final Prospectus, as the case may be. As used in this paragraph and elsewhere in this Agreement, &ldquo;<U>Time
of Sale Disclosure Package</U>&rdquo; means the Preliminary Prospectus, any subscription agreement between the Company and the Investors,
the final terms of the Offering provided to the Investors (orally or in writing) and any issuer free writing prospectus as defined in
Rule 433 of the Act (each, an &ldquo;<U>Issuer Free Writing Prospectus</U>&rdquo;), if any, that the parties hereto shall hereafter expressly
agree in writing to treat as part of the Time of Sale Disclosure Package. The term &ldquo;<U>any Prospectus</U>&rdquo; shall mean, as
the context requires, the Preliminary Prospectus, the Final Prospectus, and any supplement to either thereof. The Company has not received
any notice that the Commission has issued or intends to issue a stop order suspending the effectiveness of the Registration Statement
or the use of the Preliminary Prospectus or any prospectus supplement or intends to commence a proceeding for any such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(b) <U>Assurances</U>.
The Original Registration Statement, as amended, (and any further documents to be filed with the Commission) contains all exhibits and
schedules as required by the Securities Act. Each of the Registration Statement and any post-effective amendment thereto, at the time
it became effective, complied in all material respects with the Securities Act and the applicable Rules and Regulations and did not contain
any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein not misleading. The Final Prospectus, as of its date, complied or will comply in all material respects with the Securities Act
and the applicable Rules and Regulations. The Final Prospectus, as amended or supplemented, did not and will not contain as of the date
thereof any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in
light of the circumstances under which they were made, not misleading. The Incorporated Documents, when they were filed with the Commission,
conformed in all material respects to the requirements of the Exchange Act and the applicable Rules and Regulations promulgated thereunder,
and none of such documents, when they were filed with the Commission, contained any untrue statement of a material fact or omitted to
state a material fact necessary to make the statements therein (with respect to Incorporated Documents incorporated by reference in the
Final Prospectus, if any), in light of the circumstances under which they were made not misleading. No post-effective amendment to the
Registration Statement reflecting any facts or events arising after the date thereof which represent, individually or in the aggregate,
a fundamental change in the information set forth therein is required to be filed with the Commission. Except for this Agreement and the
Transaction Documents, there are no documents required to be filed with the Commission in connection with the transaction contemplated
hereby that (x) have not been filed as required pursuant to the Securities Act or (y) will not be filed within the requisite time period.
Except for this Agreement and the Transaction Documents, there are no contracts or other documents required to be described in the Final
Prospectus, or to be filed as exhibits or schedules to the Registration Statement, which have not been described or filed as required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(c) <U>Offering
Materials</U>. Neither the Company nor any of its directors and officers has distributed and none of them will distribute, prior to each
Closing Date, any offering material in connection with the offering and sale of the Securities other than the Time of Sale Disclosure
Package.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(d) <U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and the Time of Sale Disclosure Package and otherwise to carry out its obligations hereunder and thereunder. The execution
and delivery of each of this Agreement by the Company and the consummation by it of the transactions contemplated hereby and thereby have
been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Company&rsquo;s
Board of Directors (the &ldquo;<U>Board of Directors</U>&rdquo;) or the Company&rsquo;s shareholders in connection therewith other than
in connection with the Required Approvals (as defined in the Purchase Agreement). This Agreement has been duly executed by the Company
and, when delivered in accordance with the terms hereof, will constitute the valid and binding obligation of the Company enforceable against
the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited
by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification
and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(e) <U>No
Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the transactions contemplated pursuant to
the Time of Sale Disclosure Package, the issuance and sale of the Securities and the consummation by it of the transactions contemplated
hereby and thereby to which it is a party do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any
Subsidiary&rsquo;s certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with,
or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of
any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental
authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any
property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could
not reasonably be expected to result in a Material Adverse Effect (as defined in the Purchase Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(f) <U>Certificates</U>.
Any certificate signed by an officer of the Company and delivered to the&nbsp;Placement Agent or to counsel for the&nbsp;Placement Agent
shall be deemed to be a representation and warranty by the Company to&nbsp;the Placement Agent as to the matters set forth therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(g) <U>Reliance</U>.
The Company acknowledges that the&nbsp;Placement Agent will rely upon the accuracy and truthfulness of the foregoing representations and
warranties and hereby consents to such reliance.<B> </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(h) <U>Forward-Looking
Statements</U>. No forward-looking statements (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange
Act) contained in the Time of Sale Disclosure Package has been made or reaffirmed without a reasonable basis or has been disclosed other
than in good faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(i) <U>Statistical
or Market-Related Data</U>. Any statistical, industry-related and market-related data included or incorporated by reference in the Time
of Sale Disclosure Package, are based on or derived from sources that the Company reasonably and in good faith believes to be reliable
and accurate, and such data agree with the sources from which they are derived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(j) <U>Certain
Fees; FINRA Affiliations</U>. Except as set forth in the Registration Statement and Final Prospectus, no brokerage or finder&rsquo;s fees
or commissions are or will be payable by the Company, any Subsidiary or Affiliate of the Company to any broker, financial advisor or consultant,
finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents.
There are no other arrangements, agreements or understandings of the Company or, to the Company&rsquo;s knowledge, any of its shareholders
that may affect the Placement Agent&rsquo;s compensation, as determined by FINRA. Other than payments to the Placement Agent for this
Offering, the Company has not made and has no agreements, arrangements or understanding to make any direct or indirect payments (in cash,
securities or otherwise) to: (i)&nbsp;any person, as a finder&rsquo;s fee, consulting fee or otherwise, in consideration of such person
raising capital for the Company or introducing to the Company persons who raised or provided capital to the Company; (ii)&nbsp; any FINRA
member participating in the offering as defined in FINRA Rule 5110 (a &ldquo;<U>Participating Member</U>&rdquo;); or (iii)&nbsp;any person
or entity that has any direct or indirect affiliation or association with any Participating Member, within the 180-day period preceding
the initial filing of the Registration Statement through the 60-day period after the Effective Date. None of the net proceeds of the Offering
will be paid by the Company to any Participating Member or its affiliates, except as specifically authorized herein. To the Company&rsquo;s
knowledge, no officer, director or any beneficial owner of 10% or more of the Company&rsquo;s shares of Common Stock or Common Stock Equivalents
has any direct or indirect affiliation or association with any Participating Member in the Offering. Except for securities purchased on
the open market, no Company Affiliate is an owner of stock or other securities of any Participating Member. No Company Affiliate has made
a subordinated loan to any Participating Member. No proceeds from the sale of the Securities (excluding placement agent compensation as
disclosed in the Registration Statement and the Final Prospectus) will be paid to any Participating Member, any persons associated with
a Participating Member or an affiliate of a Participating Member. Except as disclosed in the Final Prospectus, the Company has not issued
any warrants or other securities or granted any options, directly or indirectly, to the Placement Agent within the 180-day period prior
to the initial filing date of the Prospectus. Except for securities issued to the Placement Agent as disclosed in the Registration Statement
and the Final Prospectus, no person to whom securities of the Company have been privately issued within the 180-day period prior to the
initial filing date of the Registration Statement is a Participating Member, is a person associated with a Participating Member or is
an affiliate of a Participating Member. To the Company&rsquo;s knowledge, no Participating Member in the Offering has a conflict of interest
with the Company. For this purpose, a &ldquo;conflict of interest&rdquo; exists when a Participating Member, the parent or affiliate of
a Participating Member or any person associated with a Participating Member in the aggregate beneficially own 5% or more of the Company&rsquo;s
outstanding subordinated debt or common equity, or 5% or more of the Company&rsquo;s preferred equity. &ldquo;FINRA member participating
in the Offering&rdquo; includes any associated person of a Participating Member in the Offering, any member of such associated person&rsquo;s
immediate family and any affiliate of a Participating Member in the Offering. When used in this Section 3.1(j) the term &ldquo;affiliate
of a FINRA member&rdquo; or &ldquo;affiliated with a FINRA member&rdquo; means an entity that controls, is controlled by or is under common
control with a FINRA member. The Company will advise the Placement Agent and EGS if it learns that any officer, director or owner of 10%
or more of the Company&rsquo;s outstanding shares of Common Stock or Common Stock Equivalents is or becomes an affiliate or associated
person of a Participating Member.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(k) <U>Board
of Directors</U>. The Board of Directors is comprised of the persons set forth in the Registration Statement and Final Prospectus. The
qualifications of the persons serving as board members and the overall composition of the Board of Directors comply with the Sarbanes-Oxley
Act of 2002 and the rules promulgated thereunder applicable to the Company and the rules of the Trading Market (as defined in the Purchase
Agreement). In addition, at least a majority of the persons serving on the Board of Directors qualify as &ldquo;independent&rdquo; as
defined under the rules of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(l) <U>D&amp;O
Questionnaires</U>. To the Company&rsquo;s knowledge, all information contained in the questionnaires most recently completed by each
of the Company&rsquo;s directors and officers is true and correct in all respects and the Company has not become aware of any information
which would cause the information disclosed in such questionnaires become inaccurate and incorrect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(m) <U>Representations,
Warranties and Covenants Incorporated by Reference</U>. Each of the representations, warranties and covenants (together with any related
disclosure schedules thereto) made to the Investors in the Purchase Agreement is hereby incorporated herein by reference (as though fully
restated herein) and is hereby made to, and in favor of, the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><B>B. Representation of the
Placement Agent</B>. The Placement Agent represents and warrants that it is (i) a member in good standing of FINRA, (ii) registered as
a broker/dealer under the Exchange Act, and (iii) licensed as a broker/dealer under the laws of the states applicable to the offers and
sales of Securities by the Placement Agent. The Placement Agent will immediately notify the Company in writing of any change in its status
as such. The Placement Agent covenants that it will use its reasonable best efforts to conduct the transaction hereunder in compliance
with the provisions of this Agreement and the requirements of applicable law. Except as required by law or as contemplated by this Agreement,
the Placement Agent will keep confidential all material nonpublic information, including information regarding the transaction contemplated
hereunder, provided to it by the Company or its affiliates or advisors and use such information only for the purposes contemplated herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 3. Delivery and
Payment</B>. Each Closing shall occur at the offices of Company Counsel (or at such other place as shall be agreed upon by the Placement
Agent and the Company). Subject to the terms and conditions hereof, at each Closing payment of the purchase price for the Securities sold
on such Closing Date shall be made by Federal Funds wire transfer, against delivery of such Securities, and such Securities shall be registered
in such name or names and shall be in such denominations, as the Placement Agent may request at least one business day before the time
of purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Deliveries of the documents
with respect to the purchase of the Securities, if any, shall be made at the offices of Company Counsel. All actions taken at a Closing
shall be deemed to have occurred simultaneously.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B></B></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 4. Covenants and
Agreements of the Company</B>. The Company further covenants and agrees with the Placement Agent as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(a) <U>Registration
Statement Matters</U>. The Company will advise the Placement Agent promptly after it receives notice thereof of the time when any amendment
to the Registration Statement has been filed or becomes effective or any supplement to the Final Prospectus has been filed and will furnish
the Placement Agent with copies thereof. The Company will file promptly all reports and any definitive proxy or information statements
required to be filed by the Company with the Commission pursuant to Section 13(a), 14 or 15(d) of the Exchange Act subsequent to the date
of any Prospectus and for so long as the delivery of a prospectus is required in connection with the Offering. The Company will advise
the Placement Agent, promptly after it receives notice thereof (i) of any request by the Commission to amend the Registration Statement
or to amend or supplement any Prospectus or for additional information, (ii) of the issuance by the Commission of any stop order suspending
the effectiveness of the Registration Statement or any post-effective amendment thereto or any order directed at any Incorporated Document,
if any, or any amendment or supplement thereto or any order preventing or suspending the use of the Preliminary Prospectus or the Final
Prospectus or any prospectus supplement or any amendment or supplement thereto or any post-effective amendment to the Registration Statement,
of the suspension of the qualification of the Securities for offering or sale in any jurisdiction, of the institution or threatened institution
of any proceeding for any such purpose, or of any request by the Commission for the amending or supplementing of the Registration Statement
or a Prospectus or for additional information, (iii) <FONT STYLE="background-color: white">of the issuance by any state securities commission
of any proceedings for the suspension of the qualification of the Securities for offering or sale in any jurisdiction or of the initiation,
or the threatening, of any proceeding for that purpose; (iv)&nbsp;of the mailing and delivery to the Commission for filing of any amendment
or supplement to the Registration Statement or Final Prospectus; (v)&nbsp;of the receipt of any comments or request for any additional
information from the Commission; and (vi)&nbsp;of the happening of any event during the period described in this Section 4(a) that, in
the judgment of the Company, makes any statement of a material fact made in the Registration Statement or the Final Prospectus untrue
or that requires the making of any changes in the Registration Statement or the Final Prospectus in order to make the statements therein,
in light of the circumstances under which they were made, not misleading</FONT>. The Company shall use its best efforts to prevent the
issuance of any such stop order or prevention or suspension of such use.&nbsp; If the Commission shall enter any such stop order or order
or notice of prevention or suspension at any time, the Company will use its best efforts to obtain the lifting of such order at the earliest
possible moment, or will file a new registration statement and use its best efforts to have such new registration statement declared effective
as soon as practicable.&nbsp; Additionally, the Company agrees that it shall comply with the provisions of Rules&nbsp;424(b), 430A, 430B
and 430C, as applicable, under the Securities Act, including with respect to the timely filing of documents thereunder, and will use its
reasonable efforts to confirm that any filings made by the Company under such Rule&nbsp;424(b)&nbsp;are received in a timely manner by
the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(b) <U>Blue
Sky Compliance</U>. The Company will cooperate with the Placement Agent and the Investors in endeavoring to qualify the Securities for
sale under the securities laws of such jurisdictions (United States and foreign) as the Placement Agent and the Investors may reasonably
request and will make such applications, file such documents, and furnish such information as may be reasonably required for that purpose,
provided the Company shall not be required to qualify as a foreign corporation or to file a general consent to service of process in any
jurisdiction where it is not now so qualified or required to file such a consent, and provided further that the Company shall not be required
to produce any new disclosure document. The Company will, from time to time, prepare and file such statements, reports and other documents
as are or may be required to continue such qualifications in effect for so long a period as the Placement Agent may reasonably request
for distribution of the Securities. The Company will advise the Placement Agent promptly of the suspension of the qualification or registration
of (or any such exemption relating to) the Securities for offering, sale or trading in any jurisdiction or any initiation or threat of
any proceeding for any such purpose, and in the event of the issuance of any order suspending such qualification, registration or exemption,
the Company shall use its best efforts to obtain the withdrawal thereof at the earliest possible moment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(c) <U>Amendments
and Supplements to a Prospectus and Other Matters</U>. The Company will comply with the Securities Act and the Exchange Act, and the rules
and regulations of the Commission thereunder, so as to permit the completion of the distribution of the Securities as contemplated in
this Agreement, the Incorporated Documents and any Prospectus. If during the period in which a prospectus is required by law to be delivered
in connection with the distribution of Securities contemplated by the Incorporated Documents or any Prospectus (the &ldquo;<U>Prospectus
Delivery Period</U>&rdquo;), any event shall occur as a result of which, in the judgment of the Company or in the opinion of the Placement
Agent or counsel for the Placement Agent, it becomes necessary to amend or supplement the Incorporated Documents or any Prospectus in
order to make the statements therein, in the light of the circumstances under which they were made, as the case may be, not misleading,
or if it is necessary at any time to amend or supplement the Incorporated Documents or any Prospectus or to file under the Exchange Act
any Incorporated Document to comply with any law, the Company will promptly prepare and file with the Commission, and furnish at its own
expense to the Placement Agent and to dealers, an appropriate amendment to the Registration Statement or supplement to the Registration
Statement, the Incorporated Documents or any Prospectus that is necessary in order to make the statements in the Incorporated Documents
and any Prospectus as so amended or supplemented, in the light of the circumstances under which they were made, as the case may be, not
misleading, or so that the Registration Statement, the Incorporated Documents or any Prospectus, as so amended or supplemented, will comply
with law. Before amending the Registration Statement or supplementing the Incorporated Documents or any Prospectus in connection with
the Offering, the Company will furnish the Placement Agent with a copy of such proposed amendment or supplement and will not file any
such amendment or supplement to which the Placement Agent reasonably objects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(d) <U>Copies
of any Amendments and Supplements to a Prospectus</U>. The Company will furnish the Placement Agent, without charge, during the period
beginning on the date hereof and ending on the later of the last Closing Date of the Offering, as many copies of any Prospectus or prospectus
supplement and any amendments and supplements thereto, as the Placement Agent may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(e) <U>Free
Writing Prospectus</U>. The Company covenants that it will not, unless it obtains the prior written consent of the Placement Agent, make
any offer relating to the Securities that would constitute a Company Free Writing Prospectus or that would otherwise constitute a &ldquo;<U>free
writing prospectus</U>&rdquo; (as defined in Rule 405 of the Securities Act) required to be filed by the Company with the Commission or
retained by the Company under Rule 433 of the Securities Act. In the event that the Placement Agent expressly consents in writing to any
such free writing prospectus (a &ldquo;<U>Permitted Free Writing Prospectus</U>&rdquo;), the Company covenants that it shall (i) treat
each Permitted Free Writing Prospectus as a Company Free Writing Prospectus, and (ii) comply with the requirements of Rule 164 and 433
of the Securities Act applicable to such Permitted Free Writing Prospectus, including in respect of timely filing with the Commission,
legending and record keeping.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(f) <U>Transfer
Agent</U>. The Company will maintain, at its expense, a registrar and transfer agent for the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(g) <U>Earnings
Statement</U>. As soon as practicable and in accordance with applicable requirements under the Securities Act, but in any event not later
than 18 months after the last Closing Date, the Company will make generally available to its security holders and to the Placement Agent
an earnings statement, covering a period of at least 12 consecutive months beginning after the last Closing Date, that satisfies the provisions
of Section 11(a) and Rule 158 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(h) <U>Periodic
Reporting Obligations</U>. During the Prospectus Delivery Period, the Company will duly file, on a timely basis, with the Commission and
the Trading Market all reports and documents required to be filed under the Exchange Act within the time periods and in the manner required
by the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(i) <U>Additional
Documents</U><I>.</I> The Company will enter into any subscription, purchase or other customary agreements as the Placement Agent or the
Investors deem necessary or appropriate to consummate the Offering, all of which will be in form and substance reasonably acceptable to
the Placement Agent and the Investors. The Company agrees that the Placement Agent may rely upon, and each is a third party beneficiary
of, the representations and warranties, and applicable covenants, set forth in any such purchase, subscription or other agreement with
Investors in the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(j) <U>No
Manipulation of Price</U><I>.&nbsp; </I>Neither the Company, nor, to its knowledge, any of its employees, directors or shareholders, has
taken or will take, directly or indirectly, any action designed to or that has constituted or that might reasonably be expected to cause
or result in, under the Exchange Act, or otherwise, stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(k) <U>Acknowledgment</U>.
The Company acknowledges that any advice given by the Placement Agent to the Company is solely for the benefit and use of the Board of
Directors of the Company and may not be used, reproduced, disseminated, quoted or referred to, without the Placement Agent&rsquo;s prior written
consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(l) <U>Announcement
of Offering</U>. The Company acknowledges and agrees that the Placement Agent may, subsequent to the Closing, make public its involvement
with the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(m) <U>Reliance
on Others</U>. The Company confirms that it will rely on its own counsel and accountants for legal and accounting advice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(n) <U>Research
Matters</U><FONT STYLE="font-variant: small-caps">.</FONT> By entering into this Agreement, the Placement Agent does not provide any promise,
either explicitly or implicitly, of favorable or continued research coverage of the Company and the Company hereby acknowledges and agrees
that the Placement Agent&rsquo;s selection as a placement agent for the Offering was in no way conditioned, explicitly or implicitly,
on the Placement Agent providing favorable or any research coverage of the Company. In accordance with FINRA Rule 2241(b)(2)(K), the parties
acknowledge and agree that the Placement Agent has not directly or indirectly offered favorable research, a specific rating or a specific
price target, or threatened to change research, a rating or a price target, to the Company or inducement for the receipt of business or
compensation. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against
the Placement Agent with respect to any conflict of interest that may arise from the fact that the views expressed by their independent
research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company
by the Placement Agent&rsquo;s investment banking divisions. The Company acknowledges that the Placement Agent is a full service securities
firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account
of its customers and hold long or short position in debt or equity securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(o) <U>Subsequent
Equity Sales</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(i) From
the date hereof until ninety (90) days thereafter, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to
issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration
statement or amendment or supplement thereto, other than the Prospectus, <U>provided</U>, <U>however</U>, that the Company may enter into
an agreement to issue of shares of Common Stock with the prior written consent of the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(ii) For
a period from the date hereof until ninety (90) days thereafter, the Company shall be prohibited from effecting or entering into an agreement
to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units
thereof) involving a Variable Rate Transaction. The Placement Agent shall be entitled to obtain injunctive relief against the Company
to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(iii) Notwithstanding
the foregoing, this Section 4(o) shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall be an
Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(p) <U>FINRA</U>.
The Company shall advise the Placement Agent (who shall make an appropriate filing with FINRA) if it is aware that any officer, director,
10% or greater shareholder of the Company or Person that received the Company&rsquo;s unregistered equity securities in the past 180 days
is or becomes an affiliate or associated person of a FINRA member firm prior to the earlier of the termination of this Agreement or the
60-day period after the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B></B></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 5. Conditions
of the Obligations of the Placement Agent</B>. The obligations of the Placement Agent hereunder shall be subject to the accuracy of the
representations and warranties on the part of the Company set forth in Section 2 hereof, in each case as of the date hereof and as of
each Closing Date as though then made, to the timely performance by each of the Company of its covenants and other obligations hereunder
on and as of such dates, and to each of the following additional conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(a) <U>Accountants&rsquo;
Comfort Letter</U>. On the date hereof, the Placement Agent shall have received, and the Company shall have caused to be delivered to
the Placement Agent, a letter from OneStop Assurance PAC (the independent registered public accounting firm of the Company), addressed
to the Placement Agent, dated as of the date hereof, in form and substance satisfactory to the Placement Agent. The letter shall not disclose
any change in the condition (financial or other), earnings, operations, business or prospects of the Company from that set forth in the
Incorporated Documents or the applicable Prospectus or prospectus supplement, which, in the Placement Agent&rsquo;s sole judgment, is material
and adverse and that makes it, in the Placement Agent&rsquo;s sole judgment, impracticable or inadvisable to proceed with the Offering of the
Securities as contemplated by such Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(b) <U>Compliance
with Registration Requirements; No Stop Order; No Objection from the FINRA.</U> Each Prospectus (in accordance with Rule 424(b)) and &ldquo;<U>free
writing prospectus</U>&rdquo; (as defined in Rule 405 of the Securities Act), if any, shall have been duly filed with the Commission,
as appropriate; no stop order suspending the effectiveness of the Registration Statement or any part thereof shall have been issued and
no proceeding for that purpose shall have been initiated or threatened by the Commission; no order preventing or suspending the use of
any Prospectus shall have been issued and no proceeding for that purpose shall have been initiated or threatened by the Commission; no
order having the effect of ceasing or suspending the distribution of the Securities or any other securities of the Company shall have
been issued by any securities commission, securities regulatory authority or stock exchange and no proceedings for that purpose shall
have been instituted or shall be pending or, to the knowledge of the Company, contemplated by any securities commission, securities regulatory
authority or stock exchange; all requests for additional information on the part of the Commission shall have been complied with; and
the FINRA shall have raised no objection to the fairness and reasonableness of the placement terms and arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(c) <U>Corporate
Proceedings</U>. All corporate proceedings and other legal matters in connection with this Agreement, the Registration Statement and each
Prospectus, and the registration, sale and delivery of the Securities, shall have been completed or resolved in a manner reasonably satisfactory
to the Placement Agent&rsquo;s counsel, and such counsel shall have been furnished with such papers and information as it may reasonably have
requested to enable such counsel to pass upon the matters referred to in this Section&nbsp;5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(d) <U>No
Material Adverse Change</U>. Subsequent to the execution and delivery of this Agreement and prior to each Closing Date, in the Placement
Agent&rsquo;s sole judgment after consultation with the Company, there shall not have occurred any Material Adverse Effect or any material adverse
change or development involving a prospective material adverse change in the condition or the business activities, financial or otherwise,
of the Company from the latest dates as of which such condition is set forth in the Registration Statement and Final Prospectus (&ldquo;<U>Material
Adverse Change</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(e) <U>Opinion
of Counsel for the Company</U>. The Placement Agent shall have received on each Closing Date the favorable opinion of U.S. legal counsel
to the Company, dated as of such Closing Date, including, without limitation, a negative assurance letter addressed to the Placement Agent
and in form and substance satisfactory to the Placement Agent and the favorable opinions of foreign legal counsel to the Company, addressed
to the Placement Agent and in form and substance satisfactory to the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(f) <U>Officers&rsquo;
Certificate</U>. The Placement Agent shall have received on each Closing Date a certificate of the Company, dated as of such Closing Date,
signed by the Chief Executive Officer and Chief Financial Officer of the Company, to the effect that, and the Placement Agent shall be
satisfied that, the signers of such certificate have reviewed the Registration Statement, the Incorporated Documents, the Preliminary
Prospectus, the Prospectus, and the Transaction Documents and to the further effect that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(i) The
representations and warranties of the Company in the Purchase Agreement and this Agreement are true and correct, as if made on and as
of such Closing Date, and the Company has complied with all the agreements and satisfied all the conditions on its part to be performed
or satisfied at or prior to such Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(ii) No
stop order suspending the effectiveness of the Registration Statement or the use of the Prospectus has been issued and no proceedings
for that purpose have been instituted or are pending or, to the Company&rsquo;s knowledge, threatened under the Securities Act; no order
having the effect of ceasing or suspending the distribution of the Securities or any other securities of the Company has been issued by
any securities commission, securities regulatory authority or stock exchange in the United States and no proceedings for that purpose
have been instituted or are pending or, to the knowledge of the Company, contemplated by any securities commission, securities regulatory
authority or stock exchange in the United States;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(iii) When
the Registration Statement became effective, at the time of sale, and at all times subsequent thereto up to the delivery of such certificate,
the Registration Statement and the Incorporated Documents, if any, when such documents became effective or were filed with the Commission,
and any Prospectus, contained all material information required to be included therein by the Securities Act and the Exchange Act and
the applicable rules and regulations of the Commission thereunder, as the case may be, and in all material respects conformed to the requirements
of the Securities Act and the Exchange Act and the applicable rules and regulations of the Commission thereunder, as the case may be,
and the Registration Statement and the Incorporated Documents, if any, and any Prospectus, did not and do not include any untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the
light of the circumstances under which they were made, not misleading (provided, however, that the preceding representations and warranties
contained in this paragraph (iii) shall not apply to any statements or omissions made in reliance upon and in conformity with information
furnished in writing to the Company by the Placement Agent expressly for use therein) and, since the effective date of the Registration
Statement, there has occurred no event required by the Securities Act and the rules and regulations of the Commission thereunder to be
set forth in the Incorporated Documents which has not been so set forth; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(iv) Subsequent
to the respective dates as of which information is given in the Registration Statement, the Incorporated Documents and any Prospectus,
there has not been: (a) any Material Adverse Effect; (b) any transaction that is material to the Company and the Subsidiaries taken as
a whole, except transactions entered into in the ordinary course of business; (c) any obligation, direct or contingent, that is material
to the Company and the Subsidiaries taken as a whole, incurred by the Company or any Subsidiary, except obligations incurred in the ordinary
course of business; (d) any material change in the capital stock (except changes thereto resulting from the exercise of outstanding stock
options or warrants) or outstanding indebtedness of the Company or any Subsidiary; (e) any dividend or distribution of any kind declared,
paid or made on the capital stock of the Company; or (f) any loss or damage (whether or not insured) to the property of the Company or
any Subsidiary which has been sustained or will have been sustained which has a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(g) <U>Bring-down
Comfort Letter</U><I>.&nbsp; </I>On each Closing Date, the&nbsp;Placement Agent shall have received from OneStop Assurance PAC, or such
other independent&nbsp;registered public accounting firm of the Company, a letter dated as of such Closing Date, in form and substance
satisfactory to the&nbsp;Placement Agent, to the effect that they reaffirm the statements made in the letter furnished pursuant to subsection&nbsp;(a)&nbsp;of
this Section&nbsp;5, except that the specified date referred to therein for the carrying out of procedures shall be no more than one (1)
business day prior to&nbsp;such Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(h) <U>Lock-Up
Agreements</U>. On the date hereof, the Placement Agent shall have received the executed lock-up agreements, in the form attached as <U>Exhibit
C</U> to the Purchase Agreement from each of the Company&rsquo;s officers, directors and 10% and greater shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(i) <U>Stock
Exchange Listing</U>. The Common Stock shall be registered under the Exchange Act and shall be listed on the Trading Market, and the Company
shall not have taken any action designed to terminate, or likely to have the effect of terminating,&nbsp;the registration of the Common
Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the Trading Market, nor shall the Company have
received any information suggesting that the Commission or the Trading Market is contemplating terminating such registration or listing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(j) <U>Additional
Documents</U>. On or before each Closing Date, the Placement Agent and counsel for the Placement Agent shall have received such information
and documents as they may reasonably require for the purposes of enabling them to pass upon the issuance and sale of the Securities as
contemplated herein, or in order to evidence the accuracy of any of the representations and warranties, or the satisfaction of any of
the conditions or agreements, herein contained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">If any condition specified
in this Section 5 is not satisfied when and as required to be satisfied, this Agreement may be terminated by the Placement Agent by notice
to the Company at any time on or prior to a Closing Date, which termination shall be without liability on the part of any party to any
other party, except that Section 6 (Payment of Expenses), Section 7 (Indemnification and Contribution) and Section 8 (Representations
and Indemnities to Survive Delivery) shall at all times be effective and shall survive such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 6. Payment of
Expenses</B>. Subject to the limitations set forth in Section 1(a)(iii) and Section 1(b) above, the Company agrees to pay all costs, fees
and expenses incurred by the Company in connection with the performance of its obligations hereunder and in connection with the transactions
contemplated hereby, including, without limitation: (i) all expenses incident to the issuance, delivery and qualification of the Securities
(including all printing and engraving costs); (ii) all fees and expenses of the registrar and transfer agent of the Common Stock; (iii)
all necessary issue, transfer and other stamp taxes in connection with the issuance and sale of the Securities; (iv)&nbsp;all fees and
expenses of the Company&rsquo;s counsel, independent public or certified public accountants and other advisors; (v) all costs and expenses
incurred in connection with the preparation, printing, filing, shipping and distribution of the Registration Statement (including financial
statements, exhibits, schedules, consents and certificates of experts), the Preliminary Prospectus, the Final Prospectus and each prospectus
supplement, if any, and all amendments and supplements thereto, and this Agreement; (vi) if applicable, the filing fees incident to the
review and approval by the FINRA of the Placement Agent&rsquo;s participation in the offering and distribution of the Securities; (vii) the
fees and expenses associated with including the Shares and Warrant Shares on the Trading Market; (viii) all costs and expenses incident
to the travel and accommodation of the Company&rsquo;s and the Placement Agent&rsquo;s employees on the &ldquo;<U>roadshow</U>,&rdquo; if any;
and (ix) all other fees, costs and expenses referred to in the section captioned &ldquo;Expenses&rdquo; in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B></B></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 7. Indemnification
and Contribution</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(a) The Company
agrees to indemnify and hold harmless the Placement Agent, and each dealer selected by the Placement Agent that participates in the offer
and sale of the Securities (each a &ldquo;<U>Selected Dealer</U>&rdquo;) and each of their respective directors, officers and employees
and each Person, if any, who controls the Placement Agent or any Selected Dealer (&ldquo;<U>Controlling Person</U>&rdquo;) within the
meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, against any and all loss, liability, claim, damage and
expense whatsoever (including but not limited to any and all legal or other expenses reasonably incurred in investigating, preparing or
defending against any litigation, commenced or threatened, or any claim whatsoever, whether arising out of any action between the Placement
Agent and the Company or between the Placement Agent and any third party or otherwise) to which they or any of them may become subject
under the Securities Act, the Exchange Act or any other statute or at common law or otherwise or under the laws of foreign countries,
arising out of or based upon any untrue statement or alleged untrue statement of a material fact contained in (i) any Preliminary Prospectus,
the Registration Statement or the Final Prospectus (as from time to time each may be amended and supplemented); (ii) any materials or
information provided to investors by, or with the approval of, the Company in connection with the marketing of the offering of the Securities,
including any &ldquo;road show&rdquo; or investor presentations made to investors by the Company (whether in person or electronically);
or (iii) any application or other document or written communication (in this Section 7, collectively called &ldquo;application&rdquo;)
executed by the Company or based upon written information furnished by the Company in any jurisdiction in order to qualify the Securities
under the securities laws thereof or filed with the Commission, any state securities commission or agency, Trading Market or any securities
exchange; or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading, unless such statement or omission was made in reliance
upon and in conformity with written information furnished to the Company with respect to the Placement Agent by or on behalf of the Placement
Agent expressly for use in any Preliminary Prospectus, the Registration Statement or Final Prospectus, or any amendment or supplement
thereto, or in any application, as the case may be. With respect to any untrue statement or omission or alleged untrue statement or omission
made in the Preliminary Prospectus, the indemnity agreement contained in this Section 7 shall not inure to the benefit of the Placement
Agent to the extent that any loss, liability, claim, damage or expense of the Placement Agent results from the fact that a copy of the
Final Prospectus was not given or sent to the Person asserting any such loss, liability, claim or damage at or prior to the written confirmation
of sale of the Securities to such Person as required by the Securities Act and the rules and regulations thereunder, and if the untrue
statement or omission has been corrected in the Final Prospectus, unless such failure to deliver the Final Prospectus was a result of
non-compliance by the Company with its obligations under this Agreement. The Company agrees promptly to notify the Placement Agent of
the commencement of any litigation or proceedings against the Company or any of its officers, directors or Controlling Persons in connection
with the issue and sale of the Securities or in connection with the Registration Statement or the Final Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(b) If
any action is brought against the Placement Agent, a Selected Dealer or a Controlling Person in respect of which indemnity may be sought
against the Company pursuant to Section 7(a), the Placement Agent, such Selected Dealer or Controlling Person, as the case may be, shall
promptly notify the Company in writing of the institution of such action and the Company shall assume the defense of such action, including
the employment and fees of counsel (subject to the reasonable approval of the Placement Agent or such Selected Dealer, as the case may
be) and payment of actual expenses. The Placement Agent, such Selected Dealer or Controlling Person shall have the right to employ its
or their own counsel in any such case, but the fees and expenses of such counsel shall be at the expense of the Placement Agent, such
Selected Dealer or Controlling Person unless (i) the employment of such counsel at the expense of the Company shall have been authorized
in writing by the Company in connection with the defense of such action, or (ii) the Company shall not have employed counsel to have charge
of the defense of such action, or (iii) such indemnified party or parties shall have reasonably concluded that there may be defenses available
to it or them which are different from or additional to those available to the Company (in which case the Company shall not have the right
to direct the defense of such action on behalf of the indemnified party or parties), in any of which events the reasonable fees and expenses
of not more than one additional firm of attorneys selected by the Placement Agent (in addition to local counsel), Selected Dealer and/or
Controlling Person shall be borne by the Company. Notwithstanding anything to the contrary contained herein, if the Placement Agent, Selected
Dealer or Controlling Person shall assume the defense of such action as provided above, the Company shall have the right to approve the
terms of any settlement of such action which approval shall not be unreasonably withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(c) The
Placement Agent agrees to indemnify and hold harmless the Company, its directors, officers and employees and agents who control the Company
within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act against any and all loss, liability, claim, damage
and expense described in the foregoing indemnity from the Company to the Placement Agent, as incurred, but only with respect to untrue
statements or omissions, or alleged untrue statements or omissions made in any Preliminary Prospectus, the Registration Statement or Final
Prospectus or any amendment or supplement thereto or in any application, in reliance upon, and in strict conformity with, written information
furnished to the Company with respect to the Placement Agent by or on behalf of the Placement Agent expressly for use in such Preliminary
Prospectus, the Registration Statement or Final Prospectus or any amendment or supplement thereto or in any such application. In case
any action shall be brought against the Company or any other Person so indemnified based on any Preliminary Prospectus, the Registration
Statement or Final Prospectus or any amendment or supplement thereto or any application, and in respect of which indemnity may be sought
against the Placement Agent, the Placement Agent shall have the rights and duties given to the Company, and the Company and each other
Person so indemnified shall have the rights and duties given to the Placement Agent by the provisions of this Section 7. Notwithstanding
the provisions of this Section 7(c), the Placement Agent shall not be required to indemnify the Company for any amount in excess of the
placement agent commissions applicable to the Securities purchased pursuant to the transactions contemplated pursuant to the Registration
Statement and Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(d) In
order to provide for just and equitable contribution under the Securities Act in any case in which (i) any Person entitled to indemnification
under this Section 7 makes a claim for indemnification pursuant hereto but it is judicially determined (by the entry of a final judgment
or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such
indemnification may not be enforced in such case notwithstanding the fact that this Section 7 provides for indemnification in such case,
or (ii) contribution under the Securities Act, the Exchange Act or otherwise may be required on the part of any such Person in circumstances
for which indemnification is provided under this Section 7, then, and in each such case, the Company and the Placement Agent, severally
and not jointly, shall contribute to the aggregate losses, liabilities, claims, damages and expenses of the nature contemplated by said
indemnity agreement incurred by the Company and the Placement Agent, as incurred, in such proportions that the Placement Agent is responsible
for that portion represented by the percentage that the placement agent commission appearing on the cover page of the Final Prospectus
bears to the initial offering price appearing thereon and the Company is responsible for the balance; provided, that, no Person guilty
of a fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any
Person who was not guilty of such fraudulent misrepresentation. For purposes of this Section, each director, officer and employee of the
Placement Agent or the Company, as applicable, and each Person, if any, who controls the Placement Agent or the Company, as applicable,
within the meaning of Section 15 of the Securities Act shall have the same rights to contribution as the Placement Agent or the Company,
as applicable. Notwithstanding the provisions of this Section 7(d), the Placement Agent shall not be required to contribute any amount
in excess of the placement agent commissions applicable to the Securities purchased pursuant to the transactions contemplated pursuant
to the Registration Statement and Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(e) Within
fifteen days after receipt by any party to this Agreement (or its representative) of notice of the commencement of any action, suit or
proceeding, such party will, if a claim for contribution in respect thereof is to be made against another party (&ldquo;contributing party&rdquo;),
notify the contributing party of the commencement thereof, but the failure to so notify the contributing party will not relieve it from
any liability which it may have to any other party other than for contribution hereunder. In case any such action, suit or proceeding
is brought against any party, and such party notifies a contributing party or its representative of the commencement thereof within the
aforesaid fifteen days, the contributing party will be entitled to participate therein with the notifying party and any other contributing
party similarly notified. Any such contributing party shall not be liable to any party seeking contribution on account of any settlement
of any claim, action or proceeding affected by such party seeking contribution without the written consent of such contributing party.
The contribution provisions contained in this Section 7 are intended to supersede, to the extent permitted by law, any right to contribution
under the Securities Act, the Exchange Act or otherwise available.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(f) The
reimbursement, indemnity and contribution obligations of the Company set forth herein shall apply to any modification of this Agreement
and shall remain in full force and effect regardless of any termination of, or the completion of any Indemnified Person&rsquo;s services
under or in connection with, this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 8. Representations
and Indemnities to Survive Delivery</B>. The respective indemnities, agreements, representations, warranties and other statements of the
Company or any person controlling the Company, of its officers, and of the Placement Agent set forth in or made pursuant to this Agreement
will remain in full force and effect, regardless of any investigation made by or on behalf of the Placement Agent, the Company, or any
of its or their partners, officers or directors or any controlling person, as the case may be, and will survive delivery of and payment
for the Securities sold hereunder and any termination of this Agreement. A successor to a Placement Agent, or to the Company, its directors
or officers or any person controlling the Company, shall be entitled to the benefits of the indemnity, contribution and reimbursement
agreements contained in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 9. Notices</B>.
All communications hereunder shall be in writing and shall be mailed, hand delivered or e-mailed and confirmed to the parties hereto as
follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">If to the Placement Agent to the address set forth
above, attention: James Siegel, General Counsel, email: jsiegel@maximgrp.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>With a copy to: </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Ellenoff Grossman &amp; Schole LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">1345 Avenue of the Americas, 11th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">New York, New York 10105</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">E-mail: capmkts@egsllp.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Attention: Matthew Bernstein</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Global Interactive Technologies, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">160, Yeouiseo-ro, Yeongdeungpo-gu</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Seoul, Republic of Korea, 07231</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">E-mail: tkc@gitechnologies.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Mr. Taehoon Kim</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>With a copy to: </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Olshan Frome Wolosky LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1325 Avenue of the Americas, 15th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">E-mail: sfeldman@olshanlaw.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Spencer G. Feldman</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Any party hereto may change
the address for receipt of communications by giving written notice to the others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 10. Successors</B>.
This Agreement will inure to the benefit of and be binding upon the parties hereto, and to the benefit of the employees, officers and
directors and controlling persons referred to in Section 7 hereof, and to their respective successors, and personal representative, and
no other person will have any right or obligation hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 11. Partial Unenforceability</B>.
The invalidity or unenforceability of any section, paragraph or provision of this Agreement shall not affect the validity or enforceability
of any other section, paragraph or provision hereof. If any Section, paragraph or provision of this Agreement is for any reason determined
to be invalid or unenforceable, there shall be deemed to be made such minor changes (and only such minor changes) as are necessary to
make it valid and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 12. Governing
Law; Agent for Service of Process</B>. This Agreement will be governed by, and construed in accordance with, the laws of the State of
New York applicable to agreements made and to be performed entirely in such State, without regard to the conflicts of laws principles
thereof. This Agreement may not be assigned by either party without the prior written consent of the other party. This Agreement shall
be binding upon and inure to the benefit of the parties hereto, and their respective successors and permitted assigns. Any right to trial
by jury with respect to any dispute arising under this Agreement or any transaction or conduct in connection herewith is waived. Any dispute
arising under this Agreement may be brought into the courts of the State of New York or into the Federal Court located in New York, New
York and, by execution and delivery of this Agreement, the Company hereby accepts for itself and in respect of its property, generally
and unconditionally, the jurisdiction of aforesaid courts. Each party hereto hereby irrevocably waives personal service of process and
consents to process being served in any such suit, action or proceeding by delivering a copy thereof via overnight delivery (with evidence
of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute
good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve
process in any manner permitted by law. The Company agrees that a final judgment in any such action, proceeding or counterclaim brought
in any such court shall be conclusive and binding upon the Company and may be enforced in any other courts to the jurisdiction of which
the Company is or may be subject, by suit upon such judgment. If either party to this Agreement shall commence an action or proceeding
to enforce any provisions of a Transaction Document, then the prevailing party in such action or proceeding shall be reimbursed by the
other party for its attorney&rsquo;s fees and other costs and expenses incurred with the investigation, preparation and prosecution of such
action or proceeding. In addition to and without limiting the foregoing, the Company has confirmed that it has appointed [_____], as its
authorized agent (the &ldquo;<U>Authorized Agent</U>&rdquo;) upon whom process may be served in any suit, action or proceeding arising
out of or based upon the this Agreement or the Transaction Documents or the transactions contemplated herein which may be instituted in
any New York federal or state court, by the Placement Agent, the directors, officers, partners, employees and agents of the Placement
Agent and each affiliate of the Placement Agent, and expressly accept the non-exclusive jurisdiction of any such court in respect of any
such suit, action or proceeding. The Company hereby represents and warrants that the Authorized Agent has accepted such appointment and
has agreed to act as said agent for service of process, and the Company agrees to take any and all action, including the filing of any
and all documents that may be necessary to continue such appointment in full force and effect as aforesaid. The Company hereby authorizes
and directs the Authorized Agent to accept such service. Service of process upon the Authorized Agent shall be deemed, in every respect,
effective service of process upon the Company. If the Authorized Agent shall cease to act as agent for service of process, the Company
shall appoint, without unreasonable delay, another such agent in the United States, and notify you of such appointment. Notwithstanding
the foregoing, any action arising out of or based upon this Agreement may be instituted by the Placement Agent, the directors, officers,
partners, employees and agents of the Placement Agent and each respective affiliate of the Placement Agent, in any court of competent
jurisdiction in the Republic of the Marshall Islands. This paragraph shall survive any termination of this Agreement, in whole or in part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B></B></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 13. General Provisions</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(a) This
Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and all contemporaneous
oral agreements, understandings and negotiations with respect to the subject matter hereof. Notwithstanding anything herein to the contrary,
the Engagement Letter, dated September 29, 2025 (the &ldquo;<U>Engagement Letter</U>&rdquo;), between the Company and the Placement Agent
shall continue to be effective and the terms therein shall continue to survive and be enforceable by the Placement Agent in accordance
with its terms, provided that, in the event of a conflict between the terms of the Engagement Letter and this Agreement, the terms of
this Agreement shall prevail. This Agreement may be executed in two or more counterparts, each one of which shall be an original, with
the same effect as if the signatures thereto and hereto were upon the same instrument. This Agreement may not be amended or modified unless
in writing by all of the parties hereto, and no condition herein (express or implied) may be waived unless waived in writing by each party
whom the condition is meant to benefit. Section headings herein are for the convenience of the parties only and shall not affect the construction
or interpretation of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(b) The
Company acknowledges that in connection with the offering of the Securities: (i) the Placement Agent&rsquo;s responsibility to the Company
is solely contractual and commercial in nature, (ii) the Placement Agent has acted at arms length, are not agents of, and owe no fiduciary
duties to the Company or any other person, (iii) the Placement Agent owes the Company only those duties and obligations set forth in this
Agreement and (iv) the Placement Agent may have interests that differ from those of the Company. The Company waives to the fullest extent
permitted by applicable law any claims it may have against the Placement Agent arising from any breach or alleged breach of fiduciary
duty in connection with the offering of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>The remainder of this page has been intentionally
left blank.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">If the foregoing is in accordance
with your understanding of our agreement, please sign below whereupon this instrument, along with all counterparts hereof, shall become
a binding agreement in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-indent: 0in">Very truly yours, </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="text-transform: uppercase"><B>GLOBAL INTERACTIVE TECHNOLOGIES, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 37%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The foregoing Placement Agency
Agreement is hereby confirmed and accepted as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>maxim group LLC</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 37%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 21; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>3
<FILENAME>ea026610701ex4-3_global.htm
<DESCRIPTION>FORM OF COMMON WARRANT OF THE COMPANY TO BE ISSUED IN THIS OFFERING
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Global
Interactive Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 50%; text-align: left">Warrant Shares: [_______]</TD><TD STYLE="text-align: right; width: 50%"> Initial Exercise Date: [_______], 2025</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">THIS COMMON STOCK PURCHASE WARRANT
(the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on [_____]<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT>
(the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Global Interactive Technologies, Inc.,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to ______ shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant
Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise
Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York
City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in
good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: left; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT></TD><TD STYLE="text-align: left">Insert the date that is the five year anniversary of the
Initial Exercise Date, provided that, if such date is not a Trading Day, insert the immediately following Trading Day.</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Floor
Price</U>&rdquo; means a price equal to $[___]<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2</SUP></FONT>,
subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the
Common Stock that occur after the Initial Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the Company&rsquo;s registration statement on Form S-1 (File No. 333- 288665).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock
Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2</SUP></FONT></TD><TD STYLE="text-align: left">Insert 20% of the initial exercise price</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Colonial Stock Transfer, the current transfer agent of the Company, with a mailing address of 7840 S 700 E,&nbsp;Sandy,&nbsp;UT&nbsp;84070,
and an email address of www.colonialstock.com, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within
the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section
2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified
in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise
procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder
has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall
surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise
is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares
available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal
to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant
Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise on the Trading Day
of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the
provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available
for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $[_____], subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">c) <U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may only be exercised, in whole or in
part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 75pt; text-align: left; text-indent: -20.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(A) = </TD><TD STYLE="text-align: left">as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) delivered pursuant to Section 2(a) hereof on
a day that is not a Trading Day or (2) delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular
trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day,
(ii) the highest Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
within two (2) hours of the time of the Holder&rsquo;s delivery of the Notice of Exercise pursuant to Section 2(a) hereof if such Notice
of Exercise is delivered during &ldquo;regular trading hours,&rdquo; or within two (2) hours after the close of &ldquo;regular trading
hours,&rdquo; on a Trading Day or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise
is a Trading Day and such Notice of Exercise is delivered pursuant to Section 2(a) hereof after two (2) hours following the close of
&ldquo;regular trading hours&rdquo; on such Trading Day;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(B) = </TD><TD STYLE="text-align: justify">the Exercise Price of this Warrant, as adjusted hereunder;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(X) = </TD><TD STYLE="text-align: left">the number of Warrant Shares that would be issuable upon
exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a
cashless exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act,
the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position
contrary to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"> d) <U>Mechanics of Exercise</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: -9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in"> i. <U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and (ii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its
broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common
Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise
(a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained
by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise
at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in
which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common
Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with
an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the
Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable
to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit
a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock
upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing sentence,
the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the
extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any
group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may
rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report
filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice
by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request
of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall
be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice
to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial
Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect
to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall
continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such
notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in
strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent
with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly
give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">b) <U>Share
Combination Event Ad</U>j<U>ustment</U>. In addition to the adjustments set forth in this Section 3, if at any time on or after the Issue
Date there occurs any share split, reverse share split, share dividend, share combination recapitalization or other similar transaction
involving the Common Stock (each, a &ldquo;<U>Share Combination Event</U>&rdquo;, and such date thereof, the &ldquo;<U>Share Combination
Event Date</U>&rdquo;) and the average daily VWAP during the 5 consecutive Trading Days commencing on the Share Combination Event Date
(the &ldquo;<U>Event Market Price</U>&rdquo;) (provided if the Share Combination Event is effective after close of Trading on the primary
Trading Market, then commencing on the next Trading Day which period shall be the &ldquo;<U>Share Combination Ad</U>j<U>ustment Period</U>&rdquo;)
is less than the Exercise Price then in effect (after giving effect to the adjustment in clause 3(a) above), then at the close of trading
on the primary Trading Market on the last day of the Share Combination Adjustment Period, the Exercise Price then in effect on such 5th
Trading Day shall be reduced (but in no event increased) to the Event Market Price and the number of Warrant Shares issuable hereunder
shall be increased such that the aggregate Exercise Price payable hereunder, after taking into account the decrease in the Exercise Price,
shall be equal to the aggregate Exercise Price on the Initial Exercise Date. For the avoidance of doubt, if the adjustment in the immediately
preceding sentence would otherwise result in an increase in the Exercise Price hereunder, no adjustment shall be made, and if this Warrant
is exercised, on any given Exercise Date during the Share Combination Adjustment Period, solely with respect to such portion of this Warrant
exercised on such applicable Exercise Date, such applicable Share Combination Adjustment Period shall be deemed to have ended on, and
included, the Trading Day immediately prior to such Exercise Date and the Event Market Price on such applicable Exercise Date will be
the average daily VWAP of the Common Stock immediately prior to the Share Combination Event Date and ending on, and including the Trading
Day immediately prior to such Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">c) <U>Subsequent
Equity Sales</U>. If, at any time while this Warrant is outstanding (such period, the &ldquo;<U>Adjustment Period</U>&rdquo;), the Company
issues, sells, enters into an agreement to sell, or grants any option to purchase, or sells, enters into an agreement to sell, or grants
any right to reprice, or otherwise disposes of or issues (or announces any offer, sale, grant or any option to purchase or other disposition),
or, in accordance with this Section 3(c), is deemed to have issued or sold, any shares of Common Stock or Common Stock Equivalents (excluding
any Exempt Issuance (as defined in the Purchase Agreement) issued or sold or deemed to have been issued or sold) for a consideration per
share (the &ldquo;<U>New Issuance Price</U>&rdquo;) less than a price equal to the Exercise Price in effect immediately prior to such
issue or sale or deemed issuance or sale (such Exercise Price then in effect is referred to as the &ldquo;<U>Applicable Price</U>&rdquo;)
(the foregoing a &ldquo;<U>Dilutive Issuance</U>&rdquo;), then simultaneously with the consummation (or, if earlier, the announcement)
of such Dilutive Issuance, the Exercise Price then in effect shall be reduced to an amount equal to the New Issuance Price. Notwithstanding
the foregoing, no adjustments shall be made, paid or issued under this Section 3(c) in respect of an Exempt Issuance. The Company shall
notify the Holder, in writing, no later than the Trading Day following the issuance or deemed issuance of any Common Stock or Common Stock
Equivalents subject to this Section 3(c), indicating therein the applicable issuance price, or applicable reset price, exchange price,
conversion price and other pricing terms (such notice, the &ldquo;<U>Dilutive Issuance Notice</U>&rdquo;). For purposes of clarification,
whether or not the Company provides a Dilutive Issuance Notice pursuant to this Section 3(c), upon the occurrence of any Dilutive Issuance,
the Holder is entitled to receive a number of Warrant Shares based upon the New Issuance Price regardless of whether the Holder accurately
refers to the New Issuance Price in the Notice of Exercise. If the Company enters into a Variable Rate Transaction (as defined in the
Purchase Agreement), the Company shall be deemed to have issued Common Stock or Common Stock Equivalents at the lowest possible price,
conversion price or exercise price at which such securities may be issued, converted or exercised; <U>provided</U>, <U>however</U>, any
issuance of shares upon the exercise of the Warrants will not be deemed a Variable Rate Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">i. <U>Issuance
of Options</U>. If the Company in any manner grants, issues or sells (or enters into any agreement to grant, issue or sell) any Options
and the lowest price per share for which one share of Common Stock is at any time issuable upon the exercise of any such Option or upon
conversion, exercise or exchange of any Common Stock Equivalents issuable upon exercise of any such Option or otherwise pursuant to the
terms thereof is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and to have been issued
and sold by the Company at the time of the granting, issuance or sale (or the time of execution of such agreement to grant, issue or sell,
as applicable) of such Option for such price per share. For purposes of this Section 3(c)(i), the &ldquo;lowest price per share for which
one share of Common Stock is at any time issuable upon the exercise of any such Options or upon conversion, exercise or exchange of any
Common Stock Equivalents issuable upon exercise of any such Option or otherwise pursuant to the terms thereof&rdquo; shall be equal to
(1) the lower of (x) the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to any
one share of Common Stock upon the granting, issuance or sale (or pursuant to the agreement to grant, issue or sell, as applicable) of
such Option, upon exercise of such Option and upon conversion, exercise or exchange of any Common Stock Equivalent issuable upon exercise
of such Option or otherwise pursuant to the terms thereof and (y) the lowest exercise price set forth in such Option for which one share
of Common Stock is issuable (or may become issuable assuming all possible market conditions) upon the exercise of any such Options or
upon conversion, exercise or exchange of any Common Stock Equivalents issuable upon exercise of any such Option or otherwise pursuant
to the terms thereof minus (2) the sum of all amounts paid or payable to the holder of such Option (or any other Person) upon the granting,
issuance or sale (or the agreement to grant, issue or sell, as applicable) such Option, upon exercise of such Option and upon conversion,
exercise or exchange of any Common Stock Equivalent issuable upon exercise of such Option or otherwise pursuant to the terms thereof plus
the value of any other consideration received or receivable by, or benefit conferred on, the holder of such Option (or any other Person).
Except as contemplated below, no further adjustment of the Exercise Price shall be made upon the actual issuance of such Common Stock,
or of such Common Stock Equivalents upon the exercise of such Options or otherwise pursuant to the terms of or upon the actual issuance
of such Common Stock upon conversion, exercise or exchange of such Common Stock Equivalents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">ii. <U>Issuance of
Common Stock Equivalents</U>. If the Company in any manner issues or sells (or enters into any agreement to issue or sell) any Common
Stock Equivalents and the lowest price per share for which one share of Common Stock is at any time issuable upon the conversion, exercise
or exchange thereof or otherwise pursuant to the terms thereof is less than the Applicable Price, then such Common Stock shall be deemed
to be outstanding and to have been issued and sold by the Company at the time of the issuance or sale (or the time of execution of such
agreement to issue or sell, as applicable) of such Common Stock Equivalents for such price per share. For the purposes of this Section
3(c)(ii), the &ldquo;lowest price per share for which one share of Common Stock is at any time issuable upon the conversion, exercise
or exchange thereof or otherwise pursuant to the terms thereof&rdquo; shall be equal to (1) the lower of (x) the sum of the lowest amounts
of consideration (if any) received or receivable by the Company with respect to one share of Common Stock upon the issuance or sale (or
pursuant to the agreement to issue or sell, as applicable) of the Common Stock Equivalent and upon conversion, exercise or exchange of
such Common Stock Equivalent or otherwise pursuant to the terms thereof and (y) the lowest conversion price set forth in such Common Stock
Equivalent for which one share of Common Stock is issuable (or may become issuable assuming all possible market conditions) upon conversion,
exercise or exchange thereof or otherwise pursuant to the terms thereof minus (2) the sum of all amounts paid or payable to the holder
of such Common Stock Equivalent (or any other Person) upon the issuance or sale (or the agreement to issue or sell, as applicable) of
such Common Stock Equivalent plus the value of any other consideration received or receivable by, or benefit conferred on, the holder
of such Common Stock Equivalent (or any other Person). Except as contemplated below, no further adjustment of the Exercise Price shall
be made upon the actual issuance of such Common Stock upon conversion, exercise or exchange of such Common Stock Equivalents or otherwise
pursuant to the terms thereof, and if any such issuance or sale of such Common Stock Equivalents is made upon exercise of any Options
for which adjustment of this Warrant has been or is to be made pursuant to other provisions of this Section 3(c), except as contemplated
below, no further adjustment of the Exercise Price shall be made by reason of such issuance or sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">iii. <U>Chan</U>g<U>e
in Option Price or Rate of Conversion</U>. If the purchase or exercise price provided for in any Options, the additional consideration,
if any, payable upon the issue, conversion, exercise or exchange of any Common Stock Equivalents, or the rate at which any Common Stock
Equivalents are convertible into or exercisable or exchangeable for Common Stock increases or decreases at any time (other than proportional
changes in conversion or exercise prices, as applicable, in connection with an event referred to in Section 3(a)), the Exercise Price
in effect at the time of such increase or decrease shall be adjusted to the Exercise Price which would have been in effect at such time
had such Options or Common Stock Equivalents provided for such increased or decreased purchase price, additional consideration or increased
or decreased conversion rate, as the case may be, at the time initially granted, issued or sold. For purposes of this Section 3(c)(iii),
if the terms of any Option or Common Stock Equivalent that was outstanding as of the Initial Exercise Date are increased or decreased
in the manner described in the immediately preceding sentence, then such Option or Common Stock Equivalent and the Common Stock deemed
issuable upon exercise, conversion or exchange thereof shall be deemed to have been issued as of the date of such increase or decrease.
No adjustment pursuant to this Section 3(c) shall be made if such adjustment would result in an increase of the Exercise Price then in
effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">iv. <U>Calculation
of Consideration Received.</U> If any Option and/or Common Stock Equivalents and/or Adjustment Right is issued in connection with the
issuance or sale or deemed issuance or sale of any other securities of the Company (as determined by the Holder, the &ldquo;<U>Primar</U>y
<U>Security</U>&rdquo;, and such Option and/or Common Stock Equivalents and/or Adjustment Right, the &ldquo;<U>Secondar</U>y <U>Securities</U>&rdquo;
and together with the Primary Security, each a &ldquo;<U>Unit</U>&rdquo;), together comprising one integrated transaction, the aggregate
consideration per share of Common Stock with respect to such Primary Security shall be deemed to be the lowest of (x) the purchase price
of such Unit, (y) if such Primary Security is an Option and/or Common Stock Equivalent, the lowest price per share for which one share
of Common Stock is at any time issuable upon the exercise or conversion of the Primary Security in accordance with Section 3(c)(i) or
3(c)(ii) above and (z) the average daily VWAP of the Common Stock on any Trading Day during the five (5) Trading Day period (the &ldquo;<U>Ad</U>j<U>ustment
Period</U>&rdquo;) immediately following the public announcement of such Dilutive Issuance (for the avoidance of doubt, if such public
announcement is released prior to the opening of the applicable Trading Market on a Trading Day, such Trading Day shall be the first Trading
Day in such five Trading Day period and if this Warrant is exercised, on any given Exercise Date during any such Adjustment Period, solely
with respect to such portion of this Warrant converted on such applicable Exercise Date, such applicable Adjustment Period shall be deemed
to have ended on, and included, the Trading Day immediately prior to such Exercise Date). If any Common Stock, Options or Common Stock
Equivalents are issued or sold or deemed to have been issued or sold for cash, the consideration received therefor will be deemed to be
the net amount of consideration received by the Company therefor. If any Common Stock, Options or Common Stock Equivalents are issued
or sold for a consideration other than cash, the amount of such consideration received by the Company will be the fair value of such consideration,
except where such consideration consists of publicly traded securities, in which case the amount of consideration received by the Company
for such securities will be the arithmetic average of the VWAPs of such security for each of the five (5) Trading Days immediately preceding
the date of receipt. If any Common Stock, Options or Common Stock Equivalents are issued to the owners of the non-surviving entity in
connection with any merger in which the Company is the surviving entity, the amount of consideration therefor will be deemed to be the
fair value of such portion of the net assets and business of the non-surviving entity as is attributable to such Common Stock, Options
or Common Stock Equivalents (as the case may be). The fair value of any consideration other than cash or publicly traded securities will
be determined jointly by the Company and the Holder. If such parties are unable to reach agreement within ten (10) days after the occurrence
of an event requiring valuation (the &ldquo;<U>Valuation Event</U>&rdquo;), the fair value of such consideration will be determined within
five (5) Trading Days after the tenth (10th) day following such Valuation Event by an independent, reputable appraiser jointly selected
by the Company and the Holder. The determination of such appraiser shall be final and binding upon all parties absent manifest error and
the fees and expenses of such appraiser shall be borne by the Company. For purposes of hereof, &ldquo;<U>Ad</U>j<U>ustment Right</U>&rdquo;
means any right granted with respect to any securities issued in connection with, or with respect to, any issuance or sale (or deemed
issuance or sale in accordance with this Section 3(c) of Common Stock that could result in a decrease in the net consideration received
by the Company in connection with, or with respect to, such securities (including, without limitation, any cash settlement rights, cash
adjustment or other similar rights).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">v. <U>Record Date</U>.
If the Company takes a record of the holders of Common Stock for the purpose of entitling them (A) to receive a dividend or other distribution
payable in Common Stock, Options or in Common Stock Equivalents or (B) to subscribe for or purchase Common Stock, Options or Common Stock
Equivalents, then such record date will be deemed to be the date of the issuance or sale of the Common Stock deemed to have been issued
or sold upon the declaration of such dividend or the making of such other distribution or the date of the granting of such right of subscription
or purchase (as the case may be).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">d) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">e) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the
record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>,
that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership
of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance
for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">f) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary, directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one
or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company
or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other
securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding Common Stock or greater than
50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions
effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires greater than 50% of the outstanding shares of Common Stock or greater than 50% of the voting power
of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this
Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately
prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e)
on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if
it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result
of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the
Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any
different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property
to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives
upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a
Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable at any
time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public
announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash
equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation
of such Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if the Fundamental Transaction is not within the Company&rsquo;s control,
including not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor
Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this
Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction,
whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given
the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; <U>provided</U>, <U>further</U>,
that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders
of Common Stock will be deemed to have received common stock of the Successor Entity (which Successor Entity may be the Company following
such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant
based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg, L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free
interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the
applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of (1) 100%
and (2) the 100 day volatility as obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as
of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying
price per share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus
the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the highest VWAP during the period
beginning on the Trading Day immediately preceding the public announcement of the applicable contemplated Fundamental Transaction (or
the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant
to this Section 3(f) and (D) a remaining option time equal to the time between the date of the public announcement of the applicable contemplated
Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by
wire transfer of immediately available funds (or such other consideration) within the later of (i) five Business Days of the Holder&rsquo;s
election and (ii) the date of consummation of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations
of the Company under this Warrant in accordance with the provisions of this Section 3(f) pursuant to written agreements in form and substance
reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and
shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by
a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares
of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon
exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and
with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative
value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number
of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately
prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder.
Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this
Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this Warrant
and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to each of the Company and the Successor
Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the Company,
may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume all of the
obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect as if the Company
and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. For the avoidance of doubt,
the Holder shall be entitled to the benefits of the provisions of this Section 3(f) regardless of (i) whether the Company has sufficient
authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs prior to the
Initial Exercise Date. The Company shall instruct the Transfer Agent in writing to mail, by first class mail, postage prepaid, to each
Holder, written notice of the execution of any such amendment, supplement or agreement with the Successor Entity. Any supplemented or
amended agreement entered into by the successor corporation or transferee shall provide for adjustments, which shall be as nearly equivalent
as may be practicable to the adjustments provided for in this Section 3(f). The Transfer Agent shall have no duty, responsibility or obligation
to determine the correctness of any provisions contained in such agreement or such notice, including but not limited to any provisions
relating either to the kind or amount of securities or other property receivable upon exercise of warrants or with respect to the method
employed and provided therein for any adjustments, and shall be entitled to rely conclusively for all purposes upon the provisions contained
in any such agreement. The provisions of this Section 3(f) shall similarly apply to successive reclassifications, changes, consolidations,
mergers, sales and conveyances of the kind described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">g) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">h) <U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to
such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders
of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice
or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such
notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the
Company or any of the Subsidiaries, the Company shall promptly file such notice with the Commission pursuant to a Current Report
on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the
effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">i) <U>Voluntary
Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of
this Warrant, subject to the prior written consent of the Holder, reduce the then current Exercise Price to any amount and for any period
of time deemed appropriate by the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">j) <U>Floor
Price</U>. In no event, at any time while this Warrant is outstanding, shall the Exercise Price be adjusted to a price that is less than
the Floor Price, including, for the avoidance of doubt, any adjustments provided in this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">a) <U>Transferability</U>.
This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this
Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any
transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute
and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">d) <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">e) <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough
of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.
Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in
such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo; fees and other costs and
expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts
due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">h) <U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice
of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service, addressed
to the Company, at 160, Yeouiseo-ro, Yeongdeungpo-gu, Seoul, Republic of Korea, 07231, Attention: Mr. Taehoon Kim, Chief Executive Officer,
email address: tkc@gitechnologies.com, or such other email address or address as the Company may specify for such purposes by notice to
the Holders. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing and
delivered personally, by e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the e-mail address
or address of such Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed
given and effective on the earliest of (i) the time of transmission, if such notice or communication is delivered via e-mail at the e-mail
address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission,
if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section on a day that is not a Trading
Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent
by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be
given. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company
or any Subsidiaries, the Company shall promptly file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">h) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">i) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">j) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">k) <U>Amendment</U>.
Other than Section 2(e) which may not be amended, this Warrant may be modified or amended or the provisions hereof waived with the written
consent of the Company, on the one hand, and the Holder, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">l) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">m) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="text-transform: uppercase"><B>Global Interactive Technologies,
    Inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD STYLE="width: 37%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name:</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P></TD>
    <TD STYLE="text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Title:</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="text-transform: uppercase">To: Global
Interactive Technologies, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(2) Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0in">&#9744; in lawful money
of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0in">&#9744; if permitted the
cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise
this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in
subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 10.5pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 10.5pt">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%">Name:</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Address:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Phone Number:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Email Address:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Dated: _______________ __, ______</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Holder&rsquo;s Signature: _________________</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Holder&rsquo;s Address:  _________________</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 22; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>4
<FILENAME>ea026610701ex4-4_global.htm
<DESCRIPTION>FORM OF PRE-FUNDED WARRANT OF THE COMPANY TO BE ISSUED IN THIS OFFERING
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PRE-FUNDED COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Global
Interactive Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%; font-size: 10pt">Warrant Shares: [_______]</TD>
    <TD STYLE="width: 30%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; width: 35%; font-size: 10pt">Initial Exercise Date: [_______], 2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS PRE-FUNDED COMMON STOCK
PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and until this Warrant is exercised in full (the &ldquo;<U>Termination
Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Global Interactive Technologies, Inc., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), up to ______ shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;)
of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in
Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York
City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in
good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchase
Agreement</U>&rdquo; means the securities purchase agreement, dated as of _________, 2025, among the Company and the certain purchaser
signatories therein, as amended, modified or supplemented from time to time in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the Company&rsquo;s registration statement on Form S-1 (File No. 333- 288665).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock
Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer Agent</U>&rdquo; means Colonial Stock Transfer,
the current transfer agent of the Company, with a mailing address of 7840 S 700 E, Sandy UT 84070 and an email address of [_______________],
and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Pre-Funded Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within
the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section
2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified
in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise
procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder
has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall
surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise
is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares
available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal
to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant
Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise on the Trading Day
of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the
provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available
for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Exercise
Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.001 per Warrant Share, was pre-funded
to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise
price of $0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The
Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance
or for any reason whatsoever. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.001, subject
to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Cashless
Exercise</U>. This Warrant may only be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which
the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 95.25pt; text-align: justify; text-indent: -20.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 14%"></TD><TD STYLE="width: 5%">(A) =</TD><TD STYLE="text-align: justify; width: 81%"> as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice
of Exercise if such Notice of Exercise is (1) delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) delivered
pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)
of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the highest Bid Price of the Common Stock on
the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) with two (2) hours of the time of the Holder&rsquo;s
delivery of the Notice of Exercise pursuant to Section 2(a) hereof if such Notice of Exercise is delivered during &ldquo;regular trading
hours,&rdquo; or within two (2) hours after the close of &ldquo;regular trading hours,&rdquo; on a Trading Day or (iii) the VWAP on the
date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is delivered
pursuant to Section 2(a) hereof after two (2) hours following the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 75pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 14%"></TD><TD STYLE="width: 5%; text-align: left">(B) =</TD><TD STYLE="text-align: justify; width: 81%"> the Exercise Price of this Warrant, as adjusted hereunder;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 14%"></TD><TD STYLE="width: 5%; text-align: left">(X) =</TD><TD STYLE="text-align: justify; width: 81%"> the number of Warrant Shares that would be issuable upon
exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a
cashless exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act,
the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position
contrary to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">d)</TD><TD STYLE="text-align: justify"><U>Mechanics of Exercise</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in">i.</TD><TD STYLE="text-align: justify"><U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased
hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s
balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if
the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of
the Warrant Shares to or resale of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise
by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for
the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice
of Exercise by the date that is the earlier of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and
(ii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise
(such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed
for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised,
irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case
of a cashless exercise) is received within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard
Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant
Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated
damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the
date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the
Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder
rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant
remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period,
expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on
the date of delivery of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on
or prior to 12:00 p.m. (New York City time) on the Initial Exercise Date, which may be delivered at any time after the time of execution
of the Purchase Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time)
on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that
payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in; text-align: left">ii.</TD><TD STYLE="text-align: justify"><U>Delivery of New Warrants Upon Exercise</U>. If this Warrant
shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the
time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased
Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in; text-align: left">iii.</TD><TD STYLE="text-align: justify"><U>Rescission Rights</U>. If the Company fails to cause the
Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the
Holder will have the right to rescind such exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in; text-align: left">iv.</TD><TD STYLE="text-align: justify"><U>Compensation for Buy-In on Failure to Timely Deliver Warrant
Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to
transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before
the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction
or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by
the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the
Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including brokerage
commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant
Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the
sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of
the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed
rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied
with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price
of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise
to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the
Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In
and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any
other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as
required pursuant to the terms hereof.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in; text-align: left">v.</TD><TD STYLE="text-align: justify"><U>No Fractional Shares or Scrip</U>. No fractional shares
or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder
would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect
of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in; text-align: left">vi.</TD><TD STYLE="text-align: justify"><U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares
shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such
Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of
the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>, that, in the event that Warrant
Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied
by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of
a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for
same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation
performing similar functions) required for same-day electronic delivery of the Warrant Shares.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in; text-align: left">vii.</TD><TD STYLE="text-align: justify"><U>Closing of Books</U>. The Company will not close its stockholder
books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing sentence,
the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the
extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any
group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may
rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report
filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice
by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request
of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall
be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice
to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial
Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect
to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall
continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such
notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in
strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent
with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly
give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the
record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>,
that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership
of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance
for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary, directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one
or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company
or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other
securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding Common Stock or greater than
50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions
effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires greater than 50% of the outstanding shares of Common Stock or greater than 50% of the voting power
of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this
Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately
prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e)
on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if
it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result
of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the
Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any
different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property
to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives
upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations
of the Company under this Warrant in accordance with the provisions of this Section 3(f) pursuant to written agreements in form and substance
reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and
shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by
a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares
of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon
exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and
with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative
value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number
of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately
prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder.
Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this
Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this Warrant
and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to each of the Company and the Successor
Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the Company,
may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume all of the
obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect as if the Company
and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. For the avoidance of doubt,
the Holder shall be entitled to the benefits of the provisions of this Section 3(f) regardless of (i) whether the Company has sufficient
authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs prior to the
Initial Exercise Date. The Company shall instruct the Transfer Agent in writing to mail, by first class mail, postage prepaid, to each
Holder, written notice of the execution of any such amendment, supplement or agreement with the Successor Entity. Any supplemented or
amended agreement entered into by the successor corporation or transferee shall provide for adjustments, which shall be as nearly equivalent
as may be practicable to the adjustments provided for in this Section 3(f). The Transfer Agent shall have no duty, responsibility or obligation
to determine the correctness of any provisions contained in such agreement or such notice, including but not limited to any provisions
relating either to the kind or amount of securities or other property receivable upon exercise of warrants or with respect to the method
employed and provided therein for any adjustments, and shall be entitled to rely conclusively for all purposes upon the provisions contained
in any such agreement. The provisions of this Section 3(f) shall similarly apply to successive reclassifications, changes, consolidations,
mergers, sales and conveyances of the kind described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in; text-align: left">i.</TD><TD STYLE="text-align: justify"><U>Adjustment to Exercise Price</U>. Whenever the Exercise
Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by email a notice setting
forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief
statement of the facts requiring such adjustment.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in; text-align: left">ii.</TD><TD STYLE="text-align: justify"><U>Notice to Allow Exercise by Holder</U>. If (A) the Company
shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring
cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock
rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders
of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the
Company (or any of its Subsidiaries) is a party, any sale or transfer of all or substantially all of its assets, or any compulsory share
exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary
or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be
delivered by email to the Holder at its last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar
days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be
taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as
of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are
to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected
to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to
exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation,
merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof
shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided
in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company
shall promptly file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled
to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice
except as may otherwise be expressly set forth herein.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Transferability</U>.
This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this
Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any
transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute
and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough
of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.
Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in
such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo; fees and other costs and
expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts
due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any
Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier
service, addressed to the Company, at 160, Yeouiseo-ro, Yeongdeungpo, Seoul, Republic of Korea, 07231, Attention: Mr. Taehoon Kim,
email address: tkc@gitechnologies.com, or such other email address or address as the Company may specify for such purposes by notice
to the Holders. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in
writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder
at the e-mail address or address of such Holder appearing on the books of the Company. Any notice or other communication or
deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or
communication is delivered via e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City time) on any
date, (ii) the next Trading Day after the time of transmission, if such notice or communication is delivered via e-mail at the
e-mail address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any
Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier
service, or (iv) upon actual receipt by the party to whom such notice is required to be given. To the extent that any notice
provided hereunder constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company
shall promptly file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l) <U>Amendment</U>.
Other than Section 2(e) which may not be amended, this Warrant may be modified or amended or the provisions hereof waived with the written
consent of the Company, on the one hand, and the Holder, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Global Interactive Technologies, Inc.</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 32%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">To: Global
Interactive Technologies, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&#9744; in lawful money
of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&#9744; if permitted the
cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise
this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in
subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0in"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number::</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email Address</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: _______________ __, ______</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature:__________________</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address:</FONT>___________________</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.5
<SEQUENCE>5
<FILENAME>ea026610701ex4-5_global.htm
<DESCRIPTION>FORM OF PLACEMENT AGENT WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Global
Interactive Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt">Warrant Shares: [_______]</TD>
    <TD STYLE="text-align: right; width: 40%; font-size: 10pt">Issue Date: [_______], 2025</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">THIS PLACEMENT AGENT COMMON STOCK
PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
[____], 2026<SUP>1</SUP> (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on [_____]<SUP>2</SUP>
(the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Global Interactive Technologies, Inc.,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to ______ shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant
Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise
Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain placement agency agreement, dated as of [____],
2025, by and between the Company and Maxim Group LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York
City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in
good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><SUP>1</SUP></TD><TD STYLE="text-align: justify">Insert date that is 6 months from Issue Date</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in; text-align: left"><SUP>2</SUP></TD><TD STYLE="text-align: left">Insert the date that is the five year anniversary of the
commencement of sales of the offering.</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Floor
Price</U>&rdquo; means a price equal to $[___]<SUP>3</SUP>, subject to adjustment for reverse and forward stock splits, stock dividends,
stock combinations and other similar transactions of the Common Stock that occur after the Initial Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the Company&rsquo;s registration statement on Form S-1 (File No. 333- 288665).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in; text-align: left"><SUP>3</SUP></TD><TD STYLE="text-align: left">Insert 20% of the initial exercise price</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock
Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Colonial Stock Transfer, the current transfer agent of the Company, with a mailing address of 7840 S 700 E,&nbsp;Sandy,&nbsp;UT&nbsp;84070,
and an email address of www.colonialstock.com, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Placement Agent Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless
the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records
showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice
of Exercise on the Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge
and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the
number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $[_____], subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may only be exercised, in whole or in
part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><B>(A)</B></TD><TD STYLE="text-align: left">= as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice
of Exercise if such Notice of Exercise is (1) delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) delivered
pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)
of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the highest Bid Price of the Common Stock on
the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) within two (2) hours of the time of the Holder&rsquo;s
delivery of the Notice of Exercise pursuant to Section 2(a) hereof if such Notice of Exercise is delivered during &ldquo;regular trading
hours,&rdquo; or within two (2) hours after the close of &ldquo;regular trading hours,&rdquo; on a Trading Day or (iii) the VWAP on the
date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is delivered
pursuant to Section 2(a) hereof after two (2) hours following the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 75pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(B)</TD><TD STYLE="text-align: left">= the Exercise Price of this Warrant, as adjusted hereunder;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(X)</TD><TD STYLE="text-align: left">= the number of Warrant Shares that would be issuable upon exercise
of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless
exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: left; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act,
the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position
contrary to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">d)</TD><TD STYLE="text-align: left"><U>Mechanics of Exercise</U>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">i.&nbsp;<U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the
Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The
Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a
participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares
to or resale of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical
delivery of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the
number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the
Notice of Exercise by the date that is the earlier of (i) one (1) Trading Day after the delivery to the Company of the Notice of
Exercise and (ii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the
Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the
Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which
this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) one (1) Trading Day and (ii)
the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company
fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date,
the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject
to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day
(increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such
Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain
a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used
herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days,
on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of
Exercise.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">ii.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">iii.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">iv.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">v.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">vi.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">vii.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing sentence,
the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the
extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to
any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder
may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report
filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice
by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request
of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the
conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since
the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice
to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial
Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect
to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall
continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such
notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in
strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent
with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly
give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Share
Combination Event Ad</U>j<U>ustment</U>. In addition to the adjustments set forth in this Section 3, if at any time on or after the Issue
Date there occurs any share split, reverse share split, share dividend, share combination recapitalization or other similar transaction
involving the Common Stock (each, a &ldquo;<U>Share Combination Event</U>&rdquo;, and such date thereof, the &ldquo;<U>Share Combination
Event Date</U>&rdquo;) and the average daily VWAP during the 5 consecutive Trading Days commencing on the Share Combination Event Date
(the &ldquo;<U>Event Market Price</U>&rdquo;) (provided if the Share Combination Event is effective after close of Trading on the primary
Trading Market, then commencing on the next Trading Day which period shall be the &ldquo;<U>Share Combination Ad</U>j<U>ustment Period</U>&rdquo;)
is less than the Exercise Price then in effect (after giving effect to the adjustment in clause 3(a) above), then at the close of trading
on the primary Trading Market on the last day of the Share Combination Adjustment Period, the Exercise Price then in effect on such 5th
Trading Day shall be reduced (but in no event increased) to the Event Market Price and the number of Warrant Shares issuable hereunder
shall be increased such that the aggregate Exercise Price payable hereunder, after taking into account the decrease in the Exercise Price,
shall be equal to the aggregate Exercise Price on the Initial Exercise Date. For the avoidance of doubt, if the adjustment in the immediately
preceding sentence would otherwise result in an increase in the Exercise Price hereunder, no adjustment shall be made, and if this Warrant
is exercised, on any given Exercise Date during the Share Combination Adjustment Period, solely with respect to such portion of this
Warrant exercised on such applicable Exercise Date, such applicable Share Combination Adjustment Period shall be deemed to have ended
on, and included, the Trading Day immediately prior to such Exercise Date and the Event Market Price on such applicable Exercise Date
will be the average daily VWAP of the Common Stock immediately prior to the Share Combination Event Date and ending on, and including
the Trading Day immediately prior to such Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Subsequent
Equity Sales</U>. If, at any time while this Warrant is outstanding (such period, the &ldquo;<U>Adjustment Period</U>&rdquo;), the Company
issues, sells, enters into an agreement to sell, or grants any option to purchase, or sells, enters into an agreement to sell, or grants
any right to reprice, or otherwise disposes of or issues (or announces any offer, sale, grant or any option to purchase or other disposition),
or, in accordance with this Section 3(c), is deemed to have issued or sold, any shares of Common Stock or Common Stock Equivalents (excluding
any Exempt Issuance (as defined in the Purchase Agreement) issued or sold or deemed to have been issued or sold) for a consideration
per share (the &ldquo;<U>New Issuance Price</U>&rdquo;) less than a price equal to the Exercise Price in effect immediately prior to
such issue or sale or deemed issuance or sale (such Exercise Price then in effect is referred to as the &ldquo;<U>Applicable Price</U>&rdquo;)
(the foregoing a &ldquo;<U>Dilutive Issuance</U>&rdquo;), then simultaneously with the consummation (or, if earlier, the announcement)
of such Dilutive Issuance, the Exercise Price then in effect shall be reduced to an amount equal to the New Issuance Price. Notwithstanding
the foregoing, no adjustments shall be made, paid or issued under this Section 3(c) in respect of an Exempt Issuance. The Company shall
notify the Holder, in writing, no later than the Trading Day following the issuance or deemed issuance of any Common Stock or Common
Stock Equivalents subject to this Section 3(c), indicating therein the applicable issuance price, or applicable reset price, exchange
price, conversion price and other pricing terms (such notice, the &ldquo;<U>Dilutive Issuance Notice</U>&rdquo;). For purposes of clarification,
whether or not the Company provides a Dilutive Issuance Notice pursuant to this Section 3(c), upon the occurrence of any Dilutive Issuance,
the Holder is entitled to receive a number of Warrant Shares based upon the New Issuance Price regardless of whether the Holder accurately
refers to the New Issuance Price in the Notice of Exercise. If the Company enters into a Variable Rate Transaction (as defined in the
Purchase Agreement), the Company shall be deemed to have issued Common Stock or Common Stock Equivalents at the lowest possible price,
conversion price or exercise price at which such securities may be issued, converted or exercised; <U>provided</U>, <U>however</U>, any
issuance of shares upon the exercise of the Warrants will not be deemed a Variable Rate Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">i.&nbsp;<U>Issuance of
Options</U>. If the Company in any manner grants, issues or sells (or enters into any agreement to grant, issue or sell) any Options
and the lowest price per share for which one share of Common Stock is at any time issuable upon the exercise of any such Option or upon
conversion, exercise or exchange of any Common Stock Equivalents issuable upon exercise of any such Option or otherwise pursuant to the
terms thereof is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and to have been issued
and sold by the Company at the time of the granting, issuance or sale (or the time of execution of such agreement to grant, issue or
sell, as applicable) of such Option for such price per share. For purposes of this Section 3(c)(i), the &ldquo;lowest price per share
for which one share of Common Stock is at any time issuable upon the exercise of any such Options or upon conversion, exercise or exchange
of any Common Stock Equivalents issuable upon exercise of any such Option or otherwise pursuant to the terms thereof&rdquo; shall be
equal to (1) the lower of (x) the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect
to any one share of Common Stock upon the granting, issuance or sale (or pursuant to the agreement to grant, issue or sell, as applicable)
of such Option, upon exercise of such Option and upon conversion, exercise or exchange of any Common Stock Equivalent issuable upon exercise
of such Option or otherwise pursuant to the terms thereof and (y) the lowest exercise price set forth in such Option for which one share
of Common Stock is issuable (or may become issuable assuming all possible market conditions) upon the exercise of any such Options or
upon conversion, exercise or exchange of any Common Stock Equivalents issuable upon exercise of any such Option or otherwise pursuant
to the terms thereof minus (2) the sum of all amounts paid or payable to the holder of such Option (or any other Person) upon the granting,
issuance or sale (or the agreement to grant, issue or sell, as applicable) such Option, upon exercise of such Option and upon conversion,
exercise or exchange of any Common Stock Equivalent issuable upon exercise of such Option or otherwise pursuant to the terms thereof
plus the value of any other consideration received or receivable by, or benefit conferred on, the holder of such Option (or any other
Person). Except as contemplated below, no further adjustment of the Exercise Price shall be made upon the actual issuance of such Common
Stock, or of such Common Stock Equivalents upon the exercise of such Options or otherwise pursuant to the terms of or upon the actual
issuance of such Common Stock upon conversion, exercise or exchange of such Common Stock Equivalents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">ii.&nbsp;<U>Issuance of
Common Stock Equivalents</U>. If the Company in any manner issues or sells (or enters into any agreement to issue or sell) any Common
Stock Equivalents and the lowest price per share for which one share of Common Stock is at any time issuable upon the conversion, exercise
or exchange thereof or otherwise pursuant to the terms thereof is less than the Applicable Price, then such Common Stock shall be deemed
to be outstanding and to have been issued and sold by the Company at the time of the issuance or sale (or the time of execution of such
agreement to issue or sell, as applicable) of such Common Stock Equivalents for such price per share. For the purposes of this Section
3(c)(ii), the &ldquo;lowest price per share for which one share of Common Stock is at any time issuable upon the conversion, exercise
or exchange thereof or otherwise pursuant to the terms thereof&rdquo; shall be equal to (1) the lower of (x) the sum of the lowest amounts
of consideration (if any) received or receivable by the Company with respect to one share of Common Stock upon the issuance or sale (or
pursuant to the agreement to issue or sell, as applicable) of the Common Stock Equivalent and upon conversion, exercise or exchange of
such Common Stock Equivalent or otherwise pursuant to the terms thereof and (y) the lowest conversion price set forth in such Common
Stock Equivalent for which one share of Common Stock is issuable (or may become issuable assuming all possible market conditions) upon
conversion, exercise or exchange thereof or otherwise pursuant to the terms thereof minus (2) the sum of all amounts paid or payable
to the holder of such Common Stock Equivalent (or any other Person) upon the issuance or sale (or the agreement to issue or sell, as
applicable) of such Common Stock Equivalent plus the value of any other consideration received or receivable by, or benefit conferred
on, the holder of such Common Stock Equivalent (or any other Person). Except as contemplated below, no further adjustment of the Exercise
Price shall be made upon the actual issuance of such Common Stock upon conversion, exercise or exchange of such Common Stock Equivalents
or otherwise pursuant to the terms thereof, and if any such issuance or sale of such Common Stock Equivalents is made upon exercise of
any Options for which adjustment of this Warrant has been or is to be made pursuant to other provisions of this Section 3(c), except
as contemplated below, no further adjustment of the Exercise Price shall be made by reason of such issuance or sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">iii.&nbsp;<U>Chan</U>g<U>e
in Option Price or Rate of Conversion</U>. If the purchase or exercise price provided for in any Options, the additional consideration,
if any, payable upon the issue, conversion, exercise or exchange of any Common Stock Equivalents, or the rate at which any Common Stock
Equivalents are convertible into or exercisable or exchangeable for Common Stock increases or decreases at any time (other than proportional
changes in conversion or exercise prices, as applicable, in connection with an event referred to in Section 3(a)), the Exercise Price
in effect at the time of such increase or decrease shall be adjusted to the Exercise Price which would have been in effect at such time
had such Options or Common Stock Equivalents provided for such increased or decreased purchase price, additional consideration or increased
or decreased conversion rate, as the case may be, at the time initially granted, issued or sold. For purposes of this Section 3(c)(iii),
if the terms of any Option or Common Stock Equivalent that was outstanding as of the Initial Exercise Date are increased or decreased
in the manner described in the immediately preceding sentence, then such Option or Common Stock Equivalent and the Common Stock deemed
issuable upon exercise, conversion or exchange thereof shall be deemed to have been issued as of the date of such increase or decrease.
No adjustment pursuant to this Section 3(c) shall be made if such adjustment would result in an increase of the Exercise Price then in
effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">iv.&nbsp;<U>Calculation
of Consideration Received.</U> If any Option and/or Common Stock Equivalents and/or Adjustment Right is issued in connection with the
issuance or sale or deemed issuance or sale of any other securities of the Company (as determined by the Holder, the &ldquo;<U>Primar</U>y
<U>Security</U>&rdquo;, and such Option and/or Common Stock Equivalents and/or Adjustment Right, the &ldquo;<U>Secondar</U>y <U>Securities</U>&rdquo;
and together with the Primary Security, each a &ldquo;<U>Unit</U>&rdquo;), together comprising one integrated transaction, the aggregate
consideration per share of Common Stock with respect to such Primary Security shall be deemed to be the lowest of (x) the purchase price
of such Unit, (y) if such Primary Security is an Option and/or Common Stock Equivalent, the lowest price per share for which one share
of Common Stock is at any time issuable upon the exercise or conversion of the Primary Security in accordance with Section 3(c)(i) or
3(c)(ii) above and (z) the average daily VWAP of the Common Stock on any Trading Day during the five (5) Trading Day period (the &ldquo;<U>Ad</U>j<U>ustment
Period</U>&rdquo;) immediately following the public announcement of such Dilutive Issuance (for the avoidance of doubt, if such public
announcement is released prior to the opening of the applicable Trading Market on a Trading Day, such Trading Day shall be the first
Trading Day in such five Trading Day period and if this Warrant is exercised, on any given Exercise Date during any such Adjustment Period,
solely with respect to such portion of this Warrant converted on such applicable Exercise Date, such applicable Adjustment Period shall
be deemed to have ended on, and included, the Trading Day immediately prior to such Exercise Date). If any Common Stock, Options or Common
Stock Equivalents are issued or sold or deemed to have been issued or sold for cash, the consideration received therefor will be deemed
to be the net amount of consideration received by the Company therefor. If any Common Stock, Options or Common Stock Equivalents are
issued or sold for a consideration other than cash, the amount of such consideration received by the Company will be the fair value of
such consideration, except where such consideration consists of publicly traded securities, in which case the amount of consideration
received by the Company for such securities will be the arithmetic average of the VWAPs of such security for each of the five (5) Trading
Days immediately preceding the date of receipt. If any Common Stock, Options or Common Stock Equivalents are issued to the owners of
the non-surviving entity in connection with any merger in which the Company is the surviving entity, the amount of consideration therefor
will be deemed to be the fair value of such portion of the net assets and business of the non-surviving entity as is attributable to
such Common Stock, Options or Common Stock Equivalents (as the case may be). The fair value of any consideration other than cash or publicly
traded securities will be determined jointly by the Company and the Holder. If such parties are unable to reach agreement within ten
(10) days after the occurrence of an event requiring valuation (the &ldquo;<U>Valuation Event</U>&rdquo;), the fair value of such consideration
will be determined within five (5) Trading Days after the tenth (10th) day following such Valuation Event by an independent, reputable
appraiser jointly selected by the Company and the Holder. The determination of such appraiser shall be final and binding upon all parties
absent manifest error and the fees and expenses of such appraiser shall be borne by the Company. For purposes of hereof, &ldquo;<U>Ad</U>j<U>ustment
Right</U>&rdquo; means any right granted with respect to any securities issued in connection with, or with respect to, any issuance or
sale (or deemed issuance or sale in accordance with this Section 3(c) of Common Stock that could result in a decrease in the net consideration
received by the Company in connection with, or with respect to, such securities (including, without limitation, any cash settlement rights,
cash adjustment or other similar rights).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">v.&nbsp;<U>Record Date</U>.
If the Company takes a record of the holders of Common Stock for the purpose of entitling them (A) to receive a dividend or other distribution
payable in Common Stock, Options or in Common Stock Equivalents or (B) to subscribe for or purchase Common Stock, Options or Common Stock
Equivalents, then such record date will be deemed to be the date of the issuance or sale of the Common Stock deemed to have been issued
or sold upon the declaration of such dividend or the making of such other distribution or the date of the granting of such right of subscription
or purchase (as the case may be).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise, other
than cash (including, without limitation, any distribution of stock or other securities, property or options by way of a dividend, spin
off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary, directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in
one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the
Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares
for other securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding Common Stock or greater
than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions
effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires greater than 50% of the outstanding shares of Common Stock or greater than 50% of the voting power
of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this
Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately
prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e)
on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if
it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a
result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and
the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in
a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all
of the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(f) pursuant to written agreements
in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental
Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity
evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding
number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable
and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental
Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account
the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock,
such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant
immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to
the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term &ldquo;Company&rdquo;
under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of
this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to each of the Company and
the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally
with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall
assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect
as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. For the
avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(f) regardless of (i) whether the
Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction
occurs prior to the Initial Exercise Date. The Company shall instruct the Transfer Agent in writing to mail, by first class mail, postage
prepaid, to each Holder, written notice of the execution of any such amendment, supplement or agreement with the Successor Entity. Any
supplemented or amended agreement entered into by the successor corporation or transferee shall provide for adjustments, which shall
be as nearly equivalent as may be practicable to the adjustments provided for in this Section 3(f). The Transfer Agent shall have no
duty, responsibility or obligation to determine the correctness of any provisions contained in such agreement or such notice, including
but not limited to any provisions relating either to the kind or amount of securities or other property receivable upon exercise of warrants
or with respect to the method employed and provided therein for any adjustments, and shall be entitled to rely conclusively for all purposes
upon the provisions contained in any such agreement. The provisions of this Section 3(f) shall similarly apply to successive reclassifications,
changes, consolidations, mergers, sales and conveyances of the kind described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><U>Notice to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">i.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">ii.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall promptly file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Voluntary
Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of
this Warrant, subject to the prior written consent of the Holder, reduce the then current Exercise Price to any amount and for any period
of time deemed appropriate by the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Floor
Price</U>. In no event, at any time while this Warrant is outstanding, shall the Exercise Price be adjusted to a price that is less than
the Floor Price, including, for the avoidance of doubt, any adjustments provided in this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Transferability</U>.
This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of
this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay
any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute
and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and
shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Registration
Rights. </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">a)&nbsp;To
the extent the Company does not maintain an effective registration statement for the Warrant Shares and in the further event that the
Company files a registration statement with the Commission covering the sale of its shares of Common Stock (other than a registration
statement on Form S-4 or S-8, or on another form, or in another context, in which such &ldquo;piggyback&rdquo; registration would be inappropriate),
then, for a period of three (3) years from the commencement of sales of the offering, the Company shall give written notice of such proposed
filing to the Holder as soon as practicable but in no event less than ten (10) days before the anticipated filing date, which notice shall
describe the amount and type of securities to be included in such offering, the intended method(s) of distribution, and the name of the
proposed managing underwriter or underwriters, if any, of the offering, and offer to the Holder in such notice the opportunity to register
the sale of such number of shares of Warrant Shares as such Holder may request in writing within five (5) business days following receipt
of such notice (a &ldquo;<U>Piggyback Registration</U>&rdquo;). The Company shall cause such Warrant Shares to be included in such registration
and shall use its commercially reasonable efforts to cause the managing underwriter or underwriters of a proposed underwritten offering
to permit the Warrant Shares requested to be included in a Piggyback Registration on the same terms and conditions as any similar securities
of the Company and to permit the sale or other disposition of such Warrant Shares in accordance with the intended method(s) of distribution
thereof. All Holders proposing to distribute their securities through a Piggyback Registration that involves an underwriter or underwriters
shall enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such Piggyback Registration.
Furthermore, each Holder must provide such information as reasonably requested by the Company (which information shall be limited to that
which is required for disclosure under the Securities Act and the forms, rules and regulations promulgated thereunder) to be included
in the registration statement timely or the Company may elect to exclude such Holder from the registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">b)&nbsp;In
addition, for a period of three (3) years from the commencement of sales of the offering, upon the written demand of the Holders of at
least 51% of the Warrants and underlying Warrant Shares, the Holder shall be entitled to one (1) demand right for the registration of
the Warrant Shares at the Company&rsquo;s expense and one (1) demand right for the registration of the Warrant Shares at the Holder&rsquo;s
expense (the &ldquo;<U>Demand Registration</U>&rdquo;). In the event of a Demand Registration, the Company shall use its commercially
reasonable efforts to register the applicable Warrant Shares. All Holders of Warrant Shares proposing to distribute their securities through
a Demand Registration that involves an underwriter or underwriters shall enter into an underwriting agreement in customary form with the
underwriter or underwriters selected for such Demand Registration. Furthermore, each Holder must provide such information as reasonably
requested by the Company (which information shall be limited to that which is required for disclosure under the Securities Act and the
forms, rules and regulations promulgated thereunder) to be included in the registration statement timely or the Company may elect to exclude
such Holder from the registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">c)&nbsp;Notwithstanding
the foregoing, the registration rights described in this Section 5 shall be subject to limitations imposed by the Commission&rsquo;s rules
or comments of the Commission staff in connection with its review of the registration statement for any such resale registration. Moreover,
notwithstanding the foregoing registration obligations of the Company, if the Company furnishes to the Holders requesting a Demand Registration
a certificate signed by the Company&rsquo;s chief executive officer stating that in the good faith judgment of the Company&rsquo;s Board
of Directors it would be materially detrimental to the Company and its stockholders for a registration statement to either become effective
or remain effective for as long as such registration statement otherwise would be required to remain effective, because such action would
(i) materially interfere with a significant acquisition, corporate reorganization, or other similar transaction involving the Company;
(ii) require premature disclosure of material information that the Company has a bona fide business purpose for preserving as confidential;
or (iii) render the Company unable to comply with requirements under the Securities Act or Exchange Act, then the Company shall have the
right to defer taking action with respect to such Demand Registration or withdraw a related registration statement for a period of not
more than forty-five (45) calendar days; provided, however, that the Company may not invoke this right more than twice in any twelve (12)
month period or during the twelve (12) month period prior to the Termination Date.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><U>Section 6</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York,
Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is
not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant,
the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of
this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material
damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including,
but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting
any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">h)&nbsp;<U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any
Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service,
addressed to the Company, at 160, Yeouiseo-ro, Yeongdeungpo-gu, Seoul, Republic of Korea, 07231, Attention: Mr. Taehoon Kim, Chief Executive
Officer, email address: tkc@gitechnologies.com, or such other email address or address as the Company may specify for such purposes by
notice to the Holders. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in
writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at
the e-mail address or address of such Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder
shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication is delivered via
e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day
after the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section
on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following
the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom
such notice is required to be given. To the extent that any notice provided hereunder constitutes, or contains, material, non-public
information regarding the Company or any Subsidiaries, the Company shall promptly file such notice with the Commission pursuant
to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Amendment</U>.
Other than Section 2(e) which may not be amended, this Warrant may be modified or amended or the provisions hereof waived with the written
consent of the Company, on the one hand, and the Holder, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>Global Interactive Technologies, Inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%">Name:</TD>
    <TD STYLE="width: 32%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="text-transform: uppercase">To:</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="text-transform: uppercase">Global Interactive
Technologies, Inc.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(1)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant
(only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes,
if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(2)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT>Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0in">&#9744; in lawful money
of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0in">&#9744; if permitted the
cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise
this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in
subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(3)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT>Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 10.5pt">&nbsp;<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left">Name:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><U></U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left">Address:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><U></U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left"></TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">(Please Print)</P>

</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left">Phone Number: </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left">Email Address: </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left">Dated: ____________ ___, ______</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 16%; text-align: left">Holder&rsquo;s&nbsp;Signature:<U></U></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 24%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Holder&rsquo;s&nbsp;Address:<U></U></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 21; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>6
<FILENAME>ea026610701ex5-1_global.htm
<DESCRIPTION>OPINION OF OLSHAN FROME WOLOSKY LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex5-1_001.jpg" ALT="" STYLE="height: 52px; width: 750px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">November 25, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Global Interactive Technologies, Inc.<BR>
160, Yeouiseo-ro, Yeongdeungpo-gu<BR>
Seoul, Republic of Korea, 07231</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">Re:</TD><TD STYLE="text-align: justify"><U>Registration Statement on Form S-1</U></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have acted as counsel to
Global Interactive Technologies, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), in connection with the proposed issuance of
(i) up to 4,032,258 shares (the &ldquo;Shares&rdquo;) of common stock, par value $0.001 per share, of the Company (the &ldquo;Common Stock&rdquo;),
(ii) up to 4,032,258 pre-funded warrants to purchase up to 4,032,258 shares of Common Stock (the &ldquo;Pre-funded Warrants&rdquo;), (iii)
up to 4,032,258 common warrants to purchase up to 4,032,258 shares of Common Stock (the &ldquo;Common Warrants&rdquo;) and (iv) up to
8,064,516 shares of Common Stock underlying the Pre-funded Warrants and Common Warrants (collectively, the &ldquo;Warrant Shares&rdquo;).
The Shares, the Pre-funded Warrants and the Common Warrants are included in a registration statement on Form S-1 under the Securities
Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), filed with the U.S. Securities and Exchange Commission (the &ldquo;Commission&rdquo;)
on July 14, 2025 (Registration No. 333-288665) (as amended, the &ldquo;Registration Statement&rdquo;). This opinion is being furnished
in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act, and no opinion is expressed herein as
to any matter pertaining to the contents of the Registration Statement or related Prospectus, other than as expressly stated herein with
respect to the issue of the Shares, the Pre-funded Warrants, the Common Warrants and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As such counsel, we have examined
such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied
upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified
such factual matters. We are opining herein as to the General Corporation Law of the State of Delaware (&ldquo;DGCL&rdquo;), and we express
no opinion with respect to any other laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the foregoing and
the other matters set forth herein, it is our opinion that, as of the date hereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.   When
the Shares shall have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the purchasers,
and have been issued by the Company against payment therefor (not less than par value) in the circumstances contemplated by the form of
securities purchase agreement most recently filed as an exhibit to the Registration Statement (the &ldquo;SPA&rdquo;), the issue and sale
of the Shares will have been duly authorized by all necessary corporate action of the Company, and the Shares will be validly issued,
fully paid and nonassessable. In rendering the foregoing opinion, we have assumed that the Company will comply with all applicable notice
requirements regarding uncertificated shares provided in the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.   When
the Pre-funded Warrants have been issued by the Company against payment therefor in the circumstances contemplated by the SPA, the issue
and sale of the Pre-funded Warrants will have been duly authorized by all necessary corporate action of the Company, and the Pre-funded
Warrants will be a legally valid and binding obligation of the Company, enforceable against the Company in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex5-1_002.jpg" ALT="" STYLE="height: 30px; width: 650px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">November 25, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.   When
the Common Warrants have been issued by the Company against payment therefor in the circumstances contemplated by the SPA, the issue and
sale of the Common Warrants will have been duly authorized by all necessary corporate action of the Company, and the Common Warrants will
be a legally valid and binding obligation of the Company, enforceable against the Company in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.   When
the Warrant Shares shall have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf
of the holders of such Pre-funded Warrants and Common Warrants, and have been issued by the Company against payment therefor (not less
than par value) in the circumstances contemplated by the Pre-funded Warrants and Common Warrants, the issue of the Warrant Shares will
have been duly authorized by all necessary corporate action of the Company, and upon issuance the Warrant Shares will be validly issued,
fully paid and nonassessable. In rendering the foregoing opinion, we have assumed that (i) the Company will comply with all applicable
notice requirements regarding uncertificated shares provided in the DGCL and (ii) upon the issue of any of the Warrant Shares, the total
number of shares of Common Stock issued and outstanding will not exceed the total number of shares of Common Stock that the Company is
then authorized to issue under its Restated Certificate of Incorporation, as amended, and by the board of directors of the Company in
connection with the offering contemplated by the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With your consent, we have
assumed that the status of the Pre-funded Warrants and Common Warrants as legally valid and binding obligations of the Company is not
affected by any (i) breaches of, or defaults under, agreements or instruments, (ii) violations of statutes, rules, regulations or court
or governmental orders, or (iii) failures to obtain required consents, approvals or authorizations from, or make required registrations,
declarations or filings with, governmental authorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, our opinion assumes
that each SPA, Pre-funded Warrant and Common Warrant has been duly authorized, executed and delivered by each party thereto, that
each such party is duly organized, validly existing and in good standing under the laws of its jurisdiction of organization and all jurisdictions
where it is conducting business or otherwise required to be so qualified, that each such party has full power, authority and legal right
to enter into and perform the terms and conditions of such SPA, Pre-funded Warrant and Common Warrant to be performed by it, that the
representations and warranties of each such party as set forth in such SPA, Pre-funded Warrant and Common Warrant when made were, and
on the date hereof are, true and complete, and that such SPA, Pre-funded Warrant and Common Warrant constitute a legal, valid and
binding obligation of each such party, enforceable against it in accordance with their respective terms and that the Company will receive
the requisite approval from the Nasdaq Stock Market to list the Shares and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our opinions are subject to:
(i) the effect of bankruptcy, insolvency, reorganization, preference, fraudulent transfer, moratorium or other similar laws relating to
or affecting the rights and remedies of creditors; (ii) (a) the effect of general principles of equity, whether considered in a proceeding
in equity or at law (including the possible unavailability of specific performance or injunctive relief), (b) concepts of materiality,
reasonableness, good faith and fair dealing, and (c) the discretion of the court before which a proceeding is brought; and (iii) the invalidity
under certain circumstances under law or court decisions of provisions providing for the indemnification of or contribution to a party
with respect to a liability where such indemnification or contribution is contrary to public policy. We express no opinion as to (a) any
provision for liquidated damages, default interest, late charges, monetary penalties, make-whole premiums or other economic remedies to
the extent such provisions are deemed to constitute a penalty; (b) consents to, or restrictions upon, governing law, jurisdiction, venue,
arbitration, remedies, or judicial relief; (c) any provision requiring the payment of attorneys&rsquo; fees, where such payment is contrary
to law or public policy; (d) other applicable exceptions; and (e) the severability, if invalid, of provisions to the foregoing effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This opinion is for your benefit
in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable
provisions of the Securities Act. We consent to your filing this opinion as an exhibit to the Registration Statement and to the reference
to our firm in the Prospectus under the heading &ldquo;Legal Matters.&rdquo; In giving such consent, we do not thereby admit that we are
in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission
thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 3.5in">Sincerely,<BR>
<BR>
/s/ <I>Olshan Frome Wolosky LLP</I><BR>
<BR>
Olshan Frome Wolosky LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>7
<FILENAME>ea026610701ex10-13_global.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 10.13</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Securities Purchase Agreement (this &ldquo;<U>Agreement</U>&rdquo;)
is dated as of [&#9679;], 2025, between Global Interactive Technologies, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo;
and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, subject to the terms and conditions set
forth in this Agreement and pursuant to an effective registration statement under the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase
from the Company, securities of the Company as more fully described in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">NOW, THEREFORE, IN CONSIDERATION of the mutual
covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged,
the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE I.</B><BR>
DEFINITIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1.1 <U>Definitions</U>. In addition to the terms
defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set forth in this Section
1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&ldquo;<U>Acquiring Person</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo; shall have
the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo; means
any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with
a Person as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&ldquo;<U>Board of Directors</U>&rdquo;
means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&ldquo;<U>Business Day</U>&rdquo; means
any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by law to
remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized or required by
law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any other
similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long
as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally are open
for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo; means the
closing of the purchase and sale of the Securities pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&ldquo;<U>Closing Date</U>&rdquo; means
the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and all
conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s obligations
to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the first (1<FONT STYLE="font-size: 10pt"><SUP>st</SUP></FONT>)
Trading Day following the date hereof (or the second (2<SUP>nd</SUP>) Trading Day following the date hereof if this Agreement is signed
on a day that is not a Trading Day or after 4:00 p.m. (New York City time) and before midnight (New York City time) on a Trading Day).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo; means
the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&ldquo;<U>Common Stock</U>&rdquo; means
the common stock of the Company, par value $0.001 per share, and any other class of securities into which such securities may hereafter
be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&ldquo;<U>Common Stock Equivalents</U>&rdquo;
means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&ldquo;<U>Common Warrants</U>&rdquo;
means the common stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof, in the form
of <U>Exhibit A </U>attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&ldquo;<U>Common Warrant Shares</U>&rdquo;
means the shares of Common Stock underlying the Common Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&ldquo;<U>Company Counsel</U>&rdquo;
means Olshan Frome Wolosky LLP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&ldquo;<U>Disclosure Time</U>&rdquo;
means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and before midnight
(New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date hereof, unless
otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight (New York City
time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof, unless otherwise
instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&ldquo;<U>Evaluation Date</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&ldquo;<U>Exchange Act</U>&rdquo; means
the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&ldquo;<U>Exempt Issuance</U>&#8221;
means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company pursuant to any stock or
option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members
of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) securities upon the exercise
or exchange of or conversion of any Securities issued hereunder, warrants to the Placement Agent in connection with the transaction pursuant
to this Agreement and any securities upon exercise of warrants to the Placement Agent and/or other securities exercisable or exchangeable
for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have
not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange
price or conversion price of such securities (other than in connection with stock splits or combinations) or to extend the term of such
securities, (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors
of the Company, provided that such securities are issued as &#8220;restricted securities&#8221; (as defined in Rule 144) and carry no
registration rights that require or permit the filing of any registration statement in connection therewith during the prohibition period
in Section 4.11(a) herein, and provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which is,
itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company
and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which
the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in
securities and (d) up to $[&#9679;] of Securities, less the aggregate Subscription Amount hereunder, issued to other purchasers pursuant
to the Prospectus concurrently with the Closing at the Per Share Purchase Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>FCPA</U>&#8221; means the Foreign
Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>GAAP</U>&#8221; shall have
the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Indebtedness</U>&#8221; shall
have the meaning ascribed to such term in Section 3.1(aa).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Intellectual Property Rights</U>&#8221;
shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Liens</U>&#8221; means a lien,
charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<U>Lock-Up
Agreement</U>&#8221; means the Lock-Up Agreement, dated as of the date hereof, by and among the Company and the directors, officers, and
10% and greater stockholders of the Company, in the form of <U>Exhibit C</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Material Adverse Effect</U>&#8221;
shall have the meaning assigned to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Material Permits</U>&#8221;
shall have the meaning ascribed to such term in Section 3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Per Share Purchase Price</U>&#8221;
equals $[&#9679;] subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions
of the Common Stock that occur after the date of this Agreement, provided that the purchase price per Pre-Funded Warrant shall be the
Per Share Purchase Price minus $0.001.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Person</U>&#8221; means an
individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint
stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Placement Agent</U>&#8221;
means Maxim Group LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Placement Agency Agreement</U>&#8221;
means the Placement Agency Agreement by and between the Company and the Placement Agent dated the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Placement Agent Counsel</U>&#8221;
means Ellenoff Grossman &amp; Schole LLP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><U>&#8220;Pre-Funded Warrants</U>&#8221;
means, collectively, the pre-funded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section
2.2(a) hereof, in the form attached hereto as <U>Exhibit B.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Pre-Funded Warrant Shares</U>&#8221;
means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Preliminary Prospectus</U>&#8221;
means any preliminary prospectus included in the Registration Statement, including all information, documents and exhibits filed with
or incorporated by reference into such prospectus, as originally filed or as part of any amendment thereto, or filed with the Commission
pursuant to Rule 424(a) of the rules and regulations of the Commission under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Pricing Prospectus</U>&#8221;
means (i) the Preliminary Prospectus relating to the Securities that was included in the Registration Statement immediately prior to [9:00
a.m.] (New York City time) on the date hereof and (ii) any free writing prospectus (as defined in the Securities Act) identified on Schedule
A hereto, taken together.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Proceeding</U>&#8221; means
an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such
as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;<U>&#8220;Prospectus</U>&#8221;
means the final prospectus filed for the Registration Statement, including all information, documents and exhibits filed with or incorporated
by reference into such prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Purchaser Party</U>&#8221;
shall have the meaning ascribed to such term in Section 4.7.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Registration Statement</U>&#8221;
means the effective registration statement on Form S-1 (File No. 333-288665), as amended, with the Commission, including all information,
documents and exhibits filed with or incorporated by reference into such registration statement, which registers the sale of the Securities
to the Purchasers, and includes any Rule 462(b) Registration Statement, including all information, documents and exhibits filed with or
incorporated by reference into such registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Required Approvals</U>&#8221;
shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Rule 144</U>&#8221; means Rule
144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any
similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Rule 424</U>&#8221; means Rule
424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any
similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Rule 462(b) Registration Statement</U>&#8221;
means any registration statement prepared by the Company registering additional Securities, which was filed with the Commission on or
prior to the date hereof and became automatically effective pursuant to Rule 462(b) promulgated by the Commission pursuant to the Securities
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>SEC Reports</U>&#8221; shall
have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Securities</U>&#8221; means,
collectively, the Shares, the Warrants and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Securities Act</U>&#8221; means
the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Shares</U>&#8221; means the
shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Short Sales</U>&#8221; means
all &#8220;short sales&#8221; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include locating
and/or borrowing shares of Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Subscription Amount</U>&#8221;
means, as to each Purchaser, the aggregate amount to be paid for Shares, the Pre-Funded Warrants (if applicable) and the Common Warrants
purchased hereunder as specified below such Purchaser&#8217;s name on the signature page of this Agreement and next to the heading &#8220;Subscription
Amount,&#8221; in United States dollars and in immediately available funds (excluding for the avoidance of doubt, if applicable, a Purchaser&#8217;s
aggregate exercise price of the Pre-Funded Warrants, which amounts shall be paid as and when such Pre-Funded Warrants are exercised for
cash).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Subsidiary</U>&#8221; means
any subsidiary as defined in Rule 405 under the Securities Act and listed in Exhibit 21 to the Company&#8217;s Annual Report on Form 10-K
for the fiscal year ended December 31, 2024, as amended thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Trading Day</U>&#8221; means
a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Trading Market</U>&#8221; means
any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE
American, The Nasdaq Capital Market, The Nasdaq Global Market, The Nasdaq Global Select Market, the New York Stock Exchange, OTCQB or
OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Transaction Documents</U>&#8221;
means this Agreement, the Common Warrants, the Pre-Funded Warrants, the Lock-Up Agreements, the Placement Agency Agreement, all exhibits
and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&ldquo;<U>Transfer Agent</U>&rdquo; means Colonial Stock Transfer,
with a mailing address of 7840 S 700 E, Sandy, Utah 84070 and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Variable Rate Transaction</U>&#8221;
shall have the meaning ascribed to such term in Section 4.11(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Warrants</U>&#8221; means,
collectively, the Pre-Funded Warrants and the Common Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8220;<U>Warrant Shares</U>&#8221; means,
the Pre-Funded Warrant Shares and Common Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE II.</B><BR>
PURCHASE AND SALE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2.1 <U>Closing</U>. On the Closing Date, upon
the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery of this Agreement
by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, up to an
aggregate of approximately $[&#9679;] of Shares and Common Warrants; <U>provided</U>, <U>however</U>, that, to the extent that a
Purchaser determines, in its sole discretion, that such Purchaser&#8217;s Subscription Amount (together with such Purchaser&#8217;s
Affiliates, and any Person acting as a group together with such Purchaser or any of such Purchaser&#8217;s Affiliates) would cause
such Purchaser&#8217;s beneficial ownership of the shares of Common Stock to exceed the Beneficial Ownership Limitation, or as such
Purchaser may otherwise choose, in lieu of purchasing Shares, such Purchaser may elect, by so indicating such election prior to
their issuance, to purchase Pre-Funded Warrants in lieu of Shares in such manner to result in the same aggregate purchase price
being paid by such Purchaser to the Company. The &#8220;Beneficial Ownership Limitation&#8221; shall be 4.99% (or, at the election
of the Purchaser, 9.99%) of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of the
Securities on the Closing Date. In each case, the election to receive Pre-Funded Warrants is solely at the option of the Purchaser.
Each Purchaser&#8217;s Subscription Amount as set forth on the signature page hereto executed by such Purchaser shall be made
available for &#8220;Delivery Versus Payment&#8221; (&#8220;<U>DVP</U>&#8221;) settlement with the Company or its designee. The
Company shall deliver to each Purchaser its respective Shares and Common Warrants as determined pursuant to Section 2.2(a), and the
Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of
the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of Company Counsel or such
other location as the parties shall mutually agree. Each Purchaser acknowledges that, concurrently with the Closing and pursuant to
the Prospectus, the Company may sell up to $[&#9679;], less the aggregate Subscription Amount hereunder, of additional Securities to
purchasers not party to this Agreement, and will issue to such purchasers such shares of Common Stock, Pre-Funded Warrants, if any,
and Common Warrants in the same form and at the same Per Share Purchase Price. Unless otherwise directed by the Placement Agent,
settlement of the Shares shall occur via DVP (i.e., on the Closing Date, the Company shall issue the Shares, and/or Pre-Funded
Warrants (if any) and Common Warrants, registered in the Purchasers&#8217; names and addresses and released by the Transfer Agent
directly to the account(s) at the Placement Agent identified by each Purchaser; upon receipt of such Shares, the Placement Agent
shall promptly electronically deliver such Shares to the applicable Purchaser, and payment therefor shall be made by the Placement
Agent (or its clearing firm) by wire transfer to the Company). Notwithstanding anything herein to the contrary, if at any time on or
after the time of execution of this Agreement by the Company and an applicable Purchaser, through, and including the time
immediately prior to the Closing (the &#8220;<U>Pre-Settlement Period</U>&#8221;), if such Purchaser sells to any Person all, or any
portion, of any Securities to be issued hereunder to such Purchaser at the Closing (collectively, the &#8220;<U>Pre-Settlement
Shares</U>&#8221;), such Purchaser shall, automatically hereunder (without any additional required actions by such Purchaser or the
Company), be deemed to be unconditionally bound to purchase, and the Company shall be deemed unconditionally bound to sell, such
Pre-Settlement Shares to such Purchaser at the Closing; provided, that the Company shall not be required to deliver any
Pre-Settlement Shares to such Purchaser prior to the Company&#8217;s receipt of the Subscription Amount for such Pre-Settlement
Shares hereunder; provided, further, that the Company hereby acknowledges and agrees that the forgoing shall not constitute a
representation or covenant by such Purchaser as to whether or not such Purchaser will elect to sell any Pre-Settlement Shares during
the Pre-Settlement Period. The decision to sell any shares of Common Stock will be made in the sole discretion of such Purchaser
from time to time, including during the Pre-Settlement Period. Notwithstanding anything to the contrary herein and a
Purchaser&#8217;s Subscription Amount set forth on the signature pages attached hereto, the number of Shares purchased by a
Purchaser (and its Affiliates) hereunder shall not, when aggregated with all other shares of Common Stock owned by such Purchaser
(and its Affiliates) at such time, result in such Purchaser beneficially owning (as determined in accordance with Section 13(d) of
the Exchange Act) in excess of 9.9% of the then issued and outstanding Common Stock outstanding at the Closing (the
&#8220;<U>Beneficial Ownership Maximum</U>&#8221;), and such Purchaser&#8217;s Subscription Amount, to the extent it would otherwise
exceed the Beneficial Ownership Maximum immediately prior to the Closing, shall be conditioned upon the issuance of Shares at the
Closing to the other Purchasers signatory hereto. To the extent that a Purchaser&#8217;s beneficial ownership of the Shares would
otherwise be deemed to exceed the Beneficial Ownership Maximum, such Purchaser&#8217;s Subscription Amount shall automatically be
reduced as necessary in order to comply with this paragraph. Notwithstanding the foregoing, with respect to any Notice(s) of
Exercise (as defined in the Pre-Funded Warrants) delivered on or prior to 12:00 p.m. (New York City time) on the Closing Date, which
may be delivered at any time after the time of execution of this Agreement, the Company agrees to deliver the Pre-Funded Warrant
Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Closing Date and the Closing Date shall be the Warrant
Share Delivery Date (as defined in the Pre-Funded Warrants) for purposes hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2 <U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a) On or prior to the Closing Date (except
as indicated below), the Company shall deliver or cause to be delivered to each Purchaser and the Placement Agent the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(i) this Agreement duly executed by the
Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(ii) a legal opinion of Company Counsel
directed to the Placement Agent and the Purchasers, substantially in the form acceptable to the Placement Agent and the Purchasers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(iii) on the date hereof, the duly executed
Lock-Up Agreements;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(iv) the Company&#8217;s wire instructions,
on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(v) subject to Section 2.1, a copy of the
irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver on an expedited basis via The Depository Trust
Company Deposit or Withdrawal at Custodian system (&#8220;<U>DWAC</U>&#8221;) Shares equal to such Purchaser&#8217;s Subscription Amount
divided by the Per Share Purchase Price (minus the number of shares of Common Stock issuable upon exercise of such Purchaser&#8217;s Pre-Funded
Warrant, if applicable), registered in the name of such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(vi) a Common Warrant registered in the
name of such Purchaser to purchase up to a number of shares of Common Stock equal to 100% of such Purchaser&#8217;s Shares plus Pre-Funded
Warrant Shares initially issuable upon exercise of the Pre-Funded Warrants, if applicable, with an exercise price equal to $[&#9679;],
subject to adjustment therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(vii) if applicable, for each Purchaser
of Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded Warrant registered in the name of such Purchaser to purchase up to a number
of shares of Common Stock equal to the portion of such Purchaser&#8217;s Subscription Amount applicable to Pre-Funded Warrants (as elected
by the Purchaser) divided by the Per Share Purchase Price minus $0.001, with an exercise price equal to $0.001 per share of Common Stock,
subject to adjustment therein; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(viii) the Preliminary Prospectus and Prospectus
(which may be delivered in accordance with Rule 172 under the Securities Act</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(b) On or prior to the Closing Date,
each Purchaser shall deliver or cause to be delivered to the Company, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(i) this Agreement duly executed by such
Purchaser; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(ii) such Purchaser&#8217;s Subscription
Amount (less the aggregate exercise price of the Pre-Funded Warrants issuable to such Purchaser hereunder, if applicable), which shall
be made available for &#8220;Delivery Versus Payment&#8221; settlement with the Company or its designee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2.3 <U>Closing Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a) The obligations of the Company hereunder
in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(i) the accuracy in all material respects (or, to the extent representations
or warranties are qualified by materiality or Material Adverse Effect, in all respects) on the Closing Date of the representations and
warranties of the Purchasers contained herein (unless as of a specific date therein in which case they shall be accurate in all material
respects as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(ii) all obligations, covenants and agreements
of each Purchaser required to be performed at or prior to the Closing Date shall have been performed; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(iii) the delivery by each Purchaser of
the items set forth in Section 2.2(b) of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(b) The respective obligations of the
Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(i) the accuracy in all material respects
(or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and
on the Closing Date of the representations and warranties of the Company contained herein (unless as of a specific date therein in which
case they shall be accurate all material respects (or, to the extent representations or warranties are qualified by materiality or Material
Adverse Effect, in all respects) as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(ii) all obligations, covenants and agreements
of the Company required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(iii) the delivery by the Company of the
items set forth in Section 2.2(a) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(iv) the filing of the Prospectus with
the Commission;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(v) there shall have been no Material Adverse
Effect with respect to the Company since the date hereof; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(vi) from the date hereof to the Closing
Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&#8217;s principal Trading Market, and,
at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended or
limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or on any Trading
Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall there have
occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect
on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser, makes it
impracticable or inadvisable to purchase the Securities at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE III.</B><BR>
REPRESENTATIONS AND WARRANTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">3.1 <U>Representations and Warranties of the Company</U>.
The Company hereby makes the following representations and warranties to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a) <U>Subsidiaries</U>. All of the direct
and indirect Subsidiaries of the Company are set forth in Exhibit 21 to the Company&#8217;s Annual Report on Form 10-K for the fiscal
year ended December 31, 2024. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary
free and clear of any Liens.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(b) <U>Organization and Qualification</U>.
The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties
and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of
any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents.
Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary,
except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result
in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect
on the results of operations, assets, business, or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a
whole, or (iii) a material adverse effect on the Company&#8217;s ability to perform in any material respect on a timely basis its obligations
under any Transaction Document (any of (i), (ii) or (iii), a &#8220;<U>Material Adverse Effect</U>&#8221;) and, to the knowledge of the
Company, no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail
such power and authority or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(c) <U>Authorization; Enforcement</U>.
The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement
and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery
of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated
hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the
Company, the Board of Directors or the Company&#8217;s stockholders in connection herewith or therewith other than in connection with
the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or upon delivery will have
been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and
binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable
principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement
of creditors&#8217; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief
or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(d) <U>No Conflicts</U>. The
execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the
issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will
not (i) conflict with or violate any provision of the Company&#8217;s or any Subsidiary&#8217;s certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that
with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or
assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar
adjustments, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt
or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any
Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to
the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or
other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and
state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected;
except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material
Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(e) <U>Filings, Consents and Approvals</U>.
The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration
with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery
and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant to Section 4.4 of this Agreement,
(ii) the filing with the Commission of the Prospectus, (iii) application(s) to each applicable Trading Market for the listing of the Shares
and Common Warrant Shares for trading thereon in the time and manner required thereby, and (iv) such filings as are required to be made
under applicable state securities laws (collectively, the &#8220;<U>Required Approvals</U>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(f) <U>Issuance of the Securities; Registration</U>.
The issuances of the Shares, the Warrants and the Warrant Shares are duly authorized by all necessary corporate actions on the part of
the Company. The Shares are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will
be duly and validly issued, fully paid and nonassessable, and free and clear of all Liens imposed by the Company. The Warrant Shares,
when issued in accordance with the terms of the Warrants, will be validly issued, fully paid and nonassessable, and free and clear of
all Liens imposed by the Company. The Company has reserved from its duly authorized capital stock the maximum number of shares of Common
Stock issuable pursuant to this Agreement and the Warrants. The Company has prepared and filed the Registration Statement in conformity
with the requirements of the Securities Act, which became effective on [&#9679;], 2025 (the &#8220;<U>Effective Date</U>&#8221;) including
the Prospectus and any such amendments and supplements thereto as may have been required to the date of this Agreement. The Registration
Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness of the Registration Statement
or suspending or preventing the use of the Preliminary Prospectus or the Prospectus has been issued by the Commission and no proceedings
for that purpose have been instituted or, to the knowledge of the Company, are threatened by the Commission. The Company, if required
by the rules and regulations of the Commission, shall file the Prospectus with the Commission pursuant to Rule 424(b). At the time the
Registration Statement and any amendments thereto became effective, at the date of this Agreement and at the Closing Date, the Registration
Statement and any amendments thereto conformed and will conform in all material respects to the requirements of the Securities Act and
did not and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein
or necessary to make the statements therein not misleading; and the Pricing Prospectus and the Prospectus and any amendments or supplements
thereto, at the time the Pricing Prospectus and the Prospectus or any such amendment or supplement thereto was issued and at the Closing
Date, conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain an
untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(g) <U>Capitalization</U>. As of
the date hereof, the authorized capital stock of the Company consists of 100,000,000 shares of Common Stock, $0.001 par value per
share, 10,000,000 shares of preferred stock, $0.001 par value per share. The Company has not issued any capital stock since its most
recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under the
Company&#8217;s stock option plans or vesting of restricted stock units, the issuance of shares of Common Stock to employees
pursuant to the Company&#8217;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock
Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of
first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the
Transaction Documents, except as described in the Registration Statement and SEC Reports. There are no authorized or outstanding
options, warrants, preemptive rights, rights of first refusal or other rights to purchase, or equity or debt securities convertible
into or exchangeable or exercisable for, any capital stock of the Company or any of its subsidiaries, except as described in the
Registration Statement and the SEC Reports. All of the outstanding shares of capital stock of the Company are duly authorized,
validly issued, fully paid and nonassessable, have been issued in compliance with all applicable federal and state securities laws,
and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase
securities. No further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance
and sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect to the
Company&#8217;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the
Company&#8217;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(h) <U>SEC Reports; Financial Statements</U>.
The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities
Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the 12 months preceding the date hereof (or such shorter
period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto
and documents incorporated by reference therein, together with the Registration Statement, the Pricing Prospectus and the Prospectus,
being collectively referred to herein as the &#8220;<U>SEC Reports</U>&#8221;) on a timely basis or has received a valid extension of
such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the
SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none
of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated
therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.
The Company is not, and has not been in the past two years, an issuer identified in Rule 144(i)(1)(i) and has filed with the Commission
current &#8220;Form 10 information&#8221; (as defined in Rule 144(i)(3)) at least 12 months prior to the date of this Agreement reflecting
its status as an entity that is no longer an issuer identified in Rule 144(i)(1)(i).The financial statements of the Company included in
the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission
with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States
generally accepted accounting principles applied on a consistent basis during the relevant periods (&#8220;<U>GAAP</U>&#8221;), except
as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not
contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated
Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the
case of unaudited statements, to normal, immaterial, year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(i) <U>Material Changes; Undisclosed
Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within the SEC Reports, except
as disclosed in the SEC Reports, (i) there has been no event, occurrence or development that has had or that could reasonably be expected
to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade
payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required
to be reflected in the Company&#8217;s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the
Company has not materially altered its method of accounting, and (iv) the Company has not declared or made any dividend or distribution
of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital
stock. The Company does not have pending before the Commission any request for confidential treatment of information. Except for the issuance
of the Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence or development has occurred or exists
or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects,
properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable securities
laws at the time this representation is made or deemed made that has not been publicly disclosed at least 1 Trading Day prior to the date
that this representation is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(j) <U>Litigation</U>. Except as
set forth in the SEC Reports, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the
knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before
or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or
foreign) (collectively, an &#8220;<U>Action</U>&#8221;), which (i) adversely affects or challenges the legality, validity or
enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have or
reasonably be expected to result in a Material Adverse Effect. Except as set forth in the SEC Reports, neither the Company nor any
Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or
liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of
the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or
former director or officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness
of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(k) <U>Labor Relations</U>. No labor
dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could reasonably
be expected to result in a Material Adverse Effect. To the knowledge of the Company, no executive officer of the Company or any Subsidiary,
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and
foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours,
except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(l) <U>Compliance</U>. The Company and
its Subsidiaries have been and are in compliance with all applicable laws, rules and regulations, except where failure to be so in compliance
would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(m) <U>Environmental Laws</U>. The Company
and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution or protection of human
health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating
to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or
wastes (collectively, &#8220;<U>Hazardous Materials</U>&#8221;) into the environment, or otherwise relating to the manufacture, processing,
distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees,
demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued,
entered, promulgated or approved thereunder (&#8220;<U>Environmental Laws</U>&#8221;); (ii) have received all permits licenses or other
approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance with
all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply could
be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(n) <U>Regulatory Permits</U>. The Company
and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory
authorities necessary to conduct their respective businesses as described in the SEC Reports, except where the failure to possess such
permits could not reasonably be expected to result in a Material Adverse Effect (&#8220;<U>Material Permits</U>&#8221;), and neither the
Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(o) <U>Title to Assets</U>. Except
as otherwise disclosed in the Registration Statement and the SEC Reports, the Company and the Subsidiaries have good and marketable
title in fee simple to all real property owned by them and good and marketable title in all personal property owned by them that is
material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as do
not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such
property by the Company and the Subsidiaries and (ii) Liens for the payment of federal, state or other taxes, for which appropriate
reserves have been made therefor in accordance with GAAP and, the payment of which is neither delinquent nor subject to penalties.
Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and
enforceable leases with which the Company and the Subsidiaries are in compliance, with such exceptions as are not material and do
not materially interfere with the use made or proposed to be made of such real property, improvements, equipment or personal
property by the Company or such subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(p) <U>Intellectual Property</U>. The
Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service
marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights described
in the SEC Reports as being owned or licensed by them or which are necessary for the conduct of their respective businesses as currently
conducted or as currently proposed to be conducted and which the failure to so have could have a Material Adverse Effect (collectively,
the &#8220;<U>Intellectual Property Rights</U>&#8221;). Neither the Company nor any Subsidiary has received, since the date of the latest
audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual
Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have a Material
Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement
by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures
to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(q) <U>Insurance</U>. The Company and
the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are
prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited to, directors
and officers insurance coverage. Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its
existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary
to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(r) <U>Transactions With Affiliates and
Employees</U>. Except as set forth in the SEC Reports, to the knowledge of the Company, none of the officers or directors of the Company
or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to
any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract,
agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to
or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director
or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
employee benefits, including stock option agreements under any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(s) <U>Sarbanes-Oxley; Internal
Accounting Controls</U>. The Company and the Subsidiaries are in compliance, in all material respects, with any and all applicable
requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and
regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The
Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i)
transactions are executed in accordance with management&#8217;s general or specific authorizations, (ii) transactions are recorded
as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii)
access to assets is permitted only in accordance with management&#8217;s general or specific authorization, and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect
to any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure
that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded,
processed, summarized and reported, within the time periods specified in the Commission&#8217;s rules and forms. The Company&#8217;s
certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries
as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the
&#8220;<U>Evaluation Date</U>&#8221;). The Company presented in its most recently filed periodic report under the Exchange Act the
conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations
as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting
(as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably
likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(t) <U>Certain Fees</U>. Except as set
forth in the Pricing Prospectus or the Prospectus, no brokerage or finder&#8217;s fees or commissions are or will be payable by the Company
or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with
respect to the transactions contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(u) <U>Investment Company</U>. The Company
is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be or be an Affiliate of, an
&#8220;investment company&#8221; within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct its business
in a manner so that it will not become an &#8220;investment company&#8221; subject to registration under the Investment Company Act of
1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(v) <U>Listing and Maintenance Requirements</U>.
The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to,
or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act nor
has the Company received any notification that the Commission is contemplating terminating such registration. The Company has not, in
the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted
to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is,
to its knowledge, in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic
transfer through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the
fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(w) <U>Disclosure</U>. Except with respect
to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms that neither
it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information that it
believes constitutes or might constitute material, non-public information which is not otherwise disclosed in the Pricing Prospectus or
the Prospectus. The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions
in securities of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and
its Subsidiaries, their respective businesses and the transactions contemplated hereby, taken as a whole, is true and correct in all material
respects and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the
statements made therein, in the light of the circumstances under which they were made, not misleading. The Company acknowledges and agrees
that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby other than
those specifically set forth in Section 3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(x) <U>No Integrated Offering</U>. Assuming
the accuracy of the Purchasers&#8217; representations and warranties set forth in Section 3.2, neither the Company, nor any of its Affiliates,
nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers
to buy any security, under circumstances that would cause this offering of the Securities to be integrated with prior offerings by the
Company for purposes of any applicable stockholder approval provisions of any Trading Market on which any of the securities of the Company
are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(y) <U>Tax Status</U>. Except for matters
that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the Company and
its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income and franchise tax
returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental
assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii)
has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to
which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority
of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(z) <U>Foreign Corrupt Practices</U>.
Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf
of the Company or any such Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment
or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government
officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully
any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which
is in violation of law, or (iv) violated in any material respect any provision of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(aa) <U>Accountants</U>. The Company&#8217;s
registered independent accounting firm is OneStop Assurance PAC, an independent registered public accounting firm. To the knowledge and
belief of the Company, such accounting firm is a registered public accounting firm as required by the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(bb) <U>Acknowledgment Regarding Purchasers&#8217;
Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting solely in the capacity of an arm&#8217;s
length purchaser with respect to the Transaction Documents and the transactions contemplated thereby. The Company further acknowledges
that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to the Transaction
Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or
agents in connection with the Transaction Documents and the transactions contemplated thereby is merely incidental to the Purchasers&#8217;
purchase of the Securities. The Company further represents to each Purchaser that the Company&#8217;s decision to enter into this Agreement
and the other Transaction Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the
Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(cc) <U>Acknowledgment Regarding Purchaser&#8217;s
Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except for Sections 3.2(f) and 4.13
hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked by the Company to agree, nor
has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or &#8220;derivative&#8221;
securities based on securities issued by the Company or to hold the Securities for any specified term; (ii) past or future open market
or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &#8220;derivative&#8221; transactions,
before or after the closing of this or future private placement transactions, may negatively impact the market price of the Company&#8217;s
publicly-traded securities; (iii) any Purchaser, and counter-parties in &#8220;derivative&#8221; transactions to which any such Purchaser
is a party, directly or indirectly, presently may have a &#8220;short&#8221; position in the Common Stock, and (iv) each Purchaser shall
not be deemed to have any affiliation with or control over any arm&#8217;s length counter-party in any &#8220;derivative&#8221; transaction.
The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various times during
the period that the Securities are outstanding, including, without limitation, during the periods that the value of the Warrant Shares
deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing
stockholders&#8217; equity interests in the Company at and after the time that the hedging activities are being conducted. The Company
acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(dd) <U>Regulation M Compliance</U>.
The Company has not, and to its knowledge, no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to
cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of
any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or
(iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other
than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ee) <U>Stock Option Plans</U>. Each
stock option granted by the Company under the Company&#8217;s stock option plan was granted (i) in accordance with the terms of the Company&#8217;s
stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common Stock on the date such stock option
would be considered granted under GAAP and applicable law. No stock option granted under the Company&#8217;s stock option plan has been
backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly grant, stock
options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement of material
information regarding the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ff) <U>Office of Foreign Assets Control</U>.
Neither the Company nor any Subsidiary nor, to the Company&#8217;s knowledge, any director, officer, agent, employee or Affiliate of the
Company or any Subsidiary acting on behalf of the Company or such Subsidiary is currently subject to any U.S. sanctions administered by
the Office of Foreign Assets Control of the U.S. Treasury Department (&#8220;<U>OFAC</U>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(gg) <U>Money Laundering</U>. The operations
of the Company and its Subsidiaries are and have been conducted at all times in compliance in all material respects with applicable financial
record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money
laundering statutes and applicable rules and regulations thereunder (collectively, the &#8220;<U>Money Laundering Laws</U>&#8221;), and
no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any
Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(hh) <U>Registration Rights</U>. No Person
has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company
or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ii) <U>Solvency</U>. Based on the
consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company of the
proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&#8217;s assets exceeds the amount
that will be required to be paid on or in respect of the Company&#8217;s existing debts and other liabilities (including known
contingent liabilities) as they mature, (ii) the Company&#8217;s assets do not constitute unreasonably small capital to carry on its
business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital
requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability
thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate
all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in
respect of its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its ability
to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt).
The Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or
liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date. The SEC Reports
set forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which
the Company or any Subsidiary has commitments. For the purposes of this Agreement, &#8220;Indebtedness&#8221; means (x) any
liabilities for borrowed money or amounts owed in excess of $100,000 (other than trade accounts payable incurred in the ordinary
course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether
or not the same are or should be reflected in the Company&#8217;s consolidated balance sheet (or the notes thereto), except
guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of
business; and (z) the present value of any lease payments in excess of $100,000 due under leases required to be capitalized in
accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(jj) <U>Cybersecurity</U>. (i)(x)
There has been no security breach or other compromise of or relating to any of the Company&#8217;s or any Subsidiary&#8217;s
information technology and computer systems, networks, hardware, software, data (including the data of its respective customers,
employees, suppliers, vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively,
&#8220;<U>IT Systems and Data</U>&#8221;) and (y) the Company and the Subsidiaries have not been notified of, and has no knowledge
of any event or condition that would reasonably be expected to result in, any security breach or other compromise to its IT Systems
and Data; (ii) the Company and the Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments,
orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual
obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from
unauthorized use, access, misappropriation or modification, except as would not, individually or in the aggregate, have a Material
Adverse Effect; (iii) the Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards to
maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security of all
IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology consistent
with industry standards and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(kk) <U>Compliance with Data
Privacy Laws</U>. (i) The Company and the Subsidiaries are, and at all times during the last three (3) years were, in compliance
with all applicable state, federal and foreign data privacy and security laws and regulations, including, without limitation, the
European Union General Data Protection Regulation (&#8220;<U>GDPR</U>&#8221;) (EU 2016/679) (collectively, &#8220;<U>Privacy
Laws</U>&#8221;); (ii) the Company and the Subsidiaries have in place, comply with, and take appropriate steps reasonably designed
to ensure compliance with their policies and procedures relating to data privacy and security and the collection, storage, use,
disclosure, handling and analysis of Personal Data (as defined below) (the &#8220;<U>Policies</U>&#8221;); (iii) the Company
provides accurate notice of its applicable Policies to its customers, employees, third party vendors and representatives as required
by the Privacy Laws; and (iv) applicable Policies provide accurate and sufficient notice of the Company&#8217;s then-current privacy
practices relating to its subject matter, and do not contain any material omissions of the Company&#8217;s then-current privacy
practices, as required by Privacy Laws. &#8220;Personal Data&#8221; means (i) a natural person&#8217;s name, street address,
telephone number, email address, photograph, social security number, bank information, or customer or account number; (ii) any
information which would qualify as &#8220;personally identifying information&#8221; under the Federal Trade Commission Act, as
amended; (iii) &#8220;personal data&#8221; as defined by GDPR; and (iv) any other piece of information that allows the
identification of such natural person, or his or her family, or permits the collection or analysis of any identifiable data related
to an identified person&#8217;s health or sexual orientation. (i) None of such disclosures made or contained in any of the Policies
have been inaccurate, misleading, or deceptive in violation of any Privacy Laws and (ii) the execution, delivery and performance of
the Transaction Documents will not result in a breach of any Privacy Laws or Policies. Neither the Company nor the Subsidiaries (i)
to the knowledge of the Company, has received written notice of any actual or potential liability of the Company or the Subsidiaries
under, or actual or potential violation by the Company or the Subsidiaries of, any of the Privacy Laws; (ii) is currently conducting
or paying for, in whole or in part, any investigation, remediation or other corrective action pursuant to any regulatory request or
demand pursuant to any Privacy Law; or (iii) is a party to any order, decree, or agreement by or with any court or arbitrator or
governmental or regulatory authority that imposed any obligation or liability under any Privacy Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ll) <U>U.S. Real Property Holding
Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section 897 of
the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&#8217;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(mm) <U>Bank Holding Company
Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as
amended (the &#8220;<U>BHCA</U>&#8221;) and to regulation by the Board of Governors of the Federal Reserve System (the
&#8220;<U>Federal Reserve</U>&#8221;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or
indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of
the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company
nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity
that is subject to the BHCA and to regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">3.2 <U>Representations and Warranties of the Purchasers</U>.
Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the date hereof and as of the Closing Date
to the Company as follows (unless as of a specific date therein, in which case they shall be accurate as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a) <U>Organization; Authority</U>. Such
Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws of the
jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power and
authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations
hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the transactions
contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership, limited liability company
or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a party has been duly executed
by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding
obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i) as limited by general equitable principles
and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217;
rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies
and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(b) <U>Understandings or Arrangements</U>.
Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement or understandings
with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty not limiting such
Purchaser&#8217;s right to sell the Securities pursuant to the Registration Statement, Preliminary Prospectus, Prospectus or otherwise
in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary
course of its business. Such Purchaser is acquiring such Securities as principal for his, her or its own account and not with a view to
or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state securities
law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state securities
law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of
such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting
such Purchaser&#8217;s right to sell such Securities pursuant to a registration statement or otherwise in compliance with applicable federal
and state securities laws).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(c) <U>Purchaser Status</U>. At the time
such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which it exercises any Warrants,
it will be either: (i) an &#8220;accredited investor&#8221; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities
Act or (ii) a &#8220;qualified institutional buyer&#8221; as defined in Rule 144A(a) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(d) <U>Experience of Such Purchaser</U>.
Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial
matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the
merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the Securities and, at the present
time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(e) <U>Access to Information</U>.
Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits and
schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed necessary
of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the
Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial
condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment;
and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable
effort or expense that is necessary to make an informed investment decision with respect to the investment. Such Purchaser
acknowledges and agrees that neither the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with
any information or advice with respect to the Securities nor is such information or advice necessary or desired. Neither the
Placement Agent nor any Affiliate has made or makes any representation as to the Company or the quality of the Securities and the
Placement Agent and any Affiliate may have acquired non-public information with respect to the Company which such Purchaser agrees
need not be provided to it. In connection with the issuance of the Securities to such Purchaser, neither the Placement Agent nor any
of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(f) <U>Certain Transactions and Confidentiality</U>.
Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has any Person acting on behalf of or pursuant
to any understanding with such Purchaser, directly or indirectly executed any purchases or sales, including Short Sales, of the securities
of the Company during the period commencing as of the time that such Purchaser first received pricing terms from the Company or any other
Person representing the Company setting forth the material pricing terms of the transactions contemplated hereunder and ending immediately
prior to the execution hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby
separate portfolio managers manage separate portions of such Purchaser&#8217;s assets and the portfolio managers have no direct knowledge
of the investment decisions made by the portfolio managers managing other portions of such Purchaser&#8217;s assets, the representation
set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision
to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser&#8217;s
representatives, including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates,
such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence
and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a
representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar
transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company acknowledges and agrees that the representations contained
in this Section 3.2 shall not modify, amend or affect such Purchaser&#8217;s right to rely on the Company&#8217;s representations and
warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other
document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated
hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty,
or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;ARTICLE IV.</B><BR>
OTHER AGREEMENTS OF THE PARTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1 <U>Warrant Shares</U>.
If all or any portion of a Warrant is exercised at a time when there is an effective registration statement to cover the issuance or resale
of the Warrant Shares or if the Warrant is exercised via cashless exercise, the Warrant Shares issued pursuant to any such exercise shall
be issued free of all legends. If at any time following the date hereof the Registration Statement (or any subsequent registration statement
registering the sale or resale of the Warrant Shares) is not effective or is not otherwise available for the sale or resale of the Warrant
Shares, the Company shall immediately notify the holders of the Warrants in writing that such registration statement is not then effective
and thereafter shall promptly notify such holders when the registration statement is effective again and available for the sale or resale
of the Warrant Shares (it being understood and agreed that the foregoing shall not limit the ability of the Company to issue, or any Purchaser
to sell, any of the Warrant Shares in compliance with applicable federal and state securities laws). The Company shall use commercially
reasonable efforts to keep a registration statement (including the Registration Statement) registering the issuance or resale of the Warrant
Shares effective during the term of the Warrants. The Securities shall be issued free of legends, subject to applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4.2 <U>Furnishing of Information</U>. Until the earlier of the time
that (i) no Purchaser owns Securities (ii) the Common Warrants have expired or (iii) the Pre-Funded Warrants have been fully exercised,
the Company covenants to use its commercially reasonable efforts to timely file (or obtain extensions in respect thereof and file within
the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act even if
the Company is not then subject to the reporting requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4.3 <U>Integration</U>. The Company shall not sell,
offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act)
that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such
that it would require shareholder approval prior to the closing of such other transaction unless shareholder approval is obtained before
the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4.4 <U>Securities Laws Disclosure; Publicity</U>.
The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of the transactions contemplated hereby,
and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto, with the Commission within the time
required by the Exchange Act. From and after the issuance of such press release, the Company represents to the Purchasers that it shall
have publicly disclosed all material, non-public information delivered to any of the Purchasers by the Company or any of its Subsidiaries,
or any of their respective officers, directors, employees or agents, including without limitation, the Placement Agent, in connection
with the transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such press release, the Company
acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between
the Company, any of its Subsidiaries or any of their respective officers, directors, agents, including without limitation, the Placement
Agent, employees or Affiliates on the one hand, and any of the Purchasers or any of their Affiliates on the other hand, shall terminate.
The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities
of the Company. The Company and each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions
contemplated hereby, and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement
without the prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser,
with respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure
is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement
or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name
of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such
Purchaser, except (a) as required by federal securities law in connection with the filing of final Transaction Documents with the Commission
and (b) to the extent such disclosure is required by law or regulation, Trading Market or FINRA rules or regulations, in which case the
Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause (b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4.5 <U>Shareholder Rights Plan</U>. No claim will
be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is an &#8220;Acquiring Person&#8221;
under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar
anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the
provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents or under any other agreement
between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4.6 <U>Non-Public Information</U>. Except
with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, which shall be
disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its behalf will
provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes
constitutes, material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such
information and agreed with the Company to keep such information confidential. The Company understands and confirms that each
Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the
Company, any of its Subsidiaries, or any of their respective officers, directors, agents, including without limitation, the
Placement Agent, employees or Affiliates delivers any material, non-public information to a Purchaser without such Purchaser&#8217;s
consent, the Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any
of its Subsidiaries, or any of their respective officers, directors, agents, including without limitation, the Placement Agent,
employees or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, agents,
employees or Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser shall
remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or
contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall promptly file such
notice with the Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall
be relying on the foregoing covenant in effecting transactions in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4.7 <U>Use of Proceeds</U>. The Company shall use
the net proceeds from the sale of the Securities hereunder as set forth in the Pricing Prospectus and Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4.8 <U>Indemnification of Purchasers</U>.
Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors, officers,
shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding
such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of
Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members,
partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a
lack of such title or any other title) of such controlling persons (each, a &#8220;<U>Purchaser Party</U>&#8221;) harmless from any
and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid
in settlements, court costs and reasonable attorneys&#8217; fees and costs of investigation that any such Purchaser Party may suffer
or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the
Company in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any
capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser
Party, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a
material breach of such Purchaser Party&#8217;s representations, warranties or covenants under the Transaction Documents or any
agreements or understandings such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of
state or federal securities laws or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud,
gross negligence or willful misconduct), the Company will indemnify each Purchaser Party, to the fullest extent permitted by
applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable
attorneys&#8217; fees) and expenses, as incurred, arising out of or relating to (i) any untrue or alleged untrue statement of a
material fact contained in such registration statement, any prospectus or any form of prospectus or in any amendment or supplement
thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact
required to be stated therein or necessary to make the statements therein (in the case of any prospectus or supplement thereto, in
the light of the circumstances under which they were made) not misleading, or (ii) any violation or alleged violation by the Company
of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder in connection therewith.
If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement,
such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense
thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to
employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall
be at the expense of such Purchaser Party except to the extent that (x) the employment thereof has been specifically authorized by
the Company in writing, (y) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or
(z) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of
the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and
expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (1)
for any settlement by a Purchaser Party effected without the Company&#8217;s prior written consent, which shall not be unreasonably
withheld or delayed; or (2) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any
Purchaser Party&#8217;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in
this Agreement or in the other Transaction Documents. The indemnification required by this Section 4.8 shall be made by periodic
payments of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred.
The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party
against the Company or others and any liabilities the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4.9 <U>Reservation of Common Stock</U>. As of the
date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times, free of preemptive rights,
a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant to this Agreement, Pre-Funded
Warrant Shares pursuant to any exercise of the Pre-Funded Warrants and Common Warrant Shares pursuant to any exercise of the Common Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4.10 <U>Listing of Common Stock</U>. (a) The
Company hereby agrees to use its commercially reasonable efforts to maintain the listing or quotation of the Common Stock on
the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all
of the Shares and Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and Warrant Shares on
such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market,
it will then include in such application all of the Shares and Warrant Shares, and will take such other action as is necessary to
cause all of the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company
will then take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will
comply in all respects with the Company&#8217;s reporting, filing and other obligations under the bylaws or rules of the Trading
Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust
Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository
Trust Company or such other established clearing corporation in connection with such electronic transfer.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11 <U>Subsequent Equity
Sales</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) From the date
hereof until ninety (90) days thereafter, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or
announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement
or amendment or supplement thereto, other than the Prospectus, <U>provided</U>, <U>however</U>, that the Company may enter into an agreement
to issue of shares of Common Stock with the prior written consent of the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) For a period
from the date hereof until ninety (90) days thereafter, the Company shall be prohibited from effecting or entering into an agreement
to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units
thereof) involving a Variable Rate Transaction. &#8220;<U>Variable Rate Transaction</U>&#8221; means a transaction in which the Company
(i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to
receive additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based
upon, and/or varies with, the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of
such debt or equity securities or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date
after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly
related to the business of the Company or the market for the Common Stock, other than in connection with customary anti-dilution adjustments
resulting from future stock splits, stock dividends or similar transactions, or (ii) issues or sells any amortizing convertible security
that amortizes prior to its maturity date, whereby it is required to or has the option to (or the investor in such security has the option
to require the Company to) make such amortization payments in shares of Common Stock (whether or not such payments in stock are subject
to certain equity conditions) or (iii) enters into, or effects a transaction under, any agreement, including, but not limited to, an
equity line of credit or &#8220;at-the-market&#8221; offering, whereby the Company may issue or sell securities at a future determined
price, regardless of whether shares pursuant to such agreement have actually been issued and regardless of whether such agreement is
subsequently canceled; <U>provided</U>, <U>however</U>, that, after sixty (60) days after the Closing Date, the Company may make sales
under an &#8220;at-the-market&#8221; program if such sales are made at a price per share of $[__]<SUP>1</SUP> or greater (as adjusted
for reverse and forward stock splits and the like). Any Purchaser shall be entitled to obtain injunctive relief against the Company to
preclude any such issuance, which remedy shall be in addition to any right to collect damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>1 </SUP>Insert offering price</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(c) Notwithstanding the foregoing, this
Section 4.11 shall not apply in respect of (i) an Exempt Issuance, except that no Variable Rate Transaction shall be an Exempt Issuance,
or (ii) the filing of any registration statement on Form S-8 or any successor form thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4.12 <U>Equal Treatment of Purchasers</U>. No consideration
(including any modification of any Transaction Document) shall be offered or paid to any Person to amend or consent to a waiver or modification
of any provision of the Transaction Documents unless the same consideration is also offered to all of the parties to the Transaction Documents.
For clarification purposes, this provision constitutes a separate right granted to each Purchaser by the Company and negotiated separately
by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall not in any way be construed as the Purchasers
acting in concert or as a group with respect to the purchase, disposition or voting of Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4.13 <U>Certain Transactions and Confidentiality</U>.
Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it nor any Affiliate acting on its behalf
or pursuant to any understanding with it will execute any purchases or sales, including Short Sales of any of the Company&#8217;s securities
during the period commencing with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement
are first publicly announced pursuant to the initial press release as described in Section 4.4. Each Purchaser, severally and not jointly
with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by
the Company pursuant to the initial press release as described in Section 4.4, such Purchaser will maintain the confidentiality of the
existence and terms of this transaction. Notwithstanding the foregoing and notwithstanding anything contained in this Agreement to the
contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that
it will not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated by this
Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4, (ii) no Purchaser shall be restricted
or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities laws from and
after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release
as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the
Company to the Company or its Subsidiaries after the issuance of the initial press release as described in Section 4.4. Notwithstanding
the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate
portions of such Purchaser&#8217;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the
portfolio managers managing other portions of such Purchaser&#8217;s assets, the covenant set forth above shall only apply with respect
to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4.14 <U>Exercise Procedures</U>. The form of Notice
of Exercise included in the Warrants set forth the totality of the procedures required of the Purchasers in order to exercise the Warrants.
No additional legal opinion, other information or instructions shall be required of the Purchasers to exercise their Warrants. Without
limiting the preceding sentences, no ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type
of guarantee or notarization) of any Notice of Exercise form be required in order to exercise the Warrants. The Company shall honor exercises
of the Warrants and shall deliver Warrant Shares in accordance with the terms, conditions and time periods set forth in the Transaction
Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4.15 <U>Lock-Up Agreements</U>. The Company shall
not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except to extend the term of the lock-up period and
shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If any party to a Lock-Up Agreement breaches any
provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek specific performance of the terms of such Lock-Up
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE V.</B><BR>
MISCELLANEOUS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.1 <U>Termination</U>. This Agreement may be terminated
by any Purchaser, as to such Purchaser&#8217;s obligations hereunder only and without any effect whatsoever on the obligations between
the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated on or before the
fifth (5th) Trading Day following the date hereof; <U>provided</U>, <U>however</U>, that no such termination will affect the right of
any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.2 <U>Fees and Expenses</U>. Except as expressly
set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants
and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery
and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for
same-day processing of any instruction letter delivered by the Company and any exercise notice delivered by a Purchaser), stamp taxes
and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.3 <U>Entire Agreement</U>. The Transaction Documents,
together with the exhibits and schedules thereto, the Pricing Prospectus and the Prospectus, contain the entire understanding of the parties
with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect
to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.4 <U>Notices</U>. Any and all notices or other
communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective
on the earliest of: (a) the time of transmission, if such notice or communication is delivered via email attachment at the email address
as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading
Day after the time of transmission, if such notice or communication is delivered via email attachment at the email address as set forth
on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading
Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or
(d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall
be as set forth on the signature pages attached hereto. To the extent that any notice provided pursuant to any Transaction Document constitutes,
or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice
with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.5 <U>Amendments; Waivers</U>. No provision of
this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by
the Company and Purchasers which purchased at least 50.1% in interest of the Shares and Pre-Funded Warrant Shares based on the initial
Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver, by the party against
whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately and
adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers)
shall also be required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed
to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement
hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.
Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser
relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected
Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.6 <U>Headings</U>. The headings herein are for
convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.7 <U>Successors and Assigns</U>. This
Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may
not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by
merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or
transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities,
by the provisions of the Transaction Documents that apply to the &#8220;Purchasers.&#8221;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.8 <U>Third-Party Beneficiaries</U>. The Placement
Agent shall be a third party beneficiary of the representations, warranties and covenants of the Company in this Agreement and the representations,
warranties and covenants of the Purchasers in this Agreement. This Agreement is intended for the benefit of the parties hereto and their
respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person,
except as otherwise set forth in Section 4.8 and this Section 5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.9 <U>Governing Law</U>. All questions concerning
the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by and construed and enforced
in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party
agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement
and any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough
of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not
to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action
or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process
and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight
delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such
service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit
in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce
any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section 4.8, the prevailing party
in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&#8217; fees and other costs
and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.10 <U>Survival</U>. The representations and warranties
contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.11 <U>Execution</U>. This Agreement may be executed
in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective
when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign
the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a &#8220;.pdf&#8221;
format data file, or by electronic signature such signature shall create a valid and binding obligation of the party executing (or on
whose behalf such signature is executed) with the same force and effect as if such facsimile or &#8220;.pdf&#8221; signature page or electronic
signature were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.12 <U>Severability</U>. If any term, provision,
covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable,
the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in
no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ
an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction.
It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions,
covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.13 <U>Rescission and Withdrawal Right</U>.
Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction
Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does
not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its
sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part
without prejudice to its future actions and rights; provided, however, that, in the case of a rescission of an exercise of a
Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded exercise
notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the
restoration of such Purchaser&#8217;s right to acquire such shares pursuant to such Purchaser&#8217;s Warrant (including, issuance
of a replacement warrant certificate evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.14 <U>Replacement of Securities</U>. If any certificate
or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange
and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate
or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction. The applicant
for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity)
associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.15 <U>Remedies</U>. In addition to being entitled
to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and the Company will be
entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation
for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not
to assert in any Action for specific performance of any such obligation the defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.16 <U>Payment Set Aside</U>. To the extent that
the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces or exercises its
rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated,
declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise
restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, state
or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally
intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement
or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.17 <U>Independent Nature of Purchasers&#8217;
Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations
of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance of the obligations of
any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken
by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture
or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to
such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently protect
and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents,
and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose. Each Purchaser
has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For reasons of administrative
convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through Placement Agent Counsel.
Placement Agent Counsel does not represent any of the Purchasers and only represents the Placement Agent. The Company has elected to provide
all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested
to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement and in each other
Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not
between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.18
<U>Liquidated Damages</U>. The Company&#8217;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts
have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.19 <U>Saturdays, Sundays, Holidays, etc.</U>
If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business
Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.20 <U>Construction</U>. The parties agree that
each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore,
the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed
in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to share prices and
shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends,
stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.21 <B><U>WAIVER OF JURY TRIAL</U>. <U>IN ANY
ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY,
TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL
BY JURY.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have caused
this Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>Global Interactive Technologies, Inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD STYLE="text-align: justify">By:&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: justify"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify"></TD>
    <TD STYLE="width: 5%; text-align: justify">Name:</TD>
    <TD STYLE="width: 32%; text-align: justify">[<FONT STYLE="font-family: Symbol">&middot;</FONT>]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="text-align: justify">[<FONT STYLE="font-family: Symbol">&middot;</FONT>]</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><U>Address for Notice</U>:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">160, Yeouiseo-ro, Yeongdeungpo-gu</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Seoul, Republic of Korea, 07231</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Attention: Mr. Taehoon Kim, Interim Chief Executive Officer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">E-Mail: tkc@gitechnologies.com</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Phone: +82-2-564-8588</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">With a copy to (which shall not constitute notice):</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Olshan Frome Wolosky LLP</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">1325 Avenue of the Americas, 15th Floor</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">New York, New York 10019</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Attention: Spencer G. Feldman, Esq.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Email: sfeldman@olshanlaw.com</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Phone: (212) 451-2300</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.3pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO <FONT STYLE="text-transform: uppercase">Global
Interactive Technologies, Inc.</FONT> SECURITIES PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned have caused
this Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Purchaser: ________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Purchaser</I>:
_________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: _______________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address of Authorized Signatory:_________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Facsimile Number of Authorized Signatory: _______________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Address for Delivery of Warrants to Purchaser
(if not same as address for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DWAC for Shares:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subscription Amount: $_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shares: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pre-Funded Warrants __________________ Beneficial
Ownership Blocker <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT> 4.99% or <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Common Warrants __________________ Beneficial
Ownership Blocker <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT> 4.99% or <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">EIN Number: _______________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to
purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the Company
to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii) the Closing
shall occur on the first Trading Day following the date of this Agreement and (iii) any condition to Closing contemplated by this Agreement
(but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed of any agreement, instrument,
certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead be an unconditional obligation
of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate or the like or purchase price (as
applicable) to such other party on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Schedule A</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 29; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>8
<FILENAME>ea026610701ex23-1_global.htm
<DESCRIPTION>CONSENT OF ONESTOP ASSURANCE PAC, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 23.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%">&nbsp;<IMG SRC="ex23-1_001.jpg" ALT=""></TD>
  <TD STYLE="width: 34%">&nbsp;</TD>
  <TD STYLE="width: 33%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: right"><B>Onestop
                         Assurance PAC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: right"><B>Co. Registration
No.: 201823302D</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: right"><B>10
Anson Road #21-14</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: right"><B>International
Plaza</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: right"><B>Singapore,
079903</B></P>

<P STYLE="text-align: right; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><B>Email: audit@onestop-ca.com</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0"><B>Website: www.onestop-ca.com</B></P>
</TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><U>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">We hereby consent to the incorporation
by reference in the Registration Statement on Form S- 1 (No.333-288665) under the Securities Act of 1933 of our report dated April 29,
2025 which includes an explanatory paragraph as to ability to continue as going concern, with respect to the consolidated balance sheets
of Global Interactive Techonologies, Inc. (formerly as &ldquo;Hanryu Holdings, Inc.&rdquo;) and its subsidiaries (&ldquo;the Company&rdquo;)
as of December 31, 2024 and 2023, and the related consolidated statements of operations and comprehensive loss, stockholders&rsquo; equity,
and cash flows for each of the years in the two-year period ended December 31, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.35pt 0pt 3.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">We also consent to the reference to our firm
under the heading &ldquo;Experts&rdquo; in such Registration Statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">/s/ OneStop Assurance PAC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">OneStop Assurance PAC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Singapore</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">November 25, 2025</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>9
<FILENAME>ea026610701ex-fee_global.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024-2025 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FE.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.4a -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: e2a00101f3f2cbf0a63d737d8f400b23 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
<head>
  <title>Filing Fee Exhibit</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="fee_001">S-1/A</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="fee_002">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="fee_003">0001911545</ix:nonNumeric>
      <ix:nonNumeric name="ffd:RegnFileNb" contextRef="c_report" id="fee_004">333-288665</ix:nonNumeric>
      <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="c_report" xs:nil="true" id="fee_005"></ix:nonNumeric>
      <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="c_report" id="fee_006">N/A</ix:nonNumeric>
      <ix:nonNumeric name="ffd:CombinedProspectusTableNa" contextRef="c_report" id="fee_007">N/A</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-18</xbrli:startDate>
          <xbrli:endDate>2025-11-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_10">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>10</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-18</xbrli:startDate>
          <xbrli:endDate>2025-11-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_11">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>11</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-18</xbrli:startDate>
          <xbrli:endDate>2025-11-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_12">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>12</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-18</xbrli:startDate>
          <xbrli:endDate>2025-11-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_2">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>2</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-18</xbrli:startDate>
          <xbrli:endDate>2025-11-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_3">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>3</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-18</xbrli:startDate>
          <xbrli:endDate>2025-11-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_4">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>4</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-18</xbrli:startDate>
          <xbrli:endDate>2025-11-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_5">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>5</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-18</xbrli:startDate>
          <xbrli:endDate>2025-11-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_6">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>6</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-18</xbrli:startDate>
          <xbrli:endDate>2025-11-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_7">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>7</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-18</xbrli:startDate>
          <xbrli:endDate>2025-11-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_8">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>8</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-18</xbrli:startDate>
          <xbrli:endDate>2025-11-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_9">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>9</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-18</xbrli:startDate>
          <xbrli:endDate>2025-11-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-18</xbrli:startDate>
          <xbrli:endDate>2025-11-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: right">Ex-Filing Fees</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center">CALCULATION OF FILING FEE TABLES</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="fee_008">S-1</ix:nonNumeric></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="fee_009">Global Interactive Technologies, Inc.</ix:nonNumeric></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="fee_010">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="fee_011">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="fee_012">Common Stock, par value $0.001 per share ("Common Stock")</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457oFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="fee_013">457(o)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_014">5,000,000.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_015">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_016">690.50</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_2" format="ixt:booleanfalse" id="fee_017">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_2" id="fee_018">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_2" id="fee_019">Pre-funded Warrants to purchase Common Stock ("Pre-Funded Warrants")</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(2)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_2" format="ixt:booleantrue" id="fee_020">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="fee_021">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="fee_022">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="fee_023">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_3" format="ixt:booleanfalse" id="fee_024">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_3" id="fee_025">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_3" id="fee_026">Common Stock underlying the Pre-Funded Warrants</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(3)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457oFlg" contextRef="c_offering_3" format="ixt:booleantrue" id="fee_027">457(o)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_3" id="fee_028">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_3" id="fee_029">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_3" id="fee_030">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_4" format="ixt:booleanfalse" id="fee_031">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_4" id="fee_032">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_4" id="fee_033">Warrants to purchase Common Stock ("Common Warrants")</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(4)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_4" format="ixt:booleantrue" id="fee_034">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_4" id="fee_035">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_4" id="fee_036">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_4" id="fee_037">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_5" format="ixt:booleanfalse" id="fee_038">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_5" id="fee_039">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_5" id="fee_040">Common Stock underlying the Common Warrants</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(5)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457oFlg" contextRef="c_offering_5" format="ixt:booleantrue" id="fee_041">457(o)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_5" id="fee_042">5,000,000.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_5" id="fee_043">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_5" id="fee_044">690.50</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_6" format="ixt:booleanfalse" id="fee_045">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_6" id="fee_046">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_6" id="fee_047">Placement Agent Warrants to purchase Common Stock ("Placement Agent Warrants")</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(6)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_6" format="ixt:booleantrue" id="fee_048">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_6" id="fee_049">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_6" id="fee_050">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_6" id="fee_051">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_7" format="ixt:booleanfalse" id="fee_052">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_7" id="fee_053">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_7" id="fee_054">Common Stock underlying the Placement Agent Warrants</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(7)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457oFlg" contextRef="c_offering_7" format="ixt:booleantrue" id="fee_055">457(o)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_7" id="fee_056">500,000.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_7" id="fee_057">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_7" id="fee_058">69.05</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_8" format="ixt:booleantrue" id="fee_059">Fees Previously Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_8" id="fee_060">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_8" id="fee_061">Common Stock</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(8)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457oFlg" contextRef="c_offering_8" format="ixt:booleantrue" id="fee_062">457(o)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_8" id="fee_063">5,000,000.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_8" id="fee_064">0.0001531</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_8" id="fee_065">765.50</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_9" format="ixt:booleantrue" id="fee_066">Fees Previously Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_9" id="fee_067">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_9" id="fee_068">Pre-Funded Warrants</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(9)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_9" format="ixt:booleantrue" id="fee_069">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_9" id="fee_070">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_9" id="fee_071">0.0001531</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_9" id="fee_072">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_10" format="ixt:booleantrue" id="fee_073">Fees Previously Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_10" id="fee_074">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_10" id="fee_075">Common Stock underlying the Pre-Funded Warrants</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(10)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457oFlg" contextRef="c_offering_10" format="ixt:booleantrue" id="fee_076">457(o)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_10" id="fee_077">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_10" id="fee_078">0.0001531</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_10" id="fee_079">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_11" format="ixt:booleantrue" id="fee_080">Fees Previously Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_11" id="fee_081">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_11" id="fee_082">Common Warrants</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(11)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_11" format="ixt:booleantrue" id="fee_083">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_11" id="fee_084">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_11" id="fee_085">0.0001531</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_11" id="fee_086">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_12" format="ixt:booleantrue" id="fee_087">Fees Previously Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_12" id="fee_088">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_12" id="fee_089">Common Stock underlying the Common Warrants</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(12)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457oFlg" contextRef="c_offering_12" format="ixt:booleantrue" id="fee_090">457(o)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_12" id="fee_091">5,000,000.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_12" id="fee_092">0.0001531</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_12" id="fee_093">765.50</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_094">10,500,000.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_095">1,450.05</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_096">1,531.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_097">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_098">0.00</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="fee_099">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(2)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_2" id="fee_100">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $5,000,000.00.<br/><br/>No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act with respect to the Pre-Funded Warrants, the Common Warrants or the Placement Agent Warrants because the shares of Common Stock underlying such warrants are being registered under this registration statement.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(3)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_3" id="fee_101">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.<br/><br/>The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $5,000,000.00.<br/><br/>No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act with respect to the Pre-Funded Warrants, the Common Warrants or the Placement Agent Warrants because the shares of Common Stock underlying such warrants are being registered under this registration statement.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(4)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_4" id="fee_102">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $5,000,000.00.<br/><br/>No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act with respect to the Pre-Funded Warrants, the Common Warrants or the Placement Agent Warrants because the shares of Common Stock underlying such warrants are being registered under this registration statement.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(5)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_5" id="fee_103">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(6)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_6" id="fee_104">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $5,000,000.00.<br/><br/>No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act with respect to the Pre-Funded Warrants, the Common Warrants or the Placement Agent Warrants because the shares of Common Stock underlying such warrants are being registered under this registration statement.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(7)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_7" id="fee_105">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(8)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_8" id="fee_106">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(9)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_9" id="fee_107">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $5,000,000.00.<br/><br/>No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act with respect to the Pre-Funded Warrants, the Common Warrants or the Placement Agent Warrants because the shares of Common Stock underlying such warrants are being registered under this registration statement.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(10)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_10" id="fee_108">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.<br/><br/>The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $5,000,000.00.<br/><br/>No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act with respect to the Pre-Funded Warrants, the Common Warrants or the Placement Agent Warrants because the shares of Common Stock underlying such warrants are being registered under this registration statement.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(11)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_11" id="fee_109">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $5,000,000.00.<br/><br/>No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act with respect to the Pre-Funded Warrants, the Common Warrants or the Placement Agent Warrants because the shares of Common Stock underlying such warrants are being registered under this registration statement.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(12)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_12" id="fee_110">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.</ix:nonNumeric></td></tr>
  </table>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !Y /L# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
2HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "\ 4\# 2(  A$! Q$!_\0
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M[."O^'ZT )BF,*DIK"@"G,M2PMOB4]\8-)*O6F6QY=/3F@"S2T@I: "BBEH
M**** %I58HP8'!!R*;FD$L:L ?F/91U/^% %B4?OGQ_>)J,BG9+'+=3R:0]*
M *THS5:*8VMW%<#K&X;'J.]7)!5&9>M 'N/P)U(6FNZ_X?9QLE5;R >N#@_H
MRG\*]0\0>&GUB>.ZMIDCF"A'5\X8#H>.AKYQ\ :W_8_C;PWJKOB)W^Q7!_V6
M^3G\"I_"OK#.PE6]:EI-69M2JSI3YX;G#R>%]-TR!KC6-82-$&6$>!C\\G]*
MZ2S\.Z/;*KQ6<<F0"'E^<GWYXJ$V=M)J+7MOH"-=EMQN;G"<],]S^E:D'VLJ
M3<- &/01 X'XGK248K8VJXFO->]+^OD2.L@15M_+3!Z%> /8"H_*8MF6ZD)_
MNI\H_(5-LSU8FE"@=!5G(-#<852:7YCZ"G44 1[D\SRVD!?&=N:8UQ%%<QV[
M':\@)7WQ3S!$TZSE 9%& :<P0$.P7(Z,V./QH \(^,>D"R\?Z;J6-MOK%JUI
M,>WF+\H)_ H?PKR@JRDJXPRG##T(ZU]&?&O1SJ?PZN+J-<W&F3)=H1U SM;]
M#G\*^?=299;L72?<NHUG&/4CYO\ QX-2 J&CBFNP I;."ZU*_L]/L5S=WDRP
M19[$G&?UIB$DEBA_ULBH?0\G\J+G[3:VB74FGWBVSMM2>2(HC'T!QS7TEH'P
MVT7P7;6S6>BIK&IG_6WMP02K8Z@'A1GCCGWKI-3T&+Q;X>?2_$MI'Y3NKB.&
M0_)C!&&[$'(XZCZT#/D&9<@TR(YBQ_=)%3.,@U!%Q(Z^HS^5 B3O2T44 %+1
M10 4M)2T %*"5((ZCFDHH L2_P"L)'1OF'XU&>E//S0(W=25/\Q_6FT 0R#B
MJJGRYU)X!.#5QA52://:@"WTI:I+<R(NUDW8'!_QI?M;D8$1S]: +>:"RJ,D
M@#U-4R\[_P 6W_=%(+?<<MEC[F@"=KR(< EC_LBHC=2M]Q H]2:D6 #M4HB
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M>66&/[WL:N$>9I-V!GQ\:KRC(JR14,@XJ1$4!S"5[HWZ&I*@C.V<KC[PQ4]
M!112T %%%(2!U- "TM0-=1)_%D^@YJ,W4C<)'CW- %Z,*7&]MJ#EF]!4C/YC
MM)C&XEL>F:I0J[L#(Q..0O:KG:@!#4;M@5(:KRGB@!(&WW&WOM8CZX-06V/(
M'U.:2.0PW4<@.,,,D^G>I6C-O>7%N?X'.*<=RX[DDCO*P:1V<@8!=B<#\:;1
M16IJ%%:>CZ!>:V+I[>2UA@M$5[BXNIQ%'$K':"2>>O' -7K'P5K.J[WTY+>X
MM]\B0S^>J+<&,$L8PV&;\!WI70KHYXD#K17H>C>"[>PU.$S:Y"]RD,-Q<0I:
M[E6TN,)YBLXP67S 2,<=CD5<70/"NCWUGI^JZ:50V;7<EU+<MO,\$I6: #A=
MK!& '7+#FES"YCR\$'H0?I2UZ9XP1;KP#)=37MK=&/5P]C);69MT,$B-\@RJ
M[B JD@9V\<\UYG33N-.X5/I8WM?V1ZS1>;&/]I/F_EN%04D<YL]0M;H?\LW&
M1ZCT_G2DKH4EH1RC(J33?GFGM3TGB*C_ 'AR/Y'\ZFU&V^RWDL(^X#E/=3R/
MTQ5!)3;7,4Z]8W#?D:RW1B?4/PEU&'Q)\+;6SNU$IM-UC.A/9>5_\=(_*M_2
MO VDZ9J"7R-=7,L+LT GDRL.>N  ,_4Y->5? [4Q8>+=;T$M^YNXA=0#ME>O
MYJWZ5Z#KGA.^U?6GOK[Q=>Z=%Y@6PM[*3RUC [G)^=SWZ]:/,I7V.YY[56EO
MK6(D-,&8=53+G\AFF-9QRB(W!:>2--FYCC=ZD@<9/TJ+S_L]V+6"W15^7A?E
M)!ZL!C! [TQ$C7ER[A;:Q8J0#YDS!%_+[WZ5(EY$\WV?[1 ;C&3&C@GCKQ4H
M.#FN;T[PU<V6MBY22V6W25Y 40^;(&S\K'I@9[>@I,UA&+3YG8Z3KU)-9FE:
MK+J,]W')8RVHA8",R#EUYY]CD5/J&KZ;I2YU#4+6U]!+*%)^@ZFJB^*-%:S>
M[FOTMK5#@2WBF!7XSE=X!8>XH,C5D021/&>C*5/&>M0V5N+&V"/.75"6+OQ@
M=3_4\UPNK_&KP9IFY(+R?4IAT2SB)!_X$V!7FGC'XL:WXHL9=.M+9=$TJ8;9
M7=]TTR_W>W!] .?7% ''ZC<Q7D_B&\@P;6YU4O 1T.6=N/\ @)'YU@SKQ5YY
M5:&*")"EO"#L4]23U9O<X'X "JLHXH0BQ$SRZ+N1B)K5@Z,.H*G_  *_E7UW
MH^M)K'A73M80;A=6T<I _O$#</P.:^.M/G,5XD+']U,VQQ]01G]:^AO@9JIO
M/!UWHLIS-I5T5"D\^6^2/_'@U!2/!34;"I332*9)2E!5@R]0<BGI.DAP#M/H
M:E9,U7>V5NHH D>6-/O,!^-0M>#HBEJ5;,8R%X]>WYTI\B/[TJY]%^:@",R3
M/T^7\*00,Y^=F;ZFE:[B7_5QEO=SC]!33<W#+PZQ*?[O'_UZ )UM0@RP"#U8
MXI#-:Q=7+GT0?U-43\SCYC(3^9K6LO"VMZD<VNF3^63P\@V+^9Q2OW+C"4W:
M*N:>C:#JVN0&XT^U@2VW%?.GDXR.O'_UJV'^'VM^7N74[,OCA-I _/%==X3T
M270-"2SG=7F9VDDVG(!..!^5;=<\JCOH?0T,MI.FG43N>,265U;7[Z9?P_9[
MX#,>/NR^P/OV/3M5!SD5Z%\2++?H]MJ48Q-9S ;QU"M_]<#\ZX?4E7[8TJ#"
M3JLR_P# AD_KD?A6T)75SQ<70]A5<.AD3+UJY>-OFL[K_GO" Q_VA\I_E5>5
M:M3-%-X?M_+P)K5SY@'H3P?QXJ]CF0RBD!R 1WYI:V-SH_!FOPZ!J=Z]R0+>
MZL9;<DPB4"3&Z-BAX.'5>M7+'Q_/$+&ZU#38K_5=.FDFLKMY2@0N<L'10 P!
MY&,=:Y"BE9"LC5N_$>J7<R2FX\DI:FR7R1M_<%B=A/4CG'/8#TK,FEDN)&DG
MD>61CN9I&+$GN233:*86)IKNYN4B2XN9IEA79$LDA81KZ*">!]*AHHH&%1SK
MOA8=QR*DHH!ER[/VK2["\'7887/NO3]#^E9$B]:U--(DTC4+1CS"RS)GZX/\
MZH2+6",&=)X3U\>'O$V@>(6R8;=_(N<?W/NM_P".G-?4FHZ=%K<-I<6]X$0#
M?'-&H<.C#J/T-?&D,Y@62)UWP2??7/?L1[UUWA?XB>)?"UN+72M6B>R!RMM>
MKN5/IGI^!H*C)Q=T?6(&% R3@8R:2:6.VB,MQ-'#$.2\K!5'XFOF;4OC!XRO
MXRAUFQT]#U^Q0Y8_B<G]:XF_U6349C+?W=_J4I.=US,<?ER:"3Z#UWXN6.GS
MRPQ:AI,05BJLC/>R,!W"IM0?0O7#:I\5KV^0^3'JUVA[W$ZV4'_?$6&(^KUY
M8MU,HQ D4 _Z9IS^9R::8Y)FW2NSGU8YH Z>;QMJP9C#?6>F;OO#3+8>8?K*
M<M_X]6!<WJ74QFG6XO)SUEO)BQ/^?K4:VX]*F6V.-VWCU/ _.@",75R1B+RX
M%](4"_KU_6E2++;F)9CU).32F2WC.#,I;LJ?,:Z/3/!7BW655]-\-7SQGI+.
MOE*??YL4 86W J&4<&NCUSP9XI\,V_VG6M!GBM!]ZX@82*OU()Q^.*PIHML:
M2JPDAD&4D7H<=1[$=Q3$9ROY%S'+V1@3].]>I_"S6H]!^)7ESRA+/5+5TD8G
M #H-P/\ XZ?^^J\LF7K5III+O1]Y8^=:R  C@[2,#^7ZTF-%JFFG4QCBF(0X
MJ2RL[O5-1CL+",-<.-S,WW8U]351I,NJD\$@&NX^&ZI]KUIF'[X,BY_V?F_J
M!4R=E<Z<+15:K&#V9H6'P\TN$*^H2S7\W?<Q5,^P'/ZUG^+O AN3;SZ#9PQE
M5V2PH=N?1ADUW]%<RG*]SZ:6!H.'(HV_,\JL?AEJDV&O+FWME] ?,;]./UKI
M+'X:Z+;8:YDN+MO1FV+^0Y_6NQHH=23)IY?AX?9OZE*RT?3=. %G86\)'\2H
M-WYGFKQ)/4YI**@[8QC%6BK!1110,SM?L#J>@7UF!\TD)V?[PY'ZBO(@WVC1
M+*8_>A9K=_\ T)?YM^5>W X.:\AO[/[#K6NZ4!A=WVF+Z#YN/^ LU;4GT/"S
M:G\-3Y&%(.*73XS++<PC!#P,"/Q&/UI7%)8R>3J4+'@,VP_CQ_/%;L\)#+9M
MT(!ZCBI:;)']GU"XAQ@$[E'L:=6L7=&T=@HHHYQT/%4,**NV>E7E[#)/'%MM
MX\;YY/E1<@XY]]I QWJU;>&M1GU 6+HD%P8A,$D;DQ]V&.NT<D=< T7%<R*L
M60LS<XOFF$!1N80"P;'R]>V:WY?#>DVD2M<ZV@+JQ .!O&TX=,%L@L4P#@D;
MNF*IWU_I$VDQ0P6(2Z:)3++LP5E&W.#_ '2-PP!UP:5PN8G:BCIU-2Q6UQ/&
MTD-O-+&O+/'&S!?J0.*8PTY@FKK&QQ'<H86_$8_GBHWC()5AA@<$>]0S,55)
M4/*,&!%:FH -=F91\EPJS+_P(9/ZYK*6C,9;F6T6:9]G![5=VBDQSCO2)*RV
MX]*F2 L<*I)]A6[X:\*:YXONI(-#LEE2(XFNIFVPQGW/<^W)]J]-TWX$V<V;
M;6/%;O>LI(@LE 5>!USR>H/04 >+%8HO]9*B>Q.3^0J-KZW3A%DD/_?(_K5N
M]\&>(K'6YM)?1[V2[B<IMB@9@W/# @<@^M=1H_P2\;:D5>6RBTZ,_P =W,%(
M_P" C)_2@#B6OKDC,:)$/7'/YFJDDC2J6EE9FSP&)-?0&D?L[6$>U];UR>X;
MJ8[2,(O_ 'TV3^@KO]'^&?@W0RK6F@VSRKTEN<S-G_@61^E 'S#X+\-:WKOB
M33O[+L9W"7".UQY9\N,*P)9FZ8&*^NO)U*ZG9[BX%M&LX:.. [BT8'*N2.YY
MXZ=*OJJQH$10B#HJC 'X"EH&9.D>'[;2(KN/[5?7WVMLS&_G,VX<_* > N#T
M KYR\;>%X_#/C+5]#MDVV5Q$-0L$_N]25'X!U_ 5].SQ32E1%/Y0'WL+DFO)
M/CKIYMSX?\2QJ?\ 1;@VTV/[C?,,_DP_&D!X'*N1FI-',7V]K>=@L,Z%6)[$
M?,/Y?K4]_;?9KR>#J(W(!]1V/Y8K*E!4Y'6C<1L&HGZ5*:B>F!1GKL? ]X(/
M%?EDX2_MN/=AS_0UR$PK1T^X;3SI6I _\>]QS_N[N1_.IDKJQOAZGLZL9=F>
MV44<'D'(/(/J**XS[0**** "BBB@ HHHH *\]\<0"Q\5:3J9'[J=?)E/TX/_
M (ZWZ5Z%7+?$&P-YX6DF49DM)%F'TZ'^?Z5<':1Q8^GST)+MK]QYK<P-;7$M
MN_WHG*'WP<51E!!R.HK>U@_:%LK\8_TJV4MC^\ORG^0K%E&:ZT?(DU[N+VER
M[;C(N&;U[_U_2DIQQ/H)7(\RW?..^WU_7]*C1MZ*WJ*J'8UB.J_I5]!9O=1W
M<,LUK=6[0RI$X5NH92"01D,H[>M:_A_X>^*/$T"7.FZ6YM'^[<3,(XS]">OX
M"O0-)_9_NGVOK.N11#O%9QES_P!]-@?I5MHIM'G&I^++G4-/2P%M!%:I%Y.P
M_/E1M"GMAAL7D=\GOBJ-M>:QJ%S:I:/=7,]NAB@6!"S(I&"  .X->^V?P\^'
MGA^;RY[.;4+M6V@7.^4LP ) 50%/45UEE/=PP)'HWAR&S@((Q(5@ /;A1R/6
MHYET(YET/GS2/A#XRU0*1I2V$1_CO)!'_P".\M^E=KIWP(L;8AM?\2J&&-T5
MJ%3&?]I^?TKU"^COULTEU77+;38\!IC'A0"&)PK.>A&,_2N/U#QU\-]'<,]X
MVK7**%_=*T^<9QR<+G!QGTHYFQ7;-7PY\/O <"/+I^E17ABD,9FNR9<L.XW<
M?D*[>")((Q%;Q)%&. D:A1^0KQ&_^.UQL\G0/#211CA7NGX'_ 5P/UKC]5^(
M?C;6E9+C6VM(6X,5FHB&/3(Y_6CE;'R-E7XK6VF0_$/5H-+6)8/D\Q8L;5E*
M_.!CWZ^^:YF!C/HL#'[UN[0M]#\P_7=27%JT*^9O+@GYB>N?6FZ9S->6G_/6
M+S$'JR_-_0C\:)+0)JR&.V!4!D)$I7JJ$C^5/D/'%0VV#=B,]) 4_/I^M09G
MUG\/M'LH/A?HUC'$/(NK%9)@."[2#+'/KSC\!6WI=MHUONBTS[(SPX5S'(KN
M"!CYCG.<<<UQ?PBU636/A9%:JY%U8-)9DCJ /F7_ ,=;'X5GZ%X?OK#Q9:O9
M67V>.)!'-.$V!@,=<<'G/OSS0W8I*YZ+>>(M.T^6>">Y*RPJK-& <D'ICUJ@
MGB"]U*-7TC2Y)(F'^MF.U<\C@]#T]>X]ZUI)[%9&;;')(3D[4#'.,=?IQ4!U
M%O\ 5PP*@48&X]/H!3)+&G"^%D@U$Q&ZYWF+[OM5B21(EW2.J+ZL<5P'CSQO
M)X5T-KEY\W,I,=M"@ W-CJ>^T=Z\;@U#XB:W-_:5K+?,#\P)<!#]%;C%)NPU
M=['TI-KEC%G:[2D?\\UR/S-9%[XKDCB9H+=$ [R')_(5P_@S7[W6=(F&JP&'
M4+.8P7 V[=QP"#CMP:UY@9()%'?.*38%Z;6KZY&9+MU4X("?*,?A2>([%O%7
MPRUO3&)EN8HC)%NY)9/G3^1%9-D6Q%YF"^"A],UT'AS48H=;6T8\W,9 4]"5
MYQ^6:47<;1\RWC_:K&PO>\D7E.?]M./Y;:R9EKL/$VC'1-=\1Z%C"V=W]JMQ
MC_EDWI_P%E_*N3E6J1)>-,8<5(:8:8%65:=;,TMI<VAQC:9%XYR,9_2ED'!I
M=,V_VG&K='#+^8I,:/8/#%[_ &AX9TZX)RQA",?]I?E/\JU:XSX<77_$LOM/
M8_-:W&X#_9;_ .N#79UR25F?8X6I[2C&7D%%+14G2%)2T4 )12TG>@ J&[MD
MO;.>UD^Y-&T9_$8J:B@32:LSQN"-Y/#5Q;2#$^FW1!'^RW!_\>%94@XKJ]:M
MSI_C+5K8)F+4+5I57U;&?YAJY9NF:[$[GQ-6')-P?0BL\?;!&?NRJ8S^(X_7
M%-M^$*,"=C8(]14;DHX=>&4@CZBK$N%OW9?N3*''X\U<=R8O4^NH+VRU?PS8
M7>A7]O'9+$OEXF$:Q@+@!O\ =/\ ":I:G\3?!^BILNM=@N)T #):*96)[_=X
M'YU\MVUN)@^YBL8^\ >IKHKWPI>Z)80WEW9K'%*VU,L&8\9!],<&JY#3D[L]
M*U#X[V:32/H7AN2:5^#/=,$W8X&0N2?SKC]3^*7CG5RP&I1:=$W\%G&%/_?1
MR?UK,6PTVW^>[U#<@P1% H+.#W!R<#KUYI7O]#MDD$6F-,64JKW$N N1]X =
M\]*=D4HHR);6\U-S<7DUY?-N ,LKLX!)P.3TYK4B\+7,#G[0MO:1J,F1W#?@
M,9YJO<^++I[(62S)';XQY=O$%!K*>[N;DEA$S$DG=(2>2<D\TRCI!::#:-&]
MQJ,MX0V'A@CP,>N[TJO/JFEPQR);Z7$A92OF3R%B,]P.QK"$%S*0'FVYZ*M/
M&GQQ-^\1RW7#\4[!8AN;N-H3&AW$]ZHI,;6^MKH?P.,CU%;(BC VA%QZ8K(O
MH54RHO0<CV[TFKHF:NB:_@^SWD\*\JK':?53R/T(K.(82(4^\&&/KFM2Y;[3
M8V-UW:+RG_WD./\ T$K6;*,<CJ#6)SGM7P+U3['XMUC19"52]@6ZB4]G0X8?
MDQ_*O1[J[N9+Z59Y&(#$;<\#!]*^=_"GB(Z5XMT;7WPJV]YY4X'3RWX/Z%OR
MKZ/UN 0ZNV"-LH#J?7L:70HIMJ$]H_&'C_N]ZOV=]'=G*G!/;TK"O(Y/EE5@
M,#!![U7WR1RJR9CF'(/8U1+.;^-6EO=Z9I=TN<V\SJPQU5@"?Y5G:/#-81P7
MO]KS'3TQ&UO$"=H(QG'MP:['6_$$$'A^^;588S"(74!QG<^TX ]\UXCIGBJ2
MVC$-U9QW41P=C,5 ;UXK&HF]C:E*,=SV?1+>WTN!K*&>2X:1C.TTAW,Y.,Y/
M?I5KS\W#Q,R[L9"@UA^&]:L=1T>VN(L0/M*M&1@*V>@/<5;D@@368M0\R3<R
M[,9^7%5':Q$_BN RLMQ"'*'<'##M5^VM(M.GANDE=Y(91.K.^3[_ (8S7/:W
MKUKIMZRC,DJJ0ZJ.@K@=2\2WU]<M(9FC4KL"J?X:A.S*>QW?QGTV*V\7Z'KJ
MC_1=3MVLIV[=/E/_ 'RX_P"^:\<N(7AD>*08>-BK#W'%>W:WGQG^SZETOSWN
MD%9">X,1PW_CC9_"O']587#V]ZHXNH0Y_P!\<-^HS^-;&9":::<:0TQ$+CBJ
MH<PW$<HZHP;\C5QAQ5.8=: .P\'WBV_C0HK?N;^ [?<CYA_(UZ;7BT-X;5M&
MU-3AK:50Y]@>?T_G7M.0>5.0>0?:N:HM;GTF55+TW#L_S%HHHY)P 2?05D>N
M%)4DL$UN5$\3Q%AN4.I7(]>:EM=/N[QL00,P[L?E4?4G@4[,ESBES-Z%:BMN
M+0S,B&;%H8TE$HY=F>/EN.QVG('M4L6DVHLI+ZTBDOP\*O!!*,,/FVOD*>=O
M'3UI\C.=XJFOZ_78Y^BM;Q#:+;7\,B0+;I<0))Y2]$;&&7\Q632:L[&].:G!
M274X?X@1?9;C2-84?ZF4Q2>X/(_DU<1?0"VO)X1RJ.0I]5ZC],5ZGXPL?[0\
M*7\0&7C3SD^J\_RS7E]TWGVUE=?\](0C'_:3C^6VNBF]#YK,Z?+7YNYES"G,
M<VEO-WB8QM].H_G2RBFP#?!<P^JAQ]1_^NM3S47K:X\@L&&Y&ZXJ[-JUW>%0
M3//M "F1R0 !@?I679E9##OZ$@&NJM(K!K"9IYMDZGY%Y^[CC [G/'M6RU-^
M:RN8FR\D^\ZQCT%6;70I[J;8L4TKCKD$ ?4]J?YX@=)-ZHR$,">Q'-27/B:Y
ME7RUN) F20D/R@?UH+9<_P"$<DM+9Y[A[6V"-M*NX+G! . .I&>GL:FF&B6D
M">1)-?72R*69DV1, >1@]0?6N=\VZE.4A"Y_B?K^M*+.>9@'F9F/1$&2:0CH
M!XFBLI5:TL+*W"MN&X;W/U/'Z5C7FM37\_FS-+<RX"AFXX'0?2K5IX:NIWD6
M*RE9XRH<2?+MW D$@XXX/-6KW1CI=NK2W5KYQ(!MHVRX!R<\<8Z?G1H!B;KV
M7HJQ#WZU4G@DA.7^8,?O"M:J=[-&8O+#!F)[=J8-$%@/,TJ^MNK6\BSJ/;[K
M?S!_"J4HXJWIKK%K,*O_ *JX4P/]&&/Z@U#-&R,R.,.A*L/<<&L7HSF:LQ]C
M MQIU_&"=^ P7Z D'^8KZ3T[4QK_ ,,- UMI#YD4*QS..H9?D;]5S^-?-&G7
M*VE]ND.(V4AL_G_3'XU[K\%KE;[POXC\+R'<;:4RQ*?[D@[?\"4?G4L:.1UC
MQ'>FYFV3WDELV[R9!\JD^OO6WX:\2$^'[R?5[Q)(K=EP1RZYX _.L*XN5M[>
M;SH0+%6DAB=3N)8\X'I4.NKI>G?#^VALY US=7:23*[?, %/!QVZ5G$<MQ^N
M^)_[6FW&WWVJKLBCX.#W+9ZYKA[FU"W+%(S K<QHS95AZ!O7VK0TJ*\NKU8K
M2TGNDD.TK#&7(/8\5W]G\,?$FKV)AETW[/&<E6NG";3ZXZ_I4IN+-FE*-NQP
MOA[7[VQFBL%=/L\CD89 2I/<'Z^M=H;(:Q=162W<J*%^T19/.X'E?KWK7TK]
MG^?=')JVOI&5.=EG$6/_ 'TV/Y5Z1IGP]\/:9-'.()KJ>/[LEQ*6Q] ,"J=/
MWN:)$9KD<)'!7\/VO3%D6U,LH!5D"99NW:N(LOAGXLU:9F@T>2W@)R);MA$H
M'X\_I7TJ;?R8"MFD<+#!&Q ,^WX^M*T)FL_+N7Y(^9LCL<_2KY=;F=]+'$?#
M_P "ZAX8TC4=,U6[M;JUU%<&.'<0A*E6Y/4$']*^>+JSELK2]TR?/GZ5>O$V
M>NTY4_JH_.OKZWBCAME2)]ZKGYLCDYYZ<5\]_%#2X-&^*D\\ZLMCK%LLS%1_
M&.&Q_P "0'_@54(\\H-%)3$,856E'%6CTJ"44 $#B73[BS(.[F5/P S7L'AB
M^_M'PSI]P3EC"$<_[2_*?Y5XU;L([R)CT)VGZ'BO1?AO=$V%_ISGYK:?>H_V
M6_\ KC]:QJ+0]7*ZG+6Y>Z.VK2T"X^RZ[:.6VJS^6Q] PVY_45FTHXY!P16"
M=G<^CG'GBXOJ=!$T$.HWT$=Q,E\L311W-\X/[P-SCLN0" 32ZIJ4$VGR6LUP
M)[B2WC65HA\OFQMP<]"-I(R/2N?=FD<N[,S,<EF.23257,<ZPJYE*3VM_7IY
M&Q)XBG+!XHE5]R.S.<Y<)L8X]&%9L-W+$($)+PPN76+<5&3UY'(S4%%2Y-FL
M:%.*LD6+R\DO'0LB1QQKLCC3[J+U[\GDDY-5Z**3U-8Q459"%5=2CC*,"K#U
M!ZUXR]HUK%J6G/G?8W6Y?]TG:?\ V4U[/7F_BFT%KXX!(VPZI;["?]K&W^84
MUK2>MCR,UIWIJ?9_F<;(.*AMV$=W&3T)VGZ'BK#J>0PP1P1Z&JDHKI/G":$&
M-Y8CU1JT8EN;B/+3%4Z>YK/E8&[CE'29 ?QK5L+U8!&=X22)@R$^H.16D7H;
MP>A))I7V64QW,4JRCJLH*D?A6AI^G03HS&Y@ME5@"7'0$=>O3M]:/$/BRX\1
M:HVH7[))<%!'^ZCV*%&<#]:Q'OY"?D55]SR:HLZK'AZV5<M=WKACN*CRU(SP
M1GVJ"37X[:5WL;2TL@P7!QO=2.X8]">,_2N5>:63[TC'VS3,4K"N;-SKT\\I
MDDN;B60_Q;BOK_B?SK/>^E;[H5?U-5NIP.3Z"KL>E7+,%D"P.=NU)CM9@20"
M!]1C\:87*CR._P!]V;ZFFUKC3+&T59+Z_1^0KPVQW.I(R/U&#Z9K*?9YC;-V
MS)V[NN.V?>@5R"XR(PZ_>0AA6CJF)+E;E?NW,:S#ZG[W_CP-4F&Y2I[C%6HC
MY^@0D_?M9FB/^ZW(_4'\ZSFM;F<UJ9<R]:]/^%>KG1?B;I@9_P!SJ<!LW;.
M6ZJ?S5?SKS28=:TK>_:&SL[RW)^U:=-'+]"#Q_Z"M0R#Z*NOASHFGR:GK.IW
M4QLXIY;T01+PB]<>YZX 'I4?@WPYX \1I/J-GHTLMQ#-LF34LLZ,1D';G;@B
MN\BDM=<TB.4JLMI?VZN5/1E=<X_6N>\+Z/IWA9+ZWTBVU&\>>??,\B!0"/E
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H!"\LK;8T4LQ] .M5#JL) ,$-Q<;@"OE1Y# C.03QTJ]29XQVH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #T /H# 2(  A$! Q$!_\0
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M10!6\I_2CRG]*LT4 5O*?TIRPD_>X'I4]%  .!BBBB@ HHHH **** "BBB@
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MA+N\EN)'N;J4NP!)8]A["MJ%)5;N^B,ZDG"UUN;FH>*[JX+):+Y$?3<>7/\
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MGE(3*'VR+MR^ ,_+@9JW<^&]2MM5:_T>-(2)R(XY) V!@YDYX RQ&!R 3ZT
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MPS2WBVXG,FQ9OE)V,5/ZJ?K4K^)=&6X2W_M& SOPL:MDG@'^1'YB@#D[>_\
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M<X9R'&X%2",9&.H':BBJYG;EZ"LKW*+^ M*N7CEGGO'8*N1YBJI9> ^ H&[
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+(._KZUTM%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #^ ,@# 2(  A$! Q$!_\0
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M "BBB@ HHHH @NK.WOK66UNHDF@E4HZ.,AE/45!%H^G0/<O%9PHUTJK.0O\
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MJ]6^&OB W=@^D7#YFMANB)/6/T_"KQ6'48\\.AZT(J*Y4=]12 TM><6%%%%
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MD[+'_,U%3X3JPD;UD8=%%%<A[P4444 6-+LO[3U>*W89AC_>2_0=!^)KT$#
MXKF?!]N/LMS=GK))L!]E_P#UUTXZ5UPC9'A8NISU7Y!1115G(%%%% !1110
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M*JC  ]JX:^(C!<E,=@A@CMXDBA0)&@"JJC  ]*DHHKS1A1110 4444 %%%%
M!1110 4&BB@#"UWPGIGB!,W46RX PMQ'PX_Q'UKS+6O &L:26D@C^VVX_CA'
MS >Z]?RKVJDQ6]+$3IZ)Z ?-I!5BK JPX(/!%)7T!J?A[2=74_;;&&5O[^W#
M#\1S7*7WPMT^4EK*^GMSV5P'']#7?#&P?Q:"L>545V]Q\+]8CYM[JTG';)*G
M^547^'?B1#Q:0M_NS"MUB*3^T%CEJ*ZA?AYXE;K9Q+]9EJY;_##7)3^^FM(1
M_OEOY"FZ])?:"QQ='I[]*]/LOA7:H0;[499?5(D"C\SFNKTSPIHFDX:UL(_,
M'_+1_G;\S6$\936VH6/)M&\%ZSK)5UMS;VY_Y;3C:,>PZFO3?#_@C3-!VS;?
MM-V/^6TH^[_NCM72XI:X*N)G4TV0Q!2T45S@%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M ',P>([F6XCC,,0#L%)R:=-KFJ+XQ?14M;;R6T][JWE:0[F=6"X88X7GW-:2
M:'81NKI"0RG(.X]:I7OA+3-0U>34Y_M1NG@:V)6Z=5\MA@J%!P,]?KS3=NAA
M1C4C\;N8MAXTU/\ X1#7M9OK""9]*DE6-K-R(KM4 )9"W. <@GG[IQ5N/Q]9
M"YMX+BQO82Y@2>0HI2VDF&8T<@]3QR,@9&:TM/\ ">E:=H<^C1)/)I\\9B:"
M:=Y $(V[5R>!CL*KQ>!]#BO+:Z\B9Y+<1X\R=V5S&,1LX)PS*#P32-QNJ>(=
M1T[Q1;Z<MA'-:S64]PC*Y,KO&%.T#&!G=CO53P/XPNO$TE]!>0P1S6R0R9@5
MP )%)V,'&=RD$'L:U[OPS87NNV^LS-<_;+=2D12X=553U&T''/&?H*GTG0[/
M1A.;42M+<,&FFGE:220@8&68YP!P!0!SGC'QI>^&]3@M;:U@F62+S"9"<@YQ
MVIT7BO5+OP+/KL*Z=;SPLY<W3.(E5?IR2>@'O6UJ_A;2=<N4N-0MS+(B[%(<
MKQG/:J]SX+T6YT2/1W@E%E'.+A529E(<'(.0<]:UE*G[-)+W@.<@^(.K27%F
M9])AMH%-E%?0R,WG))<@XV]L+QD'GFM>]\=1Z?KVI:;<:9=E;06ZQ2QX;[1)
M,2%11G@DCKTX/2KJ^#-&&HVVH-%/+=6X3#RW#MO*9V,X)^=EW'!/(S3]1\(Z
M1JUY/>74$AGGC1'9)F3[C;D88/#*>C=:R B_X2-]0\,76J:9Y%K+;L\<JZEE
M5@:,D.'V^F#T//'-<JWQ)U:"/2);S28;5+J*WDD202;I?-D*?NCC P-K8;G#
M"NNG\':-/X<.@O!)]A:3S743,&=]VXLS9R26Y.>M.'A33V>S:9[RX6T(:*.>
M[DD0L#D,P)PS G@GI0!LS.8H))!R54G\A7.6?B2YN;N&%X8@)& )!.172N@D
MC9&Z,,&LZ'0K""5)(X2&0Y4[B:EIWT-Z4J:B^=7?0Y'7?'NH:#KNHV4MK:S1
M0V;3P8\R-MP9%526&'SOR=G0#FK8\:7]EX9U^_OK".XOM%N#!+%:,0DO"D,I
M;D</S]*U+GP7HM]>7%S>P2W4D\;QD3SNZQJ^-P12<)G Z>E3P>%=)@T*ZT80
M.]I=;S<>9*S/*6ZLSDY)X'.>PJC HP>.;*75(;%[.]B\R=;0SN@\M+@IO\HD
M'.['<#&>,UGZYXSU31O$\NFI90749LYKB*-%D65F1 P4,1M<GGY5R1C-;%MX
M+T6UU.+4$@E:XB(=?,G=E,@79YA4G!?;QN/-2S^%=-N=7.J3"X>Y ;RB;E]L
M)9=K-&N<(Q'&10!2\%>*9O$L.H+<+;F6RF6,RVP<1R!D## <;@1D@Y]*T-4U
MB:PNQ$D<;*5#98FK.D:-9Z+;R0V:O^]D,LLDLADDD<_Q,QY)P /PJ2ZTRUNY
M?,FC+-C'WB*!,R=4\2G3/#0U$Q))=RMY5M!OVB64YVKD]!QDGL :YRT^(U[=
MBQN$T^V^QD6:WA$Q+K)<DA1'Q@A3C.>N?:NSN]"TR_TY;"]LH;FU4Y$<R!P#
MSR,]^3S61:_#[P]93V<EM:R1+:+&$B69O+<QDE&=>C,I)()H&1W7CNVL=:U?
M3KJPO$73Q %F1-PN'EX5%']XGIZ\],58?QC9'PW-J\*2[TF-J+68".3[0&VB
M(]@=W?ICFIM1\'Z3J=[=W=PDPENTC64QS,HS&<QN,=&4]#4MOX6T>'2/[+>R
MCNK4RF9UNAYIDD)R78MU8D]: .+3XHW0ATB:>PMHTN4C:<>:QW,\YA*Q'&"5
J(W'/8BBNIM? VB6<%C;6\4T=G9/YD5HLS>47W%@S+T8@G//H/2B@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "O 6@# 2(  A$! Q$!_\0
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MI: "BBB@ HHHH **** "BBB@ HHHH **** "DI:2@ HHHH *\W^)Q OM*).
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M3=%'$>9<8)^SKGL-]"/.SC="JKW._.*[?_A#(/\ G\E_[Y%'_"%P?\_DO_?
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MT2S7).+Z 9)Y/S5:M/\ 5BKCL2RU5&S_ .1P;_KP_P#:E7JHV7_(X-_UX?\
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MD?<6F').!(0.: ,3QJ-NBV8YXOH!S_O58M/]6*K^-1C1;,#H+Z ?^/58M/\
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MC:9VQ^6:I:+*G_"2:S#N'F;('V]\;2,UT&:A[EHRAX?M0P(GO01_T\MS6J.
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:M%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "] :8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#VBBBBM"0H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH ***PKSQ;IME?WEE(MPTUIY8=40$LTA 1
M5&<DDL!G&.O/% &[17/1^,M/FEFACMKYY[97:[C$(S:A#@[^<=CC&<CFA/&N
MCR2O&K3[EC@DYCX(E*A0#W(WIN';- '0T4$8)'I10 4444 %%%% !115._U.
MVTPVWVHLB7$OE*^/E5MI;YCV&%/XT 7**YR'QKIUPL;PVM^\4KB*.3R<*TI3
M>(\D_>V_AGC.:?I/C"PUF]@M;:WNUDFMUN5\U%7]VV<-USSM/2@#H**** "B
MBB@ HHHH ***Q]1\26>FW-Q \-U,;6W^TW+0Q[EAC.<%CGOM/ STH V**QIO
M$^G6[S(YFS"\*/A.\J%T_0<U-H6O6?B*P:\L1((U?81( #G /8GL10!IT444
M %%%% !1110 44 9.!7.GQKI*1QS2_:(K6:26.&YD0+'*8PQ;:2?]@@9QDXH
M Z*BN?\ ^$RTQFE6)+J5X[);XJD76,@-@$G!8*P)'8$5L6%VM_807:12Q),@
M=4E # 'D9'TH L4444 %%%% !1110 45G:GK-OI4ME%,DCR7LIAA5,<L!DYR
M1VK,?QQI -J$%Q(USM" (!M+%P%8D@ _NWX]J .DHKEAX_T9XKIXDNY6M?.\
M^-8OF01$!FP3T^88/?GTK3TKQ#;:O>W5I#!<Q36NWS5F4+M) (&,YZ$<]/>@
M#6HHHH **** "BBB@ HHHH **:[K%&\CG"(I9CZ <FO&HKWQC\2?$MY'IFIK
MI6CVN.=F[;G[HP/O.0,GG !I-C2/9=Z?WU_[Z%8NH^&-(U6^:\O#-)/L"1M]
MH(\GY@V4_NG*J?PKB)OA3XAC@ED3Q2LLJHS*IT\?.0,@9W=Z\2D\8:Y#(T<L
MT<<B$JR-" 5(Z@TKL=D?4">$=&BD,D<ERDKJZSR"Z.ZY#G+>:?XN2?\ ]50?
M\()X:6-%C@>-TS^^2X(D;E2,MWP47'I@5\S#QEK!ZW<(_P"V0H_X3+5\X^V0
M_7RA2N%D?7D>R.)4\W?M&-SOEC[D]S3]Z_WU_,5\D:;XD\0:IJ=K86TR/-<2
MK&JI &/)QG ].M>T'X3:^C;D\7*KCHRZ>/\ XJG=A9'J'2BO'=)UCQ7X#\8P
MZ-XCO1J&F76#',.@4G;O7/(()&5/K7L1X--,304'@9)P/4UC>*M='ASP_<:@
ML8DF&$AC/1G/3/MW_"O-] \*^-?&NE'7]5\5)I]G<DM C0A]R9P&QD!0>PZX
MI-V!(]?WI_?7_OH51UC2]/UW3)-.U "2VD*E@LFT@@Y!!'2O'?&OA/6/"?AJ
M76+7Q/;ZGY+H)(DM%!5&.-V0QXR1^=>7_P#"::S_ ,_,/_?I:7,QV1]4KX<T
MA-3^W*'#"3SA#YY\D2;=GF!.F[;QG^M)8^&])TV\M[JT,D<D%NEJH\[*F-<[
M01WQN-?+(\9:N1_Q^0#_ +9"D/C+6,'_ $N'C_ID.:+L+(^O]Z?WU_[Z%*"&
M. P)]C7S-X$;7/&NN26)U2*RMHH3++=M;*RIR  >0,DGUKT@_"WQ %G72?'-
MN]W'UB%L$&?0E6)'Y4<S"R/4J*\W^&_BG6Y[Z[\->)B6U*T+!96QN)4_,I(Z
M\$$'N#7I%4G<D*0D+]X@?4XK@/B;XNU+1(+?2]#XU*[Q^\ RR!FVJ%_VF/?M
MBL1?AYXD9(CK7C(173 ,T2V+3A2W8-GGI2;[#L>L[T_OK_WT*R=1\/:9J=U+
M<SO,KSP?9YQ#<%%FCYP' ZXR<?6O"OB-I_B'X?:C9V[ZFEY;W41=9_LH0!@<
M%>IYQ@_C7%_\)GK&?^/J'_OTM+F8[(^HO^$3T=KA)I)+F1E5 P>Z)60H"J,X
M[LH) /\ A5S1M%TW0+:2"PRJR,&<O+N+$*%'/L !7RE_PF.K_P#/Y!_WZ%(?
M&>L#'^E0G_MD.*+A9'U_O3^^O_?0IP((R""/:OGWP5HVK>+-(DOKO7O[/&YA
M#&-.,IE51DL,=NWX5KZIX8\8Z!:75_H?BHWKZ=A[FW6U,+JN-Q*@\/QR1]:?
M,Q61[717.>"/$K>*/#L=Y.J)=QGRYPGW2V,AA[$<_G71U0@ZTF]1U=?S%>3>
M)M>\3>*O&@\,>&+I;.WBW>=.>X7AG8CG )  '4U);?#36;N\,#^,)&FY#,^E
M?+D<'YBU3S=AV/51(H.0Z_\ ?0K!3PGHB% 1(\4;R210//NCB,@8/M4] =S?
MC7SAXCUCQ#X;\17^CW-S&9+69H]Y@"[U[,!Z$8-9@\9ZP3S=PC_MD*7,QV1]
M00>#O#ULXDBM]LNUT,OG'>R,GEE2>XV@ #M@5N0)#;6T5O$RB.) B MG  P*
M^1#XRU<?\OD)_P"V0I/^$RUHMM2XB8DX $0R:+L+(^O]Z?WU_P"^A3NV>U>-
M:?X!UF]L[:2;Q'+#=R)$SPQZ26\II!T)R!QW]*KW<GC7X>ZE97[ZK_:NC7#F
M,AHC'EAG*LAY4X!P1Z4^85D>VT5#:745]907<!S%-&)$/L1FFW]Y%IVGW%[/
MGRH(S(V.I [50BQVSVIN]/[Z_P#?0KPN'4/%_CC4[R\?6/[+TN%RBJD>X XS
MM5<C. 1DD]:+WPUJ<&EW=S9^)/M<\$32+#]@4;R!G&=U3S%6/9M0TRRU.6TE
MN)'$EI(986CEVD,1@_48J@WA+0]\LB(\3RWGVYFCFP1+@KD>@PQXZ<FOES_A
M,]9[W,0_[9+3AXRU@CF[A'_;(4N8+(^GQX/\/K)+((,236TEK(WG'+1R.78'
MWR3@]JO6^CV%OK$FJJ[O=O%Y :2;<$CR#M4=AD"OE+_A,M8R?]+AZ?\ /(5>
MT7Q!KFLZS:Z>ETB^<X5G6 -L7NV/:B["R/K'<IZ,OYTO2O#'\.W4*-+'XS\I
M@,[OL"C]0U:7@7Q7XATGQ./#WB.Y%W;3D>1/UV[L[&4]2I(((/0T^;N*W8]A
MHHHJA!1110 4444 9^O$CP]J)!P?L[X/X5S'P8C4:9K[8&1JC*/8"*.NGU['
M]@7^XD+Y+9QZ5S'P=W_V+XCV??\ [4?;]?*CJ'N4MCN9X-;:Y8P7MJL.[*JT
M)) YXZ_3\J6TTB)H2VI6UC<73.Q:5;=1D$G'7OC J:>&^DT]4AN1%<Y!,C*#
M]1BJ0M_$7REKVR'!W 1DCMC^M"1K"FI*_,EZ_P##%[^Q],_Z!UG_ -^%_P *
M/['TS_H'6?\ WX7_  I;#[>;:(WWE";!\P)SSGC!^E7*1G)6;11338;>Z22T
MM+.%0"&=80'_  (JG%:>(%U6VDEU2VDL$AQ-$+;:[R9/(.>!C''M6BBW8>?<
M\94C]U['GK^GZU#=Q7TFE&.*7;=%<%T(!!]LC%)@E=GEOQD7'B'PZ5XS;WA_
M$",YKT>'_CWB_P!Q?Y5YI\7/.&K>%OM&/.^R7>_;TW;8\UZ7!_Q[0_\ 7-?Y
M"JB)Z:'#_%?/_"++@]#(WXA.*[7PK'"_@?0XI%1D.G6^58#'^K7M7%_%7;_P
MBK9)W;9-OI]WFNG\/Z#INH^%-!N+JWWR_P!FVR[@[+D",8Z'W-)[AT-HZ%I)
M38=-M=OR\>4,<'(_6G_V/IG_ $#K/_OPO^%3VMM%96D5K I6&) B L6( Z<G
MDU-0!2_L?3/^@=9_]^%_PH_L?3/^@=9_]^%_PJR9HA((S*@<]%+#/Y5)233V
M'9HH?8-)L8I1]ELK>.X<>8/+5!(W09]3P,4ZWTW3K&\GN;>VAAN+IMTKJ,&0
M^I]ZGN;2"[4+/&)%4Y ;L?6FS6-O<3V\\BDR6Y)C(8C!/MW_ !IB/'+ $_'3
M6.>EY_[;+7JE>6:?_P ESUG_ *_/_;9:]3JHB9Y?XI7?\6O#H;D?;H%P?0(3
MC\Z]D5R9&3:0!CG'!^E>/^*-O_"UO#6"=W]H1;L_[AQ^E>EZGXEL-*G\F43R
MR]UAB+[?K22;>@-I;FG/;6]T@2X@CF4'(61 PS^-5_['TS_H'6?_ 'X7_"I+
M&_@U&V$]NQ*GJ&7!!]"#5FD,I?V/IG_0.L_^_"_X4?V/IG_0-L_^_"_X5=I,
M@#.1B@!$1(HPD:*B*,!5& *S-9D\[0-6!3'EV\J@GO\ (>?UK5K/UW_D7]2_
MZ]9?_0#0!Y9\%\_V!.2>L<''_ /_ *]>F5YG\%_^1>F_ZYP?^@5Z6WW3]*J.
MPGN>;_#1 ?B1X@9@"5M$(SZF5B:]4N[_ .RZ7<7QAD<0Q-)Y87YCM!XQ^%>7
M_#3'_"R/$6,D?9(L9_ZZ/7KF!4+8I[GG/AKQ@GB;6+N#4]&LW\JW\^.2)!(X
M7CY6!Y!YZ5T1N]!$PB_L5B^W=@:?V]>E;5IIMC8/*]I:00/*=TC1H%+'WQ5J
ME!-+WMQR:;]TR;*STF^@,J:3#& Q7$UJ$/'?!'2K::5IT;JZ6%JK*<AEA4$'
M\JMT51(5YU\9ACPC8MW&J6_\S7HM>=_&;_D3K/\ ["EO_,T :/@X$>#]+!.<
M0 4>,03X2U!?[T>#]*7P?_R*.F?]<11XOQ_PBU]DD?)V]:K[(?://_"$\4/A
M&%IB &N;C/'7]ZU;MK-;3*7MMN!P<#%8O@I5;PE &4$?:+CK_P!=6K?"(@^5
M0OT%2!$;*S))-G;DGDDQ+_A2?8;+_GSMO^_2_P"%2DU!<W/V= VPMST%3*2B
MN9[%QBV[(=]ALO\ GSMO^_2_X4]+6VCSY=O"FX8.Q ,C\*2.3>@;!&1T-2 U
M2U5Q-6*UR+."-5EA0HQP!MKF-= 'CS1E3Y0+:,C';$V178LBN!N4'ZUR&O\
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M+UH^#E;A\>_>JT47F8BY9F!51CG/:NYL?#>B:;920:QI$\TT2![BZ!.U6/\
M"O3I2O;4I1<M$<SIFOZM)#=PC4KPG9YD9^T/G*]1U]*E;6=7FCA5[VZD)R9#
MYS@CV&#5?5;:VTG7H&TB1S;3_=5AD@9P12YO+VX,%G$VT<#:/UJ;]4-JVC+]
MI<W,FJV<ES).Y59R!)*7Q\J<#)KZ4L49-.M488984!^NT5\YMH]SI-UIAN2-
MTT-P0,\C"IU_.OI&#_CVA_ZYK_(5M SD<1\4O^17F_ZY/_2F:Y\//^$W\#^%
MI(+UK2ZMK"!6*C/F1&-=R^Q].WK3OBL!_P (N#WQ+_Z!75Z%IS7GA/P](LL:
M&/3H/O1!_P"!:>S)DN:-C%^'_P .$\(ZC>ZE-=O<S3J(X X&Z*,8SD]R2*[+
M6=)M=:TR:RO PB<?>4X9#Z@]JAT[2&L+R28M;%63:HC@V,.>YW'/0=JN7<D>
MTP2*Q\U&Y\LLHP._^'>B]G=:%4^:-K.[74\:OO@_>R>)%>/45-NZ\7>0H11U
M1H\_,>GM]*]3\+^&K#PQI0M+%FDW-ODF8Y+M_0>U01:.%C!\RT,F 6?^SP,\
M8Z9_SFM6R*6UO';G:7 ^8QPE%)/<#G'YUK.O4FK2?F;U<1*HDK)>G7S9!KFD
M?VO9K&DWDSQDM%)C.TD$'CZ$UFZ/X?G@U,WERP5$YCB YW8P23Z5K7VF"ZG2
M>)HXI@NPR&(.2.H'/N3^=58]":.=3OM3#N#R)]FP7;USNXY]JQ:3W1$:LHQ<
M5U/+[//_  O#6 !DF\7\O(0UZG7EUC_R7/6/^OH?^DRUZC51ZF3/-/$__)4?
M"_\ V$5_]!->GBPG$VXM9%=V<?9N<9Z9S7EWB7CXM>'?^O\ B_\ 1=>DV]S>
M/J;6@U?3IGB.Z6!5_>A<]P&X^N*D#3%E:!0HMH=HZ#8*/L=IQ_HT/'3Y!Q4^
M01G/'K0&!Z$'Z4 0_9+7;M^SPX]-@H^R6HQ_H\/'3Y!4RNK$A6!*G!P>AI:
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MK)UQE?QUHK)]TVJD<?\ 3:HG%[M6,:BJ)IS5CVH]:2E/6DJCG"BBB@ HHHH
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MCUZM/]HVC[.8PV>?,S_2I1=VBJNE6CIDVT0W<D-&/UI\>F6T4GF1Q1H_]Y4
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M:6TB2(TY9#E=TSG]":D9+9Z5:V$SR0>9ND SND9L#VR>*6ZTRUNY1+,KEE&
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M;(D"SKT<*Q>1Q_LCA<]ZU?\ A2?AQB"[OC_93']:Z_P[X1T7PM$ZZ7:+')(
M))3R[ =L]A["BS"Z-P]:***LD**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
K **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #' ;4# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?4DFEJ!<_P"$ZT 1LQN9@PG%OY9MW\PN1N4!<9Y'(-):^/?#EW(J)?L@:-Y
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M25NFF_\ 6IQ1NE:[MOJOR?8IPGBK(JM!TJR*Z %HHHH **** "BBB@ HHHH
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M4[&2&>W74XH)1P7W?=-,#3Q1BN?M<^1-+%XB67:F7?(*H,CGVZ&HD)N$V?\
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MVI:/IM\R!&N(5E*CH"0#BK,?05FM#G9-4!LK5LYMH3D[CE!R?6IJ6@"O]AM
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M7LUM)!IN[9 J/FY0#</2OH\'*-+#*#>J,54<92:ZC;._D'A74DLLM:1Y)D(
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MZM3Y0N/OI%DE1%.2O7%*@XIBVP7^+]*E"X[U0AU%&** "BBB@ HHHH ****
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<4 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !9!/T# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@[LD],'WS5F\GMQBVFN# \H.U@VT\>AK)LX()8-3M&FWVRN#]I)YSC)RW<C
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M29"D<:$,6)&.U AUQJ4Z7PMK:T%P?*$I/FA>,XXXH35DE^Q&.,XN693N."A
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M_#'2I-4UN[\17QWF-B$9OXI6Y8_@#^M-^)VLRZKK=MX>LLN(G&]5_BE;@#\
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MN;B"K>P([T6"Y>6-$9F5%#.<L0.3]::;>%O,W1(?,QORH.['KZU%;WL-Q//
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ME7;)#&XSG#*#SZU'%=K+>W%L$(, 7+>NX9JM/J;QWKVL-E+.R*&8H0,9^IH
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M0-YN8E_>C$G'WOK5>/2-/AE62.TB5U.58#D&@#-N!);7%QIUK,I:Z8N01_J
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MWY7_  H]T/WOE^)%_;^C?]!>P_\  E/\:/[?T;_H+V'_ ($I_C4O]D:;_P!
M^T_[\K_A1_9&F_\ 0/M/^_*_X4>Z'[WR_$B_M_1O^@O8?^!*?XT?V_HW_07L
M/_ E/\:E_LC3?^@?:?\ ?E?\*/[(TW_H'VG_ 'Y7_"CW0_>^7XD7]OZ-_P!!
M>P_\"4_QH_M_1O\ H+V'_@2G^-2_V1IO_0/M/^_*_P"%']D:;_T#[3_ORO\
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M(TW_ *!]I_WY7_"CW0_>^7XD7]OZ-_T%[#_P)3_&C^W]&_Z"]A_X$I_C4O\
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M_P"%']D:;_T#[3_ORO\ A1[H?O?+\2+^W]&_Z"]A_P"!*?XT?V_HW_07L/\
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M^_*_X4>Z'[WR_$B_M_1O^@O8?^!*?XT?V_HW_07L/_ E/\:E_LC3?^@?:?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
+ %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ex5-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  V!((# 2(  A$! Q$!_\0
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MJ+_H*:Q_X'R?XT67<.:?\OXK_(VJ*Q?^$:B_Z"FL?^!\G^-'_"-1?]!36/\
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M ,(S!_T$M8_\&$O^-'_",P?]!+6/_!A+_C19=PYJG\OX_P# -JBL7_A&8/\
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M^XKE=*U"XCTG5_+O6N;_ ,Q-(L.OW"2%?WSDG/\ LU2IW5R)XI0ERM=_RO\
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MO)&,GUK0HHH K36OG7=O.6&(@P*D?>R,4EE:&S$D:R;H2V8T(^X.XSZ5:HH
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M6M10YMA&A"-K+:WX!1114FP4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ex23-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  \ .T# 2(  A$! Q$!_\0
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M&/W&'+*/8CG\* /4_'?C%?!&AQZF]BUXKSK#Y:R;",@G.<'TKSO_ (:'M_\
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MG\*ZV\O;33K5[F]N8K>!/O22N%4?B:@TW6]+UB-I--U"VNU4X8PR!L'WQTJ
M)-3TVTUC3;C3[Z)9;:X0I(A[@_UKP:#X+>(].\5036K6TVGV]VDB2-* YC#
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GX ^)OB3Q%XSLM+U":W:VE5RP2$*>%R.:]O'2@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Nov. 18, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001911545<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Global Interactive Technologies, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-288665<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-1/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Nov. 18, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock, par value $0.001 per share ("Common Stock")<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 5,000,000.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 690.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Pre-funded Warrants to purchase Common Stock ("Pre-Funded Warrants")<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $5,000,000.00.<br/><br/>No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act with respect to the Pre-Funded Warrants, the Common Warrants or the Placement Agent Warrants because the shares of Common Stock underlying such warrants are being registered under this registration statement.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=3', window );">Offering: 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock underlying the Pre-Funded Warrants<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.<br/><br/>The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $5,000,000.00.<br/><br/>No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act with respect to the Pre-Funded Warrants, the Common Warrants or the Placement Agent Warrants because the shares of Common Stock underlying such warrants are being registered under this registration statement.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=4', window );">Offering: 4</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Warrants to purchase Common Stock ("Common Warrants")<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $5,000,000.00.<br/><br/>No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act with respect to the Pre-Funded Warrants, the Common Warrants or the Placement Agent Warrants because the shares of Common Stock underlying such warrants are being registered under this registration statement.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=5', window );">Offering: 5</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock underlying the Common Warrants<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 5,000,000.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 690.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=6', window );">Offering: 6</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Placement Agent Warrants to purchase Common Stock ("Placement Agent Warrants")<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $5,000,000.00.<br/><br/>No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act with respect to the Pre-Funded Warrants, the Common Warrants or the Placement Agent Warrants because the shares of Common Stock underlying such warrants are being registered under this registration statement.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=7', window );">Offering: 7</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock underlying the Placement Agent Warrants<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 500,000.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 69.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=8', window );">Offering: 8</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 5,000,000.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 765.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=9', window );">Offering: 9</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Pre-Funded Warrants<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $5,000,000.00.<br/><br/>No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act with respect to the Pre-Funded Warrants, the Common Warrants or the Placement Agent Warrants because the shares of Common Stock underlying such warrants are being registered under this registration statement.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=10', window );">Offering: 10</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock underlying the Pre-Funded Warrants<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.<br/><br/>The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $5,000,000.00.<br/><br/>No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act with respect to the Pre-Funded Warrants, the Common Warrants or the Placement Agent Warrants because the shares of Common Stock underlying such warrants are being registered under this registration statement.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=11', window );">Offering: 11</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Warrants<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $5,000,000.00.<br/><br/>No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act with respect to the Pre-Funded Warrants, the Common Warrants or the Placement Agent Warrants because the shares of Common Stock underlying such warrants are being registered under this registration statement.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=12', window );">Offering: 12</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock underlying the Common Warrants<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 5,000,000.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 765.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457oFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection o<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457oFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=6">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=6</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=7">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=7</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=8">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=8</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=9">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=9</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=11">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=11</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=12">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=12</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Nov. 18, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 10,500,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">1,531.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">1,450.05<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>13</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea026610701ex-fee_global.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea026610701ex-fee_global.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea026610701ex-fee_global.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="ea026610701ex-fee_global.htm">ea026610701ex-fee_global.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="108">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>30
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea026610701ex-fee_global.htm": {
   "dts": {
    "inline": {
     "local": [
      "ea026610701ex-fee_global.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/ffd/2025": 6,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 13,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 108,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026610701ex-fee_global.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026610701ex-fee_global.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026610701ex-fee_global.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026610701ex-fee_global.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026610701ex-fee_global.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026610701ex-fee_global.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>31
<FILENAME>0001213900-25-114872-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-114872-xbrl.zip
M4$L#!!0    ( *J+>5M[(+DBJP\  )#&   <    96$P,C8V,3 W,#%E>"UF
M965?9VQO8F%L+FAT;>U=^W/BMA;^??\*7;>WNSL3@A_8/)+02;)++FTVF^:Q
M27?NS(ZQ!>BN']02 ?K7WR,;@TT,&)9WW6E3;$OG(7TZGXXMRZ>_]FT+O6"/
M$M<Y>RL=BV\1=@S7)$[K[.WY_66]_O;7ZIO3?^5RZ ';'4MG&+TSWB-9E LY
M^*.B&_=%[[G>=WJ$KJ\O42XW+%XCV#(KZ!ZS$W2CV[B"SBVBTQJQ\,.@@T_0
M%]WJPMF:Z]D4?2&X=S)2 6<Q1A_[;=(@[+^1WZCV\;AOTEE:;D% $V2.%(P,
MC I%'TW"7 \*!;Y7D'1<T&?)O70=YKG62.R7JR_,N.JWS:M'K7[9_O[UZ6O;
M?.J+O_\!_]JUO[_>7UPU9%7\3"X>]2?),@87G[\^&ZU'N\S^?"K0>NVNTWCZ
M\O?UY<7#U^??.E];4$^N]<PKZZ5!+A[TYX[UF9SW/SD7XH<_.H]_/OU&0>:C
M_GS'_S^^_AR[7O_Z5/M>K]UTL UV?6CWS'/Q]R]7-=*X>FS]89>_XVC=_UR(
MLWS^]$$=^8ME710E46HJ3=EH-$5=4\RB4C1+S8(H-F0ED--F@"? E$//A#9C
MG4H^W^OUCGO*L>NU\E*Y7,[W>1DA*%3I6\3Y/KTHOSHJFBA2!J/RSY^N[XTV
MMO4<<2C3'0./*C4\B\3J\3-A326?5-X<5X@6UO+!Q; HH6Y!EHJSA <E1A7Z
MT\I*W!#P%3]?W%V/B[/D\N.B>>;I#N5HUQF F$M2<Z*<D[6(D!S%1DP0'!^W
MW)>Y<DHY10KEO.JFN*?\<D.GHV8T\40;ACKA0IZ'C;!@LVDF%X0+04$.*JR;
MU3<(G3+"+%R%$ +A*3J:3_/!%5[&QDQ'7&(._]4E+V<"'[C883D>=01D!$=G
M L-]EO>AF/?KY0,MIPW7'"#*!A8^$YI0&"*#V&'H@=B8HAO<0W>NK3M'P8DC
M&"T>:8*1;TY-\A+6,PF%.#:H(,=UL."+)_T*5X ]?C0\)J:)G> X. /%;[HV
M2#20 P,0#&B:E?MNPR:4.@^=H?5]=H>;9X+QS<,=UV,"(M"&38R_P5 0JO<Y
M*7]^FH])FZL#VG+8E&FTR$+UXW.N5K^NWUQ!1/YXOX@Z0$#EHP/]-;B$?O!T
MJ^Z8N/\['LS7JPA5$7PL2Y):4!=U\0ZW'$X^-XWYB@I"55&4G%PJ:=K"BCXW
MFW#&:3WH#="F3]/6IQ6'6(!#KXNCN@'Q2VBDF,W1-]:@"=6;Q2%RZ=H-"!?F
MK>?2#C98EZ966)RI,#\Q%+@%'H8VA(D(IJ-B/,14J!_E01'RJ:'2]KA./MKI
MM #"?_@SE>,^-85A/0:QX$R@!*8;.!C_(U,F50?F4+?K1:WQ>:4R=-QWU?CF
M#CO^FR2$Y48EL8_X\>G1!6+R2TV"/>0[AQ-#]67]]SCV)RLG2*:X9</EZ)7A
M-9/X#6!^PG8#])H0R1Q_ AC#[WF?4, B'Z^<)V[<JG2:CQR=YE_+FE"6GVI)
M>&FR78:V=\ "UTQRBND>^P!3Q"KOTIPDY:322,WHVNMZV#&GU JO)!@W:45X
M?MCM*<$@'BH:Q P.2\#A8(-#%AV6@8-\J'"0,S@L#H=#14,&AB7 H!PH&)0,
M#(N#H7"@8"AD8%@<#.J!@D'-P+ X&+0#!8.6@6%Q,!0/% S%# R+@Z%TH& H
M96!8' SE P5#.0-#:C ,'\UL%PB'U\A=AP0M_'C_X77CVEBG70]7AZL!*E H
M%!=>>J6'2YRFI ,UIFL9V@\_?T@);>L>IO/4!*464Y1__3PM> 0X>CH. YJ\
M\"?JG?AS^(9KF4B2YSV,/T&V[K6(DV-NIX+$#AN=:+B,N7;%EW&">$?F=(NT
MG KR2*L-X^)C/S=>7 !^==9IA39IA %# GM"]?+\^O+Q^ORA_OD&?:ZA\7-V
M]'!^<<V?MF_'KNFK!US/3K-NH.2O3IA\#KQF=UYW]DQ_QLL3[G"+4+XPAO'%
M4/.] X*]LMR&;J$ZEZ\;C+Q@]("-MN-:;HMPF^N.<;R(_])\_QNN!^,F\/_*
MTP=(@3JFVVU8^ 1U=),OY0NN3NG8^4U8Z,#8\)_V(ZG"+;$&*&@=[&$3Z8Z)
M+G7/&_"U?#W=,\$TH^L11D9CB/F5#6Q90XO.!%'PCVE'-\+C!5?=C'PW7,O2
M.Q2#1\-?)ZA'3-;F4L1_\R5$S(M*SU'R-Y3VD?&"/48,W0H;)7 ZN:'\NCW,
M@T700\':'F:&PD.M,BC]Y2=)$T].\\Q,+B0>JRE*26D*;5R4EJI4.EFEE4DJ
MKZZI4I198<=LU+?-VCW1N_#'FS8<2RL?CL/X$,:Q"TLWOB,>4ZEK$2A]#4D#
MJC-L([XX,,&),'Z.R(1'PJDNSU,W#(N##6N[M'1*(7(R:_U*;US&@_Z:M?"E
MGY>Z970M?[WJ:</+5]%==P/^G=MNUV$1]HO(2) *? 0$!SFL+*35<.NY'9<"
MK7[2^\3NVBA,?0,O;V'*@-$M)&2/CK_P=;7:0Z7GK9:'6WRU?Z@^T+R1KKT#
MO2OW;-AS;A.%$SL.'3[1GQN8$N<),%N*1R4+-YDPU>3LS.;/O.K3A?HP K(Q
MRF(3:A\7 4[XU0HB#.08R60U.4QD/DQ>S:6C,^<?]R"DXC9A.,=GVI@O2>]Y
M>F=&-G?KX1=J#6[-FM6:S'HB2UQ1\+K F4#ZK-)P70OK3E.W:'0Q,U_[R#-I
M,!,U(&KIQ'R=_<P:YTLY$$:L>X,-7J>E41?&ADJ0_/_5!;9<R+Z4-@#SIK-"
MAN3?M6T(2_?,-;X? 6@\],+?OT$_B\>B**$.OQ/'[[J@=T*TJ/!^J89-2HO?
M2>^7KCM]]3V0<T$MNHMC:F)]O*0(51#TSOUQAX<W?=($E9\W+FK8DC7_/@+T
M\K@I@:*!G5F(,$[+ N*WV/SVY+<@D8D-8L-8/!/J-[5XJSI=VW39L$ Z5!:$
MJGHDBB+_#T 8MGMHVO)(F^XC! T^"8CXY=_U7+%CJE#E#@&F2M)B7OUX+X*'
MYS9;;\=I0E4K0RHWI<MVEESD=.12W&%RD:.&EK9%+C$KRCRWP+EFUS%AHO&D
M>_S6IM]Z,+:,MDXAIXHP"A ,+UZ+%U\ES\AKX!D.B,^L[7&^61QB$UPCP_0%
MA&%ODU2S37G;)9TH6F4IB,U[338QA^3ER68U7;@FQHDYJ<SJM9WE&R45W\B%
M'>8;)6JHNBV^B5FAQ9,9Q(G$LP;\5A+$5)1 +JNC%F5+*4PRDB9II;B-%.:?
MRRLQ5)8.@%=B#I4/E%>B3BKB7O)*(16O*-(.\THA:JB\+5Z)60%SC#3)R_!P
M'8E+88N)2S*F)AA&*62)RP8))@9/]0 ()N:0=J $$W.RN)<$HZ8CF-(.$XP:
M-;2\+8*)6E$09R<N$\2R.EI1MY2T)*-H@E(*4I:T;))38HB4#^@)3,PQY4"Y
M)>9D84\?PVBIV*6@[C"[:%%#M6VQ2\P*F&G<6N D?_D(G;?XWU3/8J;4665>
MHVTQKTD&VR0)E;*\9H,<%,-M^0#RFJA#JGB@W!-S<N9CM)UEGF(JYE'E'6:>
M8M1095O,$[.B,.>!S!2&61V_%+>4X"3#:8);5#5+<#9)+C%HPM1,/8ST)N96
M\4 I)N9DB:<WQZ*Z9QQ32A44RD.*X2*)VP6I.\8SI8BUFK@MGHE9(<5Y9G7\
M4=H2?Z2"BB9G_+%)_HA!3CF@&V0QQPHA@ZC*03%(S$F8>14U=?]ND)53Q05M
MURFD'+6VN"T*B5E1"M8JKVU]6'F+=[K2H::<W>G:()E$P5><N=AH3T@DYI!T
MH"02<U+>RSM=DI@F&A257><0[L?8W,+6WJ:,F:%N<06R)&[K+<ITB-*R;&6C
M+U3&@#ESM=&>,$S<H]*!4DS<RYG/P':78U*]6%T2=YYCHB^WEK;WQG[,C/$K
M^VO@D'6\B9\V34F)&B7+4S9)(S'L%0Z!1F(>J8=*(S$OM?VDD53O3)>*.T\C
MT3=62UM[-S]N1GE+:XZE=;R$GRI-286FLICM]K(!5HE"L2P=T+.4N&?R\NRR
ML_N]Q!Q4%GR0$MGCKK#P'G>C(#W<##3-;J"IRJQJZ]&5"5K37JA;E[,1WV?O
MRSC>J'D%,E;5+GOL\P_.'D=;'DH%84:8>W"9;HUW!@VVUJ25-8?0!V:-/@/"
M0VGRANSI0VH\%(^C**15DGBT['JT#6:<T" AK:RK+2 ADXX*JKBN]5T+ 2XI
MKY@#N@V>6;8+1\G76CM2XQT)\YYUY9V+=B2/'A3/#1IK[ZUYVP8O'9^7"&W0
M'FO%P#I?<D[9_S>8^;W_H8MWLN?''\\0$@EK3J4%NQU:8]T!?.9^-\,^S_N?
MYYCV$9+28M]@T9(_*2-4OZ7^Q]_I_,UH>L'WE']'WZ_W4R*IOHHS]:,B<\?*
M_[J4D>9@6NZD3OD@4;@7;\(<%9HT/X-Y1@KGWJGBS2L@3 V] U>D5%N+EOF;
M^J  T(A-'O$PT#&@T[]9!;D[W\&>;[5NA)OT#^]CZ:--V/F1%]V('>3RFK2K
M0P'F^MOYH^#>3W WS*\RWA\;G1N^(*FL*$=(IR ;^\_RW_%RO_Q4DF7Q)%[<
M/RF=O#_V >;_N7VE4=*FJCN"<X3&S:8,FL!_:X:V=<M",%A=:$$ !-*= >(0
MY>6 ](*/94WZ[OA62<43BNA8&6OK##6PX=H8$0H6<LPW!E!+IZ 49'#AP4;0
MM&,1!D .CDSRPK^[9H(B0">QB:6#*Z"'!@.?)GQ_:!0) $WC6/#/&FCR[@RT
MR"T=: "8,_$Q%7X5PAY^H$$??: AK =E^*<AAOB*W4WN$4!F@X/.[!H@!"[H
MP%@68",'HS87_$0-G0*\X6]0A(MY+9P#+V'EC ]3.";Q>D?^UZ'8,AXD*0G>
M]$M6M7(O8TV8K/,8PH(!4P+X:0V.EO,SIH:W5I+C[XAC6%USXGG V#1_K'8[
M< [WL6<0.JL9WQ\AXKL(_Z?HY^C=WDAHO'$A(G5TCUO^*E)#O8X^\+4F!NW6
MC*#=(ZP-$FD'&WZE*58>)3WY0$..F?H*/01-O0O>\T+CB#OMV0KM&FW4"^OR
M^-G _+PW_B)#Z,;4P)\%U,2 JNQ.0%6B 57*9BY[.W,9.9]18D:)&25FE+A?
ME%C8'4HL1"E1SG*,+*!F 34+J/L64-7=":AJ-* J68ZQMSE&-M 2!IJV.P--
MBPZT0C9SR68NV<PEF[GL6T M[DY +48#JIK-7+*9RR$-M-+N#+12=*!IV4#+
M!MHA#;3R[@RT<G2@%;,4(4L1LA0A2Q'V+:"&.PCM0D2-;H,BB:5L[K*W<Y=L
M"45&BADI9J2XKZ2X2R]$2%%2+&=Y1A92LY":A=2]"ZD[].I+=#L321*S/&-O
M\XQT0^W-:;[AF@/^#FJ;V5;U_U!+ 0(4 Q0    ( *J+>5M[(+DBJP\  )#&
M   <              "  0    !E83 R-C8Q,#<P,65X+69E95]G;&]B86PN
9:'1M4$L%!@     !  $ 2@   .4/      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>ea026610701ex-fee_global_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-18</startDate>
            <endDate>2025-11-18</endDate>
        </period>
    </context>
    <context id="c_offering_10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>10</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-18</startDate>
            <endDate>2025-11-18</endDate>
        </period>
    </context>
    <context id="c_offering_11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>11</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-18</startDate>
            <endDate>2025-11-18</endDate>
        </period>
    </context>
    <context id="c_offering_12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>12</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-18</startDate>
            <endDate>2025-11-18</endDate>
        </period>
    </context>
    <context id="c_offering_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-18</startDate>
            <endDate>2025-11-18</endDate>
        </period>
    </context>
    <context id="c_offering_3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>3</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-18</startDate>
            <endDate>2025-11-18</endDate>
        </period>
    </context>
    <context id="c_offering_4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>4</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-18</startDate>
            <endDate>2025-11-18</endDate>
        </period>
    </context>
    <context id="c_offering_5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>5</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-18</startDate>
            <endDate>2025-11-18</endDate>
        </period>
    </context>
    <context id="c_offering_6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>6</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-18</startDate>
            <endDate>2025-11-18</endDate>
        </period>
    </context>
    <context id="c_offering_7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>7</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-18</startDate>
            <endDate>2025-11-18</endDate>
        </period>
    </context>
    <context id="c_offering_8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>8</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-18</startDate>
            <endDate>2025-11-18</endDate>
        </period>
    </context>
    <context id="c_offering_9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>9</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-18</startDate>
            <endDate>2025-11-18</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
        </entity>
        <period>
            <startDate>2025-11-18</startDate>
            <endDate>2025-11-18</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="fee_001">S-1/A</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="fee_002">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="fee_003">0001911545</dei:EntityCentralIndexKey>
    <ffd:RegnFileNb contextRef="c_report" id="fee_004">333-288665</ffd:RegnFileNb>
    <ffd:OfferingTableNa contextRef="c_report" id="fee_005" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="c_report" id="fee_006">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="c_report" id="fee_007">N/A</ffd:CombinedProspectusTableNa>
    <ffd:FormTp contextRef="c_report" id="fee_008">S-1</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="fee_009">Global Interactive Technologies, Inc.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="fee_010">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="fee_011">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="fee_012">Common Stock, par value $0.001 per share ("Common Stock")</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c_offering_1" id="fee_013">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_014"
      unitRef="USD">5000000.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_015"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_016"
      unitRef="USD">690.50</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_2" id="fee_017">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_2" id="fee_018">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_2" id="fee_019">Pre-funded Warrants to purchase Common Stock ("Pre-Funded Warrants")</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_2" id="fee_020">true</ffd:FeesOthrRuleFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_2"
      decimals="INF"
      id="fee_021"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_2"
      decimals="INF"
      id="fee_022"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_2"
      decimals="INF"
      id="fee_023"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_3" id="fee_024">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_3" id="fee_025">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_3" id="fee_026">Common Stock underlying the Pre-Funded Warrants</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c_offering_3" id="fee_027">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_3"
      decimals="INF"
      id="fee_028"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_3"
      decimals="INF"
      id="fee_029"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_3"
      decimals="INF"
      id="fee_030"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_4" id="fee_031">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_4" id="fee_032">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_4" id="fee_033">Warrants to purchase Common Stock ("Common Warrants")</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_4" id="fee_034">true</ffd:FeesOthrRuleFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_4"
      decimals="INF"
      id="fee_035"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_4"
      decimals="INF"
      id="fee_036"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_4"
      decimals="INF"
      id="fee_037"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_5" id="fee_038">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_5" id="fee_039">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_5" id="fee_040">Common Stock underlying the Common Warrants</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c_offering_5" id="fee_041">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_5"
      decimals="INF"
      id="fee_042"
      unitRef="USD">5000000.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_5"
      decimals="INF"
      id="fee_043"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_5"
      decimals="INF"
      id="fee_044"
      unitRef="USD">690.50</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_6" id="fee_045">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_6" id="fee_046">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_6" id="fee_047">Placement Agent Warrants to purchase Common Stock ("Placement Agent Warrants")</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_6" id="fee_048">true</ffd:FeesOthrRuleFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_6"
      decimals="INF"
      id="fee_049"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_6"
      decimals="INF"
      id="fee_050"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_6"
      decimals="INF"
      id="fee_051"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_7" id="fee_052">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_7" id="fee_053">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_7" id="fee_054">Common Stock underlying the Placement Agent Warrants</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c_offering_7" id="fee_055">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_7"
      decimals="INF"
      id="fee_056"
      unitRef="USD">500000.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_7"
      decimals="INF"
      id="fee_057"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_7"
      decimals="INF"
      id="fee_058"
      unitRef="USD">69.05</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_8" id="fee_059">true</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_8" id="fee_060">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_8" id="fee_061">Common Stock</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c_offering_8" id="fee_062">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_8"
      decimals="INF"
      id="fee_063"
      unitRef="USD">5000000.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_8"
      decimals="INF"
      id="fee_064"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_8"
      decimals="INF"
      id="fee_065"
      unitRef="USD">765.50</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_9" id="fee_066">true</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_9" id="fee_067">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_9" id="fee_068">Pre-Funded Warrants</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_9" id="fee_069">true</ffd:FeesOthrRuleFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_9"
      decimals="INF"
      id="fee_070"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_9"
      decimals="INF"
      id="fee_071"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_9"
      decimals="INF"
      id="fee_072"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_10" id="fee_073">true</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_10" id="fee_074">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_10" id="fee_075">Common Stock underlying the Pre-Funded Warrants</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c_offering_10" id="fee_076">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_10"
      decimals="INF"
      id="fee_077"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_10"
      decimals="INF"
      id="fee_078"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_10"
      decimals="INF"
      id="fee_079"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_11" id="fee_080">true</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_11" id="fee_081">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_11" id="fee_082">Common Warrants</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_11" id="fee_083">true</ffd:FeesOthrRuleFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_11"
      decimals="INF"
      id="fee_084"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_11"
      decimals="INF"
      id="fee_085"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_11"
      decimals="INF"
      id="fee_086"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_12" id="fee_087">true</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_12" id="fee_088">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_12" id="fee_089">Common Stock underlying the Common Warrants</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c_offering_12" id="fee_090">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_12"
      decimals="INF"
      id="fee_091"
      unitRef="USD">5000000.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_12"
      decimals="INF"
      id="fee_092"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_12"
      decimals="INF"
      id="fee_093"
      unitRef="USD">765.50</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_094"
      unitRef="USD">10500000.00</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_095"
      unitRef="USD">1450.05</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_096"
      unitRef="USD">1531.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_097"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_098"
      unitRef="USD">0.00</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="fee_099">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;).&lt;br/&gt;&lt;br/&gt;Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#x2019;s securities that become issuable by reason of any share splits, share dividends or similar transactions.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_2" id="fee_100">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $5,000,000.00.&lt;br/&gt;&lt;br/&gt;No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act with respect to the Pre-Funded Warrants, the Common Warrants or the Placement Agent Warrants because the shares of Common Stock underlying such warrants are being registered under this registration statement.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_3" id="fee_101">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;).&lt;br/&gt;&lt;br/&gt;Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#x2019;s securities that become issuable by reason of any share splits, share dividends or similar transactions.&lt;br/&gt;&lt;br/&gt;The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $5,000,000.00.&lt;br/&gt;&lt;br/&gt;No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act with respect to the Pre-Funded Warrants, the Common Warrants or the Placement Agent Warrants because the shares of Common Stock underlying such warrants are being registered under this registration statement.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_4" id="fee_102">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $5,000,000.00.&lt;br/&gt;&lt;br/&gt;No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act with respect to the Pre-Funded Warrants, the Common Warrants or the Placement Agent Warrants because the shares of Common Stock underlying such warrants are being registered under this registration statement.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_5" id="fee_103">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;).&lt;br/&gt;&lt;br/&gt;Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#x2019;s securities that become issuable by reason of any share splits, share dividends or similar transactions.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_6" id="fee_104">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $5,000,000.00.&lt;br/&gt;&lt;br/&gt;No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act with respect to the Pre-Funded Warrants, the Common Warrants or the Placement Agent Warrants because the shares of Common Stock underlying such warrants are being registered under this registration statement.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_7" id="fee_105">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;).&lt;br/&gt;&lt;br/&gt;Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#x2019;s securities that become issuable by reason of any share splits, share dividends or similar transactions.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_8" id="fee_106">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;).&lt;br/&gt;&lt;br/&gt;Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#x2019;s securities that become issuable by reason of any share splits, share dividends or similar transactions.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_9" id="fee_107">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $5,000,000.00.&lt;br/&gt;&lt;br/&gt;No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act with respect to the Pre-Funded Warrants, the Common Warrants or the Placement Agent Warrants because the shares of Common Stock underlying such warrants are being registered under this registration statement.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_10" id="fee_108">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;).&lt;br/&gt;&lt;br/&gt;Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#x2019;s securities that become issuable by reason of any share splits, share dividends or similar transactions.&lt;br/&gt;&lt;br/&gt;The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $5,000,000.00.&lt;br/&gt;&lt;br/&gt;No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act with respect to the Pre-Funded Warrants, the Common Warrants or the Placement Agent Warrants because the shares of Common Stock underlying such warrants are being registered under this registration statement.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_11" id="fee_109">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $5,000,000.00.&lt;br/&gt;&lt;br/&gt;No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act with respect to the Pre-Funded Warrants, the Common Warrants or the Placement Agent Warrants because the shares of Common Stock underlying such warrants are being registered under this registration statement.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_12" id="fee_110">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;).&lt;br/&gt;&lt;br/&gt;Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#x2019;s securities that become issuable by reason of any share splits, share dividends or similar transactions.</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
